Original Article
Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery
N Engl J Med 2003; 349:1315-1323October 2, 2003
- Abstract
Background
Preliminary reports of studies involving simple coronary lesions indicate that a sirolimus-eluting stent significantly reduces the risk of restenosis after percutaneous coronary revascularization.
Methods
We conducted a randomized, double-blind trial comparing a sirolimus-eluting stent with a standard stent in 1058 patients at 53 centers in the United States who had a newly diagnosed lesion in a native coronary artery. The coronary disease in these patients was complex because of the frequent presence of diabetes (in 26 percent of patients), the high percentage of patients with longer lesions (mean, 14.4 mm), and small vessels (mean, 2.80 mm). The primary end point was failure of the target vessel (a composite of death from cardiac causes, myocardial infarction, and repeated percutaneous or surgical revascularization of the target vessel) within 270 days.
Results
The rate of failure of the target vessel was reduced from 21.0 percent with a standard stent to 8.6 percent with a sirolimus-eluting stent (P<0.001) — a reduction that was driven largely by a decrease in the frequency of the need for revascularization of the target lesion (16.6 percent in the standard-stent group vs. 4.1 percent in the sirolimus-stent group, P<0.001). The frequency of neointimal hyperplasia within the stent was also decreased in the group that received sirolimus-eluting stents, as assessed by both angiography and intravascular ultrasonography. Subgroup analyses revealed a reduction in the rates of angiographic restenosis and target-lesion revascularization in all subgroups examined.
Conclusions
In this randomized clinical trial involving patients with complex coronary lesions, the use of a sirolimus-eluting stent had a consistent treatment effect, reducing the rates of restenosis and associated clinical events in all subgroups analyzed.
Media in This Article
Figure 1
Actuarial Rate of Survival Free from Target-Vessel Failure among Patients Who Received Either a Sirolimus-Eluting Stent or a Standard Stent.Figure 2
Rates of Target-Lesion Revascularization (Either Percutaneous Transluminal Coronary Angiography or Coronary-Artery Bypass Grafting) and Odds Ratios at 270 Days for Various Subgroups of Patients.Article Activity
- Article
The demonstrated clinical usefulness of the implantation of a coronary stent as the preferred method of percutaneous revascularization is due to improved procedural safety as compared with balloon angioplasty and reduced rates of restenosis.1-7 But despite the use of coronary stents, the frequency of restenosis may be more than 30 percent in several subgroups of patients, including subgroups with diabetes mellitus, small coronary vessels, and long lesions.8-15
During the past two decades, attempts to reduce restenosis after angioplasty with the use of locally delivered or systemic pharmaceutical agents have been largely unsuccessful.16-19 Recently, sirolimus (rapamycin), a cytostatic macrocyclic lactone with both antiinflammatory and antiproliferative properties,20-22 delivered from a polymer-encapsulated stent was shown in small registry studies and randomized clinical trials to reduce the risk of restenosis in patients who were at low risk for restenosis.23-25 We conducted a study to determine the clinical usefulness of the sirolimus-eluting stent in patients with more challenging coronary stenoses.
Methods
Study Design and Eligibility
This randomized, double-blind study complied with the provisions of the Declaration of Helsinki regarding investigation in humans and was approved by the Food and Drug Administration. The study was approved by the institutional review boards at all 53 investigational sites, and written informed consent was obtained from all patients.
Eligible patients had a history of stable or unstable angina and signs of myocardial ischemia. A single newly diagnosed target lesion in a native coronary artery resulting in stenosis of 51 to 99 percent of the luminal diameter and measuring 15 to 30 mm in length (as estimated visually on angiography) was treated. Major criteria for exclusion were recent myocardial infarction (within the previous 48 hours); an ejection fraction of less than 25 percent; a target lesion in an ostium, a bifurcation, or an “unprotected” left main coronary artery or in a vessel with thrombus or severe calcification; and treatment of nontarget lesions in the same or a different coronary vessel during the index procedure.
Before the index procedure, an automated telephone randomization system was used to randomly assign eligible patients in a double-blind manner to treatment with a sirolimus-eluting stent or a standard stent (Bx Velocity, Cordis) in a 1:1 ratio at each site. Randomization blocks were created and were stratified according to the clinical center and the presence or absence of diabetes mellitus.
Coronary-Stent Procedure
Before and after the index procedure, all patients received oral aspirin (325 mg daily) and oral clopidogrel (a loading dose of 300 to 375 mg 24 hours before the procedure and then 75 mg daily for three months). During the procedure, intravenous heparin boluses were administered. The use of intravenous glycoprotein IIb/IIIa inhibitors was at the discretion of the physician. Lesions were treated with the use of standard interventional techniques, including mandated balloon dilation before the placement of the stent. One or two stents of the assigned type were used to treat the target lesion. The sirolimus-eluting stents and the standard stents (available in lengths of 8 mm and 18 mm and in diameters of 2.5 mm, 3.0 mm, and 3.5 mm) were identical in appearance. The sirolimus-eluting stents contained 140 μg of sirolimus per square centimeter of stent-surface area within a copolymer matrix that was 5 to 10 μm thick and was designed to release approximately 80 percent of the total dose of sirolimus in 30 days. Both the physician and the patient were unaware of the treatment-group assignment.
Data Collection, Follow-up, and Core Laboratory Analyses
All data were submitted to a data coordinating center (the Cardiovascular Data Analysis Center, Harvard Clinical Research Institute, Harvard Medical School, Boston), and the investigators had full access to the data. The investigators also initiated, performed, and reviewed all analyses and made the decisions about publication. Clinical follow-up information was obtained for all patients by the research coordinators at each site at 30, 90, 180, and 270 days. All clinical end points were adjudicated by an independent clinical-events committee that was unaware of the treatment-group assignments. A separate data and safety monitoring board that was not affiliated with the study sponsor or the investigators reviewed all data periodically to identify potential safety issues (all complications, including death, stent thrombosis, and myocardial infarction) and to review the conduct of the study (the pace of enrollment, patients' eligibility, and compliance with data collection). The monitoring board did not perform an interim analysis with regard to the primary efficacy end point at nine months, since enrollment was completed before the nine-month primary end point was reached in the first patient.
Coronary angiograms, obtained at base line, at the completion of the stenting procedure, and at 240 days of follow-up, were submitted to the angiographic core laboratory (Brigham and Women's Angiographic Core Laboratory, Boston) and were analyzed with the use of a computer-based system (Medis). “Binary” restenosis was defined as stenosis of more than 50 percent of the luminal diameter in the target lesion. Late luminal loss was defined as the difference between the minimal luminal diameter at the completion of the stenting procedure and that measured during follow-up. Quantitative angiographic measurements of the target lesion were obtained in the “in-stent” zone (including only the stented segment) and in the “in-segment” zone (including the stented segment as well as the margins 5 mm proximal and distal to the stent).
Intravascular ultrasonographic examinations were performed after the index stenting procedure and at 240 days in a subgroup of 250 consecutive patients at 17 centers. With the use of intravascular ultrasonography, qualitative assessments and quantitative determinations of the areas and volumes of the vessels, stents, and lumens were made by the intravascular ultrasonography core laboratory (Cardiovascular Core Analysis Laboratory, Stanford University, Stanford, Calif.).
Study End Points
The primary end point of this study was failure of the target vessel, defined as the occurrence of any of the following within 270 days after the index procedure: death from cardiac causes, Q-wave or non–Q-wave myocardial infarction, or revascularization of the target vessel (emergency or elective coronary-artery bypass grafting [CABG] or repeated percutaneous transluminal coronary angioplasty [PTCA]).
The secondary clinical end points included death from any cause, revascularization of the target lesion (clinically driven CABG or repeated PTCA due to restenosis or closure of the target lesion), and stent thrombosis. All major adverse events were determined for the in-hospital period, for the out-of-hospital period, and cumulatively for the 270 days after the placement of the stent.
Statistical Analysis
The planned sample size of 1100 patients provided 80 percent statistical power to detect a 40 percent reduction in the rate of the primary end point at 270 days (from 15 percent with the standard stent to 9 percent with the sirolimus-eluting stent) with a 5 percent false positive rate (two-sided). We prespecified that the effectiveness analysis and the safety evaluation were to be based on data from all patients who underwent randomization except those who were withdrawn before they received the assigned treatment (as described below). The differences between the treatment groups were evaluated with the use of analysis of variance or with Wilcoxon rank-sum scores for the continuous variables, when appropriate. The Cochran–Mantel–Haenszel statistic, with control for the clinical center, was used for the analysis of categorical variables. The rate of survival free of target-vessel failure during the 270-day follow-up period was analyzed with the use of the actuarial life-table method, and the difference between survival curves was assessed with the log-rank test. To identify factors that might be related to angiographic restenosis and revascularization of the target lesion, logistic-regression models were used. All statistical analyses were performed with the use of SAS software (version 6.12, SAS Institute), and all reported P values are two-sided.
Results
Characteristics of the Patients and the Lesions
Between February 2001 and August 2001, 1101 patients gave written informed consent and were randomly assigned to one of the two treatment groups. After randomization, 43 patients (4 percent of all patients, 23 in the sirolimus-stent group and 20 in the standard-stent group) were withdrawn from the study and did not receive the assigned treatment. The reasons for withdrawal were the unavailability of the assigned type of stent at the center (in the cases of 4 patients) and the discovery of criteria for exclusion that became apparent only after pretreatment angiography (in 39 patients). The final patient cohort included 1058 patients — 533 in the sirolimus-stent group and 525 in the standard-stent group.
The groups were well matched, with no significant differences in the frequency of cardiac risk factors (Table 1Table 1
Characteristics of the Patients and the Lesions.). Among all patients, the mean age was 62 years; 71 percent were men, 31 percent had had a previous myocardial infarction, and 26 percent had diabetes. Cardiac symptoms included exertional angina in 58 percent of patients, angina while at rest in 23 percent, and unstable angina (Braunwald class I, II, or III) in 53 percent. The majority (56 percent) of treated lesions were class B2 or C according to the American College of Cardiology–American Heart Association classification, the average reference-vessel diameter was 2.80 mm, and the mean lesion length was 14.4 mm.Procedural Factors
There were no differences between the groups in the rate of use of conventional interventions; glycoprotein IIb/IIIa inhibitors were given to 60 percent of patients, the maximal balloon-inflation pressure after stenting was 15 atm, and the mean (±SD) ratio of the stent length to the lesion length was 1.6±0.6. An average of 1.4 stents were implanted per target lesion, with overlapping stents in 28 percent of patients.
Quantitative Coronary Angiography
The dimensions of the lesion at base line were similar in the two groups (Table 2Table 2
Results of Quantitative Coronary Angiography.). Follow-up angiographic data were available for 350 patients in the sirolimus-stent group (86 percent of the patients assigned to undergo angiographic follow-up) and 353 in the standard-stent group (85 percent of the patients assigned to undergo angiographic follow-up). Table 2 shows that at follow-up, the minimal luminal diameter, stenosis as a percentage of the luminal diameter, and the late luminal loss in both the in-stent zone and the in-segment zone were all improved with the sirolimus stent as compared with the standard stent (P<0.001 for all comparisons). The frequency of binary in-stent restenosis (stenosis of at least 50 percent of the luminal diameter) was 3.2 percent in the sirolimus-stent group and 35.4 percent in the standard-stent group (P<0.001), and the frequency of in-segment restenosis was 8.9 percent in the sirolimus-stent group and 36.3 percent in the standard-stent group (P<0.001). The higher rate of in-segment restenosis in the sirolimus-stent group was due to a smaller reduction in late luminal loss in the in-segment zone than in the in-stent zone and a higher rate of restenosis at the proximal margin of the stent than at the distal margin or in the body of the stent.Intravascular Ultrasonography
The use of sirolimus-eluting stents, as compared with the use of standard stents, resulted in reductions in the neointimal volume in the in-stent zone (4.4 mm3 vs. 57.6 mm3, P<0.001) and in the in-stent obstruction as a percentage of volume (3.1 percent vs. 33.4 percent, P<0.001).
Clinical Outcomes
Major adverse cardiac events are listed in Table 3Table 3
Major Adverse Cardiac Events in the Hospital and outside of the Hospital during 270 Days of Follow-up.. In-hospital events occurred at a similar frequency in the two groups (including death, myocardial infarction, and repeated revascularization); the proportion of patients with any in-hospital major adverse event was 2.4 percent in the sirolimus-stent group and 1.5 percent in the standard-stent group (P=0.38). There was a lower rate of out-of-hospital adverse events during the 270 days of follow-up in the sirolimus-stent group than in the standard-stent group; reductions included those in the number of patients with non–Q-wave myocardial infarction (from 7 to 1, P=0.04), the number requiring revascularization of the target lesion (from 87 to 21, P<0.001), and the number with any major adverse event (from 93 to 26, P<0.001). Similarly, the number of patients reaching the primary clinical end point, failure of the target vessel within 270 days, was reduced by 58 percent with sirolimus stents (from 110 to 46, P<0.001). The rate of survival free of target-vessel failure for 270 days increased from 78.6 percent with a standard stent to 91.1 percent with a sirolimus stent (P<0.001) (Figure 1Figure 1Actuarial Rate of Survival Free from Target-Vessel Failure among Patients Who Received Either a Sirolimus-Eluting Stent or a Standard Stent.).Stent thrombosis was infrequent, and the rate was similar in the two treatment groups. There were no acute stent thromboses (occurring less than 24 hours after placement of the stent), there was one case of subacute stent thrombosis (occurring between 1 and 30 days after placement) in each group, and there were four late stent thromboses (occurring between 31 and 270 days after placement) — one in the sirolimus-stent group and three in the standard-stent group. The cumulative frequency of stent thrombosis was 0.4 percent in the sirolimus-stent group and 0.8 percent in the standard-stent group.
Subgroup Analyses, Multivariable Analyses, and Assessments of Treatment Effects
Among the 279 patients with diabetes (26 percent of the total study population; 131 patients in the sirolimus-stent group and 148 in the standard-stent group), the absolute frequency of in-segment restenosis and the absolute frequency of target-lesion revascularization were higher than those among patients without diabetes in both treatment groups, but the relative reductions after the placement of a sirolimus stent were of similar magnitude (the rate of in-segment restenosis was reduced from 50.5 percent to 17.6 percent, P<0.001; and the rate of target-lesion revascularization was reduced from 22.3 percent to 6.9 percent, P<0.001).
Among the third of the patient population with the smallest vessels (averaging 2.32 mm in diameter in the sirolimus-stent group and 2.29 mm in the standard-stent group), there was less (albeit still significant) improvement with sirolimus stents in both the rate of in-segment restenosis (18.4 percent, vs. 42.9 percent in the standard-stent group; P<0.001) and the rate of target-lesion revascularization (7.3 percent vs. 20.6 percent, P<0.001). Among the patients with the smallest vessels who received sirolimus stents, the restenosis was usually located at the proximal margin of the stent.
In addition to reducing the overall frequency of angiographic restenosis, the use of sirolimus stents altered the patterns of post-stenting restenosis. The mean length of a restenotic lesion was 9.1±5.8 mm after the placement of a sirolimus stent, as compared with 14.8±7.4 mm after the placement of a standard stent (P<0.001), with a diffuse pattern (a lesion length of more than 10 mm) in 58 percent of cases after the placement of a standard stent, as compared with only 13 percent of cases after the placement of a sirolimus stent (P<0.001).
The association of known risk factors for restenosis with the treatment effect of the sirolimus stent on either angiographic or clinical restenosis was evaluated with the use of multivariable logistic-regression modeling of the rate of in-segment restenosis within 240 days and the rate of target-lesion revascularization within 270 days. In the model of in-segment restenosis, diabetes was significantly associated with an increased risk of restenosis (odds ratio, 2.39; P<0.001), as were the diameter of the reference vessel (odds ratio per 1-mm decrement, 0.54; P=0.001) and the length of the lesion (odds ratio per 1-mm increment, 1.02; P=0.01).
Similarly, in the model of target-lesion revascularization, diabetes was significantly associated with an increased risk of restenosis (odds ratio, 1.65; P=0.03), as were the diameter of the reference vessel (odds ratio per 1-mm decrement, 0.37; P<0.001) and the length of the lesion (odds ratio per 1-mm increment, 1.05; P<0.001). According to both of these models, assignment to the sirolimus-stent group was associated with a significant reduction in the risk of restenosis (odds ratio for in-segment restenosis, 0.24; odds ratio for target-lesion revascularization, 0.17; P<0.001 for both comparisons).
Figure 2Figure 2
Rates of Target-Lesion Revascularization (Either Percutaneous Transluminal Coronary Angiography or Coronary-Artery Bypass Grafting) and Odds Ratios at 270 Days for Various Subgroups of Patients. shows the consistent beneficial effect of sirolimus-eluting stents on the risk of target-lesion revascularization in important clinical and angiographic subgroups, including those defined according to sex, the presence or absence of diabetes, whether or not the lesion was located in the left anterior descending artery, the size of the vessel, the length of the lesion, and the presence or absence of overlapping stents.Discussion
In comparison with previous studies of sirolimus-eluting stents,23-25 our trial enrolled patients with more challenging conditions, including a higher frequency of cardiac risk factors (especially diabetes), more complex lesion morphology, and longer lesions. Nevertheless, the suppression of in-stent neointimal hyperplasia was again demonstrated after the placement of sirolimus-eluting stents, both on angiography (an 83 percent reduction in late luminal loss and a 91 percent reduction in the rate of in-stent restenosis) and on intravascular ultrasonography (a 92 percent reduction in neointimal volume). Moreover, the clinical manifestations of excessive neointimal hyperplasia were similarly improved, with a 77 percent reduction in the rate of out-of-hospital target-lesion revascularization and an 85 percent reduction in the rate of out-of-hospital non–Q-wave myocardial infarction. There were no untoward angiographic complications (e.g., late aneurysms), and the rates of adverse clinical events (including stent thromboses) were not significantly higher in the sirolimus-stent group than in the standard-stent group.
The subgroup analyses indicated that after the placement of a sirolimus stent, the exposed margins of stents that did not cover the entire region of balloon injury were the primary sites of restenosis, which occurred predominantly at the proximal stent margin in smaller vessels. Thus, we would recommend the use of a technique including predilation with shorter balloons, the use of longer single stents in order to cover the entire zone of balloon injury, and dilation after stenting (as needed) with short, high-pressure balloons within the stented regions.
In addition to the reduction in the frequency of restenosis, the pattern of post-stenting restenosis differed with sirolimus-eluting stents: whereas restenotic lesions in standard stents were diffuse, those in sirolimus-eluting stents were focal.26 Such focal post-stenting lesions may typically be treated successfully with the use of simple balloon angioplasty,27,28 minimizing the need for subsequent vascular brachytherapy.29,30 Both patients with diabetes and those with lesions in smaller vessels have higher absolute rates of restenosis, although the relative reduction in the rate of restenosis is preserved. Most important, the sirolimus-eluting stent was found to have a consistent treatment effect in analyses of a broad range of subgroups of patients and lesions.
To determine the ultimate clinical usefulness of sirolimus-eluting stents, additional clinical trials are required that involve patients with disease in a bifurcation, chronic total occlusions, saphenous-vein graft disease, restenosis after stenting, failure of vascular brachytherapy, lesions in the left main coronary artery, and multivessel disease. The findings in two-year follow-up examinations in a cohort of 45 patients who were treated with sirolimus-eluting stents are encouraging, indicating that the angiographic and clinical efficacy are maintained.31 However, the long-term safety and durability of this very potent site-specific therapy require further substantiation in larger cohorts of patients.
A clinically efficacious drug-eluting stent system requires a meticulous integration of the stent design, drug-carrier vehicle, and therapeutic agent. Preliminary stent-based results with paclitaxel, a well-described chemotherapeutic agent that suppresses microtubule dynamics,32-34 delivered through a polymer-matrix formulation, have also shown promise.35 The results of our clinical trial demonstrate that the sirolimus-eluting stent has achieved the delicate balance of preserved safety and improved efficacy and thus has the potential to alter the course of coronary therapy in the future.
Supported by a grant from Cordis, a Johnson & Johnson company.
Dr. Moses reports having received consulting fees from Cordis (Johnson & Johnson) and lecture fees from Johnson & Johnson and holding equity interests in Johnson & Johnson; Dr. Leon reports having received consulting and lecture fees from and holding equity interests in Cordis; Dr. Popma reports having received consulting fees, lecture fees, and grant support from Cordis; Dr. Fitzgerald reports having received consulting fees, lecture fees, and grant support from Cordis; Dr. Kereiakes reports having received honorariums and research grants from Johnson & Johnson (Centocor); Dr. Williams reports having received consulting fees and grant support from Cordis; and Dr. Teirstein reports having received consulting and lecture fees from and holding equity interests in Cordis, and having received royalties from Cordis related to the sale of radiation-delivery catheters.
We are indebted to Emily Keim, Brian Firth, and David Snead for their assistance in reviewing the manuscript, and to Cathy Kennedy for editorial assistance.
Source Information
From the Lenox Hill Heart and Vascular Institute of New York, New York (J.W.M., M.B.L.); Brigham and Women's Hospital, Boston (J.J.P., R.E.K.); Stanford University Medical Center, Stanford, Calif. (P.J.F.); the Mayo Clinic, Rochester, Minn. (D.R.H.); the North Ohio Heart Center, Elyria (C.O.); Saint Joseph's Hospital, Syracuse, N.Y. (R.P.C.); the Christ Hospital–Lindner Research Center, Cincinnati (D.J.K.); Rhode Island Hospital, Providence (D.O.W.); the Scripps Clinic, La Jolla, Calif. (P.S.T.); and Cordis (Johnson & Johnson), Warren, N.J. (J.L.J.).
Address reprint requests to Dr. Moses at the Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute of New York City, 130 E. 77th St., Black Hall, 9th Fl., New York, NY 10021, or at jmoses@lenoxhill.net.
The SIRIUS investigators are listed in the Appendix.
Appendix
The following investigators and institutions participated in the multicenter, randomized, double-blind study of the sirolimus-eluting balloon-expandable stent in the treatment of patients with de novo native coronary-artery lesions (the SIRIUS trial): Sponsor — Cordis, Warren, N.J., D. Donohoe (medical director), J. Jaeger (program director), E. Keim, L. Lonzetta, L. Reynolds, J. Batiller, C. Hill; Data and Safety Monitoring Board — B. Gersch (chair), Rochester, Minn.; M. Farkouh, New York; R. Bonow, Chicago; R. D'Agostino (biostatistician), Boston; G. Mintz, Washington, D.C.; A. Schwartz, New York; Data Management — Harvard Clinical Research Institute, Boston; Coordination — E. Catapane; Clinical Events Committee — D. Cohen (chair), L. Epstein, J. Kannam, W. Manning, J. Markis; Electrocardiography Core Laboratory — P. Zimetbaum, M. Josephson; Core Angiographic Laboratory — Brigham and Women's Hospital, Boston, J. Popma (director); Core Intravascular Ultrasound Laboratory — Stanford University Medical Center, Stanford, Calif., P. Fitzgerald (director); Clinical Sites — J. Carrozza, P. Rooney, Beth Israel Deaconess Medical Center, Boston; S. Ellis, A. Robakowski, Cleveland Clinic Foundation, Cleveland; J. Douglas, P. Hyde, Emory University Hospital, Atlanta; J. Moses, M. Leon, V. Laroche, Lenox Hill Hospital, New York; P. Teirstein, E. Anderson, Scripps Clinic, La Jolla, Calif.; E. Perin, M. Harlan, Texas Heart Institute, Houston; R. Wilensky, M. Walsh, Hospital of the University of Pennsylvania, Philadelphia; L. Satler, J. Lavoie, Washington Hospital Center, Washington, D.C.; M. Cleman, C. Roberts, Yale University Hospital, New Haven, Conn.; S. DeMaio, L. Rogers, Baylor Medical Center, Dallas; E. Fry, A. Taylor, M. Potrikus, Saint Vincent's Hospital, Indianapolis; A. Yeung, C. McWard, Stanford University Medical Center, Stanford, Calif.; J. Zidar, S. Dickerson, Duke University Medical Center, Durham, N.C.; W. O'Neill, K. Dimick, William Beaumont Hospital, Royal Oak, Mich.; G. Mishkel, J. Daniels, P. Sullivan, Saint John's Hospital, Springfield, Ill.; D. McCormick, L. Mark, B. Connor, Hahnemann Hospital, Philadelphia; D. Roberts, B. Seiler, Sutter Memorial General Hospital, Sacramento, Calif.; D. Holmes, D. Shelstad, Saint Mary's Hospital, Rochester, Minn.; F. Kiernan, D. Murphy, Hartford Hospital, Hartford, Conn.; M. Midei, E. Yaker, Saint Joseph's Hospital, Baltimore; D. Williams, J. Muratori, T. Chaffee, Rhode Island Hospital, Providence; T. Fischell, S. Baskerville, Borgess Medical Center, Kalamazoo, Mich.; S. Oesterle, I. Palacios, C. Cothern, Massachusetts General Hospital, Boston; S. Yakubov, C. Gilliland, P. Vieira, Riverside Methodist Hospital, Columbus, Ohio; D. Kereiakes, R. Lengerich, Christ Hospital–Lindner Center, Cincinnati; C. Davidson, L. Eckman, Northwestern Memorial Hospital, Chicago; C. Brown, K. Reid, Piedmont Hospital, Atlanta; C. Lambert, T. Watts, N. Parker, Health First Institute, Melbourne, Fla.; D. Baim, R. Monboquette, Brigham and Women's Hospital, Boston; A. Raizner, R. Benfield, Methodist Hospital, Houston; B. Cohen, R. Lao, Morristown Memorial Hospital, Morristown, N.J.; N. Laufer, M. Balfour, Good Samaritan Regional Medical Center, Phoenix, Ariz.; S. Raible, B.J. Henehan, Jewish Hospital Heart and Lung Institute, Louisville, Ky.; P. Coleman, A. Nofi, Northern California Medical Association, Santa Rosa; S. Sorenson, K. Robinson, Latter Day Saints Hospital, Salt Lake City; M. Mooney, P. Demmer, Abbott Northwestern Hospital, Minneapolis; T. Feldman, J. Lopez, L. Loftis, University of Chicago Hospitals, Chicago; J. Lasala, K. Zuchowski, S. Aubuchon, Barnes Jewish Hospital, St. Louis; R. Caputo, C. Lastinger, Saint Joseph's Hospital, Syracuse, N.Y.; C. O'Shaughnessy, T. Julio, L. St. Marie, L. Barr, North Ohio Heart Center, Elyria; H. Madyoon, T. Weaver, Saint Joseph's Medical Center, Stockton, Calif.; J. Midwall, L. Herlan, JFK Memorial Hospital, Atlantis, Fla.; M. Bates, L. Lukhart, Charleston Area Medical Center, Charleston, W.Va.; M. Clark, L. Pennington, Integris Oklahoma Heart Institute, Oklahoma City; T. Vellinga, K. McCormick, S. Congemi, Saint Luke's Medical Center, Milwaukee; C. Simonton, C. Dellinger, G. Schwartz, Sanger Clinic, Charlotte, N.C.; F. Leya, D. Jednachowski, Loyola University Medical Center, Maywood, Ill.; G. Chapman, D. Gargus, University of Alabama, Birmingham; M. Reisman, F. Clouarte, Swedish Heart Hospital, Seattle; S. Wong, D. Reynolds, Cornell University and New York Presbyterian Hospital, New York; T. Bass, G. Morris, V. Brooks, University of Florida Health Science Center, Jacksonville; B. Bachinsky, A. Todd, C. Schaeffer, R. Yost, Harrisburg Hospital, Wormleysburg, Pa.; M. Buchbinder, J. Logan, Foundation for Cardiovascular Medicine, La Jolla, Calif.
- References
References
1
Sigwart U ,Puel J ,Mirkovitch V ,Joffre F ,Kappenberger L . Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987;316:701-706
Full Text | Web of Science | Medline2
Roubin GS ,Cannon AD ,Agrawal SK , et al. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992;85:916-927
Web of Science | Medline3
Serruys PW ,de Jaegere P ,Kiemeneij F , et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-495
Full Text | Web of Science | Medline4
Fischman DL ,Leon MB ,Baim DS , et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501
Full Text | Web of Science | Medline5
Versaci F ,Gaspardone A ,Tomai F ,Crea F ,Chiariello L ,Gioffre PA . A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med 1997;336:817-822
Full Text | Web of Science | Medline6
Rankin JM ,Spinelli JJ ,Carere RG , et al. Improved clinical outcome after widespread use of coronary-artery stenting in Canada. N Engl J Med 1999;341:1957-1965
Full Text | Web of Science | Medline7
Kimura T ,Yokoi H ,Nakagawa Y , et al. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med 1996;334:561-566
Full Text | Web of Science | Medline8
Elezi S ,Kastrati A ,Neumann FJ ,Hadamitzky M ,Dirschinger J ,Schomig A . Vessel size and long-term outcome after coronary stent placement. Circulation 1998;98:1875-1880
Web of Science | Medline9
Dussaillant GR ,Mintz GS ,Pichard AD , et al. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis. J Am Coll Cardiol 1995;26:720-724
CrossRef | Web of Science | Medline10
Akiyama T ,Moussa I ,Reimers B , et al. Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels. J Am Coll Cardiol 1998;32:1610-1618
CrossRef | Web of Science | Medline11
Kastrati A ,Elezi S ,Dirschinger J ,Hadamitzky M ,Neumann FJ ,Schomig A . Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol 1999;83:1617-1622
CrossRef | Web of Science | Medline12
Ho KKL ,Senerchia C ,Rodriguez O ,Chauhan MS ,Kuntz RE . Predictors of angiographic restenosis after stenting: pooled analysis of 1197 patients with protocol-mandated angiographic follow-up from 5 randomized stent trials. Circulation 1998;98:Suppl I:I-362 abstract.13
Kobayashi Y ,De Gregorio J ,Kobayashi N , et al. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol 1999;34:651-659
CrossRef | Web of Science | Medline14
Elezi S ,Kastrati A ,Pache J , et al. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 1998;32:1866-1873
CrossRef | Web of Science | Medline15
Abizaid A ,Kornowski R ,Mintz GS , et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998;32:584-589
CrossRef | Web of Science | Medline16
de Feyter PJ ,Vos J ,Rensing BJ . Anti-restenosis trials. Curr Interv Cardiol Rep 2000;2:326-331
Medline17
Holmes DR Jr ,Savage M ,LaBlanche JM , et al. Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 2002;106:1243-1250
CrossRef | Web of Science | Medline18
Wilensky RI ,Tanguay JF ,Ito S , et al. Heparin infusion prior to stenting (HIPS) trial: final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia. Am Heart J 2000;139:1061-1070
CrossRef | Web of Science | Medline19
Kutryk MJ ,Foley DP ,van den Brand M , et al. Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: results of the randomized investigation by the Thoraxcenter of antisense DNA using local delivery and IVUS after coronary stenting (ITALICS) trial. J Am Coll Cardiol 2002;39:281-287
CrossRef | Web of Science | Medline20
Gallo R ,Padurean A ,Jayaraman T , et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 1999;99:2164-2170
Web of Science | Medline21
Marx SO ,Marks AR . Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation 2001;104:852-855
Web of Science | Medline22
Suzuki T ,Kopia G ,Hayashi S , et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001;104:1188-1193
CrossRef | Web of Science | Medline23
Sousa JE ,Costa MA ,Abizaid A , et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001;103:192-195
Web of Science | Medline24
Rensing BJ ,Vos J ,Smits PC , et al. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur Heart J 2001;22:2125-2130
CrossRef | Web of Science | Medline25
Morice M-C ,Serruys PW ,Sousa JE , et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780
Full Text | Web of Science | Medline26
Mehran R ,Dangas G ,Abizaid AS , et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999;100:1872-1878
Web of Science | Medline27
Baim DS ,Levine MJ ,Leon MB ,Levine S ,Ellis SG ,Schatz RA . Management of restenosis within the Palmaz-Schatz coronary stent (the U.S. multicenter experience). Am J Cardiol 1993;71:364-366
CrossRef | Web of Science | Medline28
Mehran R ,Mintz GS ,Popma JJ , et al. Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis. Am J Cardiol 1996;78:618-622
CrossRef | Web of Science | Medline29
Leon MB ,Teirstein PS ,Moses JW , et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001;344:250-256
Full Text | Web of Science | Medline30
Waksman R ,White RL ,Chan RC , et al. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000;101:2165-2171
Web of Science | Medline31
Sousa JE ,Costa MA ,Abizaid AC , et al. Sustained suppression of neo-intimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 2001;104:2007-2011
CrossRef | Web of Science | Medline32
Herdeg C ,Oberhoff M ,Baumbach A , et al. Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo. J Am Coll Cardiol 2000;35:1969-1976
CrossRef | Web of Science | Medline33
Drachman DE ,Edelman ER ,Seifert P , et al. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. J Am Coll Cardiol 2000;36:2325-2332
CrossRef | Web of Science | Medline34
Heldman AW ,Cheng L ,Jenkins GM , et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of restenosis. Circulation 2001;103:2289-2295
Web of Science | Medline35
Park S-J ,Shim WH ,Ho DS , et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003;348:1537-1545
Full Text | Web of Science | Medline
- Citing Articles (1449)
Citing Articles
1
Anne Seidlitz, Werner Weitschies. (2012) In-vitro dissolution methods for controlled release parenterals and their applicability to drug-eluting stent testing. Journal of Pharmacy and Pharmacologyno-no
CrossRef2
Glenn N. Levine, Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl, Bojan Cercek, Charles E. Chambers, Stephen G. Ellis, Robert A. Guyton, Steven M. Hollenberg, Umesh N. Khot, Richard A. Lange, Laura Mauri, Roxana Mehran, Issam D. Moussa, Debabrata Mukherjee, Brahmajee K. Nallamothu, Henry H. Ting, Alice K. Jacobs, Jeffrey L. Anderson, Nancy Albert, Mark A. Creager, Steven M. Ettinger, Robert A. Guyton, Jonathan L. Halperin, Judith S. Hochman, Frederick G. Kushner, E. Magnus Ohman, William Stevenson, Clyde W. Yancy. (2012) 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: Executive Summary. Catheterization and Cardiovascular Interventions 79:3, 453-495
CrossRef3
Bodo Cremers, John L. Toner, Lewis B. Schwartz, Randolf Oepen, Ulrich Speck, Nicola Kaufels, Yvonne P. Clever, Dirk Mahnkopf, Michael Böhm, Bruno Scheller. (2012) Inhibition of neointimal hyperplasia with a novel zotarolimus coated balloon catheter. Clinical Research in Cardiology
CrossRef4
Kirk N. Garratt, David P. Lee, Eileen M. Rose, Kellie J. Windle, Hsini Liao, Chuke E. Nwachuku, Kenneth J. Winters, Thomas S. Bowman, Keith D. Dawkins. (2012) Rationale and design of the TAXUS Libertē Post-Approval Study: Examination of patients receiving the TAXUS Liberté stent with concomitant prasugrel therapy in routine interventional cardiology practice. American Heart Journal 163:2, 142-148.e6
CrossRef5
Vivian G. Ng, Alexandra J. Lansky. (2012) The Generations of Drug-Eluting Stents and Outcomes in Women. Interventional Cardiology Clinics
CrossRef6
Toshiki Sawai, Masatoshi Miyahara, Hiroshi Nakajima, Shiro Nakamori, Masataka Sakai, Hiroya Tamada, Takashi Tanigawa, Norikazu Yamada, Mashio Nakamura, Masaaki Ito. (2012) The impact of preprocedural hemoglobin A1c on the efficacy of sirolimus-eluting and paclitaxel-eluting stents. Cardiovascular Intervention and Therapeutics
CrossRef7
Guo Hua Zheng, Jian Ping Liu, Jianfeng Chu, Lijuan Mei, Hai Ying Chen, Guo Hua Zheng. 2012. Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease. .
CrossRef8
Jun-ichi Kotani, Yuji Ikari, Eisho Kyo, Masato Nakamura, Hiroyoshi Yokoi, Kiyohiro Furuno, Hideaki Inui, Ken Kozuma. (2012) Five-year outcomes of Cypher™ coronary stent: report from J-PMS Study. Cardiovascular Intervention and Therapeutics
CrossRef9
Jerome J. Federspiel, Sally C. Stearns, Kristin L. Reiter, Kimberley H. Geissler, Matthew A. Triplette, Laura P. D'Arcy, Brett C. Sheridan, Joseph S. Rossi. (2012) Disappearing and reappearing differences in drug-eluting stent use by race. Journal of Evaluation in Clinical Practiceno-no
CrossRef10
Andrew J. Epstein, Jonathan D. Ketcham, Saif S. Rathore, Peter W. Groeneveld. (2012) Variations in the Use of an Innovative Technology by Payer. Medical Care 50:1, 1-9
CrossRef11
Giulio Guagliumi, Vasile Sirbu, Giuseppe Musumeci, Robert Gerber, Giuseppe Biondi-Zoccai, Hideyuki Ikejima, Elena Ladich, Nikoloz Lortkipanidze, Aleksandre Matiashvili, Orazio Valsecchi, Renu Virmani, Gregg W. Stone. (2012) Examination of the In Vivo Mechanisms of Late Drug-Eluting Stent Thrombosis. JACC: Cardiovascular Interventions 5:1, 12-20
CrossRef12
Satoshi Takeshita, Ayumu Takagi, Shigeru Saito. (2012) Backup support of the mother-child technique: Technical considerations for the size of the mother guiding catheter. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef13
Ryota Sakurai, Tsukasa Inajima, Hideaki Kaneda, Ryozo Nagai, Hideki Hashimoto. (2012) Sirolimus-eluting stents reduce long-term mortality compared with bare metal stents in ST-segment elevation myocardial infarction: A meta-analysis of randomized controlled trials. International Journal of Cardiology
CrossRef14
Erik Jørgensen, Henning Kelbæk. (2012) It’s time to say goodbye... (to the first-generation drug-eluting stent era). EuroIntervention 7:9, 1011-1013
CrossRef15
Robert J. Applegate, James B. Hermiller, Paul C. Gordon, Manejeh Yaqub, Poornima Sood, Xiaolu Su, Sherry Cao, Krishnankutty Sudhir, Gregg W. Stone. (2012) Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents. EuroIntervention 7:9, 1030-1042
CrossRef16
Corrado Tamburino, Davide Capodanno, Maria Elena Di Salvo, Alessandra Sanfilippo, Irene Cascone, Valentina Incardona, Giovanni Longo, Daniele Giacoppo, Piera Capranzano, Carmelo Sgroi, Gianpaolo Ussia, Alfio Monaco, Alessio La Manna. (2012) Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry. EuroIntervention 7:9, 1062-1068
CrossRef17
Ami Raval, Arpan Parmar, Ankur Raval, Pratap Bahadur. (2012) Preparation and optimization of media using Pluronic® micelles for solubilization of sirolimus and release from the drug eluting stents. Colloids and Surfaces B: Biointerfaces
CrossRef18
Alessandro Cuneo, Peter Bramlage, Matthias Hochadel, Jochen Senges, Christoph Nienaber, Karl-Heinz Kuck, Ulrich Tebbe. (2011) Concurrent drug eluting/bare metal stent implantation during percutaneous coronary intervention in target vessel: outcomes and 1-year follow-up. Clinical Research in Cardiology
CrossRef19
I. S. Toor, R. Jaumdally, G. Y. H. Lip, D. Pagano, W. Dimitri, T. Millane, C. Varma. (2011) Differences between South Asians and White Europeans in five year outcome following percutaneous coronary intervention. International Journal of Clinical Practice 65:12, 1259-1266
CrossRef20
Huan Wang, Wen-juan Zhong, Ming-wei Huang, Xiao-ying Wu, Hui Chen. (2011) Efficacy of dual antiplatelet therapy combined with Naoxintong Capsules (
) following coronary microembolization induced by homologous microthrombi in rats. Chinese Journal of Integrative Medicine 17:12, 917-924
CrossRef21
Angela S. Koh, L.M. Choi, L.L. Sim, Jack W. Tan, L.W. Khin, Terrance S.J. Chua, T.H. Koh, Stanley Chia. (2011) Comparing the use of cobalt chromium stents to stainless steel stents in primary percutaneous coronary intervention for acute myocardial infarction: A prospective registry. Acute Cardiac Care 13:4, 219-222
CrossRef22
Eliano Navarese, Jacek Kubica, Fausto Castriota, C. Michael Gibson, Giuseppe De Luca, Antonino Buffon, Leonardo Bolognese, Massimo Margheri, Felicita Andreotti, Carlo Di Mario, Stefano De Servi. (2011) Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials. EuroIntervention 7:8, 985-994
CrossRef23
Young-Guk Ko, Jung-Sun Kim, Byeong-Keuk Kim, Donghoon Choi, Myeong-Ki Hong, Dong Woon Jeon, Joo-Young Yang, Young Keun Ahn, Myung Ho Jeong, Cheol Woong Yu, Kyeong-Ho Yun, Do-Sun Lim, Yangsoo Jang. (2011) Efficacy of Drug-Eluting Stents for Treating In-Stent Restenosis of Drug-Eluting Stents (from the Korean DES ISR Multicenter Registry Study [KISS]). The American Journal of Cardiology
CrossRef24
Luís Seca, Romeu Cação, Joana Silva, Paula Mota, Marco Costa, António Leitão Marques. (2011) O ressurgimento da aterectomia rotacional na era dos stents farmacoativos - A experiência de um centro. Revista Portuguesa de Cardiologia
CrossRef25
Luís Seca, Romeu Cação, Joana Silva, Paula Mota, Marco Costa, António Leitão Marques. (2011) Rotational atherectomy in the drug-eluting stent era: A recent single-center experience. Revista Portuguesa de Cardiologia (English Edition)
CrossRef26
Marc Bosiers, Dierk Scheinert, Patrick Peeters, Giovanni Torsello, Thomas Zeller, Koen Deloose, Andrej Schmidt, Jörg Tessarek, Erwin Vinck, Lewis B. Schwartz. (2011) Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. Journal of Vascular Surgery
CrossRef27
, B. Scheller, B. Levenson, M. Joner, R. Zahn, V. Klauss, C. Naber, V. Schächinger, A. Elsässer. (2011) Medikamente freisetzende Koronarstents und mit Medikamenten beschichtete Ballonkatheter. Der Kardiologe
CrossRef28
Salvatore Brugaletta, Josep Gomez-Lara, Hector M. Garcia-Garcia, Jung Ho Heo, Vasim Farooq, Robert J. Geuns, Bernard Chevalier, Stephan Windecker, Dougal McClean, Leif Thuesen, Robert Whitbourn, Ian Meredith, Cecile Dorange, Susan Veldhof, Richard Rapoza, John A. Ormiston, Patrick W. Serruys. (2011) Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold. The International Journal of Cardiovascular Imaging
CrossRef29
Ibrahim Akin, Marcus Wiemer, Steffen Schneider, Jochen Senges, Matthias Hochadel, Gert Richardt, Mohamed Abdel-Wahab, Karl-Heinz Kuck, Christoph A. Nienaber. (2011) Real-world experience of drug-eluting stents in saphenous vein grafts compared to native coronary arteries: results from the prospective multicenter German DES.DE registry. Clinical Research in Cardiology
CrossRef30
Joseph P. Carrozza. (2011) Robotic-Assisted Percutaneous Coronary Intervention—Filling an Unmet Need. Journal of Cardiovascular Translational Research
CrossRef31
Jiyeon Choi, Seong Bae Cho, Bong Soo Lee, Yoon Ki Joung, Kwideok Park, Dong Keun Han. (2011) Improvement of Interfacial Adhesion of Biodegradable Polymers Coated on Metal Surface by Nanocoupling. Langmuir111104165715004
CrossRef32
Shann S. Yu, Ryan A. Ortega, Brendan W. Reagan, John A. McPherson, Hak-Joon Sung, Todd D. Giorgio. (2011) Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 3:6, 620-646
CrossRef33
Israel M Barbash, Ron Waksman. (2011) Current status, challenges and future directions of drug-eluting balloons. Future Cardiology 7:6, 765-774
CrossRef34
Kyung Woo Park, Woo-Hyun Lim, Ji-Hyun Kim, Si-Hyuck Kang, Jung-Won Seo, Young Bin Song, Joo-Yong Hahn, Hae-Young Lee, Hyun-Jae Kang, Young-Seok Cho, Tae-Jin Youn, Bon-Kwon Koo, Seung-Hyuk Choi, In-ho Chae, Hyeon-Cheol Gwon, Dong-Ju Choi, Hyo-Soo Kim. (2011) Comparison between zotarolimus-eluting stents and first generation drug-eluting stents in the treatment of patients with acute ST-segment elevation myocardial infarction. International Journal of Cardiology
CrossRef35
Sa'ar Minha, Tamir Bental, Abid Assali, Hana Vaknin-Assa, Eli I. Lev, Eldad Rechavia, Alexander Battler, Ran Kornowski. (2011) A comparative analysis of major clinical outcomes using drug-eluting stents versus bare metal stents in diabetic versus nondiabetic patients. Catheterization and Cardiovascular Interventions 78:5, 710-717
CrossRef36
Michael A. Kutcher. (2011) Second-Generation Everolimus-Eluting Stents. JACC: Cardiovascular Interventions 4:11, 1216-1217
CrossRef37
Saami Yazdani, Marc Vorpahl, Masataka Nakano, Shih-Horng Su, Frank Kolodgie, Renu Virmani. (2011) In vitro and in vivo characterisation of biodegradable polymer-based drug-eluting stent. EuroIntervention 7:7, 835-843
CrossRef38
Glenn N. Levine, Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl, Bojan Cercek, Charles E. Chambers, Stephen G. Ellis, Robert A. Guyton, Steven M. Hollenberg, Umesh N. Khot, Richard A. Lange, Laura Mauri, Roxana Mehran, Issam D. Moussa, Debabrata Mukherjee, Brahmajee K. Nallamothu, Henry H. Ting. (2011) 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary. Journal of the American College of Cardiology
CrossRef39
Glenn N. Levine, Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl, Bojan Cercek, Charles E. Chambers, Stephen G. Ellis, Robert A. Guyton, Steven M. Hollenberg, Umesh N. Khot, Richard A. Lange, Laura Mauri, Roxana Mehran, Issam D. Moussa, Debabrata Mukherjee, Brahmajee K. Nallamothu, Henry H. Ting. (2011) 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. Journal of the American College of Cardiology
CrossRef40
Daniela S. Couto, Luis Perez-Breva, Pedro Saraiva, Charles L. Cooney. (2011) Lessons from innovation in drug-device combination products. Advanced Drug Delivery Reviews
CrossRef41
Johannes Lammer, Dierk Scheinert, Frank Vermassen, Renate Koppensteiner, Klaus A. Hausegger, Herman Schroë, Rajeev M. Menon, Lewis B. Schwartz. (2011) Pharmacokinetic analysis after implantation of everolimus-eluting self-expanding stents in the peripheral vasculature. Journal of Vascular Surgery
CrossRef42
So-Yeon Choi, Akiko Maehara, Ecaterina Cristea, Bernhard Witzenbichler, Giulio Guagliumi, Bruce Brodie, Mirle A. Kellett, Ovidiu Dressler, Alexandra J. Lansky, Helen Parise, Roxana Mehran, Gary S. Mintz, Gregg W. Stone. (2011) Usefulness of Minimum Stent Cross Sectional Area as a Predictor of Angiographic Restenosis After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction (from the HORIZONS-AMI Trial IVUS Substudy). The American Journal of Cardiology
CrossRef43
Nikhil P Jaik, Ramanan Umakanthan, Marzia Leacche, Natalia Solenkova, Jorge M Balaguer, Steven J Hoff, Stephen K Ball, David X Zhao, John G Byrne. (2011) Current status of hybrid coronary revascularization. Expert Review of Cardiovascular Therapy 9:10, 1331-1337
CrossRef44
Emilio Lorenzo, Giannignazio Carbone, Luigi Sauro, Alfredo Casafina, Michele Capasso, Rosario Sauro. (2011) Bare-Metal Stents Versus Drug-Eluting Stents for Primary Angioplasty: Long-Term Outcome. Current Cardiology Reports 13:5, 459-464
CrossRef45
Daisuke Kamoi, Hideki Ishii, Hiroshi Takahashi, Toru Aoyama, Takanobu Toriyama, Miho Tanaka, Yoshihiro Kawamura, Kazuhiro Kawashima, Daiji Yoshikawa, Tetsuya Amano, Tadayuki Uetani, Tatsuaki Matsubara, Toyoaki Murohara. (2011) Sirolimus- vs. paclitaxel-eluting stent to coronary intervention in dialysis patients. International Journal of Cardiology
CrossRef46
MARGO KLOMP, MARCEL A.M. BEIJK, PETER DAMMAN, PIER WOUDSTRA, KAREL T. KOCH, JAN G.P. TIJSSEN, ROBBERT J. DE WINTER. (2011) Three-Year Clinical Follow-Up of an Unselected Patient Population Treated with the Genous Endothelial Progenitor Cell Capturing Stent. Journal of Interventional Cardiology 24:5, 442-449
CrossRef47
Adnan Kastrati, Robert A. Byrne, Stefanie Schulz. (2011) Will We Ever Know the Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation?. JACC: Cardiovascular Interventions 4:10, 1129-1132
CrossRef48
Kyung Woo Park, In-Ho Chae, Do-Sun Lim, Kyoo-Rok Han, Han-Mo Yang, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Taehoon Ahn, Jung-Han Yoon, Myung-Ho Jeong, Taek-Jong Hong, Woo-Young Chung, Sang-Ho Jo, Young-Jin Choi, Seung-Ho Hur, Hyuck-Moon Kwon, Dong-Woon Jeon, Byung-Ok Kim, Si-Hoon Park, Nam-Ho Lee, Hui-Kyung Jeon, Hyeon-Cheol Gwon, Yang-Soo Jang, Hyo-Soo Kim. (2011) Everolimus-Eluting Versus Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention. Journal of the American College of Cardiology 58:18, 1844-1854
CrossRef49
Meng-Ling Wu, Yen-Chun Ho, Shaw-Fang Yet. (2011) A Central Role of Heme Oxygenase-1 in Cardiovascular Protection. Antioxidants & Redox Signaling 15:7, 1835-1846
CrossRef50
Thomas T. Tsai, John C. Messenger, J. Matthew Brennan, Uptal D. Patel, David Dai, Robert N. Piana, Kevin J. Anstrom, Eric L. Eisenstein, Rachel S. Dokholyan, Eric D. Peterson, Pamela S. Douglas. (2011) Safety and Efficacy of Drug-Eluting Stents in Older Patients With Chronic Kidney Disease. Journal of the American College of Cardiology 58:18, 1859-1869
CrossRef51
Usman Baber, Roxana Mehran, Samin K. Sharma, Somjot Brar, Jennifer Yu, Jung-Won Suh, Hyo-Soo Kim, Seung-Jung Park, Adnan Kastrati, Antoinette de Waha, Prakash Krishnan, Pedro Moreno, Joseph Sweeny, Michael C. Kim, Javed Suleman, Robert Pyo, Jose Wiley, Jason Kovacic, Annapoorna S. Kini, George D. Dangas. (2011) Impact of the Everolimus-Eluting Stent on Stent Thrombosis. Journal of the American College of Cardiology 58:15, 1569-1577
CrossRef52
Jochem van Werkum, Thea Godschalk, Tom Oirbans, Jurriën ten Berg. (2011) Coronary stent thrombosis: incidence, predictors and triggering mechanisms. Interventional Cardiology 3:5, 581-588
CrossRef53
Carlos A. Collet, J. Ribamar Costa, Alexandre Abizaid, Daniel Chamié, Rodolfo Staico, Ricardo Costa, Dimytri Siquera, Javier Obregon, Fausto Feres, Amanda Sousa, Jose Eduardo Sousa. (2011) Assessing the Temporal Course of Neointimal Hyperplasia Formation After Different Generations of Drug-Eluting Stents. JACC: Cardiovascular Interventions 4:10, 1067-1074
CrossRef54
Tae-Won Seo. (2011) Numerical Study of Flow Pattern and Drug Deposition in Drug-Eluting Stent. Transactions of the Korean Society of Mechanical Engineers B 35:10, 1053-1060
CrossRef55
E. G. Marcos, A. C. Fonseca, S. H. Hofma. (2011) Bridging therapy for early surgery in patients on dual antiplatelet therapy after drug-eluting stent implantation. Netherlands Heart Journal 19:10, 412-417
CrossRef56
MOHAMED ABDEL-WAHAB, RALPH TOELG, GUIDO KASSNER, LOTHAR KLATT, MOHAMMAD A. SHERIF, VOLKER GEIST, GERT RICHARDT. (2011) Long-Term Clinical Outcome of Thin-Strut Cobalt-Chromium Stents in the Drug-Eluting Stent Era: Results of the COBALT (Comparison of Bare-Metal Stents in All-Comers’ Lesion Treatment) Registry. Journal of Interventional Cardiologyno-no
CrossRef57
Kensaku Nishihira, Kinta Hatakeyama, Nehiro Kuriyama, Katsumasa Nomura, Yusuke Fukushima, Yohei Inoue, Tatsuya Nakama, Daigo Mine, Shuichirou Sagara, Keiichi Ashikaga, Akihiko Matsuyama, Kazuo Kitamura, Yoshisato Shibata, Yujiro Asada. (2011) Presence of older thrombus in patients with late and very late drug-eluting stent thrombosis. Journal of Cardiology
CrossRef58
J. Wouter Jukema, Jeffrey J. W. Verschuren, Tarek A. N. Ahmed, Paul H. A. Quax. (2011) Restenosis after PCI. Part 1: pathophysiology and risk factors. Nature Reviews Cardiology
CrossRef59
Ruomin Di, Xiangqi Wu, Zai Chang, Xia Zhao, Qiuting Feng, Shuangshuang Lu, Qing Luan, Brian Hemmings, Xinli Li, Zhongzhou Yang. (2011) S6K inhibition renders cardiac protection against myocardial infarction through PDK1 phosphorylation of Akt. Biochemical Journal
CrossRef60
Barry Kahan. (2011) Toxicity spectrum of inhibitors of mammalian target of rapamycin in organ transplantation: etiology, pathogenesis and treatment. Expert Opinion on Drug Safety 10:5, 727-749
CrossRef61
Atsushi Fukumoto, Satoru Otsuji, Shin Takiuchi, Masashi Ikushima, Katsuaki Asano, Kunihiko Terasoma, Katsuyuki Hasegawa, Masanori Yabuki, Yorihiko Higashino. (2011) Comparison of real-world clinical outcomes between Cypher- and Taxus-eluting stents: the GARA–GARA study. Cardiovascular Intervention and Therapeutics 26:3, 202-208
CrossRef62
Tadateru Takayama, Takafumi Hiro, Atsushi Hirayama. (2011) Stent thrombosis and drug-eluting stents. Journal of Cardiology 58:2, 92-98
CrossRef63
Laura M. Ellwein, Hiromasa Otake, Timothy J. Gundert, Bon-Kwon Koo, Toshiro Shinke, Yasuhiro Honda, Junya Shite, John F. LaDisa. (2011) Optical Coherence Tomography for Patient-specific 3D Artery Reconstruction and Evaluation of Wall Shear Stress in a Left Circumflex Coronary Artery. Cardiovascular Engineering and Technology 2:3, 212-227
CrossRef64
Alejandro Diego, Armando Pérez de Prado, Carlos Cuellas, Claudia Pérez-Martínez, Manuel Gonzalo-Orden, Jose R. Altonaga, Antonio de Miguel, Marta Regueiro, Jose Ajenjo, Fernando Sánchez-Lasheras, Ángel Álvarez-Arenal, Felipe Fernández-Vázquez. (2011) La reestenosis en el stent depende del daño vascular inducido. ¿Son válidos los modelos experimentales actuales de análisis de los stents farmacoactivos?. Revista Española de Cardiología 64:9, 745-751
CrossRef65
Woong Chol Kang, Yae Min Park, Kwen-Chul Shin, Chan Il Moon, Kyounghoon Lee, Seung Hwan Han, Mi Seung Shin, Jeonggeun Moon, Taehoon Ahn, Eak Kyun Shin. (2011) Comparison of edge vascular response after sirolimus- and paclitaxel-eluting stent implantation. International Journal of Cardiology
CrossRef66
Alejandro Diego, Armando Pérez de Prado, Carlos Cuellas, Claudia Pérez-Martínez, Manuel Gonzalo-Orden, Jose R. Altonaga, Antonio de Miguel, Marta Regueiro, Jose Ajenjo, Fernando Sánchez-Lasheras, Ángel Álvarez-Arenal, Felipe Fernández-Vázquez. (2011) Instent Restenosis Related to Vessel Injury Score Degree. Are Current Experimental Models Valid for Drug-Eluting Stents Analysis?. Revista Española de Cardiología (English Edition) 64:9, 745-751
CrossRef67
Shigeru Saito, Ross Prpic, Jeffery J. Popma, John Alexander, Mitchell W. Krucoff. (2011) The clinical evaluation of the Endeavor zotarolimus-eluting coronary stent in Japanese patients with de novo native coronary artery lesions: primary results and 3-year follow-up of the Endeavor Japan study. Cardiovascular Revascularization Medicine 12:5, 273-279
CrossRef68
Soon Yong Suh, Kyoung Hoon Lee, Jeonggeun Moon, Woong Chol Kang, Seung Hwan Han, Tae Hoon Ahn, Eak Kyun Shin. (2011) Comparison of efficacy between paclitaxel-eluting stents with different polymers in terms of major adverse cardiac events and stent thrombosis up to 12months of clinical follow-up. International Journal of Cardiology
CrossRef69
Jung-Sun Kim, David Wallace-Bradley, Carlos L. Alviar, Gerard Conditt, Krzysztof Milewski, Maxwell E. Afari, Yanping Cheng, Catalina Gallego, Armando Tellez, Gregg W. Stone, Greg L. Kaluza, Juan F. Granada. (2011) Correlation of Angiographic Late Loss With Neointimal Proliferation in Stents Evaluated by OCT and Histology in Porcine Coronary Arteries. JACC: Cardiovascular Imaging 4:9, 1002-1010
CrossRef70
Sandy M. Green, Faith Selzer, Suresh R. Mulukutla, Edward J. Tadajweski, Jamie A. Green, Robert L. Wilensky, Warren K. Laskey, Howard A. Cohen, Sunil V. Rao, Steven D. Weisbord, Joon S. Lee, Steven E. Reis, Kevin E. Kip, Sheryl F. Kelsey, David O. Williams, Oscar C. Marroquin. (2011) Comparison of Bare-Metal and Drug-Eluting Stents in Patients with Chronic Kidney Disease (from the NHLBI Dynamic Registry). The American Journal of Cardiology
CrossRef71
Dennis T. Ko, Helen Guo, Harindra C. Wijeysundera, Mohammad I. Zia, Vladimír Džavík, Michael W.A. Chu, Stephen E. Fremes, Eric A. Cohen, Jack V. Tu. (2011) Long-Term Safety and Effectiveness of Drug-Eluting Stents for the Treatment of Saphenous Vein Grafts Disease. JACC: Cardiovascular Interventions 4:9, 965-973
CrossRef72
Nobuo Sakamoto, Kazuhiko Nakazato, Tomofumi Misaka, Hiroyuki Mizukami, Hiroyuki Kunii, Hitoshi Suzuki, Shu-ichi Saitoh, Yasuchika Takeishi. (2011) Very late stent thrombosis and neointimal plaque rupture after implantation of sirolimus-eluting stents: observations with angiography, IVUS and OCT. Cardiovascular Intervention and Therapeutics 26:3, 263-268
CrossRef73
Gaku Nakazawa. (2011) Stent thrombosis of drug eluting stent: Pathological perspective. Journal of Cardiology 58:2, 84-91
CrossRef74
Amir Lotfi, Jiang Cui, Siddharth Wartak, Jesse Columbo, Scott Mulvey, Mary Davis, Marc Schweiger, Gregory R. Giugliano. (2011) Influence of Low-Dose Aspirin (81 mg) on the Incidence of Definite Stent Thrombosis in Patients Receiving Bare-Metal and Drug-Eluting Stents. Clinical Cardiology 34:9, 567-571
CrossRef75
Etienne Puymirat, Fabio Mangiacapra, Aaron Peace, Faisal Sharif, Micaela Conte, Jozef Bartunek, Marc Vanderheyden, William Wijns, Bernard de Bruyne, Emanuele Barbato. (2011) Long-term clinical outcome in patients with small vessel disease treated with drug-eluting versus bare-metal stenting. American Heart Journal
CrossRef76
HIROKI ITO, JAMES B. HERMILLER, MANEJEH YAQUB, WILLIAM NEWMAN, POORNIMA SOOD, JOHN C. WANG, LOUIS CANNON, JAMES E. MADDUX, KRISHNANKUTTY SUDHIR, GREGG W. STONE. (2011) Performance of Everolimus-Eluting versus Paclitaxel-Eluting Coronary Stents in Small Vessels: Results from the SPIRIT III and SPIRIT IV Clinical Trials. Journal of Interventional Cardiologyno-no
CrossRef77
Franklin L. Rosenfeldt, Mark D. Wilson, Brian F. Buxton, Silvana F. Marasco. (2011) Coronary Artery Bypass Surgery Provides Long-Term Results Superior to Percutaneous Coronary Intervention. Heart, Lung and Circulation
CrossRef78
Ankur Raval, Jigisha Parikh, Chhaya Engineer. (2011) Mechanism and in Vitro Release Kinetic Study of Sirolimus from a Biodegradable Polymeric Matrix Coated Cardiovascular Stent. Industrial & Engineering Chemistry Research 50:16, 9539-9549
CrossRef79
Volker Klauss, Patrick W. Serruys, Thomas Pilgrim, Pawel Buszman, Axel Linke, Thomas Ischinger, Franz Eberli, Roberto Corti, William Wijns, Marie-Claude Morice, Carlo di Mario, Robert Jan van Geuns, Gerrit-Anne van Es, Bindu Kalesan, Peter Wenaweser, Peter Jüni, Stephan Windecker. (2011) 2-Year Clinical Follow-Up From the Randomized Comparison of Biolimus-Eluting Stents With Biodegradable Polymer and Sirolimus-Eluting Stents With Durable Polymer in Routine Clinical Practice. JACC: Cardiovascular Interventions 4:8, 887-895
CrossRef80
Tae-Hyun Yang, Doo-Il Kim, Han-Young Jin, Young-Wan Cho, Sang Ryul Chung, Dong-Kie Kim, Yong-Bok Kim, Jae-Sik Jang, Ung Kim, Sang-Hoon Seol, Dae-Kyeong Kim, Dong-Soo Kim. (2011) “Angiographic late catch-up” phenomenon after sirolimus-eluting stent implantation. International Journal of Cardiology
CrossRef81
Kengo Tanabe, Satoru Kishi, Jiro Aoki, Shuzou Tanimoto, Yoshinobu Onuma, Sen Yachi, Masanori Taniwaki, Yoshifumi Nakajima, Hiroyoshi Nakajima, Kazuhiro Hara, Mitsuaki Isobe. (2011) Impact of Coronary Calcium on Outcome Following Sirolimus-Eluting Stent Implantation. The American Journal of Cardiology 108:4, 514-517
CrossRef82
Arturo Giordano, Alfredo Romano. (2011) Inhibition of human in-stent restenosis: a molecular view. Current Opinion in Pharmacology 11:4, 372-377
CrossRef83
Hakan Ceylan, Ayse B. Tekinay, Mustafa O. Guler. (2011) Selective adhesion and growth of vascular endothelial cells on bioactive peptide nanofiber functionalized stainless steel surface. Biomaterials
CrossRef84
SUSAN BEZENEK, JAMES HERMILLER, ALEXANDRA LANSKY, MANEJEH YAQUB, KYOKO HATTORI, SHERRY CAO, POORNIMA SOOD, KRISHNAKUTTY SUDHIR. (2011) Low Stent Thrombosis Risk with the XIENCE V® Everolimus-Eluting Coronary Stent: Evidence from Randomized and Single-Arm Clinical Trials. Journal of Interventional Cardiology 24:4, 326-341
CrossRef85
Corrado Tamburino, Daniele Giacoppo, Davide Capodanno. (2011) The Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial. Interventional Cardiology 3:4, 451-460
CrossRef86
C-L. Poh, M. Y. Chan, C. Lau, S-G. Teo, A. F. Low, H-C. Tan, C-H. Lee. (2011) Prevalence and predictors of premature discontinuation of dual antiplatelet therapy after drug-eluting stent implantation: importance of social factors in Asian patients. Internal Medicine Journal 41:8, 623-629
CrossRef87
Tarek A.N. Ahmed, Sandrin C. Bergheanu, Theo Stijnen, Josepha W.M. Plevier, Paul H.A. Quax, J. Wouter Jukema. (2011) Clinical performance of drug-eluting stents with biodegradable polymeric coating: a meta-analysis and systematic review. EuroIntervention 7:4, 505-516
CrossRef88
Johannes Lammer, Marc Bosiers, Thomas Zeller, Martin Schillinger, Els Boone, Margo J. Zaugg, Patrick Verta, Lei Peng, Xingyu Gao, Lewis B. Schwartz. (2011) First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease. Journal of Vascular Surgery 54:2, 394-401
CrossRef89
, Timm Bauer, Christoph A. Nienaber, Ibrahim Akin, Karl-Heinz Kuck, Matthias Hochadel, Jochen Senges, Thomas Fetsch, Ulrich Tebbe, Stefan N. Willich, Jürgen Stumpf, Georg V. Sabin, Sigmund Silber, Gert Richardt. (2011) Comparison between on-label versus off-label use of drug-eluting coronary stents in clinical practice: results from the German DES.DE-Registry. Clinical Research in Cardiology 100:8, 701-709
CrossRef90
Margo Klomp, Marcel A. Beijk, Chetan Varma, Jacques J. Koolen, Emmanuel Teiger, Gert Richardt, Florian Bea, Nan van Geloven, Niels J. Verouden, Yu Kwan Chan, Pier Woudstra, Peter Damman, Jan G. Tijssen, Robbert J. de Winter. (2011) 1-Year Outcome of TRIAS HR (TRI-Stent Adjudication Study–High Risk of Restenosis). JACC: Cardiovascular Interventions 4:8, 896-904
CrossRef91
Abdul Hakeem, Kunal Karmali, Shane J Larue, Sabha Bhatti, Venkat Chilakapati, Zainab Samad, Michelle Roth Cline, Mehmet Cilingiroglu, Massoud A Leesar. (2011) Clinical presentation and outcomes of drug-eluting stent-associated coronary aneurysms. EuroIntervention 7:4, 487-496
CrossRef92
Charlie C-T Hsu, John A Rophael, Reza Mofidi, Gigi NC Kwan, Mieke L van Driel, Charlie C-T Hsu. 2011. Percutaneous transluminal arterial angioplasty versus stenting for infrapopliteal arterial lesions in critical limb ischaemia. .
CrossRef93
Robert T. Gerber, Alfonso Ielasi, Rasha Al-Lamee, Azeem Latib, Flavio Airoldi, Massimo Ferraro, Luca Ferri, Giorgio Bassanelli, Cosmo Godino, Andrew S.P. Sharp, Alaide Chieffo, Mauro Carlino, Matteo Montorfano, Giuseppe M. Sangiorgi, Antonio Colombo. (2011) Long-term follow-up of multivessel percutaneous coronary intervention with drug-eluting stents for de novo lesions with correlation to the SYNTAX score. Cardiovascular Revascularization Medicine 12:4, 220-227
CrossRef94
Salvatore Cassese, Raffaele Piccolo, Gennaro Galasso, Roberta De Rosa, Federico Piscione. (2011) Twelve-month clinical outcomes of everolimus-eluting stent as compared to paclitaxel- and sirolimus-eluting stent in patients undergoing percutaneous coronary interventions. A meta-analysis of randomized clinical trials. International Journal of Cardiology 150:1, 84-89
CrossRef95
Aida Ribera, Ignacio Ferreira-González, Bruno García del Blanco, Josep R. Marsal, Purificación Cascant, Gerard Martí, Ángel R. Cequier, Joan Antoni Gómez-Hospital, Eduard Fernandez-Nofrerías, Xavier Carrillo, M. Carmen López-Pérez, Josep Navarro, Rafael Raso, David García-Dorado, Gaietà Permanyer-Miralda. (2011) Drug-eluting stents for off-label indications in real clinical world: Evidence based or ‘intuition’ based clinical practice?. International Journal of Cardiology
CrossRef96
Kosei Tanaga, Keiichiro Miura, Takahiro Kageyama, Yoshitake Nakamura, Toshihisa Inoue, Kigen Jo, Takayasu Ishikawa, Akira Miyazaki. (2011) Restenosis after implantation of sirolimus-eluting stent begins suddenly, shows short term progression, and stops suddenly. Journal of Cardiology 58:1, 26-31
CrossRef97
Michael Lee, Tae Yang, John Lasala, David Cox, Thomas Bowman, Ruth Starzyk, Keith Dawkins. (2011) Two-year clinical outcomes of paclitaxel-eluting stents for in-stent restenosis in patients from the ARRIVE programme. EuroIntervention 7:3, 314-322
CrossRef98
Peter Mortier, Matthieu De Beule, Patrick Segers, Pascal Verdonck, Benedict Verhegghe. (2011) Virtual bench testing of new generation coronary stents. EuroIntervention 7:3, 369-376
CrossRef99
Tae-Hoon Kim, Jung-Sun Kim, Byoung-Keuk Kim, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Myeong-Ki Hong. (2011) Long-term (≥2 years) follow-up optical coherence tomographic study after sirolimus- and paclitaxel-eluting stent implantation: comparison to 9-month follow-up results. The International Journal of Cardiovascular Imaging 27:6, 875-881
CrossRef100
Daniel Chamié, Alexandre Abizaid, J. Ribamar Costa, Fausto Feres, J. Fábio Almiro da Silva, Luiz Alberto P. Mattos, Rodolfo Staico, Ricardo A. Costa, Andréa Abizaid, Luiz Fernando L. Tanajura, Amanda G. M. R. Sousa, J. Eduardo Sousa. (2011) Serial angiographic and intravascular ultrasound evaluation to interrogate the presence of late “catch-up” phenomenon after cypher® sirolimus-eluting stent implantation. The International Journal of Cardiovascular Imaging 27:6, 867-874
CrossRef101
Feng Qian, Edward L. Hannan, Laurent G. Glance, Charles E. Phelps, Frederick S. Ling, Peter J. Veazie. (2011) Coronary stent use in New York State in the drug-eluting stent era. Journal of Evaluation in Clinical Practiceno-no
CrossRef102
Salvatore Brugaletta, Hector M. Garcia-Garcia, Scot Garg, Josep Gomez-Lara, Roberto Diletti, Yoshinobu Onuma, Robert Jan Geuns, Dougal McClean, Dariusz Dudek, Leif Thuesen, Bernard Chevalier, Stephan Windecker, Robert Whitbourn, Cecile Dorange, Karine Miquel-Hebert, Krishnankutty Sudhir, John A. Ormiston, Patrick W. Serruys. (2011) Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold. The International Journal of Cardiovascular Imaging 27:6, 859-866
CrossRef103
Tomokazu Ikemoto, Yukihiro Hojo, Hideyuki Kondo, Nozomu Takahashi, Masahiro Hirose, Yoshioki Nishimura, Takaaki Katsuki, Kazuyuki Shimada, Kazuomi Kario. (2011) Plasma endoglin as a marker to predict cardiovascular events in patients with chronic coronary artery diseases. Heart and Vessels
CrossRef104
Young-Guk Ko, Dong-Min Kim, Jin Man Cho, So Yeon Choi, Jung Han Yoon, Jung-Sun Kim, Byeong-Keuk Kim, Donghoon Choi, Yangsoo Jang, Myeong-Ki Hong. (2011) Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation. The International Journal of Cardiovascular Imaging
CrossRef105
Masato Nakamura. (2011) Review of the everolimus-eluting coronary stent system. Interventional Cardiology 3:3, 299-307
CrossRef106
Thomas Pilgrim, Lorenz Räber, Andreas Limacher, Lukas Löffel, Peter Wenaweser, Stéphane Cook, Jean-Christophe Stauffer, Mario Togni, Rolf Vogel, Ali Garachemani, Aris Moschovitis, Ahmed A. Khattab, Christian Seiler, Bernhard Meier, Peter Jüni, Stephan Windecker. (2011) Comparison of Titanium-Nitride-Oxide–Coated Stents With Zotarolimus-Eluting Stents for Coronary Revascularization. JACC: Cardiovascular Interventions 4:6, 672-682
CrossRef107
Evren Caglayan, Marius Vantler, Olli Leppänen, Felix Gerhardt, Lenard Mustafov, Henrik ten Freyhaus, Kai Kappert, Margarete Odenthal, Wolfram H. Zimmermann, Michelle D. Tallquist, Stephan Rosenkranz. (2011) Disruption of Platelet-Derived Growth Factor–Dependent Phosphatidylinositol 3-Kinase and Phospholipase Cγ 1 Activity Abolishes Vascular Smooth Muscle Cell Proliferation and Migration and Attenuates Neointima Formation In Vivo. Journal of the American College of Cardiology 57:25, 2527-2538
CrossRef108
Masanori Yamamoto, Masamichi Takano, Daisuke Murakami, Toru Inami, Nobuaki Kobayashi, Sigenobu Inami, Kentaro Okamatsu, Takayoshi Ohba, Chikao Ibuki, Noritake Hata, Yoshihiko Seino, Ik-Kyung Jang, Kyoichi Mizuno. (2011) The possibility of delayed arterial healing 5 years after implantation of sirolimus-eluting stents: Serial observations by coronary angioscopy. American Heart Journal 161:6, 1200-1206
CrossRef109
Pil Sang Song, Dong Ryeol Ryu, Young Bin Song, Joo-Yong Hahn, Jin-Ho Choi, Seung-Hyuk Choi, Sang Hoon Lee, Kyung Pyo Hong, Jeong Euy Park, Hyeon-Cheol Gwon. (2011) Long-Term Outcomes of Sirolimus-Eluting Stents vs Paclitaxel-Eluting Stents in Unprotected Left Main Coronary Artery Bifurcation Lesions. Clinical Cardiology 34:6, 378-383
CrossRef110
Waqar H. Ahmed, Oscar A. Mendiz, Martyn R. Thomas, . (2011) Usage patterns and 1-year outcomes with the TAXUS Liberté stent: Results of the TAXUS OLYMPIA registry. Catheterization and Cardiovascular Interventions 77:7, 979-992
CrossRef111
Y. C Chan, S. W Cheng. (2011) Drug-eluting stents and balloons in peripheral arterial disease: evidence so far. International Journal of Clinical Practice 65:6, 664-668
CrossRef112
Juan Luis Gutiérrez-Chico, Evelyn Regar, Robert-Jan van Geuns, Scot Garg, Carl Schultz, Nicolas van Mieghem, Henricus Duckers, Patrick W Serruys. (2011) Moxy® drug-coated balloon: a novel device for the treatment of coronary and peripheral vascular disease. EuroIntervention 7:2, 274-277
CrossRef113
William A. Gray, Alan C. Yeung, Donald E. Cutlip, Jeffrey J. Popma, Peter J. Fitzgerald, David O. Williams, Hubertus Heuer, Charles D. O'Shaughnessy, Paul A. Overlie, J. Tift Mann, Louis A. Cannon, James B. Hermiller, Timothy D. Henry, Robert Whitbourn, Thomas D. Stuckey, Mark G. Midei, Jessie Coe, Lewis B. Schwartz. (2011) A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: Final results of the ZoMaxx II trial. International Journal of Cardiology
CrossRef114
Dong-Hyun Choi, Kyung Woo Park, Han-Mo Yang, Hae-Young Lee, Jin-Shik Park, Hyun-Jai Kang, Yong-Jin Kim, Bon-Kwon Koo, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim. (2011) Renal dysfunction and high levels of hsCRP are additively associated with hard endpoints after percutaneous coronary intervention with drug eluting stents. International Journal of Cardiology 149:2, 174-181
CrossRef115
Tarun W. Dasari, Thomas A. Hennebry, Elias B. Hanna, Jorge F. Saucedo. (2011) Drug eluting versus bare metal stents in cardiac allograft vasculopathy. Catheterization and Cardiovascular Interventions 77:7, 962-969
CrossRef116
Shoichiro Daimon, Hidenobu Terai. (2011) Influence of Antiplatelet Medications on Bleeding Events in Hemodialysis Patients. Therapeutic Apheresis and Dialysisno-no
CrossRef117
H. Nii, K. Wagatsuma, R. Nakanishi, Y. Uchida, H. Amano, M. Toda, J. Yamazaki. (2011) Clinical outcomes of the placement of a drug-eluting stent with the use of Rotablator™ in dialytic patients: in comparison with non-dialytic patients. Cardiovascular Intervention and Therapeutics
CrossRef118
Werner Zimmerli, Parham Sendi. (2011) Pathogenesis of implant-associated infection: the role of the host. Seminars in Immunopathology 33:3, 295-306
CrossRef119
Roberto Martín-Reyes, Raul Moreno, Angel Sánchez-Recalde, Felipe Navarro, Juan Franco, Antonio Piñero, José Luis López Sendón. (2011) Comparison of the safety between first- and second-generation drug eluting stents. International Journal of Cardiology
CrossRef120
M. Kollum, C. Bode. (2011) Neue Entwicklungen bei medikamentenfreisetzenden Stents. Herz 36:3, 177-189
CrossRef121
Toshiyuki Nagai, Masaru Shibata, Satoru Suzuki, Takashi Matsubara. (2011) The potential of surgical strategy for incomplete stent apposition after implantation of a sirolimus eluting stent. Cardiovascular Intervention and Therapeutics 26:2, 157-161
CrossRef122
Margo Klomp, Marcel A.M. Beijk, Jan G.P. Tijssen, Robbert J. de Winter. (2011) One-year clinical outcome in an unselected patient population treated with the Genous™ endothelial progenitor cell capturing stent. Catheterization and Cardiovascular Interventions 77:6, 809-817
CrossRef123
Shengxian Tu, Peiyuan Hao, Gerhard Koning, Xianglong Wei, Xudong Song, Aihua Chen, Johan H.C. Reiber. (2011) In vivo assessment of optimal viewing angles from X-ray coronary angiography. EuroIntervention 7:1, 112-120
CrossRef124
Laura Mauri, Martin B. Leon, Alan C. Yeung, Manuela Negoita, Michelle J. Keyes, Joseph M. Massaro. (2011) Rationale and design of the clinical evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the treatment of de novo lesions in native coronary arteries (the RESOLUTE US clinical trial). American Heart Journal 161:5, 807-814
CrossRef125
Rosli Ali, Ralf Degenhardt, Robaayah Zambahari, Damras Tresukosol, Wan Azman Ahmad, Haizal Kamar, Sim Kui-Hian, Tiong Ong, Omar bin Ismail, Safari bin Elis, Wasan Udychalerm, Hanns Ackermann, Michael Boxberger, Martin Unverdorben. (2011) Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus. EuroIntervention 7:K, K83-K92
CrossRef126
Hiroyuki Kyono, Ken Kozuma, Yoshitaka Shiratori, Yoshio Maeno, Ryu Iino, Kaoru Takada, Shuichi Ishikawa, Kumiko Konno, Hirosada Yamamoto, Nobuaki Suzuki, Akiyoshi Miyazawa, Takeshi Yamakawa, Naoyuki Yokoyama, Takaaki Isshiki. (2011) Angiographic and clinical outcomes of 100 consecutive severe calcified lesions requiring rotational atherectomy prior to sirolimus-eluting stent implantation in hemodialysis and non-hemodialysis patients. Cardiovascular Intervention and Therapeutics 26:2, 98-103
CrossRef127
Lenard Conradi, Hermann Reichenspurner. (2011) 3 Jahre nach SYNTAX – Stent oder Skalpell?. Clinical Research in Cardiology Supplements 6:S1, 43-48
CrossRef128
Gunnar Tepe, Stephanie Schmitmeier, Thomas Zeller. (2011) Drug-coated balloons in peripheral arterial disease. EuroIntervention 7:K, K70-K76
CrossRef129
Flavio Ribichini, Fabrizio Tomai, Giuseppe De Luca, Giacomo Boccuzzi, Patrizia Presbitero, Gabriele Pesarini, Valeria Ferrero, Anna S. Ghini, Ramadan Abukaresh, Cristina Aurigemma, Leonardo De Luca, Dennis Zavalloni, Daniela Soregaroli, Paolo Marino, Roberto Garbo, Luisa Zanolla, Corrado Vassanelli. (2011) Immunosuppressive Therapy with Oral Prednisone to Prevent Restenosis after PCI. A Multicenter Randomized Trial. The American Journal of Medicine 124:5, 434-443
CrossRef130
Seshasayee Narasimhan, Vankeepuram S. Srinivas, Joseph John DeRose. (2011) Hybrid Coronary Revascularization. Cardiology in Review 19:3, 101-107
CrossRef131
Yuki Horita, Masanobu Namura, Masatoshi Ikeda, Taketoshi Tsuchiya, Hidenobu Terai, Ryota Fukuoka, Naoto Tama, Toshimitsu Takagi. (2011) Which DES is the most appropriate for very small target vessels? Experimental study of stent expandable performance with SES, PES, ZES and EES. Cardiovascular Intervention and Therapeutics 26:2, 124-130
CrossRef132
Yoshiyuki Masaki, Kazunori Shimada, Takahiko Kojima, Katsumi Miyauchi, Kenji Inoue, Takashi Kiyanagi, Makoto Hiki, Kosuke Fukao, Kuniaki Hirose, Hiromichi Ohsaka, Atsumi Kume, Tetsuro Miyazaki, Hirotoshi Ohmura, Akimichi Ohsaka, Hiroyuki Daida. (2011) Clinical significance of the measurements of plasma N-terminal pro-B-type natriuretic peptide levels in patients with coronary artery disease who have undergone elective drug-eluting stent implantation. Journal of Cardiology 57:3, 303-310
CrossRef133
Giulio G. Stefanini, Patrick W. Serruys, Sigmund Silber, Ahmed A. Khattab, Robert J. van Geuns, Gert Richardt, Pawel E. Buszman, Henning Kelbæk, Adrianus J. van Boven, Sjoerd H. Hofma, Axel Linke, Volker Klauss, William Wijns, Carlos Macaya, Philippe Garot, Carlo Di Mario, Ganesh Manoharan, Ran Kornowski, Thomas Ischinger, Antonio L. Bartorelli, Pierre Gobbens, Stephan Windecker. (2011) The Impact of Patient and Lesion Complexity on Clinical and Angiographic Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents. Journal of the American College of Cardiology 57:22, 2221-2232
CrossRef134
Shinsuke Nanto, Masaki Awata, Hideki Shimomura, Takatoshi Hayashi, Shinjo Sonoda, Yoshio Ohashi, Yoshihiro Iwasaki, Hitoshi Nakashima. (2011) Clinical usefulness of the Driver® stent in a retrospective, collaborative, multicenter, open-label study in Japanese real-world patients with coronary artery disease and the drug-eluting stent era. Cardiovascular Intervention and Therapeutics 26:2, 131-137
CrossRef135
Jian Ma, Weiwei Yang, Manpreet Singh, Tianqing Peng, Ningyuan Fang, Meng Wei. (2011) Meta-analysis of long-term outcomes of drug-eluting stent implantations for chronic total coronary occlusions. Heart & Lung: The Journal of Acute and Critical Care 40:3, e32-e40
CrossRef136
Sigmund Silber, Juan Luis Gutiérrez-Chico, Steffen Behrens, Bernhard Witzenbichler, Marcus Wiemer, Stefan Hoffmann, Ton Slagboom, Darius Harald, Harry Suryapranata, Christoph Nienaber, Bernard Chevalier, Patrick Serruys. (2011) Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial. EuroIntervention 7:1, 64-73
CrossRef137
Ian T. Meredith, Robert Whitbourn, Douglas Scott, Seif El-Jack, Robaayah Zambahari, Gregg W. Stone, Paul S. Teirstein, Ruth M. Starzyk, Dominic J. Allocco, Keith D. Dawkins. (2011) PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses. EuroIntervention 7:1, 84-90
CrossRef138
Lorenz Räber, Peter Jüni, Eveline Nüesch, Bindu Kalesan, Peter Wenaweser, Aris Moschovitis, Ahmed A. Khattab, Maryam Bahlo, Mario Togni, Stéphane Cook, Rolf Vogel, Christian Seiler, Bernhard Meier, Stephan Windecker. (2011) Long-Term Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents for Coronary Revascularization. Journal of the American College of Cardiology 57:21, 2143-2151
CrossRef139
Laura Indolfi, Filippo Causa, Concetta Giovino, Francesca Ungaro, Fabiana Quaglia, Paolo Antonio Netti. (2011) Microsphere-integrated drug-eluting stents: PLGA microsphere integration in hydrogel coating for local and prolonged delivery of hydrophilic antirestenosis agents. Journal of Biomedical Materials Research Part A 97A:2, 201-211
CrossRef140
Leif Thuesen. 2011. Bifurcation Lesions. , 298-311.
CrossRef141
Ajay J. Kirtane, Adriano Caixeta, Philippe Généreux, Rikesh Patel, Jeffrey W. Moses. 2011. Sirolimus and Paclitaxel Eluting Stent Clinical Studies. , 502-518.
CrossRef142
Jiro Aoki, Adriano Caixeta, George D. Dangas, Roxana Mehran. 2011. In-Stent Restenosis in the DES Era. , 442-463.
CrossRef143
Adriano Caixeta, Alexandre Abizaid, George D. Dangas, Martin B. Leon. 2011. Novel Drug Eluting Stent Systems. , 539-555.
CrossRef144
Adriano Caixeta, Akiko Maehara, Gary S. Mintz. 2011. Intravascular Ultrasound: Principles, Image Interpretation, and Clinical Applications. , 145-171.
CrossRef145
Jiayin Zhang, Minghua Li, Zhigang Lu, Jingyu Hang, Jingwei Pan, Leiqing Sun. (2011) In vivo evaluation of stent patency by 64-slice multidetector CT coronary angiography: shall we do it or not?. The International Journal of Cardiovascular Imaging
CrossRef146
Raul Moreno, Roberto Martin-Reyes, Santiago Jimenez-Valero, Angel Sanchez-Recalde, Guillermo Galeote, Luis Calvo, Ignacio Plaza, Jose-Luis Lopez-Sendon. (2011) Determining clinical benefits of drug-eluting coronary stents according to the population risk profile: A meta-regression from 31 randomized trials. International Journal of Cardiology 148:1, 23-29
CrossRef147
MOUNIR W.Z. BASALUS, KENNETH TANDJUNG, AART A. VAN APELDOORN, MARC J.K. ANKONE, CLEMENS VON BIRGELEN. (2011) Effect of Oversized Partial Postdilatation on Coatings of Contemporary Durable Polymer-Based Drug-Eluting Stents: A Scanning Electron Microscopy Study. Journal of Interventional Cardiology 24:2, 149-161
CrossRef148
Yoritaka Otsuka, Nobuaki Kokubu, Yoichiro Kasahara. (2011) Usefulness of a 0.010-inch guidewire compatible balloon for crossing stent-jailed sidebranches. International Journal of Cardiology 148:2, 228-231
CrossRef149
David Martin, Fergal J. Boyle. (2011) Computational structural modelling of coronary stent deployment: a review. Computer Methods in Biomechanics and Biomedical Engineering 14:4, 331-348
CrossRef150
Y. Otsuka, S. Ishiwata, T. Inada, H. Kanno, E. Kyo, Y. Hayashi, H. Fujita, I. Michishita. (2011) Comparison of haemodialysis patients and non-haemodialysis patients with respect to clinical characteristics and 3-year clinical outcomes after sirolimus-eluting stent implantation: insights from the Japan multi-centre post-marketing surveillance registry. European Heart Journal 32:7, 829-837
CrossRef151
TAKESHI SERIKAWA, TOMOHIRO KAWASAKI, HISASHI KOGA, YOSHIYA ORITA, SHINSUKE IKEDA, YOSHITAKA GOTO, YOSHIAKI SHINTANI, MASATAKA KAJIWARA, HIDENORI TANAKA, TAKAYA FUKUYAMA, NOBUHIKO KOGA. (2011) Late Catch-Up Phenomenon Associated with Stent Fracture after Sirolimus-Eluting Stent Implantation: Incidence and Outcome. Journal of Interventional Cardiology 24:2, 165-171
CrossRef152
Asmir Syed, Itsik Ben-Dor, Yanlin Li, Sara Collins, Rebecca Torguson, Kohei Wakabayashi, Manuel Gonzalez, Gabriel Maluenda, Cedric Delhaye, Loic Belle, Michael Gaglia, Zhenyi Xue, Kimberly Kaneshige, Nelson Bernardo, Kenneth Kent, William Suddath, Lowell Satler, Augusto Pichard, Joseph Lindsay, Ron Waksman. (2011) Hybrid strategy of a bare metal stent combined with a drug-eluting stent versus exclusive drug-eluting stent implantation for multivessel percutaneous coronary intervention. EuroIntervention 6:9, 1085-1090
CrossRef153
Alfonso Ielasi, Azeem Latib, Antonio Colombo. (2011) Current and future drug-eluting coronary stent technology. Expert Review of Cardiovascular Therapy 9:4, 485-503
CrossRef154
, Miodrag C. Ostojic, Zoran Perisic, Dragan Sagic, Robert Jung, Yan-Ling Zhang, Jamie Bendrick-Peart, Ronald Betts, Uwe Christians. (2011) The pharmacokinetics of Biolimus A9 after elution from the BioMatrix II stent in patients with coronary artery disease: The Stealth PK Study. European Journal of Clinical Pharmacology 67:4, 389-398
CrossRef155
Leslie Levin, Ron Goeree, Mark Levine, Murray Krahn, Tony Easty, Adalstein Brown, David Henry. (2011) Coverage with evidence development: The Ontario experience. International Journal of Technology Assessment in Health Care 27:02, 159-168
CrossRef156
Ung Kim, Doo-Il Kim, Dong-Kie Kim, Sang-Hoon Seol, Jae-Sik Jang, Tae-Hyun Yang, Dae-Kyeong Kim, Dong-Soo Kim, Ho-Ki Min, Kang-Joo Choi. (2011) Long-term clinical and angiographic outcomes of patients with sirolimus-eluting stent fracture. International Journal of Cardiology
CrossRef157
Sigmund Silber, Stephan Windecker, Pascal Vranckx, Patrick W Serruys. (2011) Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial. The Lancet 377:9773, 1241-1247
CrossRef158
Stephanie Schmitmeier, Bodo Cremers, Yvonne P Clever, Ulrich Speck, Bruno Scheller. (2011) The SeQuent™ Please drug-coated balloon system for percutaneous transluminal coronary angioplasty. Interventional Cardiology 3:2, 133-147
CrossRef159
Thomas D Stuckey, Bruce R Brodie. (2011) Outcomes with drug-eluting stents in diabetic patients. Interventional Cardiology 3:2, 235-245
CrossRef160
Zengsheng Chen, Yubo Fan, Xiaoyan Deng, Zaipin Xu. (2011) A New Way to Reduce Flow Disturbance in Endovascular Stents: A Numerical Study. Artificial Organs 35:4, 392-397
CrossRef161
Cláudia de Lourdes Sorragi, Silvia Mika Shishido, Maria Edwiges Lemos, Sissi Marcondes, Edson Antunes, Marta H. Krieger. (2011) In vitro evaluation of the safe margin, antithrombotic and antiproliferative actions for the treatment of restenosis: Nitric oxide donor and polymers. Cell Biochemistry and Function 29:3, 207-214
CrossRef162
Mariano Valdés Chavarri, Armando Bethencourt, Eduardo Pinar, Alfredo Gomez, Javier Fernández Portales, Francisco Pomar, Isabel Calvo, Jose Ramón López Minguez, Raúl Valdesuso, José Moreu, Antonio Martínez, Wail Nammas. (2011) Titanium-nitride-oxIde-coated stents multicenter registry in diaBEtic patienTs: the TIBET registry. Heart and Vessels
CrossRef163
Gregory M. Lanza, Shelton D. Caruthers, Anne H. Schmieder, Patrick M. Winter, Tillmann Cyrus, Samuel A. Wickline. 2011. Perfluorocarbon Nanoparticles: A Multidimensional Platform for Targeted Image-Guided Drug Delivery. , 725-753.
CrossRef164
(2011) Drug-Eluting or Bare-Metal Stents in Large Coronary Arteries. New England Journal of Medicine 364:12, 1178-1180
Full Text165
Bong Soo Lee, Hong-Sub Shin, Kwideok Park, Dong Keun Han. (2011) Surface grafting of blood compatible zwitterionic poly(ethylene glycol) on diamond-like carbon-coated stent. Journal of Materials Science: Materials in Medicine 22:3, 507-514
CrossRef166
Satheesh Nair, Farzin Fath-Ordoubadi, Bernard Clarke, Magdi El-Omar, James Foley, Doug G. Fraser, Vaikom S. Mahadevan, Ludwig Neyses, Raj S. Khattar, Mamas A. Mamas. (2011) Late outcomes of drug eluting and bare metal stents in saphenous vein graft percutaneous coronary intervention. EuroIntervention 6:8, 985-991
CrossRef167
Hyun-Sook Kim, Jae-Hwan Lee, Seung-Whan Lee, Young-Hak Kim, Jae-Hyeong Park, Si-Wan Choi, Jin-Ok Jeong, In-Whan Seong, Kyoung-Suk Rhee, Jae-Ki Ko, Sang-Ho Jo, Young Jin Choi. (2011) Long-term safety and efficacy of sirolimus- vs. paclitaxel-eluting stent implantation for acute ST-elevation myocardial infarction: 3-year follow-up of the PROSIT trial. International Journal of Cardiology 147:2, 253-257
CrossRef168
Geraud Souteyrand, Sebastien Levesque, Lemlih Ouchchane, Laurent Sarry, Romain Eschalier, Jean-René Lusson, Pascal Motreff. (2011) Spatial distribution of neo-intimal hyperplasia 6 months after zotarolimus-eluting stent implantation, analysed by optical coherence tomography. Archives of Cardiovascular Diseases 104:3, 147-154
CrossRef169
Nobuyuki Miyai, Noriyuki Kinoshita, Keisuke Oota, Takeshi Yamada, Reo Nakamura, Hidekazu Irie, Tetsuo Hashimoto, Shyunichi Tamaki, Hiroaki Matsubara. (2011) Long-term angiographic outcomes of post-Sirolimus-eluting stent restenosis in Japanese patients. Heart and Vessels 26:2, 168-175
CrossRef170
Ioannis Tentzeris, Rudolf Jarai, Serdar Farhan, Johann Wojta, Martin Schillinger, Alexander Geppert, Michael Nürnberg, Gerhard Unger, Kurt Huber. (2011) Long-term outcome after drug-eluting stent implantation in comparison with bare metal stents: a single centre experience. Clinical Research in Cardiology 100:3, 191-200
CrossRef171
K. Anette Birkmeier, Adnan Kastrati, Robert A. Byrne, Heidrun Holle, Stefanie Schulz, Klaus Tiroch, Sebastian Kufner, Steffen Massberg, Karl-Ludwig Laugwitz, Albert Schömig, Julinda Mehilli. (2011) Five-year clinical outcomes of sirolimus-eluting versus paclitaxel-eluting stents in high-risk patients. Catheterization and Cardiovascular Interventions 77:4, 494-501
CrossRef172
Alamgir MN Kabir, Amalan Selvarajah, Alexander M Seifalian. (2011) How safe and how good are drug-eluting stents?. Future Cardiology 7:2, 251-270
CrossRef173
Teruo Okabe, Akio Kawamura, Yuichiro Maekawa, Toshihisa Anzai, Shiro Iwanaga, Tsutomu Yoshikawa, Satoshi Ogawa. (2011) Can intravascular ultrasound guidance modify the efficacy of drug-eluting stent over bare-metal stent in an aorto-ostial lesion?. Cardiovascular Revascularization Medicine 12:2, 105-110
CrossRef174
Yue Wu, Weiping Zhang, Weimin Liu, Xiaozhen Zhuo, Zhao Zhao, Zuyi Yuan. (2011) The double-faced metabolic and inflammatory effects of standard drug therapy in patients after percutaneous treatment with drug-eluting stent. Atherosclerosis 215:1, 170-175
CrossRef175
David M. Martin, Fergal J. Boyle. (2011) Drug-eluting stents for coronary artery disease: A review. Medical Engineering & Physics 33:2, 148-163
CrossRef176
F. Gori, A. Boghi. (2011) Three-Dimensional Numerical Simulation of Blood Flow in Two Coronary Stents. Numerical Heat Transfer, Part A: Applications 59:4, 231-246
CrossRef177
David M. Charytan, Manu R. Varma, Treacy S. Silbaugh, Ann F. Lovett, Sharon-Lise T. Normand, Laura Mauri. (2011) Long-term Clinical Outcomes Following Drug-Eluting or Bare-Metal Stent Placement in Patients With Severely Reduced GFR: Results of the Massachusetts Data Analysis Center (Mass-DAC) State Registry. American Journal of Kidney Diseases 57:2, 202-211
CrossRef178
Sofia Sofroniadou, David Goldsmith. (2011) Mammalian Target of Rapamycin (mTOR) Inhibitors. Drug Safety 34:2, 97-115
CrossRef179
Fiona Foo, Keith G Oldroyd. (2011) Clinical value of antiplatelet therapy in patients with acute coronary syndromes and in percutaneous coronary intervention. Biomarkers in Medicine 5:1, 9-30
CrossRef180
Seiji Habara, Kazuaki Mitsudo, Kazushige Kadota, Tsuyoshi Goto, Satoki Fujii, Hiroyuki Yamamoto, Harumi Katoh, Naoki Oka, Yasushi Fuku, Shingo Hosogi, Akitoshi Hirono, Takeshi Maruo, Hiroyuki Tanaka, Yoshikazu Shigemoto, Daiji Hasegawa, Hiroshi Tasaka, Mana Kusunose, Suguru Otsuru, Yoji Okamoto, Naoki Saito, Yuki Tsujimoto, Haruki Eguchi, Koshi Miyake, Mitsuru Yoshino. (2011) Effectiveness of Paclitaxel-Eluting Balloon Catheter in Patients With Sirolimus-Eluting Stent Restenosis. JACC: Cardiovascular Interventions 4:2, 149-154
CrossRef181
Shengxian Tu, Niels R. Holm, Gerhard Koning, Zheng Huang, Johan H. C. Reiber. (2011) Fusion of 3D QCA and IVUS/OCT. The International Journal of Cardiovascular Imaging 27:2, 197-207
CrossRef182
Sandhir B. Prasad, Thomas David, Yuvaraj Malaiapan, James D. Cameron, Ian T. Meredith. (2011) Selective drug-eluting stent implantation for high-risk patients with acute ST-elevation myocardial infarction: Rationale and safety. Catheterization and Cardiovascular Interventions 77:2, 193-200
CrossRef183
PASI P. KARJALAINEN, ANTTI YLITALO, JUHANI KE AIRAKSINEN, WAIL NAMMAS. (2011) Five-Year Clinical Outcome of Titanium-Nitride-Oxide-Coated Bioactive Stent Implantation in a Real-World Population: A Comparison with Paclitaxel-eluting Stents: The PORI Registry. Journal of Interventional Cardiology 24:1, 1-8
CrossRef184
Patrick Alexander, Shukri David, Peter A. McCullough. (2011) Drug-Eluting Coronary Stents in Patients With Kidney Disease. American Journal of Kidney Diseases 57:2, 188-189
CrossRef185
Michael Mahmoudi, Ron Waksman. (2011) Bifurcation stenting: the current state of play. Cardiovascular Revascularization Medicine
CrossRef186
Ming-wei Huang. (2011) Chinese herbal medicine Naoxintong capsule combined with dual antiplatelet therapy in a rat model of coronary microembolization induced by homologous microthrombi. Journal of Chinese Integrative Medicine 9:1, 38-48
CrossRef187
Hideshi Ishii, Toru Kataoka, Yoshiki Kobayashi, Takara Tsumori, Hiroaki Takeshita, Ryo Matsumoto, Nobuyuki Shirai, Hiroki Nishioka, Takao Hasegawa, Shinji Nakata, Yoshihisa Shimada, Shoichi Ehara, Takashi Muro, Minoru Yoshiyama. (2011) Utility of myocardial fractional flow reserve for prediction of restenosis following sirolimus-eluting stent implantation. Heart and Vessels
CrossRef188
Hyun Kuk Kim, Young Joon Hong, Myung Ho Jeong, Weon Kim, Sung Soo Kim, Jum Suk Ko, Min Goo Lee, Doo Sun Sim, Keun Ho Park, Nam Sik Yoon, Hyun Ju Yoon, Kye Hun Kim, Hyung Wook Park, Ju Han Kim, Youngkeun Ahn, Jeong Gwan Cho, Jong Chun Park, Jung Chaee Kang. (2011) Two-Year Clinical Outcome after Carvedilol-Loaded Stent Implantation in Patients with Coronary Artery Disease. The Korean Journal of Internal Medicine 26:1, 41
CrossRef189
Takeyuki Kubota, Tetsuya Ishikawa, Yosuke Nakano, Akira Endoh, Teruhiko Suzuki, Hiroshi Sakamoto, Toshio Hasuda, Kamon Imai, Michihiro Yoshimura, Makoto Mutoh. (2011) Retrospective Comparison of Clinical and Angiographic Outcomes After Sirolimus-Eluting and Bare-Metal Stent Implantation in 312 Consecutive, Nonrandomized Severely Calcified Lesions Using a Rotablator. International Heart Journal 52:2, 65-71
CrossRef190
Ki Hong Lee, Youngkeun Ahn, Nam Sik Yoon, Hyun Ju Yoon, Young Joon Hong, Kye Hun Kim, Hyung Wook Park, Ju Han Kim, Myung Ho Jeong, Jeong Gwan Cho, Jong Chun Park, Jung Chaee Kang. (2011) Are Drug-Eluting Stents Safer and More Effective Than Bare-Metal Stents in Patients With Acute Myocardial Infarction?. International Heart Journal 52:2, 78-83
CrossRef191
Doo Sun Sim, Myung Ho Jeong, Youngkeun Ahn, Young Jo Kim, Shung Chull Chae, Taek Jong Hong, In Whan Seong, Jei Keon Chae, Chong Jin Kim, Myeong Chan Cho, Ki Bae Seung, Seung Jung Park, . (2011) Effectiveness of Drug-Eluting Stents versus Bare-Metal Stents in Large Coronary Arteries in Patients with Acute Myocardial Infarction. Journal of Korean Medical Science 26:4, 521
CrossRef192
Xavier Freixa, Ali S. Almasood, Sohail Q. Khan, Rodrigo Wainstein, Azriel Osherov, Karen Mackie, Peter H. Seidelin, Vladimír Džavík. (2011) Decreased risk of stent fracture-related restenosis between paclitaxel-eluting stents and sirolimus eluting stents: Results of long-term follow-up. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef193
Kazushige Kadota, Toshiya Muramatsu, Masashi Iwabuchi, Shigeru Saito, Yasuhiko Hayashi, Yuji Ikari, Shinsuke Nanto, Kenshi Fujii, Naoto Inoue, Atsuo Namiki, Takeshi Kimura, Kazuaki Mitsudo. (2011) Randomized comparison of the nobori biolimus A9-eluting stent with the sirolimus-eluting stent in patients with stenosis in native coronary arteries. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef194
Niklas Millauer, Peter Jüni, Alexandra Hofmann, Simon Wandel, Anupham Bhambhani, Michael Billinger, Niklaus Urwyler, Peter Wenaweser, Gerrit Hellige, Lorenz Räber, Stéphane Cook, Rolf Vogel, Mario Togni, Christian Seiler, Bernhard Meier, Stephan Windecker. (2011) Sirolimus versus paclitaxel coronary stents in clinical practice. Catheterization and Cardiovascular Interventions 77:1, 5-12
CrossRef195
Marcus Wiemer, Andreas König, Johannes Rieber, Hae-Young Sohn, Marcus Leibig, Karl Theisen, Volker Klauss, Christoph Langer, Oliver Lindner, Dieter Horstkotte, Thomas Schiele. (2011) Sirolimus-eluting stent implantation versus beta-irradiation for the treatment of in-stent restenotic lesions: clinical and ultrasound results from a randomised trial. EuroIntervention 6:6, 687-694
CrossRef196
Marcel A.M. Beijk, Karel T. Koch, Jan G.P. Tijssen, José P.S. Henriques, Jan Baan, Marije M. Vis, Martin G. Meesterman, Jan J. Piek, Robbert J. de Winter. (2011) A retrospective analysis of consecutive patients undergoing nonurgent percutaneous coronary intervention comparing bare metal stents with drug-eluting stents using the National Institute for Clinical Excellence criteria. Coronary Artery Disease 22:1, 32-39
CrossRef197
Takashi Akasaka. (2011) What Can We Expect in PCI in Patients With Chronic Coronary Artery Disease. Circulation Journal 75:1, 211-217
CrossRef198
Hiroyuki Hao, Hatsue Ishibashi-Ueda, Masahiko Tsujimoto, Yasunori Ueda, Junya Shite, Giulio Gabbiani, Kenichi Fujii, Seiichi Hirota. (2011) Drug-Eluting Stent. Circulation Journal 75:7, 1548-1558
CrossRef199
Ryuichi Funada, Yuji Oikawa, Junji Yajima, Shunsuke Matsuno, Hiroto Kano, Hajime Kirigaya, Kazuyuki Nagashima, Masahiko Kurabayashi, Tadanori Aizawa. (2011) Prediction of late restenosis after sirolimus-eluting stent implantation using serial quantitative angiographic and intravascular ultrasound analysis. Cardiovascular Intervention and Therapeutics 26:1, 26-32
CrossRef200
Takeyuki Kubota, Tetsuya Ishikawa, Makoto Mutoh. (2011) Retrospective Comparison of the Clinical and Angiographic Outcomes of the Sirolimus-eluting Stent and the Bare-metal Stent in 2031 Nonrandomized Consecutive De Novo Native Coronary Lesions. Internal Medicine 50:21, 2463-2470
CrossRef201
Iwao Goto, Tomonori Itoh, Takumi Kimura, Tetsuya Fusazaki, Hiroki Matsui, Shoma Sugawara, Kentaro Komuro, Motoyuki Nakamura. (2011) Morphological and Quantitative Analysis of Vascular Wall and Neointimal Hyperplasia After Coronary Stenting. Circulation Journal 75:7, 1633-1640
CrossRef202
Kenji Ohkubo, Yoshio Kobayashi, Yoshitake Nakamura, Akira Miyazaki. (2011) Incidence of side-effects of dual antiplatelet therapy with clopidogrel and aspirin after coronary stent implantation. Cardiovascular Intervention and Therapeutics 26:1, 33-37
CrossRef203
Rohit S. Loomba, Suraj Chandrasekar, Neil Malhotra, Rohit R. Arora. (2011) Comparison of 12-Month Outcomes with Zotarolimus- and Paclitaxel-Eluting Stents: A Meta-Analysis. ISRN Cardiology 2011, 1-6
CrossRef204
Yasuko Kato, Nobuo Shiode, Kinya Shirota, Fumiyo Tsunoda, Mai Fujiwara, Asao Mimura. (2011) Moderate stenosis in left main trunk side branches treated with single sirolimus-eluting stents should be observed without additional stenting. Cardiovascular Intervention and Therapeutics 26:1, 52-56
CrossRef205
Masaki Awata, Masaaki Uematsu, Fusako Sera, Takayuki Ishihara, Tetsuya Watanabe, Masashi Fujita, Toshinari Onishi, Osamu Iida, Yoshio Ishida, Shinsuke Nanto, Seiki Nagata. (2011) Angioscopic Assessment of Arterial Repair Following Biodegradable Polymer-Coated Biolimus A9-Eluting Stent Implantation. Circulation Journal 75:5, 1113-1119
CrossRef206
Yukio Ishikawa, Yoko Kawawa, Eiichi Kohda, Kazuyuki Shimada, Toshiharu Ishii. (2011) Significance of the Anatomical Properties of a Myocardial Bridge in Coronary Heart Disease. Circulation Journal 75:7, 1559-1566
CrossRef207
Yasushi Ino, Takashi Kubo, Hironori Kitabata, Kunihiro Shimamura, Yasutsugu Shiono, Makoto Orii, Keishi Okochi, Hiromichi Sougawa, Takashi Tanimoto, Kenichi Komukai, Kohei Ishibashi, Shigeho Takarada, Hiroko Nakanishi, Atsushi Tanaka, Keizo Kimura, Kumiko Hirata, Masato Mizukoshi, Toshio Imanishi, Takashi Akasaka. (2011) Impact of Hinge Motion on In-Stent Restenosis After Sirolimus-Eluting Stent Implantation. Circulation Journal 75:8, 1878-1884
CrossRef208
Masaya Otsuka, Mamoru Toyofuku, Noriaki Watanabe, Chikaaki Motoda, Tomoharu Kawase, Ryo Takeda, Shinji Mito, Hiromichi Tamekiyo, Tomokazu Okimoto, Hidekazu Hirao, Yuji Muraoka, Hironori Ueda, Yoshiko Masaoka, Yasuhiko Hayashi. (2011) Clinical usefulness of drug-eluting stents in the treatment of dialysis patients with coronary artery disease. EuroIntervention 6:6, 754-759
CrossRef209
Chi-Ling Hang, Bor-Tsung Hsieh, Chiung-Jen Wu, Hon-Kan Yip, Cheng-Hsu Yang, Shyh-Ming Chen, Yuan-Kai Hsieh, Morgan Fu, Sarah Chua, Gary Bih-Fang Guo, Stephen Wan Leung. (2011) Six-Year Clinical Follow-up After Treatment of Diffuse In-Stent Restenosis With Cutting Balloon Angioplasty Followed by Intracoronary Brachytherapy With Liquid Rhenium-188-Filled Balloon via Transradial Approach. Circulation Journal 75:1, 113-120
CrossRef210
Sang Min Park, Jong-Youn Kim, Bum-Kee Hong, Byoung Kwon Lee, Pil-Ki Min, Sejoong Rim, Hee-Sun Mun, Sung Woo Kwon, Sung-Joo Lee, Jong Kwan Park, Hyuck Moon Kwon. (2011) Predictors of stent fracture in patients treated with closed-cell design stents. Coronary Artery Disease 22:1, 40-44
CrossRef211
Takashi Kuwano, Shin-ichiro Miura, Kazuyuki Shirai, Amane Ike, Ken Mori, Tomohiko Shimizu, Bo Zhang, Atsushi Iwata, Hiroaki Nishikawa, Akira Kawamura, Keijiro Saku. (2011) Serum Levels of Bilirubin as an Independent Predictor of Coronary In-Stent Restenosis: A New Look at an Old Molecule. Journal of Atherosclerosis and Thrombosis 18:7, 574-583
CrossRef212
Min Goo Lee, Myung Ho Jeong, Youngkeun Ahn, Jeong Gwan Cho, Jong Chun Park, Jung Chaee Kang, Shung Chull Chae, Seung Ho Hur, Taek Jong Hong, Young Jo Kim, In Whan Seong, Jei Keon Chae, Jay Young Rhew, In Ho Chae, Myeong Chan Cho, Jang Ho Bae, Seung Woon Rha, Chong Jin Kim, Donghoon Choi, Yang Soo Jang, Junghan Yoon, Wook Sung Chung, Ki Bae Seung, Seung Jung Park. (2011) Comparison of Paclitaxel-, Sirolimus-, and Zotarolimus-Eluting Stents in Patients With Acute ST-Segment Elevation Myocardial Infarction and Metabolic Syndrome. Circulation Journal 75:9, 2120-2127
CrossRef213
B. Scheller, B. Levenson, M. Joner, R. Zahn, V. Klauss, C. Naber, V. Schächinger, A. Elsässer. (2011) Medikamente freisetzende Koronarstents und mit Medikamenten beschichtete Ballonkatheter : Positionspapier der DGK 2011. Der Kardiologe
CrossRef214
Tetsuya Amano, Tatsuaki Matsubara, Tadayuki Uetani, Masataka Kato, Bunichi Kato, Tomohiro Yoshida, Ken Harada, Soichiro Kumagai, Ayako Kunimura, Yusaku Shinbo, Hideki Ishii, Toyoaki Murohara. (2011) Lipid-Rich Plaques Predict Non-Target-Lesion Ischemic Events in Patients Undergoing Percutaneous Coronary Intervention. Circulation Journal 75:1, 157-166
CrossRef215
Young-June Yang, Mihyun Kim, Choongki Kim, Junbeom Park, Jaewon Oh, Hoyoun Won, Byeong-Keuk Kim, Myeong-Ki Hong. (2011) Late Stent Thrombosis After Drug-Eluting Stent Implantation: A Rare Case of Accelerated Neo-Atherosclerosis and Early Manifestation of Neointimal Rupture. Korean Circulation Journal 41:7, 409
CrossRef216
Gaku Nakazawa, Aloke V. Finn, Marc Vorpahl, Elena R. Ladich, Frank D. Kolodgie, Renu Virmani. (2011) Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First-Generation Sirolimus- and Paclitaxel-Eluting Stents. Journal of the American College of Cardiology 57:4, 390-398
CrossRef217
Sripal Bangalore, Helen A. Vlachos, Faith Selzer, Robert L. Wilensky, Kevin E. Kip, David O. Williams, David P. Faxon. (2011) Percutaneous coronary intervention of moderate to severe calcified coronary lesions: Insights from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheterization and Cardiovascular Interventions 77:1, 22-28
CrossRef218
Takayuki Okamura, Masunori Matsuzaki. (2011) Sirolimus-eluting stent fracture detection by three-dimensional optical coherence tomography. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef219
Tomotaka Dohi, Katsumi Miyauchi, Takafumi Iesaki, Ryo Tsuruta, Shuta Tsuboi, Manabu Ogita, Naozumi Kubota, Takatoshi Kasai, Takayuki Yokoyama, Hiroyuki Daida. (2011) Candesartan With Pioglitazone Protects Against Endothelial Dysfunction and Inflammatory Responses in Porcine Coronary Arteries Implanted With Sirolimus-Eluting Stents. Circulation Journal 75:5, 1098-1106
CrossRef220
Eric M. Saurer, Dai Yamanouchi, Bo Liu, David M. Lynn. (2011) Delivery of plasmid DNA to vascular tissue in vivo using catheter balloons coated with polyelectrolyte multilayers. Biomaterials 32:2, 610-618
CrossRef221
Masato Nakamura, Jun-ichi Kotani, Ken Kozuma, Takahiro Uchida, Masashi Iwabuchi, Toshiya Muramatsu, Haruo Hirayama, Kenshi Fujii, Shigeru Saito. (2011) Effectiveness of Paclitaxel-Eluting Stents in Complex Clinical Patients. Circulation Journal 75:11, 2573-2580
CrossRef222
X ZHAO. 2011. Bioactive materials in drug delivery systems. , 247-265.
CrossRef223
Robert A. Guyton, Steven M. Hollenberg, Glenn N. Levine, Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl, Bojan Cercek, Charles E. Chambers, Stephen G. Ellis. (2011) 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention : A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascu. Catheterization and Cardiovascular Interventionsn/a
CrossRef224
Hiroshi Ito. (2011) Optimal treatment for coronary artery disease in patients with diabetes: percutaneous coronary intervention, coronary artery bypass graft, and medications. General Thoracic and Cardiovascular Surgery 59:1, 6-13
CrossRef225
KISHORE J. HARJAI, SUDHAKAR SATTUR, PAMELA ORSHAW, JUDY BOURA. (2011) Long-Term Safety and Effectiveness of Drug-Eluting Stents Compared to Bare Metal Stents following Successful PCI in Non-ST-Elevation Myocardial Infarction: Findings from the Guthrie Health Off-Label StenT (GHOST) Registry : DES VS. BMS IN NSTEMI. Journal of Interventional Cardiologyno
CrossRef226
S. Garg, M. Magro, P.W. Serruys. 2011. Drug-Eluting Stents. , 427-448.
CrossRef227
Antonio Curcio, Daniele Torella, Ciro Indolfi. (2011) Mechanisms of Smooth Muscle Cell Proliferation and Endothelial Regeneration After Vascular Injury and Stenting. Circulation Journal 75:6, 1287-1296
CrossRef228
Seiji Habara, Kazuaki Mitsudo, Kazushige Kadota, Tsuyoshi Goto, Satoki Fujii, Hiroyuki Yamamoto, Harumi Katoh, Naoki Oka, Yasushi Fuku, Shingo Hosogi, Akitoshi Hirono, Takeshi Maruo, Hiroyuki Tanaka, Yoshikazu Shigemoto, Daiji Hasegawa, Hiroshi Tasaka, Mana Kusunose, Suguru Otsuru, Yoji Okamoto, Naoki Saito, Yuki Tsujimoto. (2011) Serial Clinical and Angiographic Follow-Up After Phosphorylcholine-Coated Stent Implantation. International Heart Journal 52:2, 88-91
CrossRef229
Salvatore Cassese, Giuseppe Luca, Bruno Villari, Sergio Berti, Pietro Bellone, Alfonso Alfieri, Antonio Montinaro, Gaetano Quaranta, Paolo Marraccini, Federico Piscione, . (2011) Reduced antiplatelet therapy after drug-eluting stenting: Multicenter Janus Flex Carbostent implantation with short dual antiplatelet treatment - two or sIX months. MATRIX Study.. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef230
Stephen Wai Luen Lee, Michael P.H. Chan, Kelvin K.W. Chan. (2011) Acute and 16-month outcomes of a new stent: The first-in-man evaluation of the medtronic S9 (integrity) stent. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef231
Young Jin Youn, Junghan Yoon, Jun-Won Lee, Sung-Gyun Ahn, Min-Soo Ahn, Jang-Young Kim, Byung-Soo Yoo, Seung-Hwan Lee, Kyung-Hoon Choe. (2011) Intravascular Ultrasound-Guided Primary Percutaneous Coronary Intervention With Drug-Eluting Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction. Clinical Cardiologyn/a-n/a
CrossRef232
Gennaro Sardella, Giulia Conti, Teodoro Bisceglia, Emanuele Canali, Massimo Mancone, Carlotta De Carlo, Leonardo Spedicato, Giorgio Morocutti, Francesco Fedele, Guglielmo Bernardi. (2011) Long-term outcome after drug-eluting stent implantation in unselected population: ROME and UDINE Experience (The RUDI Registry). Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef233
Hiroki Ikenaga, Masaharu Ishihara, Ichiro Inoue, Takuji Kawagoe, Yuji Shimatani, Fumiharu Miura, Yasuharu Nakama, Kazuoki Dai, Takayuki Otani, Kentaro Ejiri, Nozomu Oda, Masayuki Nakamura, Takashi Miki. (2011) Usefulness of Lipoprotein (a) for Predicting Progression of Non-Culprit Coronary Lesions After Acute Myocardial Infarction. Circulation Journal
CrossRef234
John Fani Srour, Gerald W. Smetana. (2011) Triple therapy in hospitalized patients: Facts and controversies. Journal of Hospital Medicinen/a-n/a
CrossRef235
Alfredo E. Rodriguez, Alfredo M. Rodriguez-Granillo, David Antoniucci, Juan Mieres, Carlos Fernandez-Pereira, Gaston A. Rodriguez-Granillo, Omar Santaera MD, Bibiana Rubilar MD, Igor F. Palacios, Patrick W. Serruys, . (2011) Randomized comparison of cost-saving and effectiveness of oral rapamycin plus bare-metal stents with drug-eluting stents: Three-year outcome from the randomized oral rapamycin in Argentina (ORAR) III trial. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef236
Xing-Sheng Yang, Hua-Gang Zhu, Zhan-Jiang Yu, Fang Ren, Yong-Qiang Chen, Xi Wu, Zheng-Cai Zhang, Li-Jie Zhang, Shu-Zheng Lu. (2011) The union of Anti-CD34 antibody can improve the performance of drug-eluting stents. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef237
Makito Ozawa, Atsunori Okamura, Motoo Date, Yoshiharu Higuchi, Hiroyuki Nagai, Masahiko Shibuya, Kimura Ryusuke, Koichi Inoue, Yasushi Koyama, Katsuomi Iwakura, Kenshi Fujii. (2011) Third in-stent restenosis in sirolimus eluting stents. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef238
Hajime Fujimoto, Masato Nakamura, Hiroyoshi Yokoi. (2011) Impact of Calcification on the Long-Term Outcomes of Sirolimus-Eluting Stent Implantation. Circulation Journal
CrossRef239
Kentaro Ejiri, Masaharu Ishihara, Kazuoki Dai, Takashi Miki, Ichiro Inoue, Takuji Kawagoe, Yuji Shimatani, Fumiharu Miura, Yasuharu Nakama, Takayuki Otani, Hiroki Ikenaga, Nozomu Oda, Masayuki Nakamura. (2011) Three-Year Follow-up of Sirolimus-Eluting Stents vs. Bare Metal Stents for Acute Myocardial Infarction. Circulation Journal
CrossRef240
Lisa Fleming. (2011) Frequency and impact of bleeding in elective coronary stent clinical trials - utility of three commonly used definitions. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef241
Shao-Liang Chen, Tian Xu, Jun-Jie Zhang, Fei Ye, Zuo-Ying Hu, Nai-Liang Tian, Yao-Jun Zhang, Jun-Ichi Kotani, Jun-Xia Zhang. (2011) Angioscopy study from a large patient population comparing sirolimus-eluting stent with biodegradable versus durable polymer. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef242
Ki-Woon Kang, Young-Guk Ko, Dong-Ho Shin, Jung-Sun Kim, Byeong-Keuk Kim, Donghoon Choi, Yangsoo Jang, Myeong-Ki Hong. (2011) Comparison of Vascular Remodeling in Patients Treated With Sirolimus-Versus Zotarolimus-Eluting Stent Following Acute Myocardial Infarction. Clinical Cardiologyn/a-n/a
CrossRef243
Yaling Han, Quanmin Jing, Yi Li, Lixia Yang, Huiliang Liu, Xiaoming Shang, Tiemin Jiang, Zhanquan Li, Hua Zhang, Gaoliang Yan, . (2011) Sustained clinical safety and efficacy of a biodegradable-polymer coated sirolimus-eluting stent in “real-world” practice: Three-year outcomes of the CREATE (multi-center registry of EXCEL biodegradable polymer drug eluting stents) study. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef244
Kyounghoon Lee, Woong Chol Kang, Taehoon Ahn, Chan Il Moon, Seung Hwan Han, Eak Kyun Shin, Chul-Hyun Park, Kook-Yang Park. (2010) Long-term outcome of drug-eluting stent for coronary artery stenosis in Takayasu's arteritis. International Journal of Cardiology 145:3, 532-535
CrossRef245
Adriano Caixeta, Alexandra J. Lansky, Patrick W. Serruys, James B. Hermiller, Peter Ruygrok, Yoshinobu Onuma, Paul Gordon, Manejeh Yaqub, Karine Miquel-Hebert, Susan Veldhof, Poornima Sood, Xiaolu Su, Lalitha Jonnavithula, Krishnankutty Sudhir, Gregg W. Stone. (2010) Clinical Follow-Up 3 Years After Everolimus- and Paclitaxel-Eluting Stents. JACC: Cardiovascular Interventions 3:12, 1220-1228
CrossRef246
Laura Mauri, Dean J. Kereiakes, Sharon-Lise T. Normand, Stephen D. Wiviott, David J. Cohen, David R. Holmes, Sripal Bangalore, Donald E. Cutlip, Michael Pencina, Joseph M. Massaro. (2010) Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions. American Heart Journal 160:6, 1035-1041.e1
CrossRef247
Jonathan B. Murphy, Fergal J. Boyle. (2010) A Numerical Methodology to Fully Elucidate the Altered Wall Shear Stress in a Stented Coronary Artery. Cardiovascular Engineering and Technology 1:4, 256-268
CrossRef248
Subroto Acharjee, Christopher P. Cannon. (2010) Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Drug-eluting Stents. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 9:4, 203-206
CrossRef249
NIRAT BEOHAR, SHERIDAN N. MEYERS, ATA ERDOGAN, MATTHEW E. HARINSTEIN, KAREN PIEPER, STEPHANIE GAGNON, CHARLES J. DAVIDSON. (2010) Off-Label Use of Drug-Eluting versus Bare Metal Stents: A Lesion-Specific Systematic Review of Long-Term Outcomes. Journal of Interventional Cardiology 23:6, 528-545
CrossRef250
Shao-Liang Chen, Jun-jie Zhang, Fei Ye, Zhi-zhong Liu, Zhong-sheng Zhu, Song Lin, Nai-liang Tian, Wei-yi Fang, Yun-dai Chen, Xue-wen Sun, Meng Wei, Shou-jie Shan, Jing Kan, Jun Qian, Song Yang, Zeng-bai Yuan, Tak W. Kwan, Da-Yi Hu. (2010) Crush Stenting With Drug-Eluting Stents: Relevance of Coronary Bifurcation Lesion Location on Angiographic and Clinical Outcomes. Clinical Cardiology 33:12, E32-E39
CrossRef251
Michael Maeng, Niels Ramsing Holm, Anne Kaltoft, Lisette Okkels Jensen, Hans-Henrik Tilsted, Leif Thuesen, Jens Flensted Lassen. (2010) Zotarolimus-eluting versus sirolimus-eluting coronary stent implantation. Interventional Cardiology 2:6, 807-812
CrossRef252
Ahmed Abdel-Latif, Debabrata Mukherjee, Paymon Mesgarzadeh, Khaled M. Ziada. (2010) Drug-eluting stents in patients with end-stage renal disease: Meta-analysis and systematic review of the literature. Catheterization and Cardiovascular Interventions 76:7, 942-948
CrossRef253
Laura Mauri, Joseph M. Massaro, Songtao Jiang, Ian Meredith, William Wijns, Jean Fajadet, David E. Kandzari, Martin B. Leon, Donald E. Cutlip, Kweli P. Thompson. (2010) Long-Term Clinical Outcomes With Zotarolimus-Eluting Versus Bare-Metal Coronary Stents. JACC: Cardiovascular Interventions 3:12, 1240-1249
CrossRef254
Matthew E. Wiisanen, Ahmed Abdel-Latif, Debabrata Mukherjee, Khaled M. Ziada. (2010) Drug-Eluting Stents Versus Bare-Metal Stents in Saphenous Vein Graft Interventions. JACC: Cardiovascular Interventions 3:12, 1262-1273
CrossRef255
Carlos Macaya. (2010) Nuevos avances en cardiología intervencionista. Clínica e Investigación en Arteriosclerosis 22, 42-47
CrossRef256
Saami Yazdani, Masataka Nakano, Fumiyuki Otsuka, Frank Kolodgie, Renu Virmani. (2010) Atheroma and coronary bifurcations: before and after stenting. EuroIntervention 6:J, J24-J30
CrossRef257
Alexandra Lansky, Manejeh Yaqub, James Hermiller, Robert Smith, Naim Farhat, Ronald Caputo, Jerome Williams, Mark Sanz, Kai Koo, Poornima Sood, Krishnankutty Sudhir, Gregg Stone. (2010) Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial. EuroIntervention 6:J, J44-J52
CrossRef258
Massimo Fineschi, Valerio Zacà, Tommaso Gori, Stefano Casini, Giuseppe Sinicropi, Carlo Pierli. (2010) Long-term outcome after drug-eluting stents implantation: Target lesion versus nontarget lesion repeated intervention. International Journal of Cardiology 145:2, 322-324
CrossRef259
Nobuaki Suzuki, Ken Kozuma, Yoshio Maeno, Hirosada Yamamoto, Yoshitaka Shiratori, Shuichi Ishikawa, Akiyoshi Miyazawa, Takaaki Isshiki. (2010) Quantitative coronary optical coherence tomography image analysis for the signal attenuation observed in-stent restenotic tissue. International Journal of Cardiology 145:2, 392-394
CrossRef260
George D. Dangas, Bimmer E. Claessen, Adriano Caixeta, Elias A. Sanidas, Gary S. Mintz, Roxana Mehran. (2010) In-Stent Restenosis in the Drug-Eluting Stent Era. Journal of the American College of Cardiology 56:23, 1897-1907
CrossRef261
Nicole Soucy, Julia Feygin, Radhika Tunstall, Melissa Casey, Douglas Pennington, Barbara Huibregtse, James Barry. (2010) Strut tissue coverage and endothelial cell coverage: a comparison between bare metal stent platforms and platinum chromium stents with and without everolimus-eluting coating. EuroIntervention 6:5, 630-637
CrossRef262
Pallav Garg, David M. Charytan, Lena Novack, Donald E. Cutlip, Jeffrey J. Popma, Jeffrey Moses, Martin B. Leon, Joachim Schofer, Guenter Breithardt, Erick Schampaert, Laura Mauri. (2010) Impact of Moderate Renal Insufficiency on Restenosis and Adverse Clinical Events After Sirolimus-Eluting and Bare Metal Stent Implantation (from the SIRIUS Trials). The American Journal of Cardiology 106:10, 1436-1442
CrossRef263
Jin M. Cheng, Yoshinobu Onuma, Nicolo Piazza, Rutger-Jan M. Nuis, Ron T. Van Domburg, Patrick W. Serruys. (2010) Comparison of Five-Year Outcome of Octogenarians Undergoing Percutaneous Coronary Intervention With Drug-Eluting Versus Bare-Metal Stents (from the RESEARCH and T-SEARCH Registries). The American Journal of Cardiology 106:10, 1376-1381
CrossRef264
Erik Jørgensen, Henning Kelbæk, Lene Kløvgaard, Leif Thuesen, Lars R. Krusell, Hans E. Bøtker, Kari Saunamäki, Jens F. Lassen, Steffen Helqvist. (2010) Sirolimus-eluting versus bare-metal stent implantation in patients with ostial lesions. International Journal of Cardiology 145:1, 162-163
CrossRef265
Olivio F. Donati, Matthias C. Burg, Lotus Desbiolles, Christoph Karlo, Paul Stolzmann, Alexander Bunck, Stephan Baumueller, Borut Marincek, Harald Seifarth, Hatem Alkadhi, Sebastian Leschka, David Maintz. (2010) High-Pitch 128-Slice Dual-Source CT for the Assessment of Coronary Stents in a Phantom Model. Academic Radiology 17:11, 1366-1374
CrossRef266
, , W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, T. Folliguet, S. Garg, K. Huber, S. James, J. Knuuti, J. Lopez-Sendon, J. Marco, L. Menicanti, M. Ostojic, M. F. Piepoli, C. Pirlet, J. L. Pomar, N. Reifart, F. L. Ribichini, M. J. Schalij, P. Sergeant, P. W. Serruys, S. Silber, M. Sousa Uva, D. Taggart, , A. Vahanian, A. Auricchio, J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, M. Tendera, P. E. Vardas, P. Widimsky, , P. Kolh, O. Alfieri, J. Dunning, S. Elia, P. Kappetein, U. Lockowandt, G. Sarris, P. Vouhe, , P. Kearney, L. von Segesser, S. Agewall, A. Aladashvili, D. Alexopoulos, M. J. Antunes, E. Atalar, A. Brutel de la Riviere, A. Doganov, J. Eha, J. Fajadet, R. Ferreira, J. Garot, J. Halcox, Y. Hasin, S. Janssens, K. Kervinen, G. Laufer, V. Legrand, S. A. M. Nashef, F.-J. Neumann, K. Niemela, P. Nihoyannopoulos, M. Noc, J. J. Piek, J. Pirk, Y. Rozenman, M. Sabate, R. Starc, M. Thielmann, D. J. Wheatley, S. Windecker, M. Zembala. (2010) Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal 31:20, 2501-2555
CrossRef267
Bimmer E Claessen, Adriano Caixeta, José PS Henriques, Jan J Piek. (2010) Current status of the Xience V ® everolimus-eluting coronary stent system. Expert Review of Cardiovascular Therapy 8:10, 1363-1374
CrossRef268
Ping Zhu, Ji-mei Chen, Shu-zhen Chen, Cheng Zhang, Shao-yi Zheng, Guang Long, Ji Chen, Zhi-ling Zhou, Rui-xin Fan, Xiao-ping Fan, Yan-fang Chen, Jian Zhuang. (2010) Matrine inhibits vascular smooth muscle cell proliferation by modulating the expression of cell cycle regulatory genes. Acta Pharmacologica Sinica 31:10, 1329-1335
CrossRef269
Motoki Inoue, Makoto Sasaki, Tetsushi Taguchi. (2010) Unusual degradation behavior of citric acid-crosslinked gelatin in vitro and in vivo. Polymer Degradation and Stability 95:10, 2088-2092
CrossRef270
Hyun-Tae Kim, Chang-Wook Nam, Seung-Ho Hur, Kwon-Bae Kim, Sang-Hee Lee, Geu-Ru Hong, Jong-Seon Park, Young-Jo Kim, Ung Kim, Tae-Hyun Yang, Doo-Il Kim, Dong-Soo Kim. (2010) Two-Year Clinical Outcomes After Large Coronary Stent (4.0 mm) Placement: Comparison of Bare-Metal Stent Versus Drug-Eluting Stent. Clinical Cardiology 33:10, 620-625
CrossRef271
Nobuyoshi Tanaka, Mitsuyasu Terashima, Sudhir Rathore, Tsuyoshi Itoh, Maoto Habara, Kenya Nasu, Masashi Kimura, Tatsuya Itoh, Yoshihisa Kinoshita, Mariko Ehara. (2010) Different Patterns of Vascular Response Between Patients With or Without Diabetes Mellitus After Drug-Eluting Stent ImplantationOptical Coherence Tomographic Analysis. JACC: Cardiovascular Interventions 3:10, 1074-1079
CrossRef272
Duk-Woo Park, Young-Hak Kim, Sung-Cheol Yun, Soo-Jin Kang, Seung-Whan Lee, Cheol-Whan Lee, Seong-Wook Park, In-Whan Seong, Jae-Hwan Lee, Seung-Jea Tahk, Myung-Ho Jeong, Yangsoo Jang, Sang-Sig Cheong, Joo-Young Yang, Do-Sun Lim, Ki-Bae Seung, Jei-Keon Chae, Seung-Ho Hur, Sang-Gon Lee, Junghan Yoon, Nae-Hee Lee, Young-Jin Choi, Hyun-Sook Kim, Kee-Sik Kim, Hyo-Soo Kim, Taeg-Jong Hong, Hun-Sik Park, Seung-Jung Park. (2010) Comparison of Zotarolimus-Eluting Stents With Sirolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization. Journal of the American College of Cardiology 56:15, 1187-1195
CrossRef273
J M Li, P E Newburger, M J Gounis, P Dargon, X Zhang, L M Messina. (2010) Local arterial nanoparticle delivery of siRNA for NOX2 knockdown to prevent restenosis in an atherosclerotic rat model. Gene Therapy 17:10, 1279-1287
CrossRef274
Cihan Simsek, Michael Magro, Eric Boersma, Yoshinobu Onuma, Sjoerd T. Nauta, Marcia P. Gaspersz, Willem J. van der Giessen, Ron T. van Domburg, Patrick W. Serruys. (2010) The Unrestricted Use of Sirolimus- and Paclitaxel-Eluting Stents Results in Better Clinical Outcomes During 6-Year Follow-Up Than Bare-Metal Stents. JACC: Cardiovascular Interventions 3:10, 1051-1058
CrossRef275
Zuzana Motovska, Jiri Knot, Petr Widimsky. (2010) REVIEW: Stent Thrombosis-Risk Assessment and Prevention. Cardiovascular Therapeutics 28:5, e92-e100
CrossRef276
Yasushi Ino, Yasuaki Toyoda, Atsushi Tanaka, Shuuta Ishii, Yoshio Kusuyama, Takashi Kubo, Shigeho Takarada, Hironori Kitabata, Takashi Tanimoto, Kumiko Hirata, Masato Mizukoshi, Toshio Imanishi, Takashi Akasaka. (2010) Serial angiographic findings and prognosis of stent fracture site without early restenosis after sirolimus-eluting stent implantation. American Heart Journal 160:4, 775.e1-775.e9
CrossRef277
Koji Yamaguchi, Tetsuzo Wakatsuki, Toshiyuki Niki, Kenya Kusunose, Kunihiko Koshiba, Shusuke Yagi, Yoshio Taketani, Takashi Iwase, Noriko Tomita, Hirotsugu Yamada. (2010) Local persistent hypercoagulability after sirolimus-eluting stent implantation in patients with stable angina. International Journal of Cardiology
CrossRef278
R. Gurvitch, J. Lefkovits, R.J. Warren, S.J. Duffy, D.J. Clark, D. Eccleston, B.P. Yan, C. Reid, A. Brennan, N. Andrianopoulos. (2010) Clinical outcomes of drug-eluting stent use in patients with ST elevation myocardial infarction. International Journal of Cardiology 143:3, 283-288
CrossRef279
Hiroki Ito, James B Hermiller. (2010) Percutaneous coronary intervention for small-vessel coronary disease: highlight on the everolimus-eluting stent. Expert Review of Cardiovascular Therapy 8:9, 1239-1245
CrossRef280
Manivannan Srinivasan, Charanjit S. Rihal, Mandeep Singh, Ryan J. Lennon, David R. Holmes, Abhiram Prasad. (2010) Percutaneous Coronary Intervention in Native Vessels With Angiographically Visible Thrombus. JACC: Cardiovascular Interventions 3:9, 937-946
CrossRef281
Béla Merkely, Zoltán Jambrik. (2010) Gyógyszerkibocsátó stent ismételt restenosisának sikeres kezelése gyógyszerkibocsátó ballonnal. Orvosi Hetilap 151:37, 1509-1514
CrossRef282
Victor Novack, Michael C. Nguyen, Meredith Rooney, Riya Chacko, Lena Novack, Michael Pencina, Patricia Apruzzese, Laura Mauri, Sidney A. Cohen, Jeffrey Moses, Martin B. Leon, Donald E. Cutlip. (2010) Effect of Coronary Target Lesion Revascularization on Late Cardiac Events After Insertion of Sirolimus-Eluting or Bare Metal Stents. The American Journal of Cardiology 106:6, 774-779
CrossRef283
Tamir Bental, Abid Assali, Hana Vaknin-Assa, Eli I. Lev, David Brosh, Shmuel Fuchs, Alexander Battler, Ran Kornowski. (2010) A comparative analysis of major clinical outcomes using drug-eluting stents versus bare-metal stents in a large consecutive patient cohort. Catheterization and Cardiovascular Interventions 76:3, 374-380
CrossRef284
Pasi P. Karjalainen, Antti-Pekka Annala, Antti Ylitalo, Tero Vahlberg, K.E. Juhani Airaksinen. (2010) Long-term clinical outcome with titanium-nitride-oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population. International Journal of Cardiology 144:1, 42-46
CrossRef285
Nathan D Lambert, Robert J Applegate. (2010) The comparative safety of bare-metal and drug-eluting intracoronary stents. Expert Review of Medical Devices 7:5, 611-624
CrossRef286
Luca Testa, Pierfrancesco Agostoni, Paul Vermeersch, Giuseppe Biondi-Zoccai, William Van Gaal, Ravinay Bhindi, Emmanouil Brilakis, Roberto Latini, Maria-Luisa Lausisa, Samuele Pizzocri, Stefania Lanotte, Nedy Brambilla, Adrian Banning, Francesco Bedogni. (2010) Drug eluting stents versus bare metal stents in the treatment of saphenous vein graft disease: a systematic review and meta-analysis. EuroIntervention 6:4, 527-536
CrossRef287
Robert Applegate, James Hermiller, Mark Sanz, Julie Doostzadeh, Wesley Pierson, Xiaolu Su, Alexandra Lansky, Krishnankutty Sudhir, Gregg Stone. (2010) Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial. EuroIntervention 6:4, 437-446
CrossRef288
Srinivas Iyengar, LeRoy E Rabbani. (2010) Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction: Drug-Eluting Stents or Bare Metal Stents?. American Journal of Therapeutics 17:5, 516-522
CrossRef289
Yong-le Li, Zheng Wan, Wen-li Lu, Jian-hua Wang. (2010) Comparison of Sirolimus- and Paclitaxel-Eluting Stents in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: A Meta-analysis of Randomized Trials. Clinical Cardiology 33:9, 583-590
CrossRef290
Pradeep K Nair, Suresh R Mulukutla, Oscar C Marroquin. (2010) Stents and statins: history, clinical outcomes and mechanisms. Expert Review of Cardiovascular Therapy 8:9, 1283-1295
CrossRef291
H. Reichenspurner, L. Conradi, J. Cremer, F. W. Mohr. (2010) Best way to revascularize patients with main stem and three-vessel lesions. Patients should be operated!. Clinical Research in Cardiology 99:9, 541-544
CrossRef292
Pasi P Karjalainen, Antti Ylitalo, Juhani KE Airaksinen, Wail Nammas. (2010) Titanium-nitride-oxide-coated Titan-2 bioactive coronary stent: a new horizon for coronary intervention. Expert Review of Medical Devices 7:5, 599-604
CrossRef293
Laurent Bonello, Ashesh N. Buch, Axel De Labriolle, Probal Roy, Daniel H. Steinberg, Tina L. Pinto Slottow, Kimberley Kaneshige, Rebecca Torguson, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman. (2010) Clinical outcomes after implantation of small diameter (=2.5 mm) sirolimus- versus paclitaxel-eluting stents. International Journal of Cardiology 144:1, 105-107
CrossRef294
Anne Kaltoft, Henning Kelbæk, Leif Thuesen, Jens Flensted Lassen, Peter Clemmensen, Lene Kløvgaard, Thomas Engstrøm, Hans E. Bøtker, Kari Saunamäki, Lars R. Krusell, Erik Jørgensen, Hans-Henrik Tilsted, Evald H. Christiansen, Jan Ravkilde, Lars Køber, Klaus F. Kofoed, Christian J. Terkelsen, Steffen Helqvist. (2010) Long-Term Outcome After Drug-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology 56:8, 641-645
CrossRef295
Inder M. Singh, Steven J. Filby, Fredy El Sakr, Eiran Z. Gorodeski, A. Michael Lincoff, Stephen G. Ellis, Mehdi H. Shishehbor. (2010) Drug-eluting stents versus bare-metal stents for treatment of bare-metal in-stent restenosis. Catheterization and Cardiovascular Interventions 76:2, 257-262
CrossRef296
Yukio Ozaki, Pedro Lemos, Tetsu Yamaguchi, Takahiko Suzuki, Masato Nakamura, Tevfik Ismail, Michihiko Kitayama, Hideo Nishikawa, Osamu Kato, Patrick Serruys. (2010) A quantitative coronary angiography-matched comparison between a prospective randomised multicentre cutting balloon angioplasty and bare metal stent trial (REDUCE III) and the Rapamycin-Eluting Stent Evaluation At Rotterdam Cardiology Hospital (RESEARCH) study. EuroIntervention 6:3, 400-406
CrossRef297
Giuseppe Luca, Rosario Sauro, Attilio Varricchio, Michele Capasso, Tonino Lanzillo, Fiore Manganelli, Ciro Mariello, Francesco Siano, Giannignazio Carbone, Maria Rosaria Pagliuca, Giuseppe Rosato, Emilio Lorenzo. (2010) Impact of diabetes on long-term outcome in STEMI patients undergoing primary angioplasty with glycoprotein IIb–IIIa inhibitors and BMS or DES. Journal of Thrombosis and Thrombolysis 30:2, 133-141
CrossRef298
Raúl Valdesuso, Pasi Karjalainen, Joan García, José Díaz, Javier Fernández Portales, Mónica Masotti, Francisco Picó, Antonio Serra, José Moreu Burgos, Luis Insa, Fina Mauri, Javier Rodriguez Collado, Wail Nammas. (2010) The EXTREME registry: Titanium-nitride-oxide coated stents in small coronary arteries. Catheterization and Cardiovascular Interventions 76:2, 281-287
CrossRef299
Heng Ge, Qing Zhang, Wei Zhou, Qing He, Zhi-hua Han, Ben He. (2010) Efficacy and safety of drug-eluting stent implantation for the treatment of in-stent restenosis occurring within bare-metal stent and drug-eluting stent. Journal of Zhejiang University SCIENCE B 11:8, 553-560
CrossRef300
Nalan Alan Selcuk, Cetin Onsel, Servet Ozturk, Tevfik Gurmen, Murat Gulbaran, Sait Sager, Levent Kabasakal, Haluk B. Sayman, Ilhami Uslu. (2010) Intravascular radiation therapy with a Re-188 liquid-filled balloon in patients with in-stent restenosis. Nuclear Medicine Communications 31:8, 746-752
CrossRef301
Alfredo E Rodriguez, Agustina Rodriguez-Granillo. (2010) Stent selection in patients with acute coronary syndromes and unstable coronary lesions. Interventional Cardiology 2:4, 545-557
CrossRef302
Michael S. Lee, Patrick P. Hu, Joseph Aragon, Atman Shah, Ravi Bhatia, Nathaniel Jones, William Penny, William French, Jonathan Tobis, Ehtisham Mahmud. (2010) Impact of chronic renal insufficiency on clinical outcomes in patients undergoing saphenous vein graft intervention with drug-eluting stents: A multicenter Southern Californian Registry. Catheterization and Cardiovascular Interventions 76:2, 272-278
CrossRef303
Clare E. Appleby, Karen Mackie, Vladimír Džavík, Joan Ivanov. (2010) Late outcomes following percutaneous coronary interventions: Results from a large, observational registry. Canadian Journal of Cardiology 26:7, e218-e224
CrossRef304
Scot Garg, Patrick W. Serruys. (2010) Coronary Stents. Journal of the American College of Cardiology 56:10, S1-S42
CrossRef305
E. Puymirat, A. Chaib, A. Chaudeurge, L. Trinquart, F. Ledru, E. Durand, N. Danchin, D. Blanchard. (2010) Endoprothèses coronaires actives : respectons-nous les recommandations de la Société française de cardiologie et de la Haute Autorité de santé dans notre pratique quotidienne ?. Annales de Cardiologie et d'Angéiologie 59:4, 196-204
CrossRef306
Takeshi Furukawa, Masahiko Kishiro, Hideo Fukunaga, Masahiro Ohtsuki, Ken Takahashi, Katsumi Akimoto, Toshiaki Shimizu, Shiori Kawasaki, Toshio Kumasaka. (2010) Drug-Eluting Stents Ameliorate Pulmonary Vein Stenotic Changes in Pigs In Vivo. Pediatric Cardiology 31:6, 773-779
CrossRef307
Toshiro Shinke, Junya Shite. (2010) Evaluation of stent placement and outcomes with optical coherence tomography. Interventional Cardiology 2:4, 535-543
CrossRef308
Shengxian Tu, Zheng Huang, Gerhard Koning, Kai Cui, Johan H.C. Reiber. (2010) A novel three-dimensional quantitative coronary angiography system: In-vivo comparison with intravascular ultrasound for assessing arterial segment length. Catheterization and Cardiovascular Interventions 76:2, 291-298
CrossRef309
Tomoko Kawai, Hisashi Umeda, Masaya Ota, Kousuke Hattori, Makoto Ishikawa, Masanori Okumura, Shino Kan, Tadashi Nakano, Hiroyuki Naruse, Shigeru Matsui, Junichi Ishii, Hitoshi Hishida, Yukio Ozaki. (2010) Do drug elution components increase the risk of fracture of sirolimus-eluting stents?. Coronary Artery Disease 21:5, 298-303
CrossRef310
Yoshihisa Nakagawa, Takeshi Kimura, Takeshi Morimoto, Masanori Nomura, Keijiro Saku, Seiichi Haruta, Toshiya Muramatsu, Masakiyo Nobuyoshi, Kazushige Kadota, Hiroshi Fujita, Ryozo Tatami, Nobuo Shiode, Hideo Nishikawa, Yoshisato Shibata, Shunichi Miyazaki, Yoshiharu Murata, Takashi Honda, Tomohiro Kawasaki, Osamu Doi, Yoshikazu Hiasa, Yasuhiko Hayashi, Masunori Matsuzaki, Kazuaki Mitsudo. (2010) Incidence and Risk Factors of Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation (3-Year Follow-Up of the j-Cypher Registry). The American Journal of Cardiology 106:3, 329-336
CrossRef311
Hui-li Gan, Jian-qun Zhang, Fangjong Huang, Cheng-xiong Gu, Qing-yu Kong, Xiong-rong Cao, Ping Bo, Chun-Shang Lu. (2010) Prognosis of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafts for Ostial Right Coronary Lesions in Propensity-Matched Individuals. Cardiovascular Therapeuticsno-no
CrossRef312
Antonio L. Bartorelli, Patrick W. Serruys, Karine Miquel-Hébert, Shui Yu, Wes Pierson, Gregg W. Stone. (2010) An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease: A pooled analysis from the SPIRIT II and SPIRIT III trials. Catheterization and Cardiovascular Interventions 76:1, 60-66
CrossRef313
David E Kandzari. (2010) Development and performance of the zotarolimus-eluting Endeavor ® coronary stent. Expert Review of Medical Devices 7:4, 449-459
CrossRef314
Cihan Simsek, Yoshinobu Onuma, Michael Magro, Sanneke de Boer, Linda Battes, Ron T. van Domburg, Eric Boersma, Patrick W. Serruys. (2010) Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease. Catheterization and Cardiovascular Interventions 76:1, 41-49
CrossRef315
Jael Z. Atary, Bas L. van der Hoeven, Su San Liem, J. Wouter Jukema, Johanna G. van der Bom, Douwe E. Atsma, Marianne Bootsma, Katja Zeppenfeld, Ernst E. van der Wall, Martin J. Schalij. (2010) Three-Year Outcome of Sirolimus-Eluting Versus Bare-Metal Stents for the Treatment of ST-Segment Elevation Myocardial Infarction (from the MISSION! Intervention Study). The American Journal of Cardiology 106:1, 4-12
CrossRef316
Cathy Jeon, Susana C. Candia, John C. Wang, Elizabeth M. Holper, Michelle Ammerer, Richard E. Kuntz, Laura Mauri. (2010) Relative spatial distributions of coronary artery bypass graft insertion and acute thrombosis: A model for protection from acute myocardial infarction. American Heart Journal 160:1, 195-201
CrossRef317
Tingfei Xi, Runlin Gao, Bo Xu, Liang Chen, Tong Luo, Jing Liu, Yan Wei, Shengping Zhong. (2010) In vitro and in vivo changes to PLGA/sirolimus coating on drug eluting stents. Biomaterials 31:19, 5151-5158
CrossRef318
S.D. Collins, S. Ahmad, R. Waksman. (2010) Percutaneous revascularization in women with coronary artery disease: We've come so far, yet have so far to go. Nutrition, Metabolism and Cardiovascular Diseases 20:6, 436-444
CrossRef319
Giuseppe Biondi-Zoccai, Claudio Moretti, Antonio Abbate, Imad Sheiban. (2010) Percutaneous coronary intervention for small vessel coronary artery disease. Cardiovascular Revascularization Medicine 11:3, 189-198
CrossRef320
Kazuoki Dai, Masaharu Ishihara, Ichiro Inoue, Takuji Kawagoe, Yuji Shimatani, Satoshi Kurisu, Yasuharu Nakama, Tatsuya Maruhashi, Eisuke Kagawa, Toshiyuki Aokage, Junichi Matsushita, Hiroki Ikenaga. (2010) Coronary angioscopic findings eight months after sirolimus-eluting stent implantation: a comparison between ST-elevation myocardial infarction and stable angina pectoris. EuroIntervention 6:2, 251-256
CrossRef321
NICK MEZILIS, PETROS DARDAS, VLASIS NINIOS, DIMITRIOS TSIKADERIS. (2010) Rotablation in the Drug Eluting Era: Immediate and Long-Term Results from a Single Center Experience. Journal of Interventional Cardiology 23:3, 249-253
CrossRef322
Marleen M.J. Ploegmakers, Anneke M. Viscaal, Lois Finch, Nancy E. Mayo, James M. Brophy. (2010) The disutility of restenosis – the impact of repeat percutaneous coronary intervention on quality of life. Canadian Journal of Cardiology 26:6, e197-e200
CrossRef323
Sanjay B. Pandya, Young-Hak Kim, Sheridan N. Meyers, Charles J. Davidson, James D. Flaherty, Duk-Woo Park, Anuj Mediratta, Karen Pieper, Eric Reyes, Robert O. Bonow, Seung-Jung Park, Nirat Beohar. (2010) Drug-Eluting Versus Bare-Metal Stents in Unprotected Left Main Coronary Artery Stenosis. JACC: Cardiovascular Interventions 3:6, 602-611
CrossRef324
Johann Auer, Alexander Leitner, Robert Berent, Gudrun Lamm, Elisabeth Lassnig, Gerald Krennmair. (2010) Long-term outcomes following coronary drug-eluting- and bare-metal-stent implantation. Atherosclerosis 210:2, 503-509
CrossRef325
Hee-Hwa Ho, Vincent Pong, Chung-Wah Siu, Man-Hong Jim, Raymond Miu, Kai-Hang Yiu, Ryan Ko, Hung-Fat Tse, On-Hing Kwok, Wing-Hing Chow. (2010) Long-term Clinical Outcomes of Drug-Eluting Stents Vs Bare-Metal Stents in Chinese Patients. Clinical Cardiology 33:6, E22-E29
CrossRef326
BEATRIZ VAQUERIZO, ANTONIO SERRA, FAUSTINO MIRANDA, JOSÉ LUIS TRIANO, GILBERTO SIERRA, GUILLERMO DELGADO, ANGEL PUENTES, SERGI MOJAL, JORDI BRUGERA. (2010) Aggressive Plaque Modification with Rotational Atherectomy and/or Cutting Balloon before Drug-Eluting Stent Implantation for the Treatment of Calcified Coronary Lesions. Journal of Interventional Cardiology 23:3, 240-248
CrossRef327
Chandrasekar Palaniswamy, Wilbert S. Aronow, Rishi Sukhija, Tarun Chugh, Navi Ramdeen, Kumar Kalapatapu, Melvin B. Weiss, Anthony L. Pucillo, Craig E. Monsen. (2010) Major Adverse Cardiac Events in Patients With Hepatitis C Infection Treated With Bare-Metal Versus Drug-Eluting Stents. Clinical Cardiology 33:6, 367-370
CrossRef328
Niels Grabow, David P. Martin, Klaus-Peter Schmitz, Katrin Sternberg. (2010) Absorbable polymer stent technologies for vascular regeneration. Journal of Chemical Technology & Biotechnology 85:6, 744-751
CrossRef329
Eyal Afergan, Meital Ben David, Hila Epstein, Nickolay Koroukhov, Dalia Gilhar, Keren Rohekar, Haim D. Danenberg, Gershon Golomb. (2010) Liposomal Simvastatin Attenuates Neointimal Hyperplasia in Rats. The AAPS Journal 12:2, 181-187
CrossRef330
Zachary M. Gertz, Robert L. Wilensky. (2010) Local Drug Delivery for Treatment of Coronary and Peripheral Artery Disease. Cardiovascular Therapeuticsno-no
CrossRef331
Janette Greenhalgh, Juliet Hockenhull, Naveen Rao, Yenal Dundar, Rumona C Dickson, Adrian Bagust, Janette Greenhalgh. 2010. Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes. .
CrossRef332
Somjot S Brar, Gregg W Stone. (2010) Decision-making: stenting in acute myocardial infarction. Future Cardiology 6:3, 301-314
CrossRef333
Byeong-Keuk Kim, Dong Whan Kim, Seungjin Oh, Se-Jung Yoon, Sungha Park, Dong Woon Jeon, Joo Young Yang. (2010) Impact of the attainment of current recommended low-density lipoprotein cholesterol goal of less than 70 mg/dl on clinical outcomes in very high-risk patients treated with drug-eluting stents. Coronary Artery Disease 21:3, 182-188
CrossRef334
Heleen van Beusekom, Oana Sorop, Mieke van den Heuvel, Yoshinobu Onuma, Dirk Duncker, A.H. Danser, Willem van der Giessen. (2010) Endothelial function rather than endothelial restoration is altered in paclitaxel- as compared to bare metal-, sirolimusand tacrolimus-eluting stents. EuroIntervention 6:1, 117-125
CrossRef335
Cheol Whan Lee, Su-Jin Kang, Duk-Woo Park, Seung-Hwan Lee, Young-Hak Kim, Jae-Joong Kim, Seong-Wook Park, Gary S. Mintz, Seung-Jung Park. (2010) Intravascular Ultrasound Findings in Patients With Very Late Stent Thrombosis After Either Drug-Eluting or Bare-Metal Stent Implantation. Journal of the American College of Cardiology 55:18, 1936-1942
CrossRef336
M. A. M. Beijk, M. Klomp, N. J. W. Verouden, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, J. G. P. Tijssen, R. J. de Winter. (2010) GenousTM endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study. European Heart Journal 31:9, 1055-1064
CrossRef337
Aris Moschovitis, Rüdiger Simon, Antje Seidenstücker, Volker Klauss, Monika Baylacher, Thomas Lüscher, Tiziano Moccetti, Stephan Windecker, Bernhard Meier, Otto Hess. (2010) Randomised comparison of titanium-nitride-oxide coated stents with bare metal stents: five year follow-up of the TiNOX trial. EuroIntervention 6:1, 63-68
CrossRef338
Sumeet Sharma, Neville Kukreja, Christos Christopoulos, Diana A Gorog. (2010) Drug-eluting balloon: new tool in the box. Expert Review of Medical Devices 7:3, 381-388
CrossRef339
Hiroyuki Kyono, Giulio Guagliumi, Vasile Sirbu, Noah Rosenthal, Satoko Tahara, Giuseppe Musumeci, Antonio Trivisonno, Hiram Bezerra, Marco Costa. (2010) Optical coherence tomography (OCT) strut-level analysis of drug-eluting stents (DES) in human coronary bifurcations. EuroIntervention 6:1, 69-77
CrossRef340
Peter Mortier, Pascal R Verdonck. (2010) Stent design matters: insights from virtual bench testing. Expert Review of Cardiovascular Therapy 8:5, 613-615
CrossRef341
Daisuke Satoh, Norihito Inami, Takayuki Shimazu, Takayuki Kajiura, Kohichi Yamada, Toshiji Iwasaka, Shosaku Nomura. (2010) Soluble TRAIL prevents RANTES-dependent restenosis after percutaneous coronary intervention in patients with coronary artery disease. Journal of Thrombosis and Thrombolysis 29:4, 471-476
CrossRef342
Gaku Nakazawa, Saami K. Yazdani, Aloke V. Finn, Marc Vorpahl, Frank D. Kolodgie, Renu Virmani. (2010) Pathological Findings at Bifurcation Lesions. Journal of the American College of Cardiology 55:16, 1679-1687
CrossRef343
Lisette Jensen, Hans Tilsted, Per Thayssen, Anne Kaltoft, Michael Maeng, Jens Lassen, Knud Hansen, Morten Madsen, Jan Ravkilde, Søren Johnsen, Henrik Sørensen, Leif Thuesen. (2010) Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry. EuroIntervention 5:8, 898-905
CrossRef344
Hilary Gallagher, William M Carroll, Yuri Rochev. (2010) The Effects of Vinblastine on Smooth Muscle Cells In Vitro: Evaluation of a Therapeutic Window for the Treatment of Restenosis. Journal of Cardiovascular Pharmacology 55:4, 399-407
CrossRef345
NEIL GUPTA, RAHUL NAYAK, SCOTT W. GRISOLANO, DANIEL C. BUCKLES, PETER N. TADROS. (2010) Defining Patients at High Risk for Gastrointestinal Hemorrhage after Drug-Eluting Stent Placement: A Cost Utility Analysis. Journal of Interventional Cardiology 23:2, 179-187
CrossRef346
Michael S. Lee, Tae Yang, David E. Kandzari, Jonathan M. Tobis, Hsini Liao, Ehtisham Mahmud. (2010) Comparison by Meta-Analysis of Drug-Eluting Stents and Bare Metal Stents for Saphenous Vein Graft Intervention. The American Journal of Cardiology 105:8, 1076-1082
CrossRef347
Mounir WZ Basalus, Clemens von Birgelen. (2010) Benchside testing of drug-eluting stent surface and geometry. Interventional Cardiology 2:2, 159-175
CrossRef348
Adnan Kastrati, Marco Balducelli, Germano Di Sciascio, Tiziano Moccetti, Alessandro Bortone, Antonio Colombo, Johannes Waltenberger, Christoph Hehrlein. (2010) A European multicentre, randomised study of the MAR-Tyn cobalt chromium tin-coated stent in patients with de novo coronary artery lesions: study design and protocol. EuroIntervention 5:8, 976-980
CrossRef349
Michael S. Lee, Giuseppe Tarantini, Jola Xhaxho, Tae Yang, Ashkan Ehdaie, Ravi Bhatia, Enrico Favaretto, Jonathan Tobis. (2010) Sirolimus- Versus Paclitaxel-Eluting Stents for the Treatment of Cardiac Allograft Vasculopathy. JACC: Cardiovascular Interventions 3:4, 378-382
CrossRef350
Jon Suh, Duk-Woo Park, Jong-Young Lee, In Hyun Jung, Seung-Whan Lee, Young-Hak Kim, Cheol Whan Lee, Sang-Sig Cheong, Jae-Joong Kim, Seong-Wook Park, Seung-Jung Park. (2010) The Relationship and Threshold of Stent Length With Regard to Risk of Stent Thrombosis After Drug-Eluting Stent Implantation. JACC: Cardiovascular Interventions 3:4, 383-389
CrossRef351
MANDEEP S. SIDHU, JEREMIAH R. BROWN, RAYSON C. YANG, JAMES T. DeVRIES, JOHN E. JAYNE, BRUCE D. HETTLEMAN, BRUCE J. FRIEDMAN, NATHANIEL W. NILES, AARON V. KAPLAN, JOHN F. ROBB, DAVID J. MALENKA, CRAIG A. THOMPSON, . (2010) Real World, Long-Term Outcomes Comparison Between Paclitaxel-Eluting and Sirolimus-Eluting Stent Platforms. Journal of Interventional Cardiology 23:2, 167-175
CrossRef352
Takahiro Uchida, Jeffrey Popma, Gregg W. Stone, Stephen G. Ellis, Mark A. Turco, John A. Ormiston, Toshiya Muramatsu, Masato Nakamura, Shinsuke Nanto, Hiroyoshi Yokoi, Donald S. Baim. (2010) The Clinical Impact of Routine Angiographic Follow-Up in Randomized Trials of Drug-Eluting Stents. JACC: Cardiovascular Interventions 3:4, 403-411
CrossRef353
Sandrin C Bergheanu, Douwe Pons, Ioannis Karalis, Orçun Özsoy, Jeffrey JW Verschuren, Mark M Ewing, Paul HA Quax, J Wouter Jukema. (2010) Genetic determinants of adverse outcome (restenosis, malapposition and thrombosis) after stent implantation. Interventional Cardiology 2:2, 147-157
CrossRef354
Young Bin Song, Joo-Yong Hahn, Seung-Hyuk Choi, Jin-Ho Choi, Sang Hoon Lee, Myung-Ho Jeong, Hyo-Soo Kim, In-Whan Seong, Ju-Young Yang, Seung Woon Rha, Yangsoo Jang, Jung Han Yoon, Seung-Jea Tahk, Ki Bae Seung, Seung-Jung Park, Hyeon-Cheol Gwon. (2010) Sirolimus- Versus Paclitaxel-Eluting Stents for the Treatment of Coronary Bifurcations. Journal of the American College of Cardiology 55:16, 1743-1750
CrossRef355
Flavio Ribichini, Gerardo Ansalone, Antonio Bartorelli, Federico Beqaraj, Andrea Berni, Salvatore Colangelo, Maurizio DʼAmico, Francesco Della Rovere, Antonio Fiscella, Gabriele Gabrielli, Ciro Indolfi, Luigi La Vecchia, Paolo Loschiavo, Giampietro Marinoni, Antonio Marzocchi, Diego Milazzo, Michele Romano, Pietro Sangiorgio, Imad Sheiban, Corrado Tamburino, Bernardino Tuccillo, Rosvaldo Villani, Barbara Cappi, Maria Josè Lopera Quijada, Corrado Vassanelli. (2010) A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial. Journal of Cardiovascular Medicine 11:4, 299-309
CrossRef356
Eberhard Grube, Joachim Schofer, Karl E. Hauptmann, Georg Nickenig, Nicholas Curzen, Dominic J. Allocco, Keith D. Dawkins. (2010) A Novel Paclitaxel-Eluting Stent With an Ultrathin Abluminal Biodegradable Polymer. JACC: Cardiovascular Interventions 3:4, 431-438
CrossRef357
MARCUS WIEMER, RALF DEGENHARDT, CHRISTIAN VALLBRACHT, DIETER HORSTKOTTE, HENRIK SCHNEIDER, CHRISTOPH NIENABER, WOLFGANG BOCKSCH, MICHAEL BOXBERGER, MARTIN UNVERDORBEN, . (2010) The Paclitaxel-Eluting Coroflex™ Stent Study II (PECOPS II) Acute and 6-Month Clinical and Angiographic Follow-Up, 1-Year Clinical Follow-Up. Journal of Interventional Cardiology 23:2, 160-166
CrossRef358
J. Doostzadeh, S. Bezenek, W.-F. Cheong, P. Sood, L. Schwartz, K. Sudhir. 2010. Clinical Trials in Interventional Cardiology: Focus on XIENCE V Drug-Eluting Stent. .
CrossRef359
Farzin Beygui, Shaida Varnous, Gilles Montalescot, Flor Fernandez, Jean-Philippe Collet, Pascal Leprince, Claude Le Feuvre, Alain Pavie, Michel Komajda, Jean-Philippe Metzger, Iradj Gandjbakhch. (2010) Long-term outcome after bare-metal or drug-eluting stenting for allograft coronary artery disease. The Journal of Heart and Lung Transplantation 29:3, 316-322
CrossRef360
Klaus Rasmussen, Michael Maeng, Anne Kaltoft, Per Thayssen, Henning Kelbæk, Hans Henrik Tilsted, Ulrik Abildgaard, Evald Høj Christiansen, Thomas Engstrøm, Lars Romer Krusell, Jan Ravkilde, Peter Riis Hansen, Knud Nørregaard Hansen, Steen Zabell Abildstrøm, Jens Aarøe, Jan Skov Jensen, Steen Dalby Kristensen, Hans Erik Bøtker, Morten Madsen, Søren Paaske Johnsen, Lisette Okkels Jensen, Henrik Toft Sørensen, Leif Thuesen, Jens Flensted Lassen. (2010) Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial. The Lancet 375:9720, 1090-1099
CrossRef361
Konstantinos Toutouzas, Andreas Synetos, Antonis Karanasos, Maria Drakopoulou, Eleutherios Tsiamis, Stamatios Lerakis, Christodoulos Stefanadis. (2010) Percutaneous Coronary Intervention in Chronic Stable Angina. The American Journal of the Medical Sciences1
CrossRef362
Lorenz Räber, Peter Jüni, Lukas Löffel, Simon Wandel, Stéphane Cook, Peter Wenaweser, Mario Togni, Rolf Vogel, Christian Seiler, Franz Eberli, Thomas Lüscher, Bernhard Meier, Stephan Windecker. (2010) Impact of Stent Overlap on Angiographic and Long-Term Clinical Outcome in Patients Undergoing Drug-Eluting Stent Implantation. Journal of the American College of Cardiology 55:12, 1178-1188
CrossRef363
Douglass A. Morrison. (2010) Limitations of stints: A good, albeit imperfect, therapy; For a less than perfect world. Catheterization and Cardiovascular Interventions 75:3, 343-344
CrossRef364
Rishi Sukhija, Wilbert S. Aronow, Chandrasekar Palaniswamy, Tarunjit Singh, Rashmi Sukhija, Kumar Kalapatapu, Diwakar Mohan, Anthony L. Pucillo, Carmine Sorbera, Priyanka Kakar, Melvin B. Weiss, Purshotam Lal, Craig E. Monsen. (2010) Major Adverse Cardiac Events in Patients With Moderate to Severe Renal Insufficiency Treated With First-Generation Drug-Eluting Stents. The American Journal of Cardiology 105:3, 293-296
CrossRef365
Ralf Zahn, Christian W. Hamm, Uwe Zeymer, Gert Richardt, Malte Kelm, Benny Levenson, Tassilo Bonzel, Ulrich Tebbe, Georg Sabin, Christoph A. Nienaber, Thomas Pfannebecker, Jochen Senges. (2010) Coronary stenting with the sirolimus-eluting stent in patients with restenosis after intracoronary brachytherapy: results from the prospective multicentre German Cypher Stent Registry. Clinical Research in Cardiology 99:2, 99-106
CrossRef366
F.W. Mohr, A.J. Rastan, J. Cremer, H. Reichenspurner. (2010) Die Bedeutung der SYNTAX-Studie für die moderne Koronarchirurgie. Zeitschrift für Herz-,Thorax- und Gefäßchirurgie 24:1, 49-57
CrossRef367
BENNY MULYANTO SETIADI, LEI HAN, CHANG JING. (2010) Adverse Events Even after Percutaneous Coronary Intervention: Is There Any Way to Predict It?. Journal of Interventional Cardiology 23:1, 86-94
CrossRef368
Jean-Marc Hyvelin, Blandine Maurel, Rustem Uzbekov, Roberto Motterlini, Patrick Lermusiaux. (2010) Hemin prevents in-stent stenosis in rat and rabbit models by inducing heme-oxygenase-1. Journal of Vascular Surgery 51:2, 417-428
CrossRef369
Takashi Kubo, Akiko Maehara, Gary S. Mintz, Hector M. Garcia-Garcia, Patrick W. Serruys, Takahiko Suzuki, Volker Klauss, Satoru Sumitsuji, Amir Lerman, Steven P. Marso, M. Pauliina Margolis, James R. Margolis, Michael C. Foster, Bernard De Bruyne, Martin B. Leon, Gregg W. Stone. (2010) Analysis of the long-term effects of drug-eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasound. American Heart Journal 159:2, 271-277
CrossRef370
Daniel Chamié, J. Ribamar Costa Jr, Alexandre Abizaid, Fausto Feres, Rodolfo Staico, Fernando Devito, Ricardo A. Costa, Andréa Abizaid, Luiz Fernando Tanajura, Amanda G.M.R. Sousa. (2010) Serial Angiography and Intravascular Ultrasound: Results of the SISC Registry (Stents In Small Coronaries). JACC: Cardiovascular Interventions 3:2, 191-202
CrossRef371
Spencer B. King, John Jeffrey Marshall, Pradyumna E. Tummala. (2010) Revascularization for Coronary Artery Disease: Stents Versus Bypass Surgery. Annual Review of Medicine 61:1, 199-213
CrossRef372
Anthony A. Hilliard, Aaron M. From, Ryan J. Lennon, Mandeep Singh, Amir Lerman, Bernard J. Gersh, David R. Holmes, Charanjit S. Rihal, Abhiram Prasad. (2010) Percutaneous Revascularization for Stable Coronary Artery Disease. JACC: Cardiovascular Interventions 3:2, 172-179
CrossRef373
Rahul Sakhuja, Laura Mauri. (2010) Controversies in the Use of Drug-Eluting Stents for Acute Myocardial Infarction: A Critical Appraisal of the Data. Annual Review of Medicine 61:1, 215-231
CrossRef374
RALF ZAHN, CHRISTIAN W. HAMM, STEFFEN SCHNEIDER, GERT RICHARDT, MALTE KELM, BENNY LEVENSON, TASSILO BONZEL, ULRICH TEBBE, GEORG SABIN, CHRISTOPH A. NIENABER, . (2010) Coronary Stenting with the Sirolimus-Eluting Stent in Clinical Practice: Final Results from the Prospective Multicenter German Cypher Stent Registry. Journal of Interventional Cardiology 23:1, 18-25
CrossRef375
Shinichi Shirai, Takeshi Kimura, Masakiyo Nobuyoshi, Takeshi Morimoto, Kenji Ando, Yoshimitsu Soga, Kyohei Yamaji, Katsuhiro Kondo, Koyu Sakai, Takeshi Arita, Masahiko Goya, Masashi Iwabuchi, Hiroyoshi Yokoi, Hideyuki Nosaka, Kazuaki Mitsudo. (2010) Impact of Multiple and Long Sirolimus-Eluting Stent Implantation on 3-Year Clinical Outcomes in the j-Cypher Registry. JACC: Cardiovascular Interventions 3:2, 180-188
CrossRef376
Sanjay Kaul, George A. Diamond. (2010) Trial and Error. Journal of the American College of Cardiology 55:5, 415-427
CrossRef377
Timothy Canan, Michael S. Lee. (2010) Drug-eluting stent fracture: Incidence, contributing factors, and clinical implications. Catheterization and Cardiovascular Interventions 75:2, 237-245
CrossRef378
Jung-Sun Kim, Myeong-Ki Hong, Chunyu Fan, Tae-Hoon Kim, Jae-Min Shim, Sang-Min Park, Young-Guk Ko, Donghoon Choi, Yangsoo Jang. (2010) Intracoronary thrombus formation after drug-eluting stents implantation: Optical coherence tomographic study. American Heart Journal 159:2, 278-283
CrossRef379
Martin B. Leon, Laura Mauri, Jeffrey J. Popma, Donald E. Cutlip, Eugenia Nikolsky, Charles O'Shaughnessy, Paul A. Overlie, Brent T. McLaurin, Stuart L. Solomon, John S. Douglas, Michael W. Ball, Ronald P. Caputo, Ash Jain, Thaddeus R. Tolleson, Bernard M. Reen, Ajay J. Kirtane, Peter J. Fitzgerald, Kweli Thompson, David E. Kandzari. (2010) A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions. Journal of the American College of Cardiology 55:6, 543-554
CrossRef380
Akhil Kapur, Roger J. Hall, Iqbal S. Malik, Ayesha C. Qureshi, Jeremy Butts, Mark de Belder, Andreas Baumbach, Gianni Angelini, Adam de Belder, Keith G. Oldroyd, Marcus Flather, Michael Roughton, Petros Nihoyannopoulos, Jens Peder Bagger, Kenneth Morgan, Kevin J. Beatt. (2010) Randomized Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Diabetic Patients. Journal of the American College of Cardiology 55:5, 432-440
CrossRef381
Paul C. Gordon, Robert J. Applegate, James B. Hermiller, Steven B. Weinsier, Julie Doostzadeh, Sherry Cao, Krishnankutty Sudhir, Alexandra J. Lansky, Gregg W. Stone. (2010) Clinical and angiographic outcomes with an everolimus-eluting stent in large coronary arteries: The SPIRIT III 4.0 mm registry. Catheterization and Cardiovascular Interventions 75:2, 179-186
CrossRef382
Roberta Rossini, Giuseppe Musumeci, Alessandro Aprile, Orazio Valsecchi. (2010) Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents. Expert Review of Pharmacoeconomics & Outcomes Research 10:1, 49-61
CrossRef383
Hideaki Kaneda, Junya Ako, Mitsuyasu Terashima, Yoshihiro Morino, Yasuhiro Honda, Paul G. Yock, Martin B. Leon, Jeffrey W. Moses, Peter J. Fitzgerald. (2010) Sirolimus-eluting stent implantation in small coronary arteries: A three dimensional intravascular ultrasound study from the SIRIUS trial. International Journal of Cardiology 138:2, 126-130
CrossRef384
G. G. Camici, J. Steffel, I. Amanovic, A. Breitenstein, J. Baldinger, S. Keller, T. F. Luscher, F. C. Tanner. (2010) Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents. European Heart Journal 31:2, 236-242
CrossRef385
Yoshihisa Nakagawa. (2010) What Is the Effectiveness of Drug-Eluting Stents in the Treatment of ST-Elevation Myocardial Infarction?. Circulation Journal 74:10, 2225-2231
CrossRef386
Jiro Aoki. (2010) Application of Drug Eluting Stents to Clinical Practice in Japan. Circulation Journal 74:8, 1532-1533
CrossRef387
Kensaku Nishihira, Yoshisato Shibata, Tetsunori Ishikawa, Katsumasa Nomura, Tatsuya Nakama, Daigo Mine, Yohei Inoue, Keiichi Ashikaga, Nehiro Kuriyama, Akihiko Matsuyama, Takuroh Imamura, Yujiro Asada, Kazuo Kitamura. (2010) Repeated Sirolimus-Eluting Stent Implantation to Treat Sirolimus-Eluting Stent and Bare-Metal Stent Restenosis. Circulation Journal 74:11, 2329-2333
CrossRef388
XiaoFan Wu, YunDai Chen, Takashi Kubo, ChangJiang Ge, Fang Ren, Xi Wu, WeiJun Chen, Yuan Zhou, Hong Liu, Shuzheng Lv. (2010) Long-Term (4-Year) Outcomes and Predictors of Adverse Cardiac Events After Sirolimus-Eluting Stent Implantation in Unprotected Left Main Coronary Artery. International Heart Journal 51:6, 377-382
CrossRef389
Ichiro Takeuchi, Masahiko Moriguchi, Ryuta Imaki, Hidehira Fukaya, Hisahito Shinagawa, Takao Shimohama, Taiki Tojo, Naoto Fukuda, Takayuki Inomata, Naoyoshi Aoyama, Kazui Soma, Tohru Izumi. (2010) Hemodialysis is an Independent Predictor of Coronary In-stent Restenosis after Paclitaxel Eluting Stent Implantation. Internal Medicine 49:22, 2379-2384
CrossRef390
Samip Vasaiwala, Daniel E. Forman, Laura Mauri. (2010) Drug-Eluting Stents in the Elderly. Current Treatment Options in Cardiovascular Medicine 12:1, 76-83
CrossRef391
Tomoki Morino, Yoshio Kobayashi, Yoshihide Fujimoto, Toshiharu Himi, Issei Komuro. (2010) Bare Metal Stent Restenosis Is Benign Clinical Entity in Japanese Patients. International Heart Journal 51:4, 227-230
CrossRef392
Julie Doostzadeh, Lee N. Clark, Susan Bezenek, Wesley Pierson, Poornima R. Sood, Krishnankutty Sudhir. (2010) Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent. Coronary Artery Disease 21:1, 46-56
CrossRef393
Katsuhisa Waseda, Takao Hasegawa, Junya Ako, Yasuhiro Honda, Eberhard Grube, Robert Whitbourn, John Ormiston, Charles D. O'Shaughnessy, Timothy D. Henry, Paul Overlie, Lewis B. Schwartz, Krishnankutty Sudhir, Bernard Chevalier, William A. Gray, Alan C. Yeung, Peter J. Fitzgerald, The ZoMaxx I and II Trial Investiga. (2010) Comparison of Vascular Response to Zotarolimus-Eluting Stent vs Paclitaxel-Eluting Stent Implantation. Circulation Journal 74:11, 2334-2339
CrossRef394
Masaru Nishimi, Tadashi Tashiro. (2010) Off-Pump Coronary Artery Bypass vs Percutaneous Coronary Intervention. Circulation Journal 74:12, 2750-2757
CrossRef395
K. VEDANTHAM, S. CHATERJI, J. KITSONGSERMTHON, K. PARK. 2010. Future outlook for drug eluting stents. , 118-153.
CrossRef396
Juan F. Granada, Carlos L. Alviar, David Wallace-Bradley, Matthew Osteen, Bijal Dave, Armando Tellez, Htut K. Win, Neal S. Kleiman, Greg L. Kaluza, Eli I. Lev. (2010) Patterns of activation and deposition of platelets exposed to the polymeric surface of the paclitaxel eluting stent. Journal of Thrombosis and Thrombolysis 29:1, 60-69
CrossRef397
Joo-Yong Hahn, Young Bin Song, Jin-Ho Choi, Sung-Hyuk Choi, Sung Yun Lee, Hun Sik Park, Seung Ho Hur, Sahng Lee, Kyoo-Rok Han, Seung-Woon Rha, Byung Ryul Cho, Jong-Sun Park, Junghan Yoon, Do Sun Lim, Sang Hoon Lee, Hyeon-Cheol Gwon, The DATE Registry Investigators. (2010) Three-Month Dual Antiplatelet Therapy After Implantation of Zotarolimus-Eluting Stents. Circulation Journal 74:11, 2314-2321
CrossRef398
Seung-Jung Park, Kyung-Hee Kim, Il-Young Oh, Dong-Ho Shin, Kyung-Il Park, Myung-Ki Seo, Jin-Wook Chung, Kyung Woo Park, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Tae-Jin Youn, Hyo-Soo Kim. (2010) Comparison of Plain Balloon and Cutting Balloon Angioplasty for the Treatment of Restenosis With Drug-Eluting Stents vs Bare Metal Stents. Circulation Journal 74:9, 1837-1845
CrossRef399
S. James Chen, John C. Messenger, John D. Carroll, Kenneth L. Jerina, Michael R. Mitchell, Terry O. Woods, Brian T. Berg, S. W. Dean. (2010) A Methodology for Quantifying Deformations in Stented Coronary Arteries Based on Three-Dimensional Angiography. Journal of ASTM International 7:1, 101873
CrossRef400
Ian Meredith, Stephen Worthley, Robert Whitbourn, Darren Walters, Dougal McClean, John Ormiston, Mark Horrigan, Gerard Wilkins, Randall Hendriks, Philip Matsis, David Muller, Donald Cutlip. (2010) Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial. EuroIntervention 5:6, 692-697
CrossRef401
Naoki Miyoshi, Junya Shite, Toshiro Shinke, Hiromasa Otake, Yusuke Tanino, Daisuke Ogasawara, Takahiro Sawada, Hiroyuki Kawamori, Hiroki Kato, Naoki Yoshino, Amane Kozuki, Ken-ichi Hirata. (2010) Comparison by Optical Coherence Tomography of Paclitaxel-Eluting Stents With Sirolimus-Eluting Stents Implanted in One Coronary Artery in One Procedure. Circulation Journal 74:5, 903-908
CrossRef402
Amane Kozuki, Junya Shite, Toshiro Shinke, Naoki Miyoshi, Takahiro Sawada, Farrel Hellig, Mark Abelson, Basil Brown, Sajidah Khan, Martin Mpe, Mpiko Ntsekhe, Damian Conway, Ken-ichi Hirata. (2010) STELLIUM 1: First-In-Man Follow-up Evaluation of Bioabsorbable Polymer-Coated Paclitaxel-Eluting Stent. Circulation Journal 74:10, 2089-2096
CrossRef403
Elvin Kedhi, Kaiyum Sheik Joesoef, Eugene McFadden, Jochem Wassing, Carlos van Mieghem, Dick Goedhart, Pieter Cornelis Smits. (2010) Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. The Lancet 375:9710, 201-209
CrossRef404
Gaku Nakazawa, Juan F. Granada, Carlos L. Alviar, Armando Tellez, Greg L. Kaluza, Margaret Yoklavich Guilhermier, Sherry Parker, Stephen M. Rowland, Frank D. Kolodgie, Martin B. Leon. (2010) Anti-CD34 Antibodies Immobilized on the Surface of Sirolimus-Eluting Stents Enhance Stent Endothelialization. JACC: Cardiovascular Interventions 3:1, 68-75
CrossRef405
M. Gagliardi, D. Silvestri, C. Cristallini, M. Guadagni, G. Crifaci, P. Giusti. (2010) Combined drug release from biodegradable bilayer coating for endovascular stents. Journal of Biomedical Materials Research Part B: Applied Biomaterials 9999B, NA-NA
CrossRef406
Seung-Pyo Lee, Song-Yi Kim, Kyung-Woo Park, Dong-Ho Shin, Hyun-Jae Kang, Bon-Kwon Koo, Jung-Won Suh, Young-Seok Cho, Tae-Jin Yeon, In-Ho Chae, Dong-Ju Choi, Hyo-Soo Kim. (2010) Long-Term Clinical Outcome of Chronic Total Occlusive Lesions Treated With Drug-Eluting Stents:. Circulation Journal 74:4, 693-700
CrossRef407
Sung Soo Kim, Young Joon Hong, Myung Ho Jeong, Weon Kim, Hyun-Kuk Kim, Jum Suk Ko, Min Goo Lee, Doo Sun Sim, Keun Ho Park, Nam Sik Yoon, Hyun Ju Yoon, Kye Hun Kim, Hyung Wook Park, Ju Han Kim, Youngkeun Ahn, Jeong Gwan Cho, Jong Chun Park, Sun-Jung Song, Dong Lyun Cho, Jung Chaee Kang. (2010) Two-Year Clinical Outcome After Abciximab-Coated Stent Implantation in Patients With Coronary Artery Disease. Circulation Journal 74:3, 442-448
CrossRef408
Byeong-Keuk Kim, Young-Guk Ko, Seungjin Oh, Jung-Sun Kim, Woong Chol Kang, Dong Woon Jeon, Joo Young Yang, Donghoon Choi, Myeong-Ki Hong, Taehoon Ahn, Yangsoo Jang. (2010) Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent. Yonsei Medical Journal 51:6, 823
CrossRef409
Katsuhisa Waseda, Junya Ako, Masao Yamasaki, Tomomi Koizumi, John Ormiston, Stephen G. Worthley, Robert J. Whitbourn, Darren L. Walters, Yasuhiro Honda, Ian T. Meredith, Peter J. Fitzgerald, The RESOLUTE Trial Investigators. (2010) Short- and Mid-Term Intravascular Ultrasound Analysis of the New Zotarolimus-Eluting Stent With Durable Polymer. Circulation Journal 74:10, 2097-2102
CrossRef410
Ali A. Youssef, Hesham Hussein, Shu-Kai Hsueh, Chien-Jen Chen, Cheng-Hsu Yang, Chi-Ling Hang, Yuan-Kai Hsieh, Chih-Yuan Fang, Hon-Kan Yip, Chiung-Jen Wu. (2010) Cobalt Chromium Coronary Stents and Drug-Eluting Stents in Real Practice. International Heart Journal 51:4, 231-237
CrossRef411
Masato Nakamura, Hiroyoshi Yokoi, Yuji Hamazaki, Masato Watarai, Mikihiro Kijima, Kazuaki Mitsudo, The Cypher J-PMS Investigators. (2010) Impact of Insulin-Treated Diabetes and Hemodialysis on Long-Term Clinical Outcomes Following Sirolimus-Eluting Stent Deployment. Circulation Journal 74:12, 2592-2597
CrossRef412
Atsushi Tanaka, Guillermo J. Tearney, Brett E. Bouma. (2010) Challenges on the frontier of intracoronary imaging: atherosclerotic plaque macrophage measurement by optical coherence tomography. Journal of Biomedical Optics 15:1, 011104
CrossRef413
Yoshimochi Nakano, Naoya Matsumoto, Yasuyuki Suzuki, Masahiko Kato, Takaaki Miki, Jun Iida, Shunichi Yoda, Keiko Sugiyama, Yuichi Sato, Shu Kasama, Toshio Kushiro, Ken Nagao, Atsushi Hirayama. (2010) Diagnostic Value of Adenosine-Induced Left Ventricular Diastolic Dysfunction for Detecting Coronary Artery Restenosis in Patients Undergoing Stent Implantation by Stress ECG-Gated Myocardial Perfusion SPECT. Circulation Journal 74:12, 2658-2665
CrossRef414
Naozumi Kubota, Katsumi Miyauchi, Takatoshi Kasai, Takafumi Iesaki, Kan Kajimoto, Katsuhiko Sumiyoshi, Tomotaka Dohi, Hiroyuki Daida. (2010) Synergistic Effects of Calcium-Channel and Angiotensin-Receptor Blockers on Endothelial Function and Inflammatory Responses in a Porcine Drug-Eluting Stent Model. Circulation Journal 74:8, 1704-1710
CrossRef415
Yoshihiro Morino, Seiji Tamiya, Naoki Masuda, Yota Kawamura, Masakazu Nagaoka, Takashi Matsukage, Nobuhiko Ogata, Gaku Nakazawa, Teruhisa Tanabe, Yuji Ikari. (2010) Intravascular Ultrasound Criteria for Determination of Optimal Longitudinal Positioning of Sirolimus-Eluting Stents. Circulation Journal 74:8, 1609-1616
CrossRef416
Peter Mortier, Gerhard A. Holzapfel, Matthieu Beule, Denis Loo, Yves Taeymans, Patrick Segers, Pascal Verdonck, Benedict Verhegghe. (2010) A Novel Simulation Strategy for Stent Insertion and Deployment in Curved Coronary Bifurcations: Comparison of Three Drug-Eluting Stents. Annals of Biomedical Engineering 38:1, 88-99
CrossRef417
Nobuo Shiode, Kinya Shirota, Fumiyo Tsunoda, Yasuko Kato, Mai Fujiwara, Asao Mimura. (2010) Late Progression After Sirolimus-Eluting Stent Implantation for de Novo Lesions. Circulation Journal 74:6, 1104-1110
CrossRef418
Kyung Woo Park, Si-Hyuck Kang, Woo-Young Chung, Hae-Young Lee, Jin-Shik Park, Hyun-Jae Kang, Young-Seok Cho, Tae-Jin Youn, Bon-Kwon Koo, In-Ho Chae, Dong-Ju Choi, Seokyung Hahn, Byung-Joo Park, Hyo-Soo Kim. (2010) `Real World' Comparison of Drug-Eluting Stents vs Bare Metal Stents in the Treatment of Unselected Patients With Acute ST-Segment Elevation Myocardial Infarction. Circulation Journal 74:6, 1111-1120
CrossRef419
Corrado Tamburino, Davide Capodanno, Alessio La Manna, Marilena di Salvo, Alessandra Sanfilippo, Francesco Prati. (2010) Rapid Evaluation of Vessel HEaling After AngiopLasty (REVEAL) trial: rationale, objectives and design. Journal of Cardiovascular Medicine 11:1, 53-58
CrossRef420
Eiji Ichimoto, Yoshio Kobayashi, Yoshihiro Iijima, Nakabumi Kuroda, Yukinori Kohno, Issei Komuro. (2010) Long-term Clinical Outcomes After Sirolimus-Eluting Stent Implantation in Dialysis Patients. International Heart Journal 51:2, 92-97
CrossRef421
Hiromasa Horiguchi, Hideo Yasunaga, Hideki Hashimoto, Shinya Matsuda. (2010) Impact of Drug-Eluting Stents on Treatment Option Mix for Coronary Artery Disease in Japan. Circulation Journal 74:8, 1635-1643
CrossRef422
Marcus Wiemer, Patrick W. Serruys, Karine Miquel-Hebert, Franz-Josef Neumann, Jan J. Piek, Eberhard Grube, Jürgen Haase, Leif Thuesen, Christian Hamm. (2010) Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT FIRST trial. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef423
Sandhir B. Prasad, Walid Ahmar, Yuvaraj Malaiapan, Ian T. Meredith. (2010) Drug-eluting Stents for the Treatment of Acute Myocardial Infarction: The View to the HORIZONS. Heart, Lung and Circulation 19:1, 11-18
CrossRef424
Tadateru Takayama, Takafumi Hiro, Atsushi Hirayama. (2010) Is Angioplasty Able to Become the Gold Standard of Treatment Beyond Bypass Surgery for Patients With Multivessel Coronary Artery Disease?. Circulation Journal 74:12, 2744-2749
CrossRef425
Ken-ichirou Yamagata, Yu Kataoka, Nobuaki Kokubu, Yoichiro Kasahara, Mitsuru Abe, Hiroyuki Nakajima, Junjiro Kobayashi, Yoritaka Otsuka. (2010) A 3-Year Clinical Outcome After Percutaneous Coronary Intervention Using Sirolimus-Eluting Stent and Off-Pump Coronary Artery Bypass Grafting for the Treatment of Diabetic Patients With Multivessel Disease. Circulation Journal 74:4, 671-678
CrossRef426
Narisato Hamada, Masaaki Miyata, Hideyuki Eto, Takahiro Shirasawa, Yuichi Akasaki, Aya Nagaki, Chuwa Tei. (2010) Tacrolimus-eluting stent inhibits neointimal hyperplasia via calcineurin/NFAT signaling in porcine coronary artery model. Atherosclerosis 208:1, 97-103
CrossRef427
Takahisa Fujikawa, Akira Tanaka, Toshihiro Abe, Yasunori Yoshimoto, Katsuhiro Kondo, Hiroyoshi Yokoi, Kei Shiraishi, Tomoharu Yoshida, Katsuhiro Seo, Masakiyo Nobuyoshi. (2010) Surgery Against Cancer of Gastrointestinal Tract and Perioperative Management in Patients Receiving Drug-Eluting Coronary Stent Implantation. The Japanese Journal of Gastroenterological Surgery 43:9, 882-892
CrossRef428
Martin B. Leon, David E. Kandzari, Eric L. Eisenstein, Kevin J. Anstrom, Laura Mauri, Donald E. Cutlip, Eugenia Nikolsky, Charles O'Shaughnessy, Paul A. Overlie, Ajay J. Kirtane. (2009) Late Safety, Efficacy, and Cost-Effectiveness of a Zotarolimus-Eluting Stent Compared With a Paclitaxel-Eluting Stent in Patients With De Novo Coronary Lesions2-Year Follow-Up From the ENDEAVOR IV Trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). JACC: Cardiovascular Interventions 2:12, 1208-1218
CrossRef429
Scot Garg, Patrick Serruys, Yoshinobu Onuma, Cécile Dorange, Susan Veldhof, Karine Miquel-Hébert, Krishnankutty Sudhir, Jean Boland, Kurt Huber, Eulogio Garcia, Jan A.M. te Riele. (2009) 3-Year Clinical Follow-Up of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions. JACC: Cardiovascular Interventions 2:12, 1190-1198
CrossRef430
Eric L. Eisenstein, Martin B. Leon, David E. Kandzari, Laura Mauri, Rex Edwards, David F. Kong, Patricia A. Cowper, Kevin J. Anstrom. (2009) Long-Term Clinical and Economic Analysis of the Endeavor Zotarolimus-Eluting Stent Versus the Cypher Sirolimus-Eluting Stent. JACC: Cardiovascular Interventions 2:12, 1199-1207
CrossRef431
James B. Hermiller, Todd Fergus, Wesley Pierson, Xiaolu Su, Poornima Sood, Krishnankutty Sudhir, Gregg W. Stone. (2009) Clinical and angiographic comparison of everolimus-eluting and paclitaxel-eluting stents in small coronary arteries: A post hoc analysis of the SPIRIT III randomized trial. American Heart Journal 158:6, 1005-1010
CrossRef432
Issam D. Moussa, Antonio Colombo. (2009) Antiplatelet therapy discontinuation following drug-eluting stent placement: Dangers, reasons, and management recommendations. Catheterization and Cardiovascular Interventions 74:7, 1047-1054
CrossRef433
Elena Ladich, Marc Vorpahl, Masataka Nakano, Renu Virmani. (2009) Latest on the pathology of drug-eluting stents. Interventional Cardiology 1:2, 165-174
CrossRef434
Eric L. Eisenstein, William Wijns, Jean Fajadet, Laura Mauri, Rex Edwards, Patricia A. Cowper, David F. Kong, Kevin J. Anstrom. (2009) Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent. JACC: Cardiovascular Interventions 2:12, 1178-1187
CrossRef435
Hiroshi Doi, Akiko Maehara, Gary S. Mintz, Alan Yu, Hong Wang, Lazar Mandinov, Jeffrey J. Popma, Stephen G. Ellis, Eberhard Grube, Keith D. Dawkins. (2009) Impact of Post-Intervention Minimal Stent Area on 9-Month Follow-Up Patency of Paclitaxel-Eluting StentsAn Integrated Intravascular Ultrasound Analysis From the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. JACC: Cardiovascular Interventions 2:12, 1269-1275
CrossRef436
Edoardo Camenzind, William Wijns, Laura Mauri, Eric Boersma, Keyur Parikh, Volkhard Kurowski, Runlin Gao, Christoph Bode, John P. Greenwood, Anthony Gershlick, William O'Neill, Patrick W. Serruys, Brenda Jorissen, P. Gabriel Steg. (2009) Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): Randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation. American Heart Journal 158:6, 902-909.e5
CrossRef437
Takashi Shiroto, Satoshi Yasuda, Ryuji Tsuburaya, Yoshitaka Ito, Jun Takahashi, Kenta Ito, Hatsue Ishibashi-Ueda, Hiroaki Shimokawa. (2009) Role of Rho-Kinase in the Pathogenesis of Coronary Hyperconstricting Responses Induced by Drug-Eluting Stents in Pigs In Vivo. Journal of the American College of Cardiology 54:24, 2321-2329
CrossRef438
James E. Tcheng, David A. Zidar. (2009) Gone But Not ForgottenThe Case for Drug-Eluting Stents in Percutaneous Revascularization of the Chronic Coronary Total Occlusion
. JACC: Cardiovascular Interventions 2:12, 1266-1268
CrossRef439
Marc Vorpahl, Aloke Finn, Masataka Nakano, Renu Virmani. (2009) The bioabsorption process: tissue and cellular mechanisms and outcomes. EuroIntervention 5:F, F28-F35
CrossRef440
Ron Waksman, Rajbabu Pakala. (2009) Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent. EuroIntervention 5:F, F36-F42
CrossRef441
Sripal Bangalore, Laura Mauri. (2009) Late loss in a disappearing frame of reference: is it still applicable to fully absorbable scaffolds?. EuroIntervention 5:F, F43-F48
CrossRef442
S. Schulz, T. Schuster, J. Mehilli, R. A. Byrne, J. Ellert, S. Massberg, J. Goedel, O. Bruskina, K. Ulm, A. Schomig, A. Kastrati. (2009) Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period. European Heart Journal 30:22, 2714-2721
CrossRef443
Thomas A. Vassiliades, Patrick D. Kilgo, John S. Douglas, Vasilis C. Babaliaros, Peter C. Block, Habib Samady, Christopher U. Cates, S Tanveer Rab, Douglas C. Morris. (2009) Clinical Outcomes After Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery 4:6, 299-306
CrossRef444
Massimo Boffini, Fabrizio Ceresa, Fabrizio Sansone, Marco Ribezzo, Chiara Comoglio, Mauro Rinaldi. (2009) Emergent coronary artery bypass grafting for cardiogenic shock caused by very late drug-eluting stent thrombosis. General Thoracic and Cardiovascular Surgery 57:11, 609-611
CrossRef445
Petra Hoppmann, Anna Erl, Serin Türk, Klaus Tiroch, Julinda Mehilli, Albert Schömig, Adnan Kastrati, Werner Koch. (2009) No Association of Chromosome 9p21.3 Variation With Clinical and Angiographic Outcomes After Placement of Drug-Eluting Stents. JACC: Cardiovascular Interventions 2:11, 1149-1155
CrossRef446
Refat Jabara, Sarah Geva, Henrique Ribeiro, Jack Chen, Dongming Hou, Jinsheng Li, Spencer King, Nicolas Chronos, Keith Robinson. (2009) A third generation ultra-thin strut cobalt chromium stent: histopathological evaluation in porcine coronary arteries. EuroIntervention 5:5, 619-626
CrossRef447
Harvey S. Hecht, Sotir Polena, Vladimir Jelnin, Marcelo Jimenez, Tandeep Bhatti, Manish Parikh, Georgia Panagopoulos, Gary Roubin. (2009) Stent Gap by 64-Detector Computed Tomographic Angiography. Journal of the American College of Cardiology 54:21, 1949-1959
CrossRef448
Martin Unverdorben, Ralf Degenhardt, Marcus Wiemer, Dieter Horstkotte, Henrik Schneider, Christoph Nienaber, Wolfgang Bocksch, Michael Gross, Michael Boxberger, Christian Vallbracht, . (2009) The paclitaxel-eluting coroflex™ please stent study (PECOPS I): The 3-year clinical follow-up. Catheterization and Cardiovascular Interventions 74:5, 674-682
CrossRef449
Jael Atary, Sandrin Bergheanu, Bas van der Hoeven, Douwe Atsma, Marianne Bootsma, Frank van der Kley, Katja Zeppenfeld, J. Wouter Jukema, Martin Schalij. (2009) Impact of sirolimus-eluting stent implantation compared to bare-metal stent implantation for acute myocardial infarction on coronary plaque composition at nine months follow-up: a Virtual Histology intravascular ultrasound analysis. Results from the Leiden MISSION! intervention study. EuroIntervention 5:5, 565-572
CrossRef450
Seung-Ho Hur, Yun-Kyeong Cho, Chang-Wook Nam, Hyungseop Kim, Seong-Wook Han, Yoon-Nyun Kim, Hee-Joon Park, Jong-Seon Park, Dong-Gu Shin, Young-Jo Kim, Bong-Sup Shim, Tae-Hyun Yang, Dae-Kyeong Kim, Doo-Il Kim, Dong-Soo Kim, Kwon-Bae Kim. (2009) Comparison of Long-term Outcomes Following Sirolimus-eluting Stent vs Paclitaxel-eluting Stent Implantation in Patients with Long Calcified Coronary Lesions. Clinical Cardiology 32:11, 633-638
CrossRef451
Pierre Yves Etienne, David Glineur, Spiridon Papadatos, Gregory Kalscheuer, Yves Mairy, Munir Boodhwani, Gebrine El Khoury, Philippe Noirhomme, Claude Hanet. (2009) Comparison of Minimally Invasive Direct Coronary Artery Bypass Surgery With Implantation of Drug-Eluting Stentsin Patients With Left Anterior Descending Coronary Artery Disease. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery 4:6, 340-344
CrossRef452
Zengsheng Chen, Yubo Fan, Xiaoyan Deng, Zaipin Xu. (2009) Swirling Flow Can Suppress Flow Disturbances in Endovascular Stents: A Numerical Study. ASAIO Journal 55:6, 543-549
CrossRef453
Alfonso Medina, Pedro Martín, Javier Suárez de Lezo, Celestina Amador, José Suárez de Lezo, Manuel Pan, Francisco Melián, Enrique Hernández, Luis Burgos, Soledad Ojeda, José Ramón Ortega, Antonio García. (2009) Anatomía vulnerable de la carina en lesiones ostiales de la arteria coronaria descendente anterior tratadas con stent flotante. Revista Española de Cardiología 62:11, 1240-1249
CrossRef454
Yih-Jer Wu, Graciela B. Sala-Newby, Kuo-Tung Shu, Hung-I. Yeh, Keiichi I. Nakayama, Keiko Nakayama, Andrew C. Newby, Mark Bond. (2009) S-phase kinase-associated protein-2 (Skp2) promotes vascular smooth muscle cell proliferation and neointima formation in vivo. Journal of Vascular Surgery 50:5, 1135-1142
CrossRef455
Gaku Nakazawa, Aloke V. Finn, Marc Vorpahl, Elena Ladich, Robert Kutys, Isidora Balazs, Frank D. Kolodgie, Renu Virmani. (2009) Incidence and Predictors of Drug-Eluting Stent Fracture in Human Coronary Artery. Journal of the American College of Cardiology 54:21, 1924-1931
CrossRef456
R. A. Byrne, A. Kastrati, S. Kufner, S. Massberg, K. A. Birkmeier, K.-L. Laugwitz, S. Schulz, J. Pache, M. Fusaro, M. Seyfarth, A. Schomig, J. Mehilli, . (2009) Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial. European Heart Journal 30:20, 2441-2449
CrossRef457
BYEONG-KEUK KIM, SEUNGJIN OH, DONG WOON JEON, JOO YOUNG YANG, JUNG-SUN KIM, SUNGHA PARK, DONGHOON CHOI, YANGSOO JANG, BUM-KEE HONG, HYUK MOON KWON, SEUNG-WHAN LEE, CHOONG WON GOH, KIHWAN KWON, SUNG KEE RYU, . (2009) Long-Term Clinical Outcomes and Stent Thrombosis of Sirolimus-Eluting Versus Bare Metal Stents in Patients with End-Stage Renal Disease: Results of Korean Multicenter Angioplasty Team (KOMATE) Registry. Journal of Interventional Cardiology 22:5, 411-419
CrossRef458
David Austin, Keith G. Oldroyd, David R. Holmes, Charanjit S. Rihal, P. Diane Galbraith, William A. Ghali, Victor Legrand, Yves Taeymans, Alex McConnachie, Jill P. Pell. (2009) Drug-eluting stents: A study of international practice. American Heart Journal 158:4, 576-584
CrossRef459
Jochen Wöhrle, Thorsten Nusser, Stephanie Hoffmann, Matthias Kochs. (2009) Angiographic results of the cobalt chromium Vision and Mini-Vision stents. Canadian Journal of Cardiology 25:10, 581-584
CrossRef460
Fusako Sera, Masaki Awata, Masaaki Uematsu, Jun-ichi Kotani, Shinsuke Nanto, Seiki Nagata. (2009) Optimal Stent-Sizing With Intravascular Ultrasound Contributes to Complete Neointimal Coverage After Sirolimus-Eluting Stent Implantation Assessed by Angioscopy. JACC: Cardiovascular Interventions 2:10, 989-994
CrossRef461
Tonga Nfor, Imran Ansaarie, Anjan Gupta, Tanvir Bajwa, Suhail Allaqaband. (2009) Comparing long-term outcomes between drug-eluting and bare-metal stents in the treatment of cardiac allograft vasculopathy. Catheterization and Cardiovascular Interventions 74:4, 543-549
CrossRef462
Margo Klomp, Marcel A.M. Beijk, Niels J.W. Verouden, Jan G.P. Tijssen, Robbert J. de Winter. (2009) Design and rationale of the TRI-stent Adjudication Study (TRIAS) Program. American Heart Journal 158:4, 527-532.e1
CrossRef463
Kenan Övünç, Hikmet Yorgun, Necla Özer. (2009) Multiple coronary artery aneurysm formation one year and four years after sirolimus-eluting coronary stent implantation. Cardiovascular Revascularization Medicine 10:4, 252-254
CrossRef464
CRAIG A. THOMPSON, MANDEEP S. SIDHU, JEREMIAH R. BROWN, SAJJAD A. SABIR, KEVIN C. FLOYD, JAMES T. DE VRIES, JOHN E. JAYNE, BRUCE J. FRIEDMAN, BRUCE D. HETTLEMAN, NATHANIEL W. NILES, JOHN F. ROBB, DAVID J. MALENKA, AARON V. KAPLAN, . (2009) Classification and Atherosclerosis Distribution in Patients with Left Main Coronary Disease. Journal of Interventional Cardiology 22:5, 431-436
CrossRef465
John A. Ormiston, Mark W.I. Webster, Robert S. Schwartz, Patrick Gladding, James T. Stewart, I. Patrick Kay, Peter N. Ruygrok, Robert Hatrick. (2009) Feasibility, Safety, and Efficacy of a Novel Polymeric Pimecrolimus-Eluting StentTraditional Pre-Clinical Safety End Points Failed to Predict 6-Month Clinical Angiographic Results. JACC: Cardiovascular Interventions 2:10, 1017-1024
CrossRef466
Eugenia Nikolsky, Alexandra J. Lansky, Krishnankutty Sudhir, Julie Doostzadeh, Donald E. Cutlip, Robert Piana, Xiaolu Su, Roseann White, Charles A. Simonton, Gregg W. Stone. (2009) SPIRIT IV trial design: A large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease. American Heart Journal 158:4, 520-526.e2
CrossRef467
Emilio Di Lorenzo, Rosario Sauro, Attilio Varricchio, Michele Capasso, Tonino Lanzillo, Fiore Manganelli, Ciro Mariello, Francesco Siano, Maria Rosaria Pagliuca, Giovanni Stanco, Giuseppe Rosato, Giuseppe De Luca. (2009) Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: Four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial. American Heart Journal 158:4, e43-e50
CrossRef468
Dennis T. Ko, Maria Chiu, Helen Guo, Peter C. Austin, Jean-François Marquis, Jack V. Tu. (2009) Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents. American Heart Journal 158:4, 592-598.e1
CrossRef469
Robert A. Byrne, Nikolaus Sarafoff, Adnan Kastrati, Albert Schömig. (2009) Drug-Eluting Stents in Percutaneous Coronary Intervention. Drug Safety 32:9, 749-770
CrossRef470
E. Meliga, H.M. Garcia-Garcia, M. Valgimigli, A. Chieffo, G. Biondi-Zoccai, A.O. Maree, N. Gonzalo, S. Cook, S. Marra, C. Moretti, S. De Servi, I.F. Palacios, S. Windecker, R. van Domburg, A. Colombo, I. Sheiban, P.W. Serruys. (2009) Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: The sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT). International Journal of Cardiology 137:1, 16-21
CrossRef471
Christopher Lichtenwalter, James A. de Lemos, Michele Roesle, Owen Obel, Elizabeth M. Holper, Donald Haagen, Bilal Saeed, Jose Miguel Iturbe, Kendrick Shunk, Joseph K. Bissett, Rajesh Sachdeva, Vassilios V. Voudris, Panagiotis Karyofillis, Biswajit Kar, James Rossen, Panayotis Fasseas, Peter Berger, Subhash Banerjee, Emmanouil S. Brilakis. (2009) Clinical Presentation and Angiographic Characteristics of Saphenous Vein Graft Failure After Stenting. JACC: Cardiovascular Interventions 2:9, 855-860
CrossRef472
Tatsuhiko Asano, Yoshio Kobayashi, Kenichi Fukushima, Yo Iwata, Hideki Kitahara, Naoki Ishio, Takashi Nakayama, Nakabumi Kuroda, Issei Komuro. (2009) Effect of balloon inflation time on expansion of sirolimus-eluting stent. Heart and Vessels 24:5, 335-339
CrossRef473
Michael A. Kutcher. (2009) Drug-eluting stents versus bypass surgery for multivessel coronary disease. Current Cardiovascular Risk Reports 3:5, 331-338
CrossRef474
Geng-Ruei Chang, Ying-Ying Wu, Yi-Shin Chiu, Wen-Ying Chen, Jiunn-Wang Liao, Hong-Ming Hsu, Te-Hsin Chao, Siu-Wan Hung, Frank Chiahung Mao. (2009) Long-term Administration of Rapamycin Reduces Adiposity, but Impairs Glucose Tolerance in High-Fat Diet-fed KK/HlJ Mice. Basic & Clinical Pharmacology & Toxicology 105:3, 188-198
CrossRef475
Mounir Basalus, K. Gert van Houwelingen, Marc Ankone, Frits de Man, Clemens von Birgelen. (2009) Scanning electron microscopic assessment of the biodegradable coating on expanded biolimus-eluting stents. EuroIntervention 5:4, 505-510
CrossRef476
Rainer Hoffmann, Helene Klinker, Umar Adamu, Malte Kelm, Rüdiger Blindt. (2009) The risk of definitive stent thrombosis is increased after “off-label” stent implantation irrespective of drug-eluting stent or bare-metal stent use. Clinical Research in Cardiology 98:9, 549-554
CrossRef477
Antonio J. Muñoz-Garcia, Antonio J. Domínguez-Franco, Juan H. Alonso-Briales, Manuel F. Jiménez-Navarro, José M. Hernández-García, Eduardo de Teresa-Galván. (2009) Comparison of incidence and angiography patterns in definite thrombosis between drug-eluting and bare-metal stents. International Journal of Cardiology 137:1, 62-64
CrossRef478
Adriano Caixeta, Martin B. Leon, Alexandra J. Lansky, Eugenia Nikolsky, Jiro Aoki, Jeffrey W. Moses, Joachim Schofer, Marie-Claude Morice, Erick Schampaert, Ajay J. Kirtane, Jeffrey J. Popma, Helen Parise, Martin Fahy, Roxana Mehran. (2009) 5-Year Clinical Outcomes After Sirolimus-Eluting Stent Implantation. Journal of the American College of Cardiology 54:10, 894-902
CrossRef479
A. Menozzi, E. Solinas, P. Ortolani, A. Repetto, F. Saia, G. Piovaccari, A. Manari, E. Magagnini, L. Vignali, E. Bonizzoni, P. A. Merlini, C. Cavallini, D. Ardissino, . (2009) Twenty-four months clinical outcomes of sirolimus-eluting stents for the treatment of small coronary arteries: the long-term SES-SMART clinical study. European Heart Journal 30:17, 2095-2101
CrossRef480
Philippe Steg, Gregory Ducrocq. (2009) Stent selection in patients on oral anticoagulants: can we prevent restenosis and avoid bleeding?. EuroIntervention 5:4, 405-407
CrossRef481
Joseph John DeRose. (2009) Current State of Integrated “Hybrid” Coronary Revascularization. Seminars in Thoracic and Cardiovascular Surgery 21:3, 229-236
CrossRef482
Giuseppe Luca, Marco Valgimigli, Christian Spaulding, Maurizio Menichelli, Hans Peter Brunner-La Rocca, Bas L. Hoeven, Emilio Lorenzo, Luis-S. Diaz Llera, Vincenzo Pasceri, Undine Pittl, Gianfranco Percoco, Roberto Violini, Gregg W. Stone. (2009) Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. Journal of Thrombosis and Thrombolysis 28:2, 200-210
CrossRef483
Sachiko Sato, Yasuhide Nakayama, Toshio Matsuhashi, Kazumasa Seiji, Kenichi Matsunaga, Chiaki Takasawa, Tadashi Ishibashi, Yue-Min Zhou, Hatsue Ishibashi-Ueda, Yoshihiro Okamoto, Hiroyuki Asano, Shoki Takahashi. (2009) Evaluation of self-expandable, FK506-coated, covered stents in canine animal model. Journal of Biomedical Materials Research Part B: Applied Biomaterials 90B:2, 647-652
CrossRef484
Shinichi Furuichi, Giuseppe Sangiorgi, Cosmo Godino, Flavio Airoldi, Matteo Montorfano, Alaide Chieffo, Iassen Michev, Mauro Carlino, Antonio Colombo. (2009) Rotational atherectomy followed by drug-eluting stent implantation in calcified coronary lesions. EuroIntervention 5:3, 370-374
CrossRef485
SUDHIR RATHORE, MITSUYASU TERASHIMA, M. HABARA, YOSHIHISA KINOSHITA, KENYA NASU, OSAMU KATOH, TAKAHIKO SUZUKI. (2009) Incomplete Stent Apposition after Coronary Stent Implantation: Myth or Reality?. Journal of Interventional Cardiology 22:4, 341-349
CrossRef486
Stephen E. Horn, Daniel H. Steinberg. (2009) Grayscale intravascular ultrasound: Current concepts in percutaneous coronary interventions. Current Cardiovascular Imaging Reports 2:4, 259-267
CrossRef487
Ryan K. Kaple, Kenichi Tsujita, Akiko Maehara, Gary S. Mintz. (2009) Accuracy of Stent Measurements Using ECG-Gated Greyscale Intravascular Ultrasound Images: A Validation Study. Ultrasound in Medicine & Biology 35:8, 1265-1270
CrossRef488
R. Cohen, R. Foucher, A. Sfaxi, M. Hakim, T. Domniez, S. Elhadad. (2009) Résultats immédiats et à long terme après angioplastie coronaire avec stents actifs de lésions de bifurcation par la technique du « crush stenting ». Annales de Cardiologie et d'Angéiologie 58:4, 208-214
CrossRef489
Sudhir Rathore, Mitsuyasu Terashima, Osamu Katoh, Hitoshi Matsuo, Noboyushi Tanaka, Yoshihisa Kinoshita, Masashi Kimura, Etsuo Tuschikane, Kenya Nasu, Mariko Ehara, Keiko Asakura, Yasushi Asakura, Takahiko Suzuki. (2009) Predictors of angiographic restenosis after drug eluting stents in the coronary arteries: contemporary practice in real world patients. EuroIntervention 5:3, 349-354
CrossRef490
Maksymilian P. Opolski, Radoslaw Pracon, Gary S. Mintz, Teruo Okabe, Jerzy Pregowski, Sung Yun Lee, Eva C. van der Waal, Lukasz Kalinczuk, Probal Roy, Kimberly A. Smith, Rebecca Torguson, Zhenyi Xue, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman, Neil J. Weissman. (2009) Relation of Drug-Eluting Stent Strut Distribution to Stent Thrombosis in Coronary Arteries. The American Journal of Cardiology 104:3, 343-348
CrossRef491
Hideo Kawakami, Hiroshi Matsuoka, Akira Oshita, Tamami Kono, Susumu Shigemi. (2009) A case of a newly developed yellow neointima at stent implanted site 1 year after sirolimus-eluting stent placement. Journal of Cardiology 54:1, 153-157
CrossRef492
Victor Novack, Donald Cutlip, Neal Kleiman, Michael Pencina, Laura Mauri, Chen-Hsing Yen, Peter Berger, Steven Goldberg, Mirle Kellett, Ronald Waksman, Mun Hong, Albert E. Raizner, David J. Cohen. (2009) In-Hospital and 1-Year Outcomes Among Unselected Percutaneous Coronary Intervention Patients Treated With Either Sirolimus- or Paclitaxel-Eluting Stents. JACC: Cardiovascular Interventions 2:8, 767-775
CrossRef493
Li-Jian Gao, Ji-Lin Chen, Jun Chen, Yue-Jin Yang, Run-Lin Gao, Jian-Jun Li, Xue-Wen Qin, Shu-Bin Qiao, Bo Xu, Min Yao, Hai-Bo Liu, Yong-Jian Wu, Jin-Qing Yuan, Jue Chen, Shi-Jie You, Jun Dai. (2009) Long-Term Clinical Efficacy of Cutting Balloon Angioplasty Followed by Bare Metal Stent Implantation for Treating Ostial Left Anterior Descending Artery Lesions. Clinical Cardiology 32:8, E31-E35
CrossRef494
Umesh Tamhane, Pascal Meier, Stanley Chetcuti, Kang-Yin Chen, Seung-Woon Rha, Michael Grossman, Hitinder Gurm. (2009) Efficacy of Cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials. EuroIntervention 5:3, 384-393
CrossRef495
Jin Oh Na, Jin Won Kim, Cheol Ung Choi, Un Jung Choi, Seung Yong Shin, Hong Euy Lim, Eung Ju Kim, Seung-Woon Rha, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh. (2009) Bare-metal stents versus drug-eluting stents in large (≥3.5mm) single coronary artery: Angiographic and clinical outcomes at 6 months. Journal of Cardiology 54:1, 108-114
CrossRef496
Fausto Feres, Pedro Andrade, Ricardo Costa, J. de Ribamar Costa, Alexandre Abizaid, Rodolfo Staico, Luiz Tanajura, Dimytri Siqueira, Julio Maia, Leandro Lasave, Amanda Sousa, J. Sousa. (2009) Angiographic and intravascular ultrasound findings following implantation of the Endeavor™ zotarolimus-eluting stents in patients from the real-world clinical practice. EuroIntervention 5:3, 355-362
CrossRef497
Khaled M. Ziada, Ahmed Abdel-Latif. (2009) Drug-Eluting Stents in Patients With ESRD on Dialysis: A Small Step Forward. American Journal of Kidney Diseases 54:2, 197-200
CrossRef498
KENICHI CHATANI, TOSHIYA MURAMATSU, REIKO TSUKAHARA, YOSHIAKI ITO, HIROSHI ISHIMORI, KEISUKE HIRANO, MASATSUGU NAKANO, MASAHIRO YAMAWAKI, MOTOHARU ARAKI, MASAYUKI SAKURAI, KAZUYUKI IUCHI, TAKASHI NOZAWA, HIROSHI INOUE. (2009) Predictive Factors of Re-restenosis after Repeated Sirolimus-Eluting Stent Implantation for SES Restenosis and Clinical Outcomes after Percutaneous Coronary Intervention for SES Restenosis. Journal of Interventional Cardiology 22:4, 354-361
CrossRef499
Anelize S. Fogo, Eliane Antonioli, João B. Calixto, Alexandre H. Campos. (2009) Tormentic acid reduces vascular smooth muscle cell proliferation and survival. European Journal of Pharmacology 615:1-3, 50-54
CrossRef500
Katsuhisa Waseda, Akiyoshi Miyazawa, Junya Ako, Takao Hasegawa, Ichizo Tsujino, Ryota Sakurai, Paul G. Yock, Yasuhiro Honda, David E. Kandzari, Martin B. Leon. (2009) Intravascular Ultrasound Results From the ENDEAVOR IV TrialRandomized Comparison Between Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease. JACC: Cardiovascular Interventions 2:8, 779-784
CrossRef501
Cheol Ung Choi, Seung-Woon Rha, Kang-Yin Chen, Zhe Jin, Yoshiyasu Minami, Seung Yong Shin, Jin Oh Na, Soon Yong Suh, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh. (2009) Mid-term angiographic benefit of sirolimus-eluting stents compared with paclitaxel-eluting stents in patients with acute myocardial infarction. Journal of Cardiology 54:1, 80-85
CrossRef502
Sen Yachi, Kengo Tanabe, Shuzou Tanimoto, Jiro Aoki, Gaku Nakazawa, Hirosada Yamamoto, Shuji Otsuki, Atsuhiko Yagishita, Satoru Kishi, Masataka Nakano, Masahiro Taniwaki, Shunsuke Sasaki, Hiroyoshi Nakajima, Naofumi Mise, Tokuichiro Sugimoto, Kazuhiro Hara. (2009) Clinical and Angiographic Outcomes Following Percutaneous Coronary Intervention With Sirolimus-Eluting Stents Versus Bare-Metal Stents in Hemodialysis Patients. American Journal of Kidney Diseases 54:2, 299-306
CrossRef503
Judit E. Puskas, Lyn G. Muñoz-Robledo, Robert A. Hoerr, John Foley, Steven P. Schmidt, Michelle Evancho-Chapman, Jinping Dong, Chris Frethem, Greg Haugstad. (2009) Drug-eluting stent coatings. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 1:4, 451-462
CrossRef504
Yong-Seok Kim, Bon-Kwon Koo, Jae-Bin Seo, Kyung Woo Park, Jung-Won Suh, Hae-Young Lee, Jin-Shik Park, Hyun-Jae Kang, Young-Seok Cho, Woo-Young Chung, In-Ho Chae, Dong-Ju Choi, Hyo-Soo Kim, Byung-Hee Oh, Young-Bae Park. (2009) The incidence and predictors of postprocedural incomplete stent apposition after angiographically successful drug-eluting stent implantation. Catheterization and Cardiovascular Interventions 74:1, 58-63
CrossRef505
Andrew D. Frutkin, Jason B. Lindsey, Sameer K. Mehta, John A. House, John A. Spertus, David J. Cohen, John S. Rumsfeld, Steven P. Marso. (2009) Drug-Eluting Stents and the Use of Percutaneous Coronary Intervention Among Patients With Class I Indications for Coronary Artery Bypass Surgery Undergoing Index Revascularization. JACC: Cardiovascular Interventions 2:7, 614-621
CrossRef506
Karine Vallières, Éric Petitclerc, Gaétan Laroche. (2009) On the ability of imatinib mesylate to inhibit smooth muscle cell proliferation without delaying endothelialization: An in vitro study. Vascular Pharmacology 51:1, 50-56
CrossRef507
Somjot S. Brar, Gregg W. Stone. (2009) Advances in percutaneous coronary intervention. Current Cardiology Reports 11:4, 245-251
CrossRef508
Adel Aminian, Tito Kabir, Eric Eeckhout. (2009) Treatment of drug-eluting stent restenosis: An emerging challenge. Catheterization and Cardiovascular Interventions 74:1, 108-116
CrossRef509
Margo Klomp, Marcel AM Beijk, Robbert J de Winter. (2009) Genous™ endothelial progenitor cell-capturing stent system: a novel stent technology. Expert Review of Medical Devices 6:4, 365-375
CrossRef510
Xiushui Ren, Marina Trilesskaya, Damon M. Kwan, Kim Nguyen, Richard E. Shaw, Peter Y. Hui. (2009) Comparison of Outcomes Using Bare Metal Versus Drug-Eluting Stents in Coronary Artery Disease Patients With and Without Human Immunodeficiency Virus Infection. The American Journal of Cardiology 104:2, 216-222
CrossRef511
Hideaki Kaneda, Junya Ako, Mitsuyasu Terashima, Katsuhisa Waseda, Paul G. Yock, Peter J. Fitzgerald. (2009) Distribution pattern of neointimal hyperplasia following sirolimus-eluting stent implantation assessed by 3-dimensional intravascular ultrasound. International Journal of Cardiology 135:2, 243-245
CrossRef512
Riya Chacko, Meredith Mulhearn, Victor Novack, Lena Novack, Laura Mauri, Sidney A. Cohen, Jeffrey Moses, Martin B. Leon, Donald E. Cutlip. (2009) Impact of Target Lesion and Nontarget Lesion Cardiac Events on 5-Year Clinical Outcomes After Sirolimus-Eluting or Bare-Metal Stenting. JACC: Cardiovascular Interventions 2:6, 498-503
CrossRef513
Tsutomu Takagi, Hiroyuki Okura, Yoshiki Kobayashi, Toru Kataoka, Haruyuki Taguchi, Iku Toda, Koichi Tamita, Atsushi Yamamuro, Yuji Sakanoue, Akira Ito, Shiro Yanagi, Kenji Shimeno, Katsuhisa Waseda, Masao Yamasaki, Peter J. Fitzgerald, Fumiaki Ikeno, Yasuhiro Honda, Minoru Yoshiyama, Junichi Yoshikawa. (2009) A Prospective, Multicenter, Randomized Trial to Assess Efficacy of Pioglitazone on In-Stent Neointimal Suppression in Type 2 Diabetes. JACC: Cardiovascular Interventions 2:6, 524-531
CrossRef514
Yosuke Takamiya, Shin-Ichiro Miura, Akira Kawamura, Hiroyuki Tanigawa, Bo Zhang, Atsushi Iwata, Hiroaki Nishikawa, Kunihiro Matsuo, Kazuyuki Shirai, Keijiro Saku. (2009) Intensive LOwering of BlOod pressure and low-density lipoprotein ChOlesterol with statin theraPy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease. Coronary Artery Disease 20:4, 288-294
CrossRef515
Alfredo Rodriguez, Andrew Maree, Sonia Tarragona, Carlos Fernandez-Pereira, Omar Santaera, Alfredo Rodriguez Granillo, Gaston Rodriguez-Granillo, Miguel Russo-Felssen, Neville Kukreja, David Antoniucci, Igor Palacios, Patrick Serruys. (2009) Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study. EuroIntervention 5:2, 255-264
CrossRef516
A. R. Tzafriri, A. D. Levin, E. R. Edelman. (2009) Diffusion-limited binding explains binary dose response for local arterial and tumour drug delivery. Cell Proliferation 42:3, 348-363
CrossRef517
Holger Thiele, Patrick Neumann-Schniedewind, Stephan Jacobs, Enno Boudriot, Thomas Walther, Friedrich-Wilhelm Mohr, Gerhard Schuler, Volkmar Falk. (2009) Randomized Comparison of Minimally Invasive Direct Coronary Artery Bypass Surgery Versus Sirolimus-Eluting Stenting in Isolated Proximal Left Anterior Descending Coronary Artery Stenosis. Journal of the American College of Cardiology 53:25, 2324-2331
CrossRef518
Bryan P. Yan, David J. Clark, Brian Buxton, Andrew E. Ajani, Julian A. Smith, Stephen J. Duffy, Gil C. Shardey, Peter D. Skillington, Omar Farouque, Michael Yii, Cheng-Hon Yap, Nick Andrianopoulos, Angela Brennan, Diem Dinh, Christopher M. Reid. (2009) Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: Insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries. Heart, Lung and Circulation 18:3, 184-190
CrossRef519
Gennaro Sardella, Riccardo Colantonio, Leonardo De Luca, Giulia Conti, Angelo Di Roma, Massimo Mancone, Emanuele Canali, Giulia Benedetti, Francesco Fedele. (2009) Comparison between balloon angioplasty and additional coronary stent implantation for the treatment of drug-eluting stent restenosis: 18-month clinical outcomes. Journal of Cardiovascular Medicine 10:6, 469-473
CrossRef520
Daiju Fukuda, Soichiro Enomoto, Ibuki Shirakawa, Ryozo Nagai, Masataka Sata. (2009) Fluvastatin accelerates re-endothelialization impaired by local sirolimus treatment. European Journal of Pharmacology 612:1-3, 87-92
CrossRef521
Hongling Liu, Lan Wu, Shaoying Fu, Yongsheng Hou, Ping Liu, Hao Cui, Jingjing Liu, Lin Xing, Xiaomei Zhang. (2009) Polylactide-glycoli acid and rapamycin coating intraocular lens prevent posterior capsular opacification in rabbit eyes. Graefe's Archive for Clinical and Experimental Ophthalmology 247:6, 801-807
CrossRef522
Jochen Wöhrle, Thorsten Nusser, Simone Langenwalder, Vinzenz Heombach, Matthias Kochs. (2009) Carbon-coated Stents in Patients with Acute Coronary Syndromes. Clinical Cardiology 32:6, E1-E6
CrossRef523
Minori Tateishi, Yasuko Tomizawa. (2009) Intravascular foreign bodies: danger of unretrieved fragmented medical devices. Journal of Artificial Organs 12:2, 80-89
CrossRef524
Robert A. Vogel. (2009) Drug-Eluting Stents: Safe But Not Sufficient
CrossRef525
EDWARD F. EWEN, LIPING ZHAO, PAUL KOLM, CLAUDINE JURKOVITZ, DOGAN FIDAN, HARVEY D. WHITE, RICHARD GALLO, WILLIAM S. WEINTRAUB. (2009) Determining the In-Hospital Cost of Bleeding in Patients Undergoing Percutaneous Coronary Intervention. Journal of Interventional Cardiology 22:3, 266-273
CrossRef526
Emilio Di Lorenzo, Giuseppe De Luca, Rosario Sauro, Attilio Varricchio, Michele Capasso, Tonino Lanzillo, Fiore Manganelli, Ciro Mariello, Francesco Siano, Maria Rosaria Pagliuca, Giovanni Stanco, Giuseppe Rosato. (2009) The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial. JACC: Cardiovascular Interventions 2:6, 515-523
CrossRef527
Yoseph Rozenman, Valentin Witzling, Israel Tamari, Vladimir Turkisher, Michael Kriviski, Christoph Bode, Patrick Henry, Emmanuel Teiger, Ana Cebrian, Hans-Peter Stoll, Christian Spaulding. (2009) Impact of stent length on restenosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: analysis based on data from the Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON). EuroIntervention 5:2, 219-223
CrossRef528
MOHAMMAD REZA MOVAHED, RADHAKRISHNAN RAMARAJ, M. MAZEN JAMAL, MEHRTASH HASHEMZADEH. (2009) Nationwide Trends in the Utilization of Multivessel Percutaneous Coronary Intervention (MVPCI) in the United States across Different Gender and Ethnicities. Journal of Interventional Cardiology 22:3, 247-251
CrossRef529
Stefan Verheye, Giovanna Sarno, Ralf Müller, Ralf Birkemeyer, Christiaan Vrints, Werner Jung, Pierfrancesco Agostoni, Glenn van Langenhove, Steven Haine, Tine Willems, Michael Haude, Eberhard Grube, William Wijns. (2009) The ProLimus trial: a prospective, non-randomised, multicentre trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic). EuroIntervention 5:2, 233-238
CrossRef530
Lin Mei, Hongfan Sun, Cunxian Song. (2009) Local delivery of modified paclitaxel-loaded poly(ε-caprolactone)/pluronic F68 nanoparticles for long-term inhibition of hyperplasia. Journal of Pharmaceutical Sciences 98:6, 2040-2050
CrossRef531
Francesco Tomassini, Ferdinando Varbella, Andrea Gagnor, Vincenzo Infantino, Stefania Luceri, Maria Rosa Conte. (2009) Severe multivessel coronary spasm after sirolimus-eluting stent implantation. Journal of Cardiovascular Medicine 10:6, 485-488
CrossRef532
Neville Kukreja, Yoshinobu Onuma, Hector M. Garcia-Garcia, Joost Daemen, Ron van Domburg, Patrick W. Serruys. (2009) The Risk of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Bare-Metal and Drug-Eluting Stents. JACC: Cardiovascular Interventions 2:6, 534-541
CrossRef533
Peter H. Feenstra, Charles A. Taylor. (2009) Drug transport in artery walls: A sequential porohyperelastic-transport approach. Computer Methods in Biomechanics and Biomedical Engineering 12:3, 263-276
CrossRef534
Henri Roukoz, Anthony A. Bavry, Michael L. Sarkees, Girish R. Mood, Dharam J. Kumbhani, Mark G. Rabbat, Deepak L. Bhatt. (2009) Comprehensive Meta-Analysis on Drug-Eluting Stents versus Bare-Metal Stents during Extended Follow-up. The American Journal of Medicine 122:6, 581.e1-581.e10
CrossRef535
Takeshi Serikawa, Tomohiro Kawasaki, Hisashi Koga. (2009) Impressive sirolimus-eluting stent fracture immediately after stent implantation: A case report. International Journal of Cardiology 134:3, e113-e116
CrossRef536
Stone, Gregg W., Lansky, Alexandra J., Pocock, Stuart J., Gersh, Bernard J., Dangas, George, Wong, S. Chiu, Witzenbichler, Bernhard, Guagliumi, Giulio, Peruga, Jan Z., Brodie, Bruce R., Dudek, Dariusz, Möckel, Martin, Ochala, Andrzej, Kellock, Alison, Parise, Helen, Mehran, Roxana, . (2009) Paclitaxel-Eluting Stents versus Bare-Metal Stents in Acute Myocardial Infarction. New England Journal of Medicine 360:19, 1946-1959
Full Text537
Lauren J. Kim, Spencer B. King, Kenneth Kent, Maria Mori Brooks, Kevin E. Kip, J. Dawn Abbott, Alice K. Jacobs, Charanjit Rihal, Whady A. Hueb, Edwin Alderman, Ivan R. Pena Sing, Michael J. Attubato, Frederick Feit. (2009) Factors Related to the Selection of Surgical Versus Percutaneous Revascularization in Diabetic Patients With Multivessel Coronary Artery Disease in the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) Trial. JACC: Cardiovascular Interventions 2:5, 384-392
CrossRef538
G Maluenda, G Lemesle, R Waksman. (2009) A Critical Appraisal of the Safety and Efficacy of Drug-Eluting Stents. Clinical Pharmacology & Therapeutics 85:5, 474-480
CrossRef539
Xuebo Liu, Hiroshi Doi, Akiko Maehara, Gary S. Mintz, Jose de Ribamar Costa, Koichi Sano, Giora Weisz, George D. Dangas, Alexandra J. Lansky, Edward M. Kreps, Michael Collins, Martin Fahy, Gregg W. Stone, Jeffrey W. Moses, Martin B. Leon, Roxana Mehran. (2009) A Volumetric Intravascular Ultrasound Comparison of Early Drug-Eluting Stent Thrombosis Versus Restenosis. JACC: Cardiovascular Interventions 2:5, 428-434
CrossRef540
Julinda Mehilli, Adnan Kastrati, Robert A. Byrne, Olga Bruskina, Raisuke Iijima, Stefanie Schulz, Jürgen Pache, Melchior Seyfarth, Steffen Maßberg, Karl-Ludwig Laugwitz, Josef Dirschinger, Albert Schömig. (2009) Paclitaxel- Versus Sirolimus-Eluting Stents for Unprotected Left Main Coronary Artery Disease. Journal of the American College of Cardiology 53:19, 1760-1768
CrossRef541
Tomoaki Higo, Yasunori Ueda, Jota Oyabu, Katsuki Okada, Mayu Nishio, Akio Hirata, Kazunori Kashiwase, Nobuyuki Ogasawara, Shinichi Hirotani, Kazuhisa Kodama. (2009) Atherosclerotic and Thrombogenic Neointima Formed Over Sirolimus Drug-Eluting Stent. JACC: Cardiovascular Imaging 2:5, 616-624
CrossRef542
Kyung Woo Park, Jung-Han Yoon, Jung-Sun Kim, Joo-Yong Hahn, Young-Seok Cho, In-Ho Chae, Hyeon-Cheol Gwon, Taehoon Ahn, Byung-Hee Oh, Jeong-Euy Park, Won-Heum Shim, Eak-Kyun Shin, Yang-Soo Jang, Hyo-Soo Kim. (2009) Efficacy of Xience/promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) trial: Study design and rationale of a Korean multicenter prospective randomized trial. American Heart Journal 157:5, 811-817.e1
CrossRef543
Philip Moore, Peter Barlis, Jonathan Spiro, Gopal Ghimire, Michael Roughton, Carlo Di Mario, William Wallis, Charles Ilsley, Andrew Mitchell, Mark Mason, Rajesh Kharbanda, Peter Vincent, Spencer Sherwin, Miles Dalby. (2009) A Randomized Optical Coherence Tomography Study of Coronary Stent Strut Coverage and Luminal Protrusion With Rapamycin-Eluting Stents. JACC: Cardiovascular Interventions 2:5, 437-444
CrossRef544
Pamela S. Douglas, J. Matthew Brennan, Kevin J. Anstrom, Art Sedrakyan, Eric L. Eisenstein, Ghazala Haque, David Dai, David F. Kong, Bradley Hammill, Lesley Curtis, David Matchar, Ralph Brindis, Eric D. Peterson. (2009) Clinical Effectiveness of Coronary Stents in Elderly Persons. Journal of the American College of Cardiology 53:18, 1629-1641
CrossRef545
Masaki Awata, Shinsuke Nanto, Masaaki Uematsu, Takakazu Morozumi, Tetsuya Watanabe, Toshinari Onishi, Osamu Iida, Fusako Sera, Hitoshi Minamiguchi, Jun-ichi Kotani, Seiki Nagata. (2009) Heterogeneous Arterial Healing in Patients Following Paclitaxel-Eluting Stent Implantation. JACC: Cardiovascular Interventions 2:5, 453-458
CrossRef546
Neville Kukreja, Yoshinobu Onuma, Patrick W Serruys. (2009) Xience V™ everolimus-eluting coronary stent. Expert Review of Medical Devices 6:3, 219-229
CrossRef547
Thomas Weichhart, Marcus D. Säemann. (2009) The multiple facets of mTOR in immunity. Trends in Immunology 30:5, 218-226
CrossRef548
J. Ribamar Costa, Alexandre Abizaid, Ricardo Costa, Fausto Feres, Luiz Fernando Tanajura, Andréa Abizaid, Galo Maldonado, Rodolfo Staico, Dimytri Siqueira, Amanda G.M.R. Sousa, Raoul Bonan, J. Eduardo Sousa. (2009) 1-Year Results of the Hydroxyapatite Polymer-Free Sirolimus-Eluting Stent for the Treatment of Single De Novo Coronary Lesions. JACC: Cardiovascular Interventions 2:5, 422-427
CrossRef549
Dennis T. Ko, Maria Chiu, Helen Guo, Peter C. Austin, Ron Goeree, Eric Cohen, Marino Labinaz, Jack V. Tu. (2009) Safety and Effectiveness of Drug-Eluting and Bare-Metal Stents for Patients With Off- and On-Label Indications. Journal of the American College of Cardiology 53:19, 1773-1782
CrossRef550
Francesco Saia, Giancarlo Piovaccari, Antonio Manari, Paolo Guastaroba, Luigi Vignali, Elisabetta Varani, Andrea Santarelli, Alberto Benassi, Armando Liso, Gianluca Campo, Stefano Tondi, Fabio Tarantino, Rossana De Palma, Antonio Marzocchi. (2009) Patient selection to enhance the long-term benefit of first generation drug-eluting stents for coronary revascularisation procedures. Insights from a large multicentre registry. EuroIntervention 5:1, 57-66
CrossRef551
Corrado Tamburino, Davide Capodanno. (2009) Evolution of stents: past, present and future. Expert Review of Cardiovascular Therapy 7:5, 443-446
CrossRef552
B. Struk, M. Gailani, C. Michael Gross. (2009) Die Behandlung der koronaren Mehrgefäßerkrankung: Bypassoperation oder perkutane Katheterintervention?. Clinical Research in Cardiology Supplements 4:S2, 154-159
CrossRef553
Michelle J. Butler, David Eccleston, David J. Clark, Andrew E. Ajani, Nick Andrianopoulos, Angela Brennan, Gishel New, Alexander Black, Gregory Szto, Chris M. Reid. (2009) The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents. American Heart Journal 157:5, 899-907
CrossRef554
John Lasala, David Cox, Stephen Lewis, Peter Tadros, Robert Haas, Marc Schweiger, Anil Chhabra, William Untereker, Ruth Starzyk, Stephen Mascioli, Keith Dawkins, Donald Baim. (2009) Expanded use of the TAXUS Express Stent: two-year safety insights from the 7,500 patient ARRIVE Registry programme. EuroIntervention 5:1, 67-77
CrossRef555
Mounir Basalus, Marc Ankone, Gert van Houwelingen, Frits de Man, Clemens von Birgelen. (2009) Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy. EuroIntervention 5:1, 157-165
CrossRef556
Somjot S. Brar, Martin B. Leon, Gregg W. Stone, Roxana Mehran, Jeffrey W. Moses, Simerjeet K. Brar, George Dangas. (2009) Use of Drug-Eluting Stents in Acute Myocardial Infarction. Journal of the American College of Cardiology 53:18, 1677-1689
CrossRef557
JEFFREY J. POPMA, ALEXANDRA ALMONACID. (2009) Angiographic Markers of Restenosis after Drug-Eluting Stent Implantation: Surrogates for Late Clinical Outcomes?. Journal of Interventional Cardiology 22, S64-S71
CrossRef558
Axel De Labriolle, Rajbabu Pakala, Laurent Bonello, Gilles Lemesle, Mickey Scheinowitz, Ron Waksman. (2009) Paclitaxel-eluting balloon: From bench to bed. Catheterization and Cardiovascular Interventions 73:5, 643-652
CrossRef559
Giora Weisz, Martin B. Leon, David R. Holmes, Dean J. Kereiakes, Jeffrey J. Popma, Paul S. Teirstein, Sidney A. Cohen, Hong Wang, Donald E. Cutlip, Jeffrey W. Moses. (2009) Five-Year Follow-Up After Sirolimus-Eluting Stent Implantation. Journal of the American College of Cardiology 53:17, 1488-1497
CrossRef560
RAYMOND MIU, PATRICK W. SERRUYS, GREGG W. STONE. (2009) Performance of Everolimus-Eluting Stents: Pooled Analysis from the SPIRIT Trials. Journal of Interventional Cardiology 22, S41-S47
CrossRef561
Corrado Tamburino, Rossella Barbagallo, Davide Capodanno, Sergio di Matteo, Giorgio L Colombo, Martino Recchia, Saverio Ciriminna. (2009) Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry. Journal of Cardiovascular Medicine 10:4, 322-329
CrossRef562
Yaling Han, Quanmin Jing, Bo Xu, Lixia Yang, Huiliang Liu, Xiaoming Shang, Tieming Jiang, Zhanquan Li, Hua Zhang, Hui Li, Jian Qiu, Yingfeng Liu, Yi Li, Xuezhi Chen, Runlin Gao. (2009) Safety and Efficacy of Biodegradable Polymer-Coated Sirolimus-Eluting Stents in “Real-World” Practice. JACC: Cardiovascular Interventions 2:4, 303-309
CrossRef563
Hisashi Umeda, Tomoko Gochi, Mitsunori Iwase, Hideo Izawa, Takeshi Shimizu, Ryoji Ishiki, Haruo Inagaki, Junji Toyama, Mitsuhiro Yokota, Toyoaki Murohara. (2009) Frequency, predictors and outcome of stent fracture after sirolimus-eluting stent implantation. International Journal of Cardiology 133:3, 321-326
CrossRef564
Robert A. Byrne, Raisuke Iijima, Julinda Mehilli, Susanne Pinieck, Olga Bruskina, Albert Schömig, Adnan Kastrati. (2009) Durability of Antirestenotic Efficacy in Drug-Eluting Stents With and Without Permanent Polymer. JACC: Cardiovascular Interventions 2:4, 291-299
CrossRef565
Aloke V. Finn, Gaku Nakazawa, Frank D. Kolodgie, Renu Virmani. (2009) Temporal Course of Neointimal Formation After Drug-Eluting Stent Placement. JACC: Cardiovascular Interventions 2:4, 300-302
CrossRef566
GERRIT HELLIGE, STEPHAN WINDECKER. (2009) Head-to-Head and Extrapolated Comparisons of Different Drug-Eluting Stents: Differences in Late Loss, Restenosis, and Clinical Outcomes. Journal of Interventional Cardiology 22, S48-S63
CrossRef567
John H. Pang, David Kim, Nirat Beohar, Sheridan N. Meyers, Donald Lloyd-Jones, Vahid Yaghmai. (2009) Detection of Stent Fractures. Academic Radiology 16:4, 412-417
CrossRef568
Ron Goeree, James M. Bowen, Gord Blackhouse, Charles Lazzam, Eric Cohen, Maria Chiu, Rob Hopkins, Jean-Eric Tarride, Jack V. Tu. (2009) Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario. International Journal of Technology Assessment in Health Care 25:02, 196
CrossRef569
ABDALLAH G. REBEIZ, ELIE ZOGHBI, RAMI HARB, SONIA YOUHANNA, HADI N. SKOURI, ADEL DIMASSI, GILBERT ABOU-NADER, ANTOINE NASRALLAH, JABER SAWAYA, WALID GHARZUDDINE, SAMIR ALAM. (2009) Comparison of the Systemic Levels of Inflammatory Markers after Percutaneous Coronary Intervention with Bare Metal versus Sirolimus-Eluting Stents. Journal of Interventional Cardiology 22:2, 169-174
CrossRef570
Taro Tsunoda, Hisao Hara, Kaori Nakajima, Hideo Shinji, Shingo Ito, Raisuke Iijima, Rintaro Nakajima, Takuro Takagi, Masato Nakamura, Kaoru Sugi. (2009) Stent deformation: an experimental study of coronary ostial stenting
. Cardiovascular Revascularization Medicine 10:2, 80-87
CrossRef571
Gilles Lemesle, Laurent Bonello, Axel de Labriolle, Daniel H. Steinberg, Probal Roy, Tina L. Pinto Slottow, Rebecca Torguson, Kimberly Kaneshige, Zhenyi Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Joseph Lindsay, Augusto D. Pichard, Ron Waksman. (2009) Prognostic value of the syntax score in patients undergoing coronary artery bypass grafting for three-vessel coronary artery disease. Catheterization and Cardiovascular Interventions 73:5, 612-617
CrossRef572
SANJAY SASTRY, MARIE-CLAUDE MORICE. (2009) Choice of DES: A European Clinician's Perspective. Journal of Interventional Cardiology 22, S86-S95
CrossRef573
Tao Jiang, Guixue Wang, Juhui Qiu, Lailong Luo, Guoquan Zhang. (2009) Heparinized poly(vinyl alcohol)–small intestinal submucosa composite membrane for coronary covered stents. Biomedical Materials 4:2, 025012
CrossRef574
Horma Ouldzein, Jérome Roncalli, Walid Zouaoui, Vanina Bongard, Nicolas Boudou, Nicolas Dumonteil, Thibaut Lhermusier, Meyer Elbaz, Jacques Puel, Didier Carrié. (2009) Drug-eluting or bare-metal stents in subjects over 75 years of age: what is the best therapeutic strategy? Data from 460 consecutive patients with 1-year outcome. Cardiovascular Revascularization Medicine 10:2, 94-102
CrossRef575
David R Plas, George Thomas. (2009) Tubers and tumors: rapamycin therapy for benign and malignant tumors. Current Opinion in Cell Biology 21:2, 230-236
CrossRef576
YUTAKA HIKICHI, TERUO INOUE, KOICHI NODE. (2009) Benefits and Limitations of Cypher Stent-Based Bifurcation Approaches: In Vitro Evaluation Using Micro-Focus CT Scan. Journal of Interventional Cardiology 22:2, 128-134
CrossRef577
David Busseuil, Bertrand Collin, Gilles Rioufol, Claudia Korandji, Marianne Zeller, Philippe Maingon, François Briot, Yves Cottin, Luc Rochette. (2009) Combining Sirolimus-eluting Stents and External Irradiation in Cholesterol-fed Rabbits Increased Incomplete Stent Apposition and Decreased Re-endothelialization. Journal of Cardiovascular Pharmacology 53:4, 318-324
CrossRef578
Jeffrey J. Popma, Klaus Tiroch, Alexandra Almonacid, Sidney Cohen, David E. Kandzari, Martin B. Leon. (2009) A Qualitative and Quantitative Angiographic Analysis of Stent Fracture Late Following Sirolimus-Eluting Stent Implantation. The American Journal of Cardiology 103:7, 923-929
CrossRef579
Ron Waksman, Raimund Erbel, Carlo Di Mario, Jozef Bartunek, Bernard de Bruyne, Franz R. Eberli, Paul Erne, Michael Haude, Mark Horrigan, Charles Ilsley, Dirk Böse, Hans Bonnier, Jacques Koolen, Thomas F. Lüscher, Neil J. Weissman. (2009) Early- and Long-Term Intravascular Ultrasound and Angiographic Findings After Bioabsorbable Magnesium Stent Implantation in Human Coronary Arteries. JACC: Cardiovascular Interventions 2:4, 312-320
CrossRef580
Nuno M. Pires, J. Wouter Jukema. (2009) Early Systemic Inflammatory Response to Drug-Eluting Stents Implantation: The Heart of the Difference?. Cardiovascular Drugs and Therapy 23:2, 103-105
CrossRef581
Albert E. Alahmar, Antony D. Grayson, Mohammed Andron, Mohaned Egred, Elved D. Roberts, Bilal Patel, Roger K.G. Moore, Khaled Albouaini, Mark Jackson, Raphael A. Perry. (2009) Reduction in mortality and target-lesion revascularisation at 2 years: A comparison between drug-eluting stents and conventional bare-metal stents in the “real world”. International Journal of Cardiology 132:3, 398-404
CrossRef582
Francesco De Felice, Rosario Fiorilli, Antonio Parma, Maurizio Menichelli, Marco Stefano Nazzaro, Edoardo Pucci, Alban Dibra, Carmine Musto, Roberto Violini. (2009) Clinical outcome of patients with chronic total occlusion treated with drug-eluting stents. International Journal of Cardiology 132:3, 337-341
CrossRef583
Hisashi Umeda, Mitsunori Iwase, Tomoko Gochi, Hideo Izawa, Ryoji Ishiki, Haruo Inagaki, Takeshi Shimizu, Mitsuhiro Yokota, Toyoaki Murohara. (2009) Safety and efficacy of 2.5-mm sirolimus-eluting stent implantation at lower deployment pressures in very small vessels (<2.5 mm). Coronary Artery Disease 20:2, 163-168
CrossRef584
Christopher Hansi, Amina Arab, Alexander Rzany, Ingo Ahrens, Christoph Bode, Christoph Hehrlein. (2009) Differences of platelet adhesion and thrombus activation on amorphous silicon carbide, magnesium alloy, stainless steel, and cobalt chromium stent surfaces. Catheterization and Cardiovascular Interventions 73:4, 488-496
CrossRef585
Clemens Steinwender, Bernhard Hartenthaler, Thomas Lambert, Alexander Kypta, Jurgen Kammler, Simon Honig, Robert Hofmann, Klaus Kerschner, Franz Leisch. (2009) Incidence of stent thrombosis in patients with drug eluting stents and short-term dual antiplatelet therapy. EuroIntervention 4:5, 593-599
CrossRef586
Mehmood Butt, Derek Connolly, Gregory YH Lip. (2009) Drug-eluting stents: a comprehensive appraisal. Future Cardiology 5:2, 141-157
CrossRef587
Hiroshi Doi, Akiko Maehara, Gary S. Mintz, Kenichi Tsujita, Takashi Kubo, Celia Castellanos, Jian Liu, Junqing Yang, Carlos Oviedo, Jiro Aoki, Theresa Franklin-Bond, Neil Dasgupta, Alexandra J. Lansky, George D. Dangas, Gregg W. Stone, Jeffrey W. Moses, Roxana Mehran, Martin B. Leon. (2009) Classification and Potential Mechanisms of Intravascular Ultrasound Patterns of Stent Fracture. The American Journal of Cardiology 103:6, 818-823
CrossRef588
Corrado Tamburino, Alessio La Manna, Maria Elena Di Salvo, Giorgio Sacchetta, Davide Capodanno, Roxana Mehran, George Dangas, Thierry Corcos, Francesco Prati. (2009) First-in-Man 1-Year Clinical Outcomes of the Catania Coronary Stent System With Nanothin Polyzene-F in De Novo Native Coronary Artery Lesions. JACC: Cardiovascular Interventions 2:3, 197-204
CrossRef589
Lakshmana K. Pendyala, Jinsheng Li, Toshiro Shinke, Sarah Geva, Xinhua Yin, Jack P. Chen, Spencer B. King, Keith A. Robinson, Nicolas A.F. Chronos, Dongming Hou. (2009) Endothelium-Dependent Vasomotor Dysfunction in Pig Coronary Arteries With Paclitaxel-Eluting Stents Is Associated With Inflammation and Oxidative Stress. JACC: Cardiovascular Interventions 2:3, 253-262
CrossRef590
Susana Ayyanathan, David Hersh, Neil L. Coplan, Kirk Garratt. (2009) The Problem of Stent Thrombosis Associated With Drug-Eluting Stents and the Optimal Duration of Dual Antiplatelet Therapy. Preventive Cardiology 12:2, 59-64
CrossRef591
Antonio Colombo, Andrew SP Sharp. (2009) The bioabsorbable stent as a virtual prosthesis. The Lancet 373:9667, 869-870
CrossRef592
Robert J. Applegate, Matthew T. Sacrinty, Michael A. Kutcher, Renato M. Santos, Sanjay K. Gandhi, William C. Little. (2009) 3-Year Comparison of Drug-Eluting Versus Bare-Metal Stents. JACC: Cardiovascular Interventions 2:3, 231-239
CrossRef593
Wen Qiang Chen, Lin Zhong, Lei Zhang, Xiao Ping Ji, Mei Zhang, Yu Xia Zhao, Cheng Zhang, Yun Zhang. (2009) Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels. British Journal of Pharmacology 156:6, 941-951
CrossRef594
Alberto Berenguer, Pascual Bordes, Vicente Mainar, Jose Valencia, Silvia Gómez, Teresa Lozano. (2009) Predictors of death after coronary stenting with sirolimus-eluting stent in high-risk patients. International Journal of Cardiology 132:3, 342-347
CrossRef595
Yoritaka Otsuka. (2009) A novel 0.010-inch guidewire for crossing jailed sidebranches. Catheterization and Cardiovascular Interventions 73:3, 346-349
CrossRef596
Dimitrios E. Kiousis, Alexander R. Wulff, Gerhard A. Holzapfel. (2009) Experimental Studies and Numerical Analysis of the Inflation and Interaction of Vascular Balloon Catheter-Stent Systems. Annals of Biomedical Engineering 37:2, 315-330
CrossRef597
Christodoulos Stefanadis, Konstantinos Toutouzas. (2009) Paclitaxel Versus Sirolimus. Journal of the American College of Cardiology 53:8, 665-666
CrossRef598
Michael Maeng, Lisette Okkels Jensen, Anders Michael Galloe, Per Thayssen, Evald Hoej Christiansen, Knud Nørregaard Hansen, Steffen Helqvist, Hans Erik Botker, Jens Flensted Lassen, Leif Thuesen. (2009) Comparison of the Sirolimus-Eluting Versus Paclitaxel-Eluting Coronary Stent in Patients With Diabetes Mellitus: The Diabetes and Drug-Eluting Stent (DiabeDES) Randomized Angiography Trial. The American Journal of Cardiology 103:3, 345-349
CrossRef599
Anne Kaltoft, Lisette Okkels Jensen, Michael Maeng, Hans Henrik Tilsted, Per Thayssen, Morten Bøttcher, Jens Flensted Lassen, Lars Romer Krusell, Klaus Rasmussen, Knud Nørregaard Hansen, Lars Pedersen, Søren Paaske Johnsen, Henrik Toft Sørensen, Leif Thuesen. (2009) 2-Year Clinical Outcomes After Implantation of Sirolimus-Eluting, Paclitaxel-Eluting, and Bare-Metal Coronary Stents. Journal of the American College of Cardiology 53:8, 658-664
CrossRef600
Flavio Ribichini, Fabrizio Tomai, Giuseppe De Luca, Giacomo Boccuzzi, Patrizia Presbitero, Gabriele Pesarini, Valeria Ferrero, Anna S Ghini, Francesca Pastori, Leonardo De Luca, Denis Zavalloni, Daniela Soregaroli, Roberto Garbo, Elena Franchi, Paolo Marino, Massimo Minelli, Corrado Vassanelli. (2009) A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) – study design and rationale. Journal of Cardiovascular Medicine 10:2, 192-199
CrossRef601
LAKSHMANA PENDYALA, REFAT JABARA, KEITH ROBINSON, NICOLAS CHRONOS. (2009) Passive and Active Polymer Coatings for Intracoronary Stents: Novel Devices to Promote Arterial Healing. Journal of Interventional Cardiology 22:1, 37-48
CrossRef602
Armin Arbab-Zadeh. (2009) Medical Therapy Versus Percutaneous Coronary Intervention for Patients With Stable Coronary Artery Disease. Journal of the American College of Cardiology 53:6, 528-529
CrossRef603
Corrado Tamburino, Maria Elena Di Salvo, Davide Capodanno, Piera Capranzano, Rosario Parisi, Francesca Mirabella, Francesco Scardaci, Gianpaolo Ussia, Alfredo Ruggero Galassi, Damiana Fiscella, Roxana Mehran, George Dangas. (2009) Real world safety and efficacy of the Janus tacrolimus-eluting stent: Long-term clinical outcome and angiographic findings from the tacrolimus-eluting stent (TEST) registry. Catheterization and Cardiovascular Interventions 73:2, 243-248
CrossRef604
Daniel H. Steinberg, Michael A. Gaglia, Tina L. Pinto Slottow, Probal Roy, Laurent Bonello, Axel De Labriolle, Gilles Lemesle, Rebecca Torguson, Kimberly Kineshige, Zhenyi Xue, William O. Suddath, Kenneth M. Kent, Lowell F. Satler, Augusto D. Pichard, Joseph Lindsay, Ron Waksman. (2009) Outcome Differences With the Use of Drug-Eluting Stents for the Treatment of In-Stent Restenosis of Bare-Metal Stents Versus Drug-Eluting Stents. The American Journal of Cardiology 103:4, 491-495
CrossRef605
Dean J. Kereiakes. (2009) Medical and catheter-based therapies for managing stable coronary disease: Lessons from the COURAGE trial. Current Treatment Options in Cardiovascular Medicine 11:1, 45-53
CrossRef606
Federico Piscione, Raffaele Piccolo, Salvatore Cassese, Gennaro Galasso, Massimo Chiariello. (2009) Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef607
B RAHEL, G LAARMAN, J KELDER, J TENBERG, M SUTTORP. (2009) Three-year clinical outcome after primary stenting of totally occluded native coronary arteriesA randomized comparison of bare-metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (Primary Stenting of Totally Occluded Native Coronary Arteries [PRISON] II study). American Heart Journal 157:1, 149-155
CrossRef608
Tae-Hyun Yang, Doo-Il Kim, Seong-Gill Park, Jeong-Sook Seo, Hwan-Jin Cho, Sang-Hoon Seol, Seong-Man Kim, Dae-Kyeong Kim, Dong-Soo Kim. (2009) Clinical characteristics of stent fracture after sirolimus-eluting stent implantation. International Journal of Cardiology 131:2, 212-216
CrossRef609
Hiroyuki Hikita, Akira Sato, Toshihiro Nozato, Tomoyuki Kawashima, Yoshihide Takahashi, Taishi Kuwahara, Atsushi Takahashi. (2009) Low coronary flow velocity and shear stress predict restenosis after sirolimus-eluting stent implantation. Scandinavian Cardiovascular Journal 43:5, 298-303
CrossRef610
Jian-Jun Li, Yu-Ping Zhang, Chun Wang, Li-Jian Gao, Xue-Wen Qin, Bo Xu, Ji-Lin Chen, Yue-Jin Yang, Run-Lin Gao. (2009) Impact of direct sirolimus-eluting stent implantation on the early systemic inflammatory response compared with complementary stent implantation. Coronary Artery Disease 20:1, 65-70
CrossRef611
Aika Yamawaki, Makoto Satake, Hiroaki Kaneko, Yoshihiro Suematsu, Akihiko Usui, Yuichi Ueda, Masato Mutsuga, Yuji Narita. (2009) A new strategy for prevention of anastomotic stricture using tacrolimus-eluting biodegradable nanofiber. Journal of Thoracic and Cardiovascular Surgery 137:3, 703
CrossRef612
Kazumasa Sugimoto, Yoshio Kobayashi, Nakabumi Kuroda, Issei Komuro. (2009) Cost Analysis of Sirolimus-Eluting Stents in the Japanese Health Insurance System. International Heart Journal 50:6, 723-730
CrossRef613
Takahiro Sawada, Junya Shite, Noriyuki Negi, Toshiro Shinke, Yusuke Tanino, Daisuke Ogasawara, Hiroyuki Kawamori, Hiroki Kato, Naoki Miyoshi, Naoki Yoshino, Amane Kozuki, Masanobu Koto, Ken-ichi Hirata. (2009) Factors That Influence Measurements and Accurate Evaluation of Stent Apposition by Optical Coherence Tomography. Circulation Journal 73:10, 1841-1847
CrossRef614
Shinsuke Nanto. (2009) The current status of laser coronary angioplasty. Nippon Laser Igakkaishi 31:1, 24-28
CrossRef615
Hideki Kitahara, Yoshio Kobayashi, Hideo Takebayashi, Yoshihide Fujimoto, Yoshitake Nakamura, Nakabumi Kuroda, Toshiharu Himi, Akira Miyazaki, Seiichi Haruta, Issei Komuro. (2009) Re-Restenosis and Target Lesion Revascularization After Treatment of Sirolimus-Eluting Stent Restenosis. Circulation Journal 73:5, 867-871
CrossRef616
Jung-Sun Kim, Seung-Yul Lee, Jung Myung Lee, Young Won Yoon, Chul-Min Ahn, Myung-Hyun Kim, Pil-Ki Min, Young-Guk Ko, Bum-Kee Hong, Donghoon Choi, Hyuck Moon Kwon, Yangsoo Jang, Won-Heum Shim. (2009) Significant association of coronary stent fracture with in-stent restenosis in sirolimus-eluting stents. Coronary Artery Disease 20:1, 59-63
CrossRef617
Mizuhiro Arima, Tatsuji Kanoh, Shinya Okazaki, Yoshitaka Iwama, Shigeru Matsuda, Yuji Nakazato. (2009) Long-Term Clinical and Angiographic Follow-up in Patients With Isolated Ostial Stenosis of the Left Coronary Artery. Circulation Journal 73:7, 1271-1277
CrossRef618
Sinisa Stojkovic, Miodrag Ostojic, Milan Nedeljkovic, Goran Stankovic, Branko Beleslin, Vladan Vukcevic, Dejan Orlic, Aleksandra Arandjelovic, Jelena Kostic, Miodrag Dikic, Miloje Tomasevic. (2009) Systemic rapamycin without loading dose for restenosis prevention after coronary bare metal stent implantation. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef619
R.T. Gerber, A. Latib, A. Ielasi, J. Cosgrave, A. Qasim, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, I. Michev, J. Tobis, A. Colombo. (2009) Defining a new standard for IVUS optimized drug eluting stent implantation: The PRAVIO study. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef620
Hiroki Katoh, Junya Shite, Toshiro Shinke, Daisuke Matsumoto, Yusuke Tanino, Daisuke Ogasawara, Takahiro Sawada, Naoki Miyoshi, Hiroyuki Kawamori, Naoki Yoshino, Ken-ichi Hirata. (2009) Delayed Neointimalization on Sirolimus-Eluting Stents. Circulation Journal 73:6, 1033-1037
CrossRef621
Yun-Kyeong Cho, Seung-Ho Hur, Hyun-Tae Kim, In-Cheol Kim, Hyoung-Seob Park, Hyuck-Jun Yoon, Chang-Wook Nam, Hyungseop Kim, Seong-Wook Han, Yoon-Nyun Kim, Kwon-Bae Kim. (2009) Comparison of Sirolimus and Paclitaxel-Eluting Stents for Complex Coronary Lesions: An Intravascular Ultrasound Study. The Korean Journal of Internal Medicine 24:4, 323
CrossRef622
Hidehiko Iwahashi, Tadashi Tashiro, Noritsugu Morishige, Yoshio Hayashida, Nobuhisa Ito, Kazuma Takeuchi, Masaru Nishimi, Go Kuwahara, Yuta Sukehiro. (2009) Tranexamic Acid Reduces Bleeding during Off-Pump Coronary Artery Bypass Grafting in a Patient on Clopidogrel. Japanese Journal of Cardiovascular Surgery 38:6, 389-393
CrossRef623
Jozef Jakabc
in, Radim S
CrossRef624
Hideki Kitahara, Yoshio Kobayashi, Hideo Takebayashi, Yoshitake Nakamura, Nakabumi Kuroda, Akira Miyazaki, Seiichi Haruta, Issei Komuro. (2009) Angiographic Patterns of Restenosis After Sirolimus-Eluting Stent Implantation. Circulation Journal 73:3, 508-511
CrossRef625
Sophia Vaina, Vassilis Voudris, Marie-Claude Morice, Bernard De Bruyne, Antonio Colombo, Carlos Macaya, Gert Richardt, Jean Fajadet, Christian Hamm, Monique Schuijer, Nathalie Macours, Hans-Peter Stoll, Dennis Cokkinos, Christodoulos Stefanadis, Patrick Serruys. (2009) Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: Insights from ARTS I and ARTS II. EuroIntervention 4:4, 492-501
CrossRef626
Yuji Ikari, Junichi Kotani, Ken Kozuma, Eishou Kyo, Masato Nakamura, Hiroyoshi Yokoi, The J-PMS study group. (2009) Assessment of Sirolimus-Eluting Coronary Stent Implantation With Aspirin Plus Low Dose Ticlopidine Administration. Circulation Journal 73:6, 1038-1044
CrossRef627
Kenta Izumi, Yoichi Hisata, Shiro Hazama. (2009) OPCAB after Placement of Drug-Eluting Stent: A Case of Cardiac Tamponade Developing after Resumption of Ticlopidine Administration in the Early Postoperative Period. Japanese Journal of Cardiovascular Surgery 38:3, 197-200
CrossRef628
Takashi Nakayama, Yoshio Kobayashi, Hiroyuki Takano, Nakabumi Kuroda, Kenzo Hiroshima, Issei Komuro. (2009) Silent Very Late Thrombotic Occlusion of Sirolimus-Eluting Stent Confirmed by Directional Coronary Atherectomy. Circulation Journal 73:9, 1762-1764
CrossRef629
Ken-ichi Ishigami, Shiro Uemura, Yoshinobu Morikawa, Tsunenari Soeda, Satoshi Okayama, Taku Nishida, Yasuhiro Takemoto, Kenji Onoue, Satoshi Somekawa, Yukiji Takeda, Hiroyuki Kawata, Manabu Horii, Yoshihiko Saito. (2009) Long-Term Follow-up of Neointimal Coverage of Sirolimus-Eluting Stents. Circulation Journal 73:12, 2300-2307
CrossRef630
Johannes Dahm, Tine Willems, Hans Wolpers, Hans Nordbeck, Jürgen Becker, Jörg Ruppert. (2009) Clinical investigation into the observation that silicon carbide coating on cobalt chromium stents leads to early differentiating functional endothelial layer, increased safety and DES-like recurrent stenosis rates: results of the PRO-Heal Registry (PRO-Kinetic enhancing rapid in-stent endothelialisation). EuroIntervention 4:4, 502-508
CrossRef631
Shumpei Mori, Satoshi Yasuda, Yu Kataoka, Isao Morii, Atsushi Kawamura, Shunichi Miyazaki. (2009) Significant Association of Coronary Artery Calcification in Stent Delivery Route With Restenosis After Sirolimus-Eluting Stent Implantation. Circulation Journal 73:10, 1856-1863
CrossRef632
Nilesh J. Goswami, Matthew Gaffigan, Gadiel Berrio, Anna L. Plessa, Amanda M. Pfeiffer, Stephen J. Markwell, Gregory J. Mishkel. (2009) Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease:. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef633
Taro Saito, Seiji Hokimoto, Syuichi Oshima, Katsuo Noda, Yasuko Kojyo, Kayoko Matsunaga. (2009) Metal allergic reaction in chronic refractory in-stent restenosis. Cardiovascular Revascularization Medicine 10:1, 17-22
CrossRef634
Hong-Yu Peng, Ming Chen, Bo Zheng, Xin-Gang Wang, Yong Huo. (2009) Long-Term Effects of Novel Biodegradable, Polymer-Coated, Sirolimus-Eluting Stents on Neointimal Formation in a Porcine Coronary Model. International Heart Journal 50:6, 811-822
CrossRef635
Feng Chai, Anne Ochsenbein, Michel Traisnel, Ralf Busch, Jürgen Breme, Hartmut F. Hildebrand. (2009) Improving endothelial cell adhesion and proliferation on titanium by sol-gel derived oxide coating. Journal of Biomedical Materials Research Part A 9999A, NA-NA
CrossRef636
Vassilis Voudris, Panagiotis Kariofillis, Sophia Thomopoulou, Sotiris Patsilinakos, Athanasios Manginas, Constantinos Spargias, Gregory Pavlides, Dennis Cokkinos. (2009) Predictors for very late stent thrombosis after drug-eluting stent implantation in diabetic patients. EuroIntervention 4:4, 485-491
CrossRef637
David Maintz, Matthias C. Burg, Harald Seifarth, Alexander C. Bunck, Murat Özgün, Roman Fischbach, Kai Uwe Jürgens, Walter Heindel. (2009) Update on multidetector coronary CT angiography of coronary stents: in vitro evaluation of 29 different stent types with dual-source CT. European Radiology 19:1, 42-49
CrossRef638
Giuseppe Patti, Germano Di Sciascio. (2009) Antithrombotic strategies in patients on oral anticoagulant therapy undergoing percutaneous coronary intervention: A proposed algorithm based on individual risk stratification. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef639
Andrea Pavei, Jacopo Oreglia, Guillaume Martin, Petr Tousek, Faisal Sharif, Bruno Farah, Antoine Sauguet, Jean Fajadet. (2009) Long-term follow-up of percutaneous coronary intervention of unprotected left main lesions with drug eluting stents: predictors of clinical outcome. EuroIntervention 4:4, 457-463
CrossRef640
Daisuke Murakami, Masamichi Takano, Masanori Yamamoto, Shigenobu Inami, Takayoshi Ohba, Yoshihiko Seino, Kyoichi Mizuno. (2009) Advanced Neointimal Growth is Not Associated With a Low Risk of In-Stent Thrombus. Circulation Journal 73:9, 1627-1634
CrossRef641
Mehmet Cilingiroglu, James Elliott, Pramod Sangi, Holly Matthews, Fermin Tio, Brett Trauthen, John Elicker, Steven Bailey. (2009) In vivo evaluation of a biolimus eluting nickel titanium self expanding stent with overlapping balloon expandable drug eluting and bare metal stents in a porcine coronary model. EuroIntervention 4:4, 534-541
CrossRef642
David X. Zhao, Marzia Leacche, Jorge M. Balaguer, Konstantinos D. Boudoulas, Julie A. Damp, James P. Greelish, John G. Byrne. (2009) Routine Intraoperative Completion Angiography After Coronary Artery Bypass Grafting and 1-Stop Hybrid Revascularization. Journal of the American College of Cardiology 53:3, 232-241
CrossRef643
Yasushi Ino, Yasuaki Toyoda, Atsushi Tanaka, Shuuta Ishii, Yoshio Kusuyama, Takashi Kubo, Shigeho Takarada, Hironori Kitabata, Takashi Tanimoto, Masato Mizukoshi, Toshio Imanishi, Takashi Akasaka. (2009) Predictors and Prognosis of Stent Fracture After Sirolimus-Eluting Stent Implantation. Circulation Journal 73:11, 2036-2041
CrossRef644
Kenji Goto, Nobuo Shiode, Kinya Shirota, Yukihiro Fukuda, Fumiyo Kitamura, Koichi Tominaga, Yasuko Kato, Hiroshi Miura, Katsumi Inoue, Masakiyo Nobuyoshi. (2009) Pathological Finding of Sirolimus-Eluting Stent (SES) Restenosis Lesion With Black Hole Appearance on Intravascular Ultrasound. Circulation Journal 73:10, 1969-1971
CrossRef645
Teruo Inoue, Koichi Node. (2009) Molecular Basis of Restenosis and Novel Issues of Drug-Eluting Stents. Circulation Journal 73:4, 615-621
CrossRef646
Giuseppe De Luca, Harry Suryapranata, Arnoud WJ vanʼt Hof, Jan Paul Ottervanger, Jan CA Hoorntje, Jan-Henk Dambrink, AT Marcel Gosselink, Menko-Jan de Boer. (2009) Routine stenting vs. balloon angioplasty in ST-segment elevation myocardial infarction due to proximal left anterior descending coronary artery occlusion. Journal of Cardiovascular Medicine 10:1, 22-26
CrossRef647
Satoshi Yasuda, Hiroaki Shimokawa. (2009) Acute Myocardial Infarction. Circulation Journal 73:11, 2000-2008
CrossRef648
Wolfgang Bocksch, Francisco Pomar, Mieczyslaw Dziarmaga, Damras Tresukosol, Omar Ismail, Bronislav Janek, Joerg Carlsson, Jean-Philippe Simon, . (2009) Clinical safety and efficacy of a novel thin-strut cobalt-chromium coronary stent system: Results of the real world Coroflex Blue Registry. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef649
Spencer B. King, Thomas Aversano, William L. Ballard, Robert H. Beekman, Michael J. Cowley, Stephen G. Ellis, David P. Faxon, Edward L. Hannan, John W. Hirshfeld, Alice K. Jacobs, Mirle A. Kellett, Stephen E. Kimmel, Joel S. Landzberg, Louis S. McKeever, Mauro Moscucci, Richard M. Pomerantz, Karen M. Smith, George W. Vetrovec. (2009) ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians task Force on Clinical Competence and Training (writing committee to update the 1998 clinical competence statement on recommendations for the assessment and maintenance of proficiency in coronary interventional procedures). Catheterization and Cardiovascular InterventionsNA-NA
CrossRef650
Sun Hong Yoo, Seung Won Jin, Sung Ho Her, Hee Jeoung Yoon, Hyoung Doo Kim, Yun Sun Im, Ki Bae Seung, Jae Hyung Kim. (2009) Complete Fracture of Sirolimus-Eluting Stent in a Saphenous Vein Graft to Left Anterior Descending Artery. Korean Circulation Journal 39:6, 251
CrossRef651
Gaku Nakazawa, Aloke V Finn, Frank D Kolodgie, Renu Virmani. (2009) A review of current devices and a look at new technology: drug-eluting stents. Expert Review of Medical Devices 6:1, 33-42
CrossRef652
Matthew J. Smith, Donna C. Smith, Gary L. Bowlin, Kimber L. White. (2009) Modulation of murine innate and acquired immune responses following in vitro exposure to electrospun blends of collagen and polydioxanone. Journal of Biomedical Materials Research Part A 9999A, NA-NA
CrossRef653
Neville Kukreja, Yoshinobu Onuma, Hector M. Garcia-Garcia, Joost Daemen, Ron van Domburg, Patrick W. Serruys. (2009) Three-Year Survival Following Multivessel Percutaneous Coronary Intervention With Bare-Metal or Drug-Eluting Stents in Unselected Patients. The American Journal of Cardiology 103:2, 203-211
CrossRef654
Yu Kataoka, Satoshi Yasuda, Isao Morii, Atsushi Kawamura, Shunichi Miyazaki. (2009) Improved Long-Term Prognosis of Elderly Women in the Era of Sirolimus-Eluting Stents. Circulation Journal 73:7, 1219-1227
CrossRef655
Decha Pinkaew, Sung Gook Cho, David Y. Hui, John E. Wiktorowicz, Nongporn Hutadilok-Towatana, Wilawan Mahabusarakam, Moltira Tonganunt, Lewis J. Stafford, Amornrat Phongdara, Mingyao Liu, Ken Fujise. (2009) Morelloflavone blocks injury-induced neointimal formation by inhibiting vascular smooth muscle cell migration. Biochimica et Biophysica Acta (BBA) - General Subjects 1790:1, 31-39
CrossRef656
WAQAR HABIB AHMED, ROBAAYAH ZAMBAHARI, IBRAHIM AL-RASHDAN, ABDULLAH AL NAEEMI, FUAD A. SAEED, STEPHEN MASCIOLI. (2008) One-Year Outcomes with the TAXUS Liberté Stent in the Real World: The TAXUS OLYMPIA Registry (Phase I). Journal of Interventional Cardiology 21:6, 512-518
CrossRef657
Miodrag Ostojic, Dragan Sagic, Robert Jung, Yan-Ling Zhang, Milan Nedeljkovic, Ljupco Mangovski, Sinisa Stojkovic, Dragan Debeljacki, Mirko Colic, Branko Beleslin, Bratislav Milosavljevic, Dejan Orlic, Dragan Topic, Nevena Karanovic, Dragica Paunovic, Uwe Christians, . (2008) The pharmacokinetics of Biolimus A9 after elution from the Nobori stent in patients with coronary artery disease: The NOBORI PK study. Catheterization and Cardiovascular Interventions 72:7, 901-908
CrossRef658
M TURCO, J ORMISTON, J POPMA, J HALL, T MANN, L CANNON, M WEBSTER, G MISHKEL, C OSHAUGHNESSY, T MCGARRY. (2008) Reduced Risk of Restenosis in Small Vessels and Reduced Risk of Myocardial Infarction in Long Lesions With the New Thin-Strut TAXUS Liberté Stent1-Year Results From the TAXUS ATLAS Program. JACC: Cardiovascular Interventions 1:6, 699-709
CrossRef659
LG Sahler, D Davis, WEA Saad, NC Patel, DE Lee, DL Waldman. (2008) Comparison of vasa vasorum after intravascular stent placement with sirolimis drug-eluting and bare metal stents. Journal of Medical Imaging and Radiation Oncology 52:6, 570-575
CrossRef660
Imad Sheiban, Matteo Anselmino, Claudio Moretti, Giuseppe Biondi-Zoccai, Marco Galloni, Cristina Vignolini, Mario Mattoni, Filippo Sciuto, Pierluigi Omedè, Gian Paolo Trevi. (2008) Effect of a novel drug-eluted balloon coated with Genistein before stent implantation in porcine coronary arteries. Clinical Research in Cardiology 97:12, 891-898
CrossRef661
Michael S. Lee, Jon Kobashigawa, Jonathan Tobis. (2008) Comparison of Percutaneous Coronary Intervention With Bare-Metal and Drug-Eluting Stents for Cardiac Allograft Vasculopathy. JACC: Cardiovascular Interventions 1:6, 710-715
CrossRef662
E MOLDOVEANU, B MUTVITCU, G TANASEANU, D MARTA, G MANEA, T KOSAKA, C VIDULESCU, C TANASEANU. (2008) Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: Lipoprotein associated phospholipase A2, and myeloperoxidase. Clinical Biochemistry 41:18, 1429-1433
CrossRef663
Jing Yang, Yong Zeng, Youngjun Li, Cunxian Song, Wenling Zhu, Heng Guan, Xiaohui Li. (2008) Intravascular site-specific delivery of a therapeutic antisense for the inhibition of restenosis. European Journal of Pharmaceutical Sciences 35:5, 427-434
CrossRef664
John Kao, Ricardo Vicuna, John A. House, John S. Rumsfeld, Henry H. Ting, John A. Spertus. (2008) Disparity in drug-eluting stent utilization by insurance type. American Heart Journal 156:6, 1133-1140
CrossRef665
CHI-HANG LEE, JUNJIE ZHANG, ANAND KAILASAM, BEE-CHOO TAI, FEI YE, ADRIAN F. LOW, XUMIN HOU, EDOURDO TIN HAY, SWEE-GUAN TEO, YEAN-TENG LIM, SHAOLIANG CHEN, HUAY-CHEEM TAN. (2008) An Intravascular Ultrasound Study of Cypher, Taxus, and Endeavor Stents on Relation between Neointimal Proliferation and Residual Plaque Burden. Journal of Interventional Cardiology 21:6, 519-527
CrossRef666
Michael S. Lee, Daniel Jurewitz, Raymond Zimmer, Antonio Pessegueiro, Ravi Bhatia, Jesse Currier, Larry Yeatman, Jonathan M. Tobis. (2008) Impact of diabetes and acute coronary syndrome on survival in patients treated with drug-eluting stents. Catheterization and Cardiovascular Interventions 72:7, 909-914
CrossRef667
Koki Nakamura, Nobusada Funabashi, Masae Uehara, Kazushi Suzuki, Makoto Terao, Kenji Okubo, Yuzuru Mita, Fumiaki Maeda, Issei Komuro. (2008) Impairment factors for evaluating the patency of drug-eluting stents and bare metal stents in coronary arteries by 64-slice computed tomography versus conventional coronary angiography. International Journal of Cardiology 130:3, 349-356
CrossRef668
J. Shan, T. B. Nguyen, H. Totary-Jain, H. Dansky, S. O. Marx, A. R. Marks. (2008) Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors. Proceedings of the National Academy of Sciences 105:48, 19006-19011
CrossRef669
Bryan P. Yan, Andrew E. Ajani, Gishel New, Stephen J. Duffy, Omar Farouque, James Shaw, Martin Sebastian, Robert Lew, Angela Brennan, Nick Andrianopoulos, Chris Reid, David J. Clark. (2008) Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry. International Journal of Cardiology 130:3, 374-379
CrossRef670
G SANGIORGI, E ROMAGNOLI, G BIONDIZOCCAI, M MARGHERI, C TAMBURINO, R BARBAGALLO, E FALCHETTI, G VITTORI, P AGOSTONI, J COSGRAVE. (2008) Percutaneous coronary implantation of sirolimus-eluting stents in unselected patients and lesions: Clinical results and multiple outcome predictors. American Heart Journal 156:5, 871-878
CrossRef671
Ulrike Stampfl, Christof-Matthias Sommer, Heidi Thierjung, Sibylle Stampfl, Ruben Lopez-Benitez, Boris Radeleff, Irina Berger, Goetz M. Richter. (2008) Reduction of Late In-Stent Stenosis in a Porcine Coronary Artery Model by Cobalt Chromium Stents with a Nanocoat of Polyphosphazene (Polyzene-F). CardioVascular and Interventional Radiology 31:6, 1184-1192
CrossRef672
Gaku Nakazawa, Aloke V Finn, Elena Ladich, Flavio Ribichini, Leslie Coleman, Frank D Kolodgie, Renu Virmani. (2008) Drug-eluting stent safety: findings from preclinical studies. Expert Review of Cardiovascular Therapy 6:10, 1379-1391
CrossRef673
Masato Nishimura, Toshihiko Ono. (2008) Clinical utility of myocardial fatty acid imaging in patients with end-stage renal disease. Journal of Nuclear Cardiology 15:6, 830-837
CrossRef674
Chi-Hang Lee, Adrian Low, Eric Hong, Bee-Choo Tai, Ing-Haan Lim, Swee-Guan Teo, Yean-Teng Lim, Huay-Cheem Tan. (2008) Long-term safety and efficacy are observed after implantation of Zotarolimus-Eluting Stent in real-world clinical practice. EuroIntervention 4:3, 338-344
CrossRef675
William Hillegass. (2008) Native vessel PCI in the diabetic: DES whenever feasible. Catheterization and Cardiovascular Interventions 72:5, 608-609
CrossRef676
Trung Tran, Michael Brown, John Lasala. (2008) An evidence-based approach to the use of rotational and directional coronary atherectomy in the era of drug-eluting stents: When does it make sense?. Catheterization and Cardiovascular Interventions 72:5, 650-662
CrossRef677
Nadia Garro, Davide Capodanno, Valeria Cammalleri, Corrado Tamburino. (2008) Very late thrombosis in acute myocardial infarction: drug-eluting versus uncoated stents. EuroIntervention 4:3, 324-330
CrossRef678
Lisa M. Ballou, Richard Z. Lin. (2008) Rapamycin and mTOR kinase inhibitors. Journal of Chemical Biology 1:1-4, 27-36
CrossRef679
Robert Byrne, Raisuke Iijima, Julinda Mehilli, Jürgen Pache, Stefanie Schulz, Albert Schömig, Adnan Kastrati. (2008) Tratamiento de la reestenosis de stents liberadores de paclitaxel mediante implantación de stents liberadores de sirolimus. Resultados angiográficos y clínicos. Revista Española de Cardiología 61:11, 1134-1139
CrossRef680
Charles Chan, Robaayah Zambahari, Upendra Kaul, CP Lau, Hall Whitworth, Sidney Cohen, Maurice Buchbinder, . (2008) A randomized comparison of sirolimus-eluting versus bare metal stents in the treatment of diabetic patients with native coronary artery lesions: The DECODE study. Catheterization and Cardiovascular Interventions 72:5, 591-600
CrossRef681
Gijong Yi, Young-Nam Youn, Kyung-Jong Yoo, You-Sun Hong. (2008) Comparison of Off-pump Coronary Artery Bypass Grafting With Percutaneous Coronary Intervention Versus Drug-Eluting Stents for Three-Vessel Coronary Artery Disease. The Annals of Thoracic Surgery 86:5, 1438-1443
CrossRef682
K TSUCHIDA, J DAEMEN, S TANIMOTO, H GARCIAGARCIA, N KUKREJA, S VAINA, A ONG, G SIANOS, P DEJAEGERE, R VANDOMBURG. (2008) Two-year outcome of the use of paclitaxel-eluting stents in aorto-ostial lesions. International Journal of Cardiology 129:3, 348-353
CrossRef683
Kimie Tanaka, Masataka Sata. (2008) Contribution of circulating vascular progenitors in lesion formation and vascular healing: lessons from animal models. Current Opinion in Lipidology 19:5, 498-504
CrossRef684
John M. Lasala, David A. Cox, David Dobies, Joseph B. Muhlestein, John N. Katopodis, George Revtyak, Donald S. Baim, . (2008) Usage patterns and 2-year outcomes with the TAXUS express stent: Results of the US ARRIVE 1 registry. Catheterization and Cardiovascular Interventions 72:4, 433-445
CrossRef685
J SHAW, N ANDRIANOPOULOS, S DUFFY, A WALTON, D CLARK, R LEW, M SEBASTIAN, G NEW, A BRENNAN, C REID. (2008) Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents. Cardiovascular Revascularization Medicine 9:4, 218-223
CrossRef686
Matthew J. Price, Paul S. Teirstein. (2008) The off- versus on-label use of medical devices in interventional cardiovascular medicine: Clarifying the ambiguity between regulatory labeling and clinical decision-making, Part 1: PCI. Catheterization and Cardiovascular Interventions 72:4, 500-504
CrossRef687
Jozef Jakabčin, Marian Bystroň, Radim Špaček, Josef Veselka, Martin Kvašňak, Petr Kala, Jaroslav Malý, Pavel Červinka. (2008) The lack of endothelization after drug-eluting stent implantation as a cause of fatal late stent thrombosis. Journal of Thrombosis and Thrombolysis 26:2, 154-158
CrossRef688
Gilles Lemesle, Arnaud Sudre, Thomas Modine, Cédric Delhaye, Guillaume Rosey, Terry Gourlay, Christophe Bauters, Jean-Marc Lablanche. (2008) High incidence of recurrent in stent thrombosis after successful treatment of a first in stent thrombosis. Catheterization and Cardiovascular Interventions 72:4, 470-478
CrossRef689
Peter J. Fitzgerald, Hiromasa Otake. (2008) Evaluación de la respuesta vascular al intervencionismo coronario. Revista Española de Cardiología 61:10, 1001-1006
CrossRef690
S. R. Steinhubl, P. B. Berger. (2008) Aspirin following PCI: too much of a good thing?. European Heart Journal 30:8, 882-884
CrossRef691
J. M. Ruiz-Nodar, F. Marin, J. Sanchez-Paya, J. A. Hurtado, J. Valencia-Martin, S. Manzano-Fernandez, V. Roldan, V. Perez-Andreu, F. Sogorb, M. Valdes, G. Y.H. Lip. (2008) Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation. European Heart Journal 30:8, 932-939
CrossRef692
Mauri, Laura, Silbaugh, Treacy S., Garg, Pallav, Wolf, Robert E., Zelevinsky, Katya, Lovett, Ann, Varma, Manu R., Zhou, Zheng, Normand, Sharon-Lise T., . (2008) Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction. New England Journal of Medicine 359:13, 1330-1342
Full Text693
Rolf Dörr. (2008) Akutes Koronarsyndrom – eine Herausforderung für die Kooperation zwischen ambulanter und stationärer Versorgung. Herz Kardiovaskuläre Erkrankungen 33:6, 395-401
CrossRef694
John P Girod, Suresh R Mulukutla, Oscar C Marroquin. (2008) Off-label use of stents: bare-metal versus drug-eluting stents. Expert Review of Cardiovascular Therapy 6:8, 1095-1106
CrossRef695
Robert J. Applegate, Matthew T. Sacrinty, William C. Little, Renato M. Santos, Sanjay K. Gandhi, Michael A. Kutcher. (2008) Incidence of Coronary Stent Thrombosis Based on Academic Research Consortium Definitions. The American Journal of Cardiology 102:6, 683-688
CrossRef696
Ron Waksman. (2008) Drug-eluting stents: is new necessarily better?. The Lancet 372:9644, 1126-1128
CrossRef697
Rosetta Melfi, Annunziata Nusca, Giuseppe Patti, Germano Sciascio. (2008) The risks and benefits of drug-eluting stents in the setting of STEMI. Current Cardiology Reports 10:5, 402-406
CrossRef698
Stephan Windecker, Patrick W Serruys, Simon Wandel, Pawel Buszman, Stanislaw Trznadel, Axel Linke, Karsten Lenk, Thomas Ischinger, Volker Klauss, Franz Eberli, Roberto Corti, William Wijns, Marie-Claude Morice, Carlo di Mario, Simon Davies, Robert-Jan van Geuns, Pedro Eerdmans, Gerrit-Anne van Es, Bernhard Meier, Peter Jüni. (2008) Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. The Lancet 372:9644, 1163-1173
CrossRef699
E. Maor, A. Ivorra, J. Leor, B. Rubinsky. (2008) Irreversible Electroporation Attenuates Neointimal Formation After Angioplasty. IEEE Transactions on Biomedical Engineering 55:9, 2268-2274
CrossRef700
Luigi Pedon, Marco Zennaro, Diego Calzolari, Mario Zanchetta. (2008) Strut fracture: a further concern with drug-eluting stents. Journal of Cardiovascular Medicine 9:9, 949-952
CrossRef701
Tobias Deuse, Reinhold G. Erben, Fumiaki Ikeno, Boris Behnisch, Rainer Boeger, Andrew J. Connolly, Hermann Reichenspurner, Claudia Bergow, Marc P. Pelletier, Robert C. Robbins, Sonja Schrepfer. (2008) Introducing the first polymer-free leflunomide eluting stent. Atherosclerosis 200:1, 126-134
CrossRef702
Giuseppe GL Biondi-Zoccai, Claudio Moretti, Marzia Lotrionte, Imad Sheiban. (2008) Safety of drug-coated stents. Expert Opinion on Drug Safety 7:5, 597-606
CrossRef703
Teruo Okabe, Joseph Lindsay, Ashesh N. Buch, Daniel H. Steinberg, Probal Roy, Tina L. Pinto Slottow, Kimberly Smith, Rebecca Torguson, Zhenyi Xue, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Neil J. Weissman, Ron Waksman. (2008) Drug-Eluting Stents Versus Bare Metal Stents for Narrowing in Saphenous Vein Grafts. The American Journal of Cardiology 102:5, 530-534
CrossRef704
Anne Neubert, Katrin Sternberg, Stefan Nagel, Claus Harder, Klaus-Peter Schmitz, Heyo K. Kroemer, Werner Weitschies. (2008) Development of a vessel-simulating flow-through cell method for the in vitro evaluation of release and distribution from drug-eluting stents. Journal of Controlled Release 130:1, 2-8
CrossRef705
Girish R. Mood, Anthony A. Bavry, Deepak L. Bhatt. (2008) Clopidogrel and coronary stents: Risks and benefits. Current Atherosclerosis Reports 10:4, 303-308
CrossRef706
KISHORE J. HARJAI, PAMELA ORSHAW, CHETAN SHENOY, SUBASIT ACHARJI, DANIEL SPORN, ALI ABOUFARES, DWIGHT STAPLETON. (2008) Clinical Outcomes Following Drug-Eluting versus Bare Metal Stent Implantation for Lesion Subsets Excluded from Pivotal Clinical Trials: Findings from the GHOST Study (Guthrie Health System Off-Label StenT Study). Journal of Interventional Cardiology 21:4, 315-324
CrossRef707
Kae-Woei Liang, Sui-Chu Yin, Chih-Tai Ting, Shing-Jong Lin, Chi-Mei Hsueh, Chiu-Yuan Chen, Shih-Lan Hsu. (2008) Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells. European Journal of Pharmacology 590:1-3, 343-354
CrossRef708
C. M. Gross, S. Schmidt, M. Bergmann. (2008) Standortbestimmung der Drug-Eluting-Stents ein Jahr nach Beginn der Sicherheitsdiskussion. Clinical Research in Cardiology Supplements 3:1, 85-89
CrossRef709
AMANDA SOUSA, J. RIBAMAR COSTA, Jr, ADRIANA C. MOREIRA, MANUEL CANO, GALO MALDONADO, RICARDO A. COSTA, RICARDO PAVANELLO, EDSON R. ROMANO, CANTIDIO CAMPOS, NAGIB HADDAD, ALEXANDRE ABIZAID, FAUSTO FERES, LUIZ ALBERTO MATTOS, RODOLFO STAICO, J. EDUARDO SOUSA. (2008) Long-Term Clinical Outcomes of the Drug-Eluting Stents in the Real World (DESIRE) Registry. Journal of Interventional Cardiology 21:4, 307-314
CrossRef710
Pasi Karjalainen, Antti Ylitalo, Matti Niemelä, Kari Kervinen, Timo Mäkikallio, Mikko Pietilä, Jussi Sia, Petri Tuomainen, Kai Nyman, K.E. Airaksinen. (2008) Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a 12-months follow-up report from the TITAX AMI trial. EuroIntervention 4:2, 234-241
CrossRef711
Probal Roy, Laurent Bonello, Axel de Labriolle, Teruo Okabe, Tina L. Pinto Slottow, Daniel H. Steinberg, Rebecca Torguson, Kimberly Smith, Zhenyi Xue, Lowell F. Satler, Kenneth M. Kent, William O. Suddath, Augusto D. Pichard, Ron Waksman. (2008) Two-Year Outcome of Patients Treated With Sirolimus- Versus Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease (from the REWARDS Registry). The American Journal of Cardiology 102:3, 292-297
CrossRef712
Dekel Shlomi, Nir Peled, David Shitrit, Daniele Bendayan, Anat Amital, Mordechai R. Kramer. (2008) Protective Effect of Immunosuppression on Granulation Tissue Formation in Metallic Airway Stents. The Laryngoscope 118:8, 1383-1388
CrossRef713
Pieter Stella, Ralf Mueller, George Pavlakis, Bernard De Bruyne, Karl Hauptmann, Marie-Claude Morice, Bernard Chevalier, Jean Fajadet, Horst Sievert, Eberhard Grube. (2008) One year results of a new in situ length-adjustable stent platform with a biodegradable Biolimus A9 eluting polymer: results of the CUSTOM-II trial. EuroIntervention 4:2, 200-207
CrossRef714
Lisa T. Newsome, Michael A. Kutcher, Roger L. Royster. (2008) Coronary Artery Stents: Part I. Evolution of Percutaneous Coronary Intervention. Anesthesia & Analgesia 107:2, 552-569
CrossRef715
Paul Barragan, Jean Fajadet, Imad Sheiban, Patrick Serruys, Antonio Colombo, Ricardo Seabra-Gomes, Jean-Jacques Goy, Stéphane Cook, Paolo Rubino, Thierry Lefèvre. (2008) Elective implantation of sirolimus-eluting stents for bifurcated and non-bifurcated unprotected left main coronary artery lesions: clinical outcomes at one year. EuroIntervention 4:2, 262-270
CrossRef716
Anton Razuvaev, Kent Lund, Joy Roy, Ulf Hedin, Kenneth Caidahl. (2008) Noninvasive real-time imaging of intima thickness after rat carotid artery balloon injury using ultrasound biomicroscopy. Atherosclerosis 199:2, 310-316
CrossRef717
Marc A. Simon, John Watson, J. Timothy Baldwin, William R. Wagner, Harvey S. Borovetz. (2008) Current and Future Considerations in the Use of Mechanical Circulatory Support Devices*. Annual Review of Biomedical Engineering 10:1, 59-84
CrossRef718
Yaling Han, Quanmin Jing, Xuezhi Chen, Shouli Wang, Yingyan Ma, Haiwei Liu, Bo Luan, Geng Wang, Yi Li, Zulu Wang, Dongmei Wang, Bo Xu, Runlin Gao. (2008) Long-term clinical, angiographic, and intravascular ultrasound outcomes of biodegradable polymer-coated sirolimus-eluting stents. Catheterization and Cardiovascular Interventions 72:2, 177-183
CrossRef719
Satoshi Takeshita, Takaaki Shiono, Ayumu Takagi, Takenari Ito, Shigeru Saito. (2008) Percutaneous coronary intervention using a novel 4-French coronary accessor. Catheterization and Cardiovascular Interventions 72:2, 222-227
CrossRef720
Masato Nishimura, Toshiko Tokoro, Masasya Nishida, Tetsuya Hashimoto, Hiroyuki Kobayashi, Satoru Yamazaki, Ryo Imai, Koji Okino, Hakuo Takahashi, Toshihiko Ono. (2008) Myocardial fatty acid imaging identifies a group of hemodialysis patients at high risk for cardiac death after coronary revascularization. Kidney International 74:4, 513-520
CrossRef721
Michael J. Mack, Syma L. Prince, Morley Herbert, Phillip P. Brown, Marc Katz, George Palmer, James R. Edgerton, Eric Eichhorn, Mitchell J. Magee, Todd M. Dewey. (2008) Current Clinical Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting. The Annals of Thoracic Surgery 86:2, 496-503
CrossRef722
Gladius Lewis. (2008) Materials, fluid dynamics, and solid mechanics aspects of coronary artery stents: A state‐of‐the‐art review. Journal of Biomedical Materials Research Part B: Applied Biomaterials 86B:2, 569-590
CrossRef723
Emilia Solinas, George Dangas, Ajay J. Kirtane, Alexandra J. Lansky, Theresa Franklin-Bond, Paul Boland, George Syros, Young-Hak Kim, Anuj Gupta, Gary Mintz, Martin Fahy, Michael Collins, Susheel Kodali, Gregg W. Stone, Jeffrey W. Moses, Martin B. Leon, Roxana Mehran. (2008) Angiographic Patterns of Drug-Eluting Stent Restenosis and One-Year Outcomes After Treatment With Repeated Percutaneous Coronary Intervention. The American Journal of Cardiology 102:3, 311-315
CrossRef724
K. O. Niemela. (2008) Biodegradable coating for drug-eluting stents--more than a facelift?. European Heart Journal 29:16, 1930-1931
CrossRef725
J. Mehilli, R. A. Byrne, A. Wieczorek, R. Iijima, S. Schulz, O. Bruskina, J. Pache, R. Wessely, A. Schomig, A. Kastrati, . (2008) Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis. European Heart Journal 29:16, 1975-1982
CrossRef726
P. Roy, D. H. Steinberg, S. J. Sushinsky, T. Okabe, T. L. Pinto Slottow, K. Kaneshige, Z. Xue, L. F. Satler, K. M. Kent, W. O. Suddath, A. D. Pichard, N. J. Weissman, J. Lindsay, R. Waksman. (2008) The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. European Heart Journal 29:15, 1851-1857
CrossRef727
Michael Maeng, Lisette O. Jensen, Anne Kaltoft, Hans H.T. Hansen, Morten Bøttcher, Jens F. Lassen, Per Thayssen, Lars R. Krusell, Klaus Rasmussen, Lars Pedersen, Henrik T. Sørensen, Søren P. Johnsen, Leif Thuesen. (2008) Comparison of Stent Thrombosis, Myocardial Infarction, and Mortality Following Drug-Eluting Versus Bare-Metal Stent Coronary Intervention in Patients With Diabetes Mellitus. The American Journal of Cardiology 102:2, 165-172
CrossRef728
G MISHKEL, A MOORE, S MARKWELL, M SHELTON. (2008) Correlates of late and very late thrombosis of drug eluting stents. American Heart Journal 156:1, 141-147
CrossRef729
David F. Kong, Eric L. Eisenstein, Robert A. Harrington. (2008) Late adverse events after drug-eluting stent implantation. Current Cardiology Reports 10:4, 253-262
CrossRef730
Roxana Mehran, Bruce Brodie, David A. Cox, Cindy L. Grines, Barry Rutherford, Deepak L. Bhatt, George Dangas, Fred Feit, E. Magnus Ohman, Helen Parise, Martin Fahy, Alexandra J. Lansky, Gregg W. Stone. (2008) The Harmonizing Outcomes with RevascularIZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: Study design and rationale. American Heart Journal 156:1, 44-56
CrossRef731
Giuseppe Gioia, Alberto Benassi, Raghar Mohendra, Khaza Chowdhury, Iqbal Masood, William Matthai. (2008) Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts. Catheterization and Cardiovascular Interventions 72:1, 13-20
CrossRef732
Robert J. Applegate, Matthew Sacrinty, Michael Kutcher, Renato Santos, Sanjay Gandhi, William Little. (2008) Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: Propensity score analysis. Catheterization and Cardiovascular Interventions 72:1, 7-12
CrossRef733
Helge Möllmann, Albrecht Elsässer, Holger Nef, Steffen Schneider, Christoph A. Nienaber, Gert Richardt, Michael Weber, Malte Kelm, Benny Levenson, Tassilo Bonzel, Ulrich Tebbe, Georg Sabin, Thomas Pfannebecker, Jochen Senges, Christian W. Hamm. (2008) Treatment of in-stent restenosis with sirolimus-eluting-stents: results from the prospective German Cypher stent registry. Clinical Research in Cardiology 97:7, 432-440
CrossRef734
Zhan Gao, Yue Jin Yang, Run Lin Gao. (2008) Comparative Study of Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions in Daily Practice in Chinese Patients. Clinical Cardiology 31:7, 317-322
CrossRef735
Kishore Udipi, Mingfei Chen, Peiwen Cheng, Kevin Jiang, Diane Judd, Alejandra Caceres, Robert J. Melder, Josiah N. Wilcox. (2008) Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent. Journal of Biomedical Materials Research Part A 85A:4, 1064-1071
CrossRef736
S. G. Ellis, C. D. O'Shaughnessy, S. L. Martin, K. Kent, T. McGarry, M. A. Turco, D. J. Kereiakes, J. J. Popma, M. Friedman, J. Koglin, G. W. Stone, . (2008) Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial. European Heart Journal 29:13, 1625-1634
CrossRef737
Ehtisham Mahmud, Guilherme Bromberg-Marin, Vachaspathi Palakodeti, Lawrence Ang, Dana Creanga, Anthony N. DeMaria. (2008) Clinical Efficacy of Drug-Eluting Stents in Diabetic Patients. Journal of the American College of Cardiology 51:25, 2385-2395
CrossRef738
Emanuele Meliga, Hector Manuel Garcia-Garcia, Marco Valgimigli, Alaide Chieffo, Giuseppe Biondi-Zoccai, Andrew O. Maree, Stephen Cook, Lindsay Reardon, Claudio Moretti, Stefano De Servi, Igor F. Palacios, Stephen Windecker, Antonio Colombo, Ron van Domburg, Imad Sheiban, Patrick W. Serruys. (2008) Longest Available Clinical Outcomes After Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease. Journal of the American College of Cardiology 51:23, 2212-2219
CrossRef739
Eugenia Nikolsky, David R. Holmes, Roxana Mehran, George Dangas, Erick Schampaert, Marie-Claude Morice, Joachim Schofer, J. Eduardo Sousa, Martin Fahy, Yingbo Na, Dennis J. Donohoe, Jeffrey W. Moses, Martin B. Leon. (2008) Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents. Catheterization and Cardiovascular Interventions 71:7, 896-906
CrossRef740
Stephan Windecker, Peter Jüni. (2008) Safety of drug-eluting stents. Nature Clinical Practice Cardiovascular Medicine 5:6, 316-328
CrossRef741
Somjot S. Brar, John Kim, Simerjeet K. Brar, Ray Zadegan, Michael Ree, In-Lu A. Liu, Prakash Mansukhani, Vicken Aharonian, Ric Hyett, Albert Yuh-Jer Shen. (2008) Long-Term Outcomes by Clopidogrel Duration and Stent Type in a Diabetic Population With De Novo Coronary Artery Lesions. Journal of the American College of Cardiology 51:23, 2220-2227
CrossRef742
Peter W. Groeneveld, Mary Anne Matta, Alexis P. Greenhut, Feifei Yang. (2008) The costs of drug-eluting coronary stents among Medicare beneficiaries. American Heart Journal 155:6, 1097-1105
CrossRef743
Ravi K. Ramana, Adam Ronan, Kevin Cohoon, David Homan, Jessica Sutherland, Lowell Steen, Jayson Liu, Henry Loeb, Bruce E. Lewis. (2008) Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease. Catheterization and Cardiovascular Interventions 71:7, 886-893
CrossRef744
Pablo del Saz-Saucedo, José Francisco Maestre-Moreno, Juan Francisco Arenillas-Lara. (2008) Ateromatosis intracraneal. Medicina Clínica 131:4, 141-152
CrossRef745
KISHORE J. HARJAI, CINDY L. GRINES. (2008) Management of Multivessel Coronary Disease: Let Us Not Shortchange Drug-Eluting Stents. Journal of Interventional Cardiology 21:3, 213-217
CrossRef746
L. O. Jensen, M. Maeng, P. Thayssen, E. H. Christiansen, K. N. Hansen, A. Galloe, H. Kelbaek, J. F. Lassen, L. Thuesen. (2008) Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: The Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial. European Heart Journal 29:22, 2733-2741
CrossRef747
Michelle Olive, Jason A. Mellad, Leilani E. Beltran, Mingchao Ma, Thomas Cimato, Audrey C. Noguchi, Hong San, Richard Childs, Jason C. Kovacic, Manfred Boehm. (2008) p21Cip1 modulates arterial wound repair through the stromal cell–derived factor-1/CXCR4 axis in mice. Journal of Clinical Investigation
CrossRef748
Ashesh N. Buch, Aamir Javaid, Daniel H. Steinberg, Probal Roy, Tina L. Pinto Slottow, Zhenyi Xue, Kimberly Smith, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman. (2008) Outcomes After Sirolimus- and Paclitaxel-Eluting Stent Implantation in Patients With Insulin-Treated Diabetes Mellitus. The American Journal of Cardiology 101:9, 1253-1258
CrossRef749
Fernando Rivero, Raúl Moreno, Laura Barreales, Guillermo Galeote, Angel Sánchez-Recalde, Luis Calvo, Santiago Jimenez-Valero, Alexis Villate, Mauricio Vanegas, José-Luis López-Sendón. (2008) Lower levels of in-stent late loss are not associated with the risk of stent thrombosis in patients receiving drug-eluting stents. EuroIntervention 4:1, 124-132
CrossRef750
Pallav Garg, David J. Cohen, Thomas Gaziano, Laura Mauri. (2008) Balancing the Risks of Restenosis and Stent Thrombosis in Bare-Metal Versus Drug-Eluting Stents. Journal of the American College of Cardiology 51:19, 1844-1853
CrossRef751
Henning Kelbæk, Lene Kløvgaard, Steffen Helqvist, Jens F. Lassen, Lars R. Krusell, Thomas Engstrøm, Hans E. Bøtker, Erik Jørgensen, Kari Saunamäki, Samir Aljabbari, Per Thayssen, Anders Galløe, Gunnar V.H. Jensen, Leif Thuesen. (2008) Long-Term Outcome in Patients Treated With Sirolimus-Eluting Stents in Complex Coronary Artery Lesions. Journal of the American College of Cardiology 51:21, 2011-2016
CrossRef752
Mamas Mamas, Douglas Fraser, Farzin Fath-Ordoubadi. (2008) The role of thrombectomy and distal protection devices during percutaneous coronary interventions. EuroIntervention 4:1, 115-123
CrossRef753
Sameer Dani, Neville Kukreja, Prakashvir Parikh, Hasit Joshi, Jayesh Prajapati, Sharad Jain, Sunil Thanvi, Bhupesh Shah, Jyoti-Prakash Dutta. (2008) Biodegradable-polymer-based, sirolimus-eluting Supralimus® stent: 6-month angiographic and 30-month clinical follow-up results from the Series I prospective study. EuroIntervention 4:1, 59-63
CrossRef754
Giuseppe De Luca, Harry Suryapranata, Gregg W. Stone, David Antoniucci, Giuseppe Biondi-Zoccai, Adnan Kastrati, Massimo Chiariello, Paolo Marino. (2008) Coronary stenting versus balloon angioplasty for acute myocardial infarction: A meta-regression analysis of randomized trials. International Journal of Cardiology 126:1, 37-44
CrossRef755
Eberhard Grube, Horst Sievert, Karl-Eugen Hauptmann, Ralf Mueller, Ulrich Gerckens, Lutz Buellesfeld, Junya Ako, Takao Shimohama, Marco Costa, Peter Fitzgerald. (2008) Novel drug eluting stent system for customised treatment of coronary lesions: CUSTOM I feasibility trial 24 month results. EuroIntervention 4:1, 71-76
CrossRef756
Abid Assali, Yael Raz, Hana Vaknin-Assa, Itsik Ben-Dor, David Brosh, Igal Teplitsky, Shmuel Fuchs, Ran Kornowski. (2008) Beneficial 2-years results of drug-eluting stents in saphenous vein graft lesions. EuroIntervention 4:1, 108-114
CrossRef757
Peter W. Groeneveld, Mary Anne Matta, Alexis P. Greenhut, Feifei Yang. (2008) Drug-Eluting Compared With Bare-Metal Coronary Stents Among Elderly Patients. Journal of the American College of Cardiology 51:21, 2017-2024
CrossRef758
H. Ramakrishna, G. Godet, Y. Le Manach, F. Lesache, S. Perbet, P. Coriat. (2008) Drug-eluting stent thrombosis in patients undergoing non-cardiac surgery. British Journal of Anaesthesia 101:1, 130-130
CrossRef759
Richard P. Konstance, Eric L. Eisenstein, Kevin J. Anstrom, Linda K. Shaw, Robert M. Califf, Robert A. Harrington, David B. Matchar, Kevin A. Schulman, David F. Kong. (2008) Outcomes of Second Revascularization Procedures after Stent Implantation. Journal of Medical Systems 32:2, 177-186
CrossRef760
M. Zähringer, P. M. T. Pattynama, A. Talen, M. Sapoval. (2008) Drug-eluting stents in renal artery stenosis. European Radiology 18:4, 678-682
CrossRef761
Barry Reicher, Robert S. Poston, Mandeep R. Mehra, Ashish Joshi, Patrick Odonkor, Zachary Kon, Peter A. Reyes, David A. Zimrin. (2008) Simultaneous “hybrid” percutaneous coronary intervention and minimally invasive surgical bypass grafting: Feasibility, safety, and clinical outcomes. American Heart Journal 155:4, 661-667
CrossRef762
Stephen D Wiviott, Eugene Braunwald, Carolyn H McCabe, Ivan Horvath, Matyas Keltai, Jean-Paul R Herrman, Frans Van de Werf, William E Downey, Benjamin M Scirica, Sabina A Murphy, Elliott M Antman. (2008) Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. The Lancet 371:9621, 1353-1363
CrossRef763
Mitchell W. Krucoff, Dean J. Kereiakes, John L. Petersen, Roxana Mehran, Vic Hasselblad, Alexandra J. Lansky, Peter J. Fitzgerald, Jyotsna Garg, Mark A. Turco, Charles A. Simonton, Stefan Verheye, Christophe L. Dubois, Roger Gammon, Wayne B. Batchelor, Charles D. O'Shaughnessy, James B. Hermiller, Joachim Schofer, Maurice Buchbinder, William Wijns. (2008) A Novel Bioresorbable Polymer Paclitaxel-Eluting Stent for the Treatment of Single and Multivessel Coronary Disease. Journal of the American College of Cardiology 51:16, 1543-1552
CrossRef764
Giuseppe Tarantini, Enrico Favaretto, Arianna Gardin, Massimo Napodano, Gianbattista Isabella, Marco Panfili, Gino Gerosa, Sabino Iliceto, Angelo Ramondo. (2008) Drug-eluting stents for the treatment of coronary lesions in cardiac transplant vasculopathy: acute and mid-term clinical and angiographic outcomes. Journal of Cardiovascular Medicine 9:4, 396-402
CrossRef765
Christopher J. Lockhart, Paul K. Hamilton, Katherine A. McVeigh, Gary E. McVeigh. (2008) A cardiologist view of vascular disease in diabetes. Diabetes, Obesity and Metabolism 10:4, 279-292
CrossRef766
Run-lin Gao, Bo Xu, Shu-zheng Lu, Ji-lin Chen, Ya-ling Han, Jun-zhu Chen, Lu-yue Gai, Jun-bo Ge, Wei-min Wang, Zhi-min Du, Yong Huo, Le-feng Wang, Wei Gao, Ji-yan Chen, Ben He, Guo-liang Jia, Zhi-jian Yang, Ke-jiang Cao, Wei-min Li, Wei-feng Shen, Zheng Wan, De-jia Huang, Guo-ying Zhu. (2008) Safety and efficacy of the CYPHER Select Sirolimus-eluting stent in the “Real World”—Clinical and angiographic results from the China CYPHER Select registry. International Journal of Cardiology 125:3, 339-346
CrossRef767
Luigi Vignali, Francesco Saia, Antonio Manari, Andrea Santarelli, Andrea Rubboli, Elisabetta Varani, Giancarlo Piovaccari, Alberto Menozzi, Gianfranco Percoco, Alberto Benassi, Guido Rusticali, Paolo Marzaroli, Paolo Guastaroba, Roberto Grilli, Aleardo Maresta, Antonio Marzocchi. (2008) Long-Term Outcomes With Drug-Eluting Stents Versus Bare Metal Stents in the Treatment of Saphenous Vein Graft Disease (Results from the REgistro Regionale AngiopLastiche Emilia-Romagna Registry). The American Journal of Cardiology 101:7, 947-952
CrossRef768
Matthias Pfisterer, Osmund Bertel, Piero O. Bonetti, Hans Peter Brunner-La Rocca, Franz R. Eberli, Paul Erne, Soeren Galatius, Burkhard Hornig, Wolfgang Kiowski, Otmar Pachinger, Giovanni Pedrazzini, Hans Rickli, Stefano De Servi, Christoph Kaiser. (2008) Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: Study protocol and design. American Heart Journal 155:4, 609-614
CrossRef769
David Tanous, Neil Hime, Roland Stocker. (2008) Anti-atherosclerotic and anti-diabetic properties of probucol and related compounds. Redox Report 13:2, 48-59
CrossRef770
Edward L. Hannan, Michael Racz, Gary Walford, David R. Holmes, Robert H. Jones, Samin Sharma, Stanley Katz, Spencer B. King. (2008) Drug-Eluting Versus Bare-Metal Stents in the Treatment of Patients With ST-Segment Elevation Myocardial Infarction. JACC: Cardiovascular Interventions 1:2, 129-135
CrossRef771
Christian Zellerhoff, Steffen Schneider, Jochen Senges, Thomas Pfannebecker, Christian Hamm, Ulrich Tebbe. (2008) Sirolimus-eluting stents in the treatment of chronic total coronary occlusions. Clinical Research in Cardiology 97:4, 253-259
CrossRef772
Nobuaki Suzuki, Hitesh Nanda, Dominick J. Angiolillo, Hiran Bezerra, Manel Sabaté, Pilar Jiménez-Quevedo, Fernando Alfonso, Carlos Macaya, Theodore A. Bass, Olusegun J. Ilegbusi, Marco A. Costa. (2008) Assessment of potential relationship between wall shear stress and arterial wall response after bare metal stent and sirolimus-eluting stent implantation in patients with diabetes mellitus. The International Journal of Cardiovascular Imaging 24:4, 357-364
CrossRef773
H HECHT, M ZARIC, V JELNIN, L LUBARSKY, M PRAKASH, G ROUBIN. (2008) Usefulness of 64-Detector Computed Tomographic Angiography for Diagnosing In-Stent Restenosis in Native Coronary Arteries. The American Journal of Cardiology 101:6, 820-824
CrossRef774
Miodrag Ostojic, Dragan Sagic, Branko Beleslin, Robert Jung, Zoran Perisic, Nikola Jagic, Milan Nedeljkovic, Ljupco Mangovski, Bratislav Milosavljevic, Sinisa Stojkovic, Dejan Orlic, Zelimir Antonic, Vladimir Miloradovic, Dragan Topic, Dragica Paunovic. (2008) First clinical comparison of Nobori –Biolimus A9 eluting stents with Cypher– Sirolimus eluting stents: Nobori Core nine months angiographic and one year clinical outcomes. EuroIntervention 3:5, 574-579
CrossRef775
Michael S. Lee, Raymond Zimmer, Antonio Pessegueiro, Daniel Jurewitz, Jonathan Tobis. (2008) Outcomes of nonagenarians who undergo percutaneous coronary intervention with drug-eluting stents. Catheterization and Cardiovascular Interventions 71:4, 526-530
CrossRef776
Peter Lanzer, Lutz Prechelt. (2008) Spelling out risk reduction strategies for intracoronary stenting. EuroIntervention 3:5, 622-626
CrossRef777
Jaspal S Taggar, Gregory YH Lip, Aravinda Nanjundappa, Robert S Dieter, Sangeeta Mandapaka, Pranab Das, Shakeel Ahmad. (2008) Idraparinux for the prevention of thromboembolism in patients with atrial fibrillation. Therapy 5:2, 139-144
CrossRef778
Giuseppe De Luca, Harry Suryapranata, Paolo Marino. (2008) Reperfusion Strategies in Acute ST-Elevation Myocardial Infarction: An Overview of Current Status. Progress in Cardiovascular Diseases 50:5, 352-382
CrossRef779
Dietmar Trenk, Franz-Josef Neumann. (2008) Drug-eluting coronary stents: as safe as bare-metal stents, but optimized antiplatelet therapy may further improve clinical outcome. European Journal of Clinical Pharmacology 64:3, 227-232
CrossRef780
Jun Tanigawa, Peter Barlis, Konstantinos Dimopoulos, Carlo Di Mario. (2008) Optical coherence tomography to assess malapposition in overlapping drug-eluting stents. EuroIntervention 3:5, 580-583
CrossRef781
Allen Jeremias, Christopher P. Ruisi, Ajay J. Kirtane, Tobias Lee, Brett Sylvia, Duane S. Pinto, Kalon K.L. Ho, Donald E. Cutlip, Joseph P. Carrozza, David J. Cohen. (2008) Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the ‘real world’. Coronary Artery Disease 19:2, 111-115
CrossRef782
Patrick Ohlmann, Gary S. Mintz, Sang-Wook Kim, Augusto D. Pichard, Lowel F. Satler, Kenneth M. Kent, William O. Suddath, Ron Waksman, Neil J. Weissman. (2008) Intravascular ultrasound findings in patients with restenosis of sirolimus- and paclitaxel-eluting stents. International Journal of Cardiology 125:1, 11-15
CrossRef783
K KIP. (2008) The Problem With Composite End Points in Cardiovascular StudiesThe Story of Major Adverse Cardiac Events and Percutaneous Coronary Intervention. Journal of the American College of Cardiology 51:7, 701-707
CrossRef784
Myeong-Ki Hong, Gary S. Mintz, Cheol Whan Lee, Duk-Woo Park, Seung-Whan Lee, Young-Hak Kim, In-Hyun Jung, Sang-Hyun Kim, Sang-Sig Cheong, Jae-Joong Kim, Seong-Wook Park, Seung-Jung Park. (2008) Late target lesion revascularization after implantation of sirolimus-eluting stent. Catheterization and Cardiovascular Interventions 71:3, 299-303
CrossRef785
Jack P. Chen. (2008) Safety and Efficacy of the Drug-Eluting Stent: A Double-Edged Sword?. Southern Medical Journal 101:2, 174-178
CrossRef786
Bas L. van der Hoeven, Su-San Liem, J. Wouter Jukema, Navin Suraphakdee, Hein Putter, Jouke Dijkstra, Douwe E. Atsma, Marianne Bootsma, Katja Zeppenfeld, Pranobe V. Oemrawsingh, Ernst E. van der Wall, Martin J. Schalij. (2008) Sirolimus-Eluting Stents Versus Bare-Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction: 9-Month Angiographic and Intravascular Ultrasound Results and 12-Month Clinical Outcome. Journal of the American College of Cardiology 51:6, 618-626
CrossRef787
Ren Kawaguchi, Manel Sabate, Dominick J. Angiolillo, Pilar Jimenez-Quevedo, Nobuaki Suzuki, Cecilia Corros, Hideki Futamatsu, Fernando Alfonso, Rosana Hernandez-Antolin, Carlos Macaya, Theodore A. Bass, Marco A. Costa. (2008) Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitus. The International Journal of Cardiovascular Imaging 24:2, 125-132
CrossRef788
Corrado Tamburino, Saverio Ciriminna, Rossella Barbagallo, Alfredo Ruggero Galassi, Gianpaolo Ussia, Piera Capranzano, Francesco Tagliareni, Salvatore Tolaro, Antonino Nicosia, Amerigo Stabile, Rosario Grassi, Antonio Fiscella, Aldo Patti, Giovanni Saccone. (2008) Sicilian DES Registry: prospective in-hospital and 9-month clinical and angiographic follow-up in selected high restenosis risk patients. Journal of Cardiovascular Medicine 9:2, 161-168
CrossRef789
RON WAKSMAN, RAJBABU PAKALA, RICHARD BAFFOUR, RUFUS SEABRON, DAVID HELLINGA, FERMIN O. TIO. (2008) Short-Term Effects of Biocorrodible Iron Stents in Porcine Coronary Arteries. Journal of Interventional Cardiology 21:1, 15-20
CrossRef790
Pim van der Harst, Hendrik C. Groenewegen, Anton J.M. Roks, Hendrik Buikema, Felix Zijlstra, Wiek H. van Gilst, Bart J.G.L. de Smet. (2008) Rosuvastatin attenuates angiotensin II-induced neointimal formation after stent implantation in the rat. Coronary Artery Disease 19:1, 47-53
CrossRef791
Ajay J. Kirtane, Stephen G. Ellis, Keith D. Dawkins, Antonio Colombo, Eberhard Grube, Jeffrey J. Popma, Martin Fahy, Martin B. Leon, Jeffrey W. Moses, Roxana Mehran, Gregg W. Stone. (2008) Paclitaxel-Eluting Coronary Stents in Patients With Diabetes Mellitus. Journal of the American College of Cardiology 51:7, 708-715
CrossRef792
M. Kitoga, A. Pasquet, V. Preumont, J. Kefer, M.-P. Hermans, J.-L. Vanoverschelde, M. Buysschaert. (2008) Coronary in-stent restenosis in diabetic patients after implantation of sirolimus or paclitaxel drug-eluting coronary stents. Diabetes & Metabolism 34:1, 62-67
CrossRef793
Probal Roy, Ashesh N. Buch, Aamir Javaid, Teruo Okabe, Vikram Raya, Tina L. Pinto Slottow, Daniel H. Steinberg, Kimberly Smith, Zhenyi Xue, Natalie Gevorkian, Lowell F. Satler, Kenneth M. Kent, William O. Suddath, Augusto D. Pichard, Joseph Lindsay, Ron Waksman. (2008) Impact of “Off-Label” Utilization of Drug-Eluting Stents on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention. The American Journal of Cardiology 101:3, 293-299
CrossRef794
Henry H. Ting, Matthew T. Roe, Bernard J. Gersh, John A. Spertus, John S. Rumsfeld, Fang-Shu Ou, John Kao, Kirsten Hall Long, David R. Holmes, Eric D. Peterson. (2008) Factors Associated With Off-Label Use of Drug-Eluting Stents in Patients With ST-Elevation Myocardial Infarction. The American Journal of Cardiology 101:3, 286-292
CrossRef795
Juying Qian, Feng Zhang, Hongyi Wu, Bing Fan, Lei Ge, Junbo Ge. (2008) Comparison of intravascular ultrasonic imaging with versus without incomplete stent apposition at follow-up after drug-eluting stent implantation. The International Journal of Cardiovascular Imaging 24:2, 133-139
CrossRef796
Ahmed A. Khattab, Christian W. Hamm, Jochen Senges, Ralph Toelg, Volker Geist, Tassilo Bonzel, Malte Kelm, Benny Levenson, Christoph A. Nienaber, Thomas Pfannebecker, Georg Sabin, Steffen Schneider, Ulrich Tebbe, Gert Richardt. (2008) Prognostic Value of the Modified American College of Cardiology/American Heart Association Lesion Morphology Classification for Clinical Outcome After Sirolimus-Eluting Stent Placement (Results of the Prospective Multicenter German Cypher Registry). The American Journal of Cardiology 101:4, 477-482
CrossRef797
Robert J. Applegate, Matthew T. Sacrinty, Michael A. Kutcher, Renato M. Santos, Sanjay K. Gandhi, Talal T. Baki, William C. Little. (2008) “Off-Label” Stent Therapy. Journal of the American College of Cardiology 51:6, 607-614
CrossRef798
Carrozza, Joseph P. Jr., . (2008) Drug-Eluting Stents — Pushing the Envelope beyond the Labels?. New England Journal of Medicine 358:4, 405-407
Full Text799
Hannan, Edward L., Wu, Chuntao, Walford, Gary, Culliford, Alfred T., Gold, Jeffrey P., Smith, Craig R., Higgins, Robert S.D., Carlson, Russell E., Jones, Robert H., . (2008) Drug-Eluting Stents vs. Coronary-Artery Bypass Grafting in Multivessel Coronary Disease. New England Journal of Medicine 358:4, 331-341
Full Text800
Marroquin, Oscar C., Selzer, Faith, Mulukutla, Suresh R., Williams, David O., Vlachos, Helen A., Wilensky, Robert L., Tanguay, Jean-François, Holper, Elizabeth M., Abbott, J. Dawn, Lee, Joon S., Smith, Conrad, Anderson, William D., Kelsey, Sheryl F., Kip, Kevin E., . (2008) A Comparison of Bare-Metal and Drug-Eluting Stents for Off-Label Indications. New England Journal of Medicine 358:4, 342-352
Full Text801
Shinichiro Tanaka, Sachiro Watanabe, Hitoshi Matsuo, Tomonori Segawa, Makoto Iwama, Takeshi Hirose, Haruki Takahashi, Koji Ono, Shunichiro Warita, Tai Kojima, Shinya Minatoguchi, Hisayoshi Fujiwara. (2008) Prospective randomized trial comparing a nitinol self-expanding coronary stent with low-pressure dilatation and a high-pressure balloon expandable bare metal stent. Heart and Vessels 23:1, 1-8
CrossRef802
Hiroshi Sakamoto, Tetsuya Ishikawa, Makoto Mutoh, Kamon Imai, Seibu Mochizuki. (2008) Angiographic and Clinical Outcomes After Sirolimus-Eluting Stent Implantation to De Novo Ostial Lesion of the Right Coronary Artery. Circulation Journal 72:6, 880-885
CrossRef803
ANTHONY H. GERSHLICK. 2008. Current major trials in interventional cardiology. , 527-552.
CrossRef804
Sun Hwa Lee, Jei-Keon Chae, Kang-Hyu Lee, Sang-Rok Lee, Kyoung-Suk Rhee, Won-Ho Kim, Jae-Ki Ko. (2008) Full Metal Jackets (≥60 mm) of Drug-Eluting Stents: Short- and Long-term Clinical and Angiographic Outcomes. Korean Circulation Journal 38:2, 87
CrossRef805
Stuart J. Pocock, Alexandra J. Lansky, Roxana Mehran, Jeffrey J. Popma, Martin P. Fahy, Yingbo Na, George Dangas, Jeffrey W. Moses, Tereza Pucelikova, David E. Kandzari, Stephen G. Ellis, Martin B. Leon, Gregg W. Stone. (2008) Angiographic Surrogate End Points in Drug-Eluting Stent Trials. Journal of the American College of Cardiology 51:1, 23-32
CrossRef806
Jun Ho Joe, Kwang Suk Lim, Ji Yong Jin, Kyung Soo Kim. (2008) Effect of Udenafil on Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia in Rat Carotid Artery Injury Model. Korean Circulation Journal 38:6, 320
CrossRef807
Florence Gizard, Dennis Bruemmer. (2008) Transcriptional Control of Vascular Smooth Muscle Cell Proliferation by Peroxisome Proliferator-Activated Receptor-γ: Therapeutic Implications for Cardiovascular Diseases. PPAR Research 2008, 1-11
CrossRef808
Toru Aoyama, Hideki Ishii, Takanobu Toriyama, Hiroshi Takahashi, Hirotake Kasuga, Ryuichiro Murakami, Tetsuya Amano, Tadayuki Uetani, Yoshinari Yasuda, Yukio Yuzawa, Shoichi Maruyama, Seiichi Matsuo, Tatsuaki Matsubara, Toyoaki Murohara. (2008) Sirolimus-Eluting Stents vs Bare Metal Stents for Coronary Intervention in Japanese Patients With Renal Failure on Hemodialysis. Circulation Journal 72:1, 56-60
CrossRef809
R. Kornowski, H. Vaknin-Assa, E. Lev, I. Ben-Dor, I. Teplitsky, E. Rechavia, D. Brosh, S. Fuchs, A. Assali. (2008) Clinical results of drug eluting stents compared to bare metal stents for patients with ST elevation acute myocardial infarction. Acute Cardiac Care 10:3, 167-172
CrossRef810
Bob Kiaii, R. Scott McClure, Peter Stewart, Reiza Rayman, Stuart A. Swinamer, Yoshihiro Suematsu, Stephanie Fox, Jennifer Higgins, Caroline Albion, William J. Kostuk. (2008) Simultaneous integrated coronary artery revascularization with long-term angiographic follow-up. Journal of Thoracic and Cardiovascular Surgery 136:3, 702
CrossRef811
P. Commeau. (2008) Endovascular procedures for below the knee arteries in diabetics. Annales de Cardiologie et d Angéiologie 57:6, 352
CrossRef812
Jae-Hwan Lee, Hyun-Sook Kim, Seung-Whan Lee, Jae-Hyeong Park, Si-Wan Choi, Jin-Ok Jeong, Yoonhaeng Cho, Naehee Lee, Kyoung-Suk Rhee, Jae-Ki Ko, In-Whan Seong. (2008) Prospective randomized comparison of sirolimus- versus paclitaxel-eluting stents for the treatment of acute ST-elevation myocardial infarction. Catheterization and Cardiovascular Interventions
CrossRef813
Gaku Nakazawa, Kengo Tanabe, Jiro Aoki, Yoshinobu Onuma, Yasutomi Higashikuni, Hirosada Yamamoto, Shuji Ohtsuki, Sen Yachi, Atsuhiko Yagishita, Hiroyoshi Nakajima, Kazuhiro Hara. (2008) Sirolimus-Eluting Stents Suppress Neointimal Formation Irrespective of Metallic Allergy. Circulation Journal 72:6, 893-896
CrossRef814
Hideto Sako, Shin-ichiro Miura, Atsushi Iwata, Hiroaki Nishikawa, Akira Kawamura, Kunihiro Matsuo, Kazuyuki Shirai, Keijiro Saku. (2008) Changes in CCR2 Chemokine Receptor Expression and Plasma MCP-1 Concentration after the Implantation of Bare Metal Stents Versus Sirolimus-eluting Stents in Patients with Stable Angina. Internal Medicine 47:1, 7-13
CrossRef815
A.G. Grant, C.J. White, T.J. Collins, J.S. Jenkins, J.P. Reilly, S.R. Ramee,. (2008) Infrapopliteal drug-eluting stents for chronic limb ischemia. Catheterization and Cardiovascular Interventions 71:1, 108-111
CrossRef816
Paweł Buszman, Stanisław Trznadel, Krzysztof Milewski, Janusz Rzeźniczak, Tadeusz Przewłocki, Maciej Kośmider, Jaroslaw Wójcik, Jacek Janczak, Aleksander Żurakowski, Marek Kondys, Marek Król, Leszek Kinasz, Andrzej Jaklik, Łukasz Rzeszutko, Grzegorz L. Kałuża, Stephan Kiesz, Robert Gil. (2008) Novel paclitaxel-eluting, biodegradable polymer coated stent in the treatment of de novo coronary lesions: A prospective multicenter registry. Catheterization and Cardiovascular Interventions 71:1, 51-57
CrossRef817
Seung-Jung Park, Duk-Woo Park. (2008) Drug-Eluting Stents for Left Main Coronary Artery Stenosis: Case Selection and Technical Issues. The American Heart Hospital Journal 6:1, 21-29
CrossRef818
Sahin Kaplan, Peter Barlis, Sahin Kaplan, Peter Barlis, Abdulkadir Kiris, Konstantinos Dimopoulos, Sukru Celik, Carlo Di Mario. (2008) Immediate procedural and long-term clinical outcomes following drug-eluting stent implantation to ostial saphenous vein graft lesions. Acute Cardiac Care 10:2, 88-92
CrossRef819
Leonardo De Luca, Gennaro Sardella, Giovanni De Persio, Alessandro Petrolini, Francesco Fedele. (2008) Impact of abciximab on coronary restenosis in diabetic patients undergoing elective paclitaxel-eluting stent implantation. A prospective, randomized, placebo-controlled study. Acute Cardiac Care 10:2, 93-99
CrossRef820
R KAWAGUCHI. (2008) Impact of lesion calcification on clinical and angiographic outcome after sirolimus-eluting stent implantation in real-world patients. Cardiovascular Revascularization Medicine 9:1, 2-8
CrossRef821
A MIYAZAWA, J AKO, Y HONGO, S HUR, I TSUJINO, B COURTNEY, A HASSAN, D KANDZARI, Y HONDA, P FITZGERALD. (2008) Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: Intravascular ultrasound results from ENDEAVOR III. American Heart Journal 155:1, 108-113
CrossRef822
Kazumiki Nomoto, Ikuyoshi Watanabe, Tomiya Oba, Ken Nagao, Toshio Kushiro, Atsushi Hirayama. (2008) Safety and Efficacy of Sirolimus-Eluting Stent in Patients With Acute Coronary Syndrome Undergoing Emergency Procedure. Circulation Journal 72:7, 1054-1058
CrossRef823
S VAINA. 2008. Drug-eluting stents. , 83-99.
CrossRef824
Tae Kun Lee, Han Cheol Lee, Ki Won Hwang, Kook Jin Chun, Taek Jong Hong, Yung Woo Shin. (2008) A Case of Late Recurrent Vasospasm After Sirolimus-Eluting Stent Implantation. Korean Circulation Journal 38:3, 174
CrossRef825
Jiro Aoki, Ajay J. Kirtane, George D. Dangas, Alexandra J. Lansky, Andy Morales, Masashi Kimura, Young-Hak Kim, Issam Moussa, Giora Weisz, Edward M. Kreps, Michael Collins, Theresa Frankin-Bond, Gregg W. Stone, Jeffrey W. Moses, Martin B. Leon, Roxana Mehran. (2008) Clinical Outcomes After Heterogeneous Overlap Stenting With Drug-Eluting Stents and Bare-Metal Stents for de Novo Coronary Artery Narrowings. The American Journal of Cardiology 101:1, 58-62
CrossRef826
Masami Nishino, Shiro Hoshida, Hiroyasu Kato, Yasuyuki Egami, Ryu Shutta, Hitoshi Yamaguchi, Kenjiro Tanaka, Jun Tanouchi, Masatsugu Hori, Yoshio Yamada. (2008) Preprocedural Statin Administration can Reduce Thrombotic Reaction After Stent Implantation. Circulation Journal 72:2, 232-237
CrossRef827
Yashiro Makiyama, Ken Toba, Kiminori Kato, Satoru Hirono, Takuya Ozawa, Takashi Saigawa, Shiro Minagawa, Manabu Isoda, Fuyuki Asami, Noboru Ikarashi, Masato Oda, Masato Moriyama, Masutaka Higashimura, Toshiki Kitajima, Keita Otaki, Yoshifusa Aizawa. (2008) Imatinib Mesilate Inhibits Neointimal Hyperplasia via Growth Inhibition of Vascular Smooth Muscle Cells in a Rat Model of Balloon Injury. The Tohoku Journal of Experimental Medicine 215:4, 299-306
CrossRef828
Hyeon Gook Lee, Kook Jin Chun, Kyoung Im Cho, Dong Won Lee, Jun Hyuk Oh, Byung Jae Ahn, Seong Ho Kim, Joon Sang Lee, Moo Young Kim, Woo Hyung Bae, Woo Seog Ko, Joon Hoon Jeong, Tae Ik Kim, Han Cheol Lee, Jun Kim, June Hong Kim, Taek Jong Hong, Yung Woo Shin. (2008) Impact of Drug-Eluting Stents on Clinical Outcomes in Patients With Diffuse Coronary Lesions. Korean Circulation Journal 38:11, 612
CrossRef829
Tina L. Pinto Slottow, Daniel H. Steinberg, Probal Roy, Aamir Javaid, Ashesh N. Buch, Teruo Okabe, Zhenyi Xue, Kimberly Smith, Rebecca Torguson, Augusto D. Pichard, Lowell F. Satler, William O. Suddath, Kenneth M. Kent, Ron Waksman. (2008) Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction. Cardiovascular Revascularization Medicine 9:1, 24-28
CrossRef830
Nobuo Shiode, Kinya Shirota, Kenji Goto, Akinori Sairaku, Shinya Mikami, Yasuko Kato, Kazuyoshi Suenari, Hiroshige Ishi. (2008) Comparison of Long-Term Angiographic Follow-Up After Sirolimus-Eluting Stent and Bare-Metal Stent Implantation. Internal Medicine 47:4, 201-204
CrossRef831
Takenori Okada, Yasuhiko Hayashi, Mamoru Toyofuku, Michinori Imazu, Masaya Otsuka, Tadamichi Sakuma, Hironori Ueda, Hideya Yamamoto, Nobuoki Kohno. (2008) One-Year Clinical Outcomes of Dialysis Patients After Implantation With Sirolimus-Eluting Coronary Stents. Circulation Journal 72:9, 1430-1435
CrossRef832
Jing Lu, Masaru P. Rao, Noel C. MacDonald, Dongwoo Khang, Thomas J. Webster. (2008) Improved endothelial cell adhesion and proliferation on patterned titanium surfaces with rationally designed, micrometer to nanometer features. Acta Biomaterialia 4:1, 192-201
CrossRef833
Ran Kornowski, Stephen Fort, Yaron Almagor, Sigmund Silber, Basil S. Lewis, on behalf of the NIRTOP investigato. (2008) Impact of vessel size, lesion length and diabetes mellitus on angiographic restenosis outcomes: Insights from the NIRTOP study. Acute Cardiac Care 10:2, 104-110
CrossRef834
AZFAR G. ZAMAN, JAGATH HERATH. 2008. Percutaneous coronary intervention in saphenous vein graft disease. , 309-318.
CrossRef835
Sang Rok Lee, Myung Ho Jeong, Young Keun Ahn, Shung Chull Chae, Seung Ho Hur, Young Jo Kim, In Whan Seong, Jei Keon Chae, Taek Jong Hong, Jae Young Rhew, Myeong Chan Cho, Jang Ho Bae, Seung Woon Rha, Chong Jin Kim, Yang Soo Jang, Seung Jung Park, Korea Acute Myocardial Infarction R. (2008) Clinical Safety of Drug-Eluting Stents in the Korea Acute Myocardial Infarction Registry. Circulation Journal 72:3, 392-398
CrossRef836
Shiro Tomari, Masaru Sawazaki, Koji Yamana, Wataru Katou, Yuichi Ueda. (2008) A Case of Coronary Artery Spasm in the Perioperative Period of Off-Pump Coronary Artery Bypass Grafting after Drug-Eluting Stent Implantation. Japanese Journal of Cardiovascular Surgery 37:6, 372-376
CrossRef837
Kyoung-Woo Seo, Seung-Jea Tahk, So-Yeon Choi, Myeong-Ho Yoon, Byoung-Joo Choi, Hong-Seok Lim, Joon-Han Shin, Gyo-Seung Hwang, Soo-Jin Kang, Jin-Woo Kim, Nam-Kyu Lim, Myoung-Hee Lee. (2008) A Case of Huge Coronary Aneurysm After Implantation of a Sirolimus-Eluting Stent. Korean Circulation Journal 38:4, 230
CrossRef838
Satoshi Okayama, Shiro Uemura, Taku Nishida, Yoshinobu Morikawa, Kenji Onoue, Yasuhiro Takemoto, Tsunenari Soeda, Satoshi Somekawa, Ken-ichi Ishigami, Yukiji Takeda, Manabu Horii, Hiroyuki Kawata, Minoru Takaoka, Tamio Nakajima, Yoshihiko Saito. (2008) Progression of Non-Culprit Coronary Artery Atherosclerosis After Acute Myocardial Infarction in Comparison with Stable Angina Pectoris. Journal of Atherosclerosis and Thrombosis 15:5, 228-234
CrossRef839
Bruce R. Thomadsen, Jeffrey F. Williamson, Mark J. Rivard, Ali S. Meigooni. (2008) Anniversary Paper: Past and current issues, and trends in brachytherapy physics. Medical Physics 35:10, 4708
CrossRef840
Dong Il Shin, Ki-Bae Seung, Pum Joon Kim, Kiyuk Chang, Jae Kee Choi, Doo Soo Jeon, Mi-Jeong Kim, Man Young Lee, Wook Sung Chung. (2008) Long-Term Coronary Endothelial Function After Zotarolimus-Eluting Stent Implantation. International Heart Journal 49:6, 639-652
CrossRef841
Masao Yamasaki, Junya Ako, Yasuhiro Honda, Ali Hassan, Bon Koo, Alexandre Abizaid, Peter Fitzgerald, Robert Whitbourn. (2008) Novel guidewire-based stent delivery system. Catheterization and Cardiovascular Interventions
CrossRef842
P SORAJJA. 2008. Percutaneous coronary intervention in small vessels. , 297-308.
CrossRef843
W KANG, K OH, S HAN, T AHN, W CHUNG, M SHIN, K KOH, I CHOI, E SHIN. (2007) Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: Comparison with same drug-eluting overlapping stents. International Journal of Cardiology 123:1, 12-17
CrossRef844
Young Joon Hong, Myung Ho Jeong, Sun Ho Hwang, Nam Sik Yun, Sang Yup Lim, Sang Rok Lee, Seo Na Hong, Kye Hun Kim, Hyung Wook Park, Ju Han Kim, Weon Kim, Young Keun Ahn, Jeong Gwan Cho, Jong Chun Park, Jung Chaee Kang. (2007) Impact of postprocedure minimum stent area on long-term results following abciximab-coated stent implantation: An intravascular ultrasound analysis. International Journal of Cardiology 123:1, 23-28
CrossRef845
C STEFANADIS, K TOUTOUZAS, E STEFANADI, A LAZARIS, E PATSOURIS, N KIPSHIDZE. (2007) Inhibition of plaque neovascularization and intimal hyperplasia by specific targeting vascular endothelial growth factor with bevacizumab-eluting stent: An experimental study. Atherosclerosis 195:2, 269-276
CrossRef846
Peter Braun, . (2007) Prospective randomized study of the restenotic process in small coronary arteries using a Carbofilm™ coated stent in comparison with plain old balloon angioplasty:. Catheterization and Cardiovascular Interventions 70:7, 920-927
CrossRef847
JEFFREY J. POPMA, BONNIE WEINER, MICHAEL J. COWLEY, CHARLES SIMONTON, DAN McCORMICK, TED FELDMAN. (2007) FDA Advisory Panel on the Safety and Efficacy of Drug-Eluting Stents: Summary of Findings and Recommendations. Journal of Interventional Cardiology 20:6, 425-446
CrossRef848
Luigi Campolo, Paolo Pantaleo, Maria Cristina Barattoni, Arianna Berardo, Luca Ghetti, Danilo Fusco, Alberto Cremonesi, Chiara Grattoni, Alfredo Marchese, Vincenzo Pernice, Alessandro Alberti, Enri Gliozheni, Carlo Perucci. (2007) RESTEM: a percutaneous coronary intervention ‘real world’ registry in the drug-eluting stent era. Coronary Artery Disease 18:8, 653-662
CrossRef849
Soon Jun Hong, Wan Joo Shim, Jong Il Choi, Hyung Joon Joo, Seung Yong Shin, Seong Mi Park, Sang Yup Lim, Do-Sun Lim. (2007) Comparison of Effects of Telmisartan and Valsartan on Late Lumen Loss and Inflammatory Markers After Sirolimus-Eluting Stent Implantation in Hypertensive Patients. The American Journal of Cardiology 100:11, 1625-1629
CrossRef850
Ajay J. Kirtane, Martin B. Leon. (2007) Clinical Use of Sirolimus-Eluting Stents. Cardiovascular Drug Reviews 25:4, 316-332
CrossRef851
Alexandre Abizaid, Jeffrey J. Popma, Luis F. Tanajura, Kyoko Hattori, Brad Solberg, Cristina Larracas, Fausto Feres, José de Ribamar Costa, Lewis B. Schwartz. (2007) Clinical and angiographic results of percutaneous coronary revascularization using a trilayer stainless steel-tantalum-stainless steel phosphorylcholine-coated stent: The TriMaxx trial. Catheterization and Cardiovascular Interventions 70:7, 914-919
CrossRef852
Lawrence J. Dacey, Donald S. Likosky, Thomas J. Ryan, John F. Robb, Reed D. Quinn, James T. DeVries, Michael J. Hearne, Bruce J. Leavitt, Robert F. Dunton, Robert A. Clough, Donato Sisto, Cathy S. Ross, Elaine M. Olmstead, Gerald T. O’Connor, David J. Malenka. (2007) Long-Term Survival After Surgery Versus Percutaneous Intervention in Octogenarians With Multivessel Coronary Disease. The Annals of Thoracic Surgery 84:6, 1904-1911
CrossRef853
ROBERT M. MINUTELLO, SHERRITA BHAGAN, ATUL SHARMA, ALEXANDER J. SLOTWINER, DMITRIY N. FELDMAN, LINDA J. CUOMO, S. CHIU WONG. (2007) Long-Term Clinical Benefit of Sirolimus-Eluting Stents Compared to Bare Metal Stents in the Treatment of Saphenous Vein Graft Disease. Journal of Interventional Cardiology 20:6, 458-465
CrossRef854
Mamoo Nakamura, Alexandre Abizaid, Atsushi Hirohata, Yasuhiro Honda, J. Edward Sousa, Peter J. Fitzgerald. (2007) Efficacy of reduced-dose sirolimus-eluting stents in the human coronary artery: Serial IVUS analysis of neointimal hyperplasia and luminal dimension. Catheterization and Cardiovascular Interventions 70:7, 946-951
CrossRef855
C. J. Pan, J. J. Tang, Y. J. Weng, J. Wang, N. Huang. (2007) Preparation and characterization of rapamycin-loaded PLGA coating stent. Journal of Materials Science: Materials in Medicine 18:11, 2193-2198
CrossRef856
Ryan Berg, Joseph Aragon, Vladimir Royter, John F. Shanley, Greg Cogert, Renu Vermani, Saibal Kar, Neal Eigler, Frank Litvack. (2007) Pimecrolimus and dual pimecrolimus-paclitaxel eluting stents decrease neointimal proliferation in a porcine model. Catheterization and Cardiovascular Interventions 70:6, 871-879
CrossRef857
Rainer Hoffmann, Christian Hamm, Christoph A. Nienaber, Benny Levenson, Tassilo Bonzel, Georg Sabin, Jochen Senges, Ralf Zahn, Ulrich Tebbe, Thomas Pfannebecker, Hans Gert Richardt, Steffen Schneider, Malte Kelm. (2007) Implantation of sirolimus-eluting stents in saphenous vein grafts is associated with high clinical follow-up event rates compared with treatment of native vessels. Coronary Artery Disease 18:7, 559-564
CrossRef858
Emilia Solinas, Eugenia Nikolsky, Alexandra J. Lansky, Ajay J. Kirtane, Marie-Claude Morice, Jeffrey J. Popma, Joachim Schofer, Erick Schampaert, Tereza Pucelikova, Jiro Aoki, Martin Fahy, George D. Dangas, Jeffrey W. Moses, Donald E. Cutlip, Martin B. Leon, Roxana Mehran. (2007) Gender-Specific Outcomes After Sirolimus-Eluting Stent Implantation. Journal of the American College of Cardiology 50:22, 2111-2116
CrossRef859
Karl F. von Tiehl, Matthew J. Price, Rafael Valencia, Katherine J. Ludington, Paul S. Teirstein, Ronald A. Simon. (2007) Clopidogrel Desensitization After Drug-Eluting Stent Placement. Journal of the American College of Cardiology 50:21, 2039-2043
CrossRef860
Steffen Helqvist, Henning Kelbæk, Leif Thuesen, Lene Kløvgaard, Lars Krusell, Erik Jørgensen, Hans Bøtker, Gunnar Jensen, Jens Lassen, Per Thayssen, Anders Galløe, Kari Saunamäki. (2007) Efficiency and safety of the sirolimus eluting stent in complex coronary artery lesions after cessation of dual antiplatelet therapy: fifteen months clinical outcome of the randomised Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial. EuroIntervention 3:3, 309-314
CrossRef861
Pavel Červinka, Jozef Jakabčin, Jiři Jäger, Josef Veselka, Petr Kala, Jaroslav Maly. (2007) Long-term health outcome and mortality evaluation after invasive coronary treatment using drug-eluting stents: HOME DES registry. Coronary Artery Disease 18:7, 577-581
CrossRef862
Takayuki Ohno, Shinichi Takamoto, Noboru Motomura, Minoru Ono, Jiro Ando, Toshihiro Morita, Hideo Fujita, Yasunobu Hirata, Ryozo Nagai, Takashi Shigeeda, Akira Hirose. (2007) Coronary Artery Bypass Grafting Versus Coronary Implantation of Sirolimus-Eluting Stents in Patients with Diabetic Retinopathy. The Annals of Thoracic Surgery 84:5, 1474-1478
CrossRef863
Joost Daemen, Christian Spaulding, Sophie Jacob, Eric Boersma, Olivier Varenne, Patrick Serruys. (2007) A pooled safety analysis of data comparing paclitaxel-eluting stents with bare-metal stents. EuroIntervention 3:3, 392-399
CrossRef864
Pallav Garg, Laura Mauri. (2007) The conundrum of late and very late stent thrombosis following drug-eluting stent implantation. Current Opinion in Cardiology 22:6, 565-571
CrossRef865
Héctor M. García-García, Joost Daemen, Neville Kukreja, Shuzou Tanimoto, Carlos A.G. van Mieghem, Martin van der Ent, Ron T. van Domburg, Patrick W. Serruys. (2007) Three-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: Insights from the rapamycin-eluting stent evaluated at rotterdam cardiology hospital—(RESEARCH) registry. Catheterization and Cardiovascular Interventions 70:5, 635-639
CrossRef866
Steven E. Nissen. (2007) Late thrombosis with drug-eluting stents: Anatomy of a controversy and lessons learned. Current Cardiology Reports 9:6, 429-431
CrossRef867
Martin Unverdorben, Ralf Degenhardt, Marcus Wiemer, Dieter Horstkotte, Henrik Schneider, Christoph Nienaber, Wolfgang Bocksch, Michael Gross, Michael Boxberger, Christian Vallbracht, . (2007) The Paclitaxel-Eluting Coroflex™ Please Stent Pilot Study (PECOPS I). Clinical Research in Cardiology 96:11, 803-811
CrossRef868
Raúl Moreno, Christian Spaulding, Gert Jan Laarman, Ilkka Tierala, Christoph Kaiser, Jose-Luis Lopez-Sendon. (2007) Effectiveness and safety of paclitaxel-eluting stents in patients with ST-segment elevation acute myocardial infarction. EuroIntervention 3:3, 386-391
CrossRef869
J. Dawn Abbott, Matthew R. Voss, Mamoo Nakamura, Howard A. Cohen, Faith Selzer, Kevin E. Kip, Helen A. Vlachos, Robert L. Wilensky, David O. Williams. (2007) Unrestricted Use of Drug-Eluting Stents Compared With Bare-Metal Stents in Routine Clinical Practice. Journal of the American College of Cardiology 50:21, 2029-2036
CrossRef870
Jason Ryan, Donald E. Cutlip, David J. Cohen, Duane S. Pinto. (2007) Drug eluting stents for ST-elevation myocardial infarction: risk and benefit. Journal of Thrombosis and Thrombolysis 24:3, 293-299
CrossRef871
Shuzou Tanimoto, Patrick W. Serruys, Leif Thuesen, Dariusz Dudek, Bernard de Bruyne, Bernard Chevalier, John A. Ormiston. (2007) Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: Insights from the ABSORB and SPIRIT trials. Catheterization and Cardiovascular Interventions 70:4, 515-523
CrossRef872
Jeffrey W. Moses, Giora Weisz, Gregory Mishkel, Ronald Caputo, Charles O'Shaughnessey, S. Chiu Wong, Tim A. Fischell, Michael Mooney, David O. Williams, Jeffrey J. Popma, Peter Fitzgerald, Sidney Smith, Richard E. Kuntz, Michael Collins, Sidney A. Cohen, Martin B. Leon. (2007) The SIRIUS-DIRECT trial: A multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions. Catheterization and Cardiovascular Interventions 70:4, 505-512
CrossRef873
D STEINBERG, T PINTOSLOTTOW, A BUCH, A JAVAID, P ROY, S GARG, T OKABE, R TORGUSON, K SMITH, Z XUE. (2007) Impact of In-Stent Restenosis on Death and Myocardial Infarction. The American Journal of Cardiology 100:7, 1109-1113
CrossRef874
Jyun-ei Obata, Yoshinobu Kitta, Hajime Takano, Yasushi Kodama, Takamitsu Nakamura, Akira Mende, Ken-ichi Kawabata, Yukio Saitoh, Daisuke Fujioka, Tsuyoshi Kobayashi, Toshiaki Yano, Kiyotaka Kugiyama. (2007) Sirolimus-Eluting Stent Implantation Aggravates Endothelial Vasomotor Dysfunction in the Infarct-Related Coronary Artery in Patients With Acute Myocardial Infarction. Journal of the American College of Cardiology 50:14, 1305-1309
CrossRef875
H VAKNINASSA, A ASSALI, S UKABI, E LEV, R KORNOWSKI. (2007) Stent thrombosis following drug-eluting stent implantation. A single-center experience. Cardiovascular Revascularization Medicine 8:4, 243-247
CrossRef876
C M Hartford, M J Ratain. (2007) Rapamycin: Something Old, Something New, Sometimes Borrowed and Now Renewed. Clinical Pharmacology & Therapeutics 82:4, 381-388
CrossRef877
Mitsutoshi Oguri, Kimihiko Kato, Takeshi Hibino, Kiyoshi Yokoi, Tomonori Segawa, Hitoshi Matsuo, Sachiro Watanabe, Yoshinori Nozawa, Toyoaki Murohara, Yoshiji Yamada. (2007) Genetic risk for restenosis after coronary stenting. Atherosclerosis 194:2, e172-e178
CrossRef878
Dean J. Kereiakes, Paul S. Teirstein, Ian J. Sarembock, David R. Holmes, Mitchell W. Krucoff, William W. O’Neill, Ron Waksman, David O. Williams, Jeffrey J. Popma, Maurice Buchbinder, Roxana Mehran, Ian T. Meredith, Jeffrey W. Moses, Gregg W. Stone. (2007) The Truth and Consequences of the COURAGE Trial. Journal of the American College of Cardiology 50:16, 1598-1603
CrossRef879
Santiago Jimenez-Valero, Belen Santos, Fernando Pajin, Tomas Canton, Esther Lazaro, Jose Moreu, Gonzalo Hernandez, Luis Rodriguez Padial. (2007) Clinical outcomes of dexamethasone-eluting stent implantation in ST-elevation acute myocardial infarction. Catheterization and Cardiovascular Interventions 70:4, 492-497
CrossRef880
Dietrich Baumgart, Volker Klauss, Frank Baer, Franz Hartmann, Helmut Drexler, Wolfgang Motz, Heinrich Klues, Stefan Hofmann, Wolfgang Völker, Thomas Pfannebecker, Hans-Peter Stoll, Georg Nickenig. (2007) One-Year Results of the SCORPIUS Study. Journal of the American College of Cardiology 50:17, 1627-1634
CrossRef881
Edward L. Hannan, Michael Racz, Gary Walford, Luther T. Clark, David R. Holmes, Spencer B. King, Samin Sharma. (2007) Differences in Utilization of Drug-Eluting Stents by Race and Payer. The American Journal of Cardiology 100:8, 1192-1198
CrossRef882
Antonio Manari, Elena Costa, Alessandro Scivales, Patrizia Ponzi, Francesca Di Stasi, Vincenzo Guiducci, Gianluca Pignatelli, Paola Giacometti. (2007) Economic appraisal of the angioplasty procedures performed in 2004 in a high-volume diagnostic and interventional cardiology unit. Journal of Cardiovascular Medicine 8:10, 792-798
CrossRef883
VANKEEPURAM S. SRINIVAS, FAITH SELZER, ROBERT L. WILENSKY, DAVID R. HOLMES, HOWARD A. COHEN, E. SCOTT MONRAD, ALICE K. JACOBS, SHERYL F. KELSEY, DAVID O. WILLIAMS, KEVIN E. KIP. (2007) Completeness of Revascularization for Multivessel Coronary Artery Disease and Its Effect on One-Year Outcome: A Report from the NHLBI Dynamic Registry. Journal of Interventional Cardiology 20:5, 373-380
CrossRef884
Marie-Claude Morice, Patrick W. Serruys, Paul Barragan, Christoph Bode, Gerrit-Anne Van Es, Hans-Peter Stoll, David Snead, Laura Mauri, Donald E. Cutlip, Eduardo Sousa. (2007) Long-Term Clinical Outcomes With Sirolimus-Eluting Coronary Stents. Journal of the American College of Cardiology 50:14, 1299-1304
CrossRef885
N KIPSHIDZE, P IVERSEN, P OVERLIE, T DUNLAP, B TITUS, D LEE, J MOSES, P OHANLEY, M LAUER, M LEON. (2007) First human experience with local delivery of novel antisense AVI-4126 with Infiltrator catheter in de novo native and restenotic coronary arteries: 6-month clinical and angiographic follow-up from AVAIL study. Cardiovascular Revascularization Medicine 8:4, 230-235
CrossRef886
Dean J. Kereiakes. (2007) The Emperor’s New Clothes. Journal of the American College of Cardiology 50:14, 1381-1385
CrossRef887
RON WAKSMAN, RAJBABU PAKALA, TERUO OKABE, DAVID HELLINGA, ROSANNA CHAN, MIN O. TIO, ERIC WITTCHOW, SONJA HARTWIG, KARL-HEINZ WALDMANN, CLAUS HARDER. (2007) Efficacy and Safety of Absorbable Metallic Stents with Adjunct Intracoronary Beta Radiation in Porcine Coronary Arteries. Journal of Interventional Cardiology 20:5, 367-372
CrossRef888
Yasuhide Nakayama, Yue-Min Zhou, Hatsue Ishibashi-Ueda. (2007) Development of in vivo tissue-engineered autologous tissue-covered stents (biocovered stents). Journal of Artificial Organs 10:3, 171-176
CrossRef889
Elad I. Levy, Aquilla S. Turk, Felipe C. Albuquerque, David B. Niemann, Beverly Aagaard-Kienitz, Lee Pride, Phil Purdy, Babu Welch, Henry Woo, Peter A. Rasmussen, L. Nelson Hopkins, Thomas J. Masaryk, Cameron G. McDougall, David J. Fiorella. (2007) WINGSPAN IN-STENT RESTENOSIS AND THROMBOSIS. Neurosurgery 61:3, 644-651
CrossRef890
Mario Togni, Stéphanie Eber, Jeannette Widmer, Michael Billinger, Peter Wenaweser, Stéphane Cook, Rolf Vogel, Christian Seiler, Franz R. Eberli, Willibald Maier, Roberto Corti, Marco Roffi, Thomas F. Lüscher, Ali Garachemani, Otto M. Hess, Simon Wandel, Bernhard Meier, Peter Jüni, Stephan Windecker. (2007) Impact of Vessel Size on Outcome After Implantation of Sirolimus-Eluting and Paclitaxel-Eluting Stents. Journal of the American College of Cardiology 50:12, 1123-1131
CrossRef891
Chang-Bum Park, Myeong-ki Hong, Young-Hak Kim, Duk-Woo Park, Ki-Hoon Han, Cheol Whan Lee, Duck-Hyun Kang, Jae-Kwan Song, Jae-Joong Kim, Seong-Wook Park, Seung-Jung Park. (2007) Comparison of angiographic patterns of in-stent restenosis between sirolimus- and paclitaxel-eluting stent. International Journal of Cardiology 120:3, 387-390
CrossRef892
S MANZOSILBERMAN, O VARENNE, C SPAULDING. (2007) Limites des stents actifs. Annales de Cardiologie et d'Angéiologie 56, S48-S52
CrossRef893
Daniela Trabattoni, Franco Fabbiocchi, Piero Montorsi, Paolo Ravagnani, Stefano Galli, Giovanni Teruzzi, Giuseppe Calligaris, Stefano De Martini, Antonio L. Bartorelli. (2007) Stent thrombosis after sirolimus- and paclitaxel-eluting stent implantation in daily clinical practice: Analysis of a single center registry. Catheterization and Cardiovascular Interventions 70:3, 415-421
CrossRef894
Rishi Sukhija, Wilbert S. Aronow, Ravi Sureddi, Sumith Aleti, Behzad Molavi, Rajesh Sachdeva, Jawahar L. Mehta. (2007) Predictors of In-stent Restenosis and Patient Outcome After Percutaneous Coronary Intervention in Patients With Diabetes Mellitus. The American Journal of Cardiology 100:5, 777-780
CrossRef895
Cheol Whan Lee, Chong-Hiok Tan, Jon Suh, Se-Whan Lee, Duk-Woo Park, Seung-Whan Lee, Young-Hak Kim, Myeong-Ki Hong, Jae-Joong Kim, Seong-Wook Park, Seung-Jung Park. (2007) Sirolimus-eluting stent implantation for treatment of proximal left anterior descending coronary artery lesions: Long-term outcome and predictors of adverse cardiac events. Catheterization and Cardiovascular Interventions 70:3, 368-373
CrossRef896
Alaide Chieffo, Azeem Latib, Antonio Colombo. (2007) Drug-eluting stents: What is the balance of risks and benefits?. Current Cardiovascular Risk Reports 1:4, 279-283
CrossRef897
Ryota Sakurai, Yoichiro Hongo, Masao Yamasaki, Yasuhiro Honda, Heidi N. Bonneau, Paul G. Yock, Donald Cutlip, Jeffrey J. Popma, Peter Zimetbaum, Jean Fajadet, Richard E. Kuntz, William Wijns, Peter J. Fitzgerald. (2007) Detailed Intravascular Ultrasound Analysis of Zotarolimus-Eluting Phosphorylcholine-Coated Cobalt-Chromium Alloy Stent in de Novo Coronary Lesions (Results from the ENDEAVOR II Trial)††Conflicts of interest: Dr. Fitzgerald has worked as a consultant for Medtronic Vascular. Dr. Kuntz is currently an employee of Medtronic Vascular.. The American Journal of Cardiology 100:5, 818-823
CrossRef898
E.-K. Choi, B.-K. Koo, H.-S. Kim, Y.-M. Cho, H.-J. Kang, Y.-S. Cho, W.-Y. Chung, I.-H. Chae, D.-J. Choi, B.-H. Oh, Y.-B. Park, Y.-S. Choi. (2007) Prognostic significance of asymptomatic coronary artery disease in patients with diabetes and need for early revascularization therapy. Diabetic Medicine 24:9, 1003-1011
CrossRef899
Christoph Stettler, Simon Wandel, Sabin Allemann, Adnan Kastrati, Marie Claude Morice, Albert Schömig, Matthias E Pfisterer, Gregg W Stone, Martin B Leon, José Suarez de Lezo, Jean-Jacques Goy, Seung-Jung Park, Manel Sabaté, Maarten J Suttorp, Henning Kelbaek, Christian Spaulding, Maurizio Menichelli, Paul Vermeersch, Maurits T Dirksen, Pavel Cervinka, Anna Sonia Petronio, Alain J Nordmann, Peter Diem, Bernhard Meier, Marcel Zwahlen, Stephan Reichenbach, Sven Trelle, Stephan Windecker, Peter Jüni. (2007) Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. The Lancet 370:9591, 937-948
CrossRef900
Nedy Brambilla, Maurizio Ferrario, Alessandra Repetto, Ezio Bramucci, Luigi Angoli, Umberto Canosi, Roberta Rosso, Marco Ferlini, Catherine Klersy, Luigi Tavazzi. (2007) Use of sirolimus-eluting stents for treatment of in-stent restenosis: long-term follow-up. Journal of Cardiovascular Medicine 8:9, 699-705
CrossRef901
Michael B. Pliam, Alex Zapolanski, Peter Anastassiou, Colman J. Ryan, Louis L. Manila, Richard E. Shaw, Bob-Kenneth Pira. (2007) Influence of Prior Coronary Stenting on the Immediate and Mid-term Outcome of Isolated Coronary Artery Bypass Surgery. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery 2:5, 217-225
CrossRef902
Charles A. Simonton, Bruce Brodie, Barrett Cheek, Fred Krainin, Chris Metzger, James Hermiller, Stanley Juk, Peter Duffy, Angela Humphrey, Marcy Nussbaum, Sherry Laurent. (2007) Comparative Clinical Outcomes of Paclitaxel- and Sirolimus-Eluting Stents. Journal of the American College of Cardiology 50:13, 1214-1222
CrossRef903
Gregory Ducrocq, Victor Serebruany, Jean-Francois Tanguay. (2007) Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives. Expert Review of Cardiovascular Therapy 5:5, 939-953
CrossRef904
Rahul Bose, Gaurav Gupta, Paul A. Grayburn, Emily A. Laible, Mi Jung Kang, James W. Choi. (2007) Safety of Drug-Eluting Stents in the Coronary Artery in ST-Elevation Myocardial Infarction at a Single High-Volume Medical Center. The American Journal of Cardiology 100:6, 949-952
CrossRef905
Probal Roy, Teruo Okabe, Tina L. Pinto Slottow, Daniel H. Steinberg, Kimberly Smith, Rebecca Torguson, Zhenyi Xue, Natalie Gevorkian, Lowell F. Satler, Kenneth M. Kent, William O. Suddath, Augusto D. Pichard, Ron Waksman. (2007) Correlates of Clinical Restenosis Following Intracoronary Implantation of Drug-Eluting Stents. The American Journal of Cardiology 100:6, 965-969
CrossRef906
Marcel Beijk, Franz-Josef Neumann, Marcus Wiemer, Eberhard Grube, Jürgen Haase, Leif Thuesen, Christian Hamm, Susan Veldhof, Cecile Dorange, Patrick Serruys, Jan Piek. (2007) Two-year results of a durable polymer everolimus-eluting stent in de novo coronary artery stenosis (The SPIRIT FIRST Trial). EuroIntervention 3:2, 206-212
CrossRef907
Ricardo Seabra-Gomes, José Sousa, Amanda Sousa, Rui Teles, Helder Pereira, Pedro Farto Abreu, Ricardo Santos, Manuela Adão, António Leitão Marques, Vasco Gama Ribeiro, Luís Mourão, Henrique Cyrne Carvalho. (2007) Small coronary arteries treated with sirolimus-eluting stents: one-year results of the PORTO multicentre registry. EuroIntervention 3:2, 197-205
CrossRef908
S LEE, S PARK, D PARK, S LEE, S KIM, J JANG, Y JEONG, Y KIM, C LEE, M HONG. (2007) Comparison of Six-Month Angiographic and Three-Year Outcomes After Sirolimus-Eluting Stent Implantation Versus Brachytherapy for Bare Metal In-Stent Restenosis. The American Journal of Cardiology 100:3, 425-430
CrossRef909
Qian Yang, Kun-Liang Guan. (2007) Expanding mTOR signaling. Cell Research 17:8, 666-681
CrossRef910
Teruo Okabe, Gary S. Mintz, Ashesh N. Buch, Probal Roy, Young Joon Hong, Kimberly A. Smith, Rebecca Torguson, Natalie Gevorkian, Zhenyi Xue, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Neil J. Weissman, Ron Waksman. (2007) Intravascular Ultrasound Parameters Associated With Stent Thrombosis After Drug-Eluting Stent Deployment. The American Journal of Cardiology 100:4, 615-620
CrossRef911
Diane E. Head, Joshua J. Sebranek, Cameron Zahed, Douglas B. Coursin, Richard C. Prielipp. (2007) A tale of two stents: perioperative management of patients with drug-eluting coronary stents. Journal of Clinical Anesthesia 19:5, 386-396
CrossRef912
Patrice Guérin, Yann Gouëffic, Marie-Françoise Heymann, Paul Pillet, Oussama Al Habash, Dominique Crochet, Pierre Pacaud, Gervaise Loirand. (2007) Direct stenting limits sirolimus-eluting stent edge neointimal thickening. Journal of Vascular Surgery 46:2, 354-359
CrossRef913
Elisabetta Varani, Marco Balducelli, Giuseppe Vecchi, Matteo Aquilina, Aleardo Maresta. (2007) One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease. Journal of Cardiovascular Medicine 8:8, 596-601
CrossRef914
TANIA CHECHI, GUIDO VITTORI, GIUSEPPE G.L. BIONDI ZOCCAI, SABINE VECCHIO, ELENA FALCHETTI, GAIA SPAZIANI, GIORGIO BALDERESCHI, CRISTINA GIGLIOLI, SERAFINA VALENTE, MASSIMO MARGHERI. (2007) Single-Center Randomized Evaluation of Paclitaxel-Eluting Versus Conventional Stent in Acute Myocardial Infarction (SELECTION). Journal of Interventional Cardiology 20:4, 282-291
CrossRef915
Imad Sheiban, Gian Paolo Ballari, Claudio Moretti, Walter Grosso Marra, Emanuele Meliga, Pierluigi Omedè, Filippo Sciuto, Gian Paolo Trevi. (2007) Paclitaxel-eluting stents for the treatment of complex coronary lesions: immediate and 12-month results. Journal of Cardiovascular Medicine 8:8, 582-588
CrossRef916
Michael Jonas, Frederic S. Resnic, Andrew D. Levin, Nipun Arora, Campbell David Rogers. (2007) Transition from bare metal to drug eluting stenting in contemporary US practice: Effect on incidence and predictors of clinically driven target lesion revascularization. Catheterization and Cardiovascular Interventions 70:2, 175-183
CrossRef917
Alexandre Berger, Jean-Christophe Stauffer, Charles Seydoux, Manon Siegenthaler, Alain Benoît, Jean-Jacques Goy. (2007) Three-year follow-up of the first prospective randomized comparison between paclitaxel and sirolimus stents: The TAXi-LATE trial. Catheterization and Cardiovascular Interventions 70:2, 163-166
CrossRef918
Probal Roy, Rebecca Torguson, Teruo Okabe, Tina L. Pinto Slottow, Daniel H. Steinberg, Kimberly Smith, Zhenyi Xue, Natalie Gevorkian, Lowell L. Satler, Kenneth M. Kent, William O. Suddath, Augusto D. Pichard, Ron Waksman. (2007) Comparison between sirolimus- and paclitaxel-eluting stents in complex patient and lesions subsets. Catheterization and Cardiovascular Interventions 70:2, 167-172
CrossRef919
Thomas Albrecht, Ulrich Speck, Claudia Baier, Karl-J??rgen Wolf, Michael B??hm, Bruno Scheller. (2007) Reduction of Stenosis Due to Intimal Hyperplasia After Stent Supported Angioplasty of Peripheral Arteries by Local Administration of Paclitaxel in Swine. Investigative Radiology 42:8, 579-585
CrossRef920
Seung-Jung Park. (2007) Incidence and predictors of clinically driven target lesion revascularization from bare-metal stents to drug-eluting stents. Catheterization and Cardiovascular Interventions 70:2, 184-184
CrossRef921
Didier Blanchard, Gian Danzi, Philip Urban, Morris Moseri, Craig Juergens, Philip Guyon, Bernd Nowak, Damras Tresucosol, Maarten Suttorp, Ahmad Farshid, Ran Kornowski, Eulogio Garcia, Richard Yeend, Hirofumi Nagai, Dragica Paunovic. (2007) A novel ultra-thin bare metal stent (BMS): results from a worldwide registry. EuroIntervention 3:2, 249-255
CrossRef922
Gregg W. Stone, Jeffrey W. Moses, Martin B. Leon. (2007) Left Main Drug-Eluting Stents. Journal of the American College of Cardiology 50:6, 498-500
CrossRef923
Stephen Fort, Ran Kornowski, Sigmund Silber, Basil Lewis, Luc Bilodeau, Yaron Almagor, Eric van Remortel, Marie-Claude Morice, Antonio Colombo. (2007) ‘Fused-Gold’ vs. ‘Bare’ stainless steel NIRflex stents of the same geometric design in diseased native coronary arteries. Long-term results from the NIR TOP Study. EuroIntervention 3:2, 256-261
CrossRef924
Esteban Escolar, Gary S. Mintz, Jeffrey Popma, Aleksandra Michalek, Sang Wook Kim, Lazar Mandinov, Joerg Koglin, Gregg Stone, Stephen G. Ellis, Eberhard Grube, Keith D. Dawkins, Neil J. Weissman. (2007) Meta-Analysis of Angiographic Versus Intravascular Ultrasound Parameters of Drug-Eluting Stent Efficacy (from TAXUS IV, V, and VI). The American Journal of Cardiology 100:4, 621-626
CrossRef925
S. Silber, M. Borggrefe, M. Böhm, H.M. Hoffmeister, R. Dietz, G. Ertl, G. Heusch. (2007) Positionspapier der DGK zur Wirksamkeit und Sicherheit von Medikamente freisetzenden Koronarstents (DES). Der Kardiologe 1:2, 84-111
CrossRef926
Ralf Zahn, C. W. Hamm, S. Schneider, U. Zeymer, G. Richardt, M. Kelm, B. Levenson, T. Bonzel, U. Tebbe, G. Sabin, C. A. Nienaber, Thomas Pfannebecker, J. Senges, . (2007) The Sirolimus-eluting coronary stent in daily routine practice in Germany:. Clinical Research in Cardiology 96:8, 548-556
CrossRef927
Ryota Sakurai, Junya Ako, Ali H.M. Hassan, Heidi N. Bonneau, Franz-Josef Neumann, Walter Desmet, David R. Holmes, Paul G. Yock, Peter J. Fitzgerald, Yasuhiro Honda. (2007) Neointimal progression and luminal narrowing in sirolimus-eluting stent treatment for bare metal in-stent restenosis: A quantitative intravascular ultrasound analysis. American Heart Journal 154:2, 361-365
CrossRef928
Andrew E. Ajani, Bryan P. Yan, David J. Clark, David Eccleston, Anthony Walton, Robert Lew, Adam Meehan, Angela Brennan, Chris Reid, Stephen J. Duffy. (2007) Contemporary Treatment of In-Stent Restenosis and the Incidence of Recurrent In-Stent Restenosis in the Era of Drug-Eluting Stents. Heart, Lung and Circulation 16:4, 269-273
CrossRef929
Douglas C Shook, Wendy Gross. (2007) Offsite anesthesiology in the cardiac catheterization lab. Current Opinion in Anaesthesiology 20:4, 352-358
CrossRef930
Gennaro Sardella, Chiara Bucciarelli-Ducci, Massimo Mancone, Riccardo Colantonio, Giuseppe Massimo Sangiorgi, Francesco Fedele. (2007) Very late paclitaxel-eluting stent thrombosis despite 21 months of clopidogrel treatment after percutaneous coronary intervention. Journal of Cardiovascular Medicine 8:8, 625-628
CrossRef931
Lisette Okkels Jensen, Michael Maeng, Anne Kaltoft, Per Thayssen, Hans Henrik Tilsted Hansen, Morten Bottcher, Jens Flensted Lassen, Lars Romer Krussel, Klaus Rasmussen, Knud Noerregaard Hansen. (2007) Stent Thrombosis, Myocardial Infarction, and Death After Drug-Eluting and Bare-Metal Stent Coronary Interventions. Journal of the American College of Cardiology 50:5, 463-470
CrossRef932
Avi Domb, Ben Corn, Rajendra Pawar, Neeraj Kumar, Deepak Chitkara, Anupama Mittal. 2007. Polymeric Carriers for Regional Drug Therapy. , 359-400.
CrossRef933
Letícia Weiss Ribeiro, Jorge P. Ribeiro, Ricardo Stein, Cristiane Leitão, Carísi Anne Polanczyk. (2007) Trimetazidine added to combined hemodynamic antianginal therapy in patients with type 2 diabetes: a randomized crossover trial. American Heart Journal 154:1, 78.e1-78.e7
CrossRef934
Shaila Garg, Kimberly Smith, Rebecca Torguson, Teruo Okabe, Tina L. Pinto Slottow, Daniel H. Steinberg, Probal Roy, Zhenyi Xue, Natalie Gevorkian, Lowell F. Satler, Kenneth M. Kent, William O. Suddath, Augusto D. Pichard, Ron Waksman. (2007) Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent. Catheterization and Cardiovascular Interventions 70:1, 9-14
CrossRef935
Luis-S Díaz de la Llera, Sara Ballesteros, Jaime Nevado, Mónica Fernández, Manuel Villa, Ángel Sánchez, Gabriel Retegui, Dolores García, Ángel Martínez. (2007) Sirolimus-eluting stents compared with standard stents in the treatment of patients with primary angioplasty. American Heart Journal 154:1, 164.e1-164.e6
CrossRef936
Spencer B. King, Thomas Aversano, William L. Ballard, Robert H. Beekman, Michael J. Cowley, Stephen G. Ellis, David P. Faxon, Edward L. Hannan, John W. Hirshfeld, Alice K. Jacobs, Mirle A. Kellett, Stephen E. Kimmel, Joel S. Landzberg, Louis S. McKeever, Mauro Moscucci, Richard M. Pomerantz, Karen M. Smith, George W. Vetrovec, Mark A. Creager, John W. Hirshfeld, David R. Holmes, L. Kristin Newby, Howard H. Weitz, Geno Merli, Ileana Piña, George P. Rodgers, Cynthia M. Tracy. (2007) ACCF/AHA/SCAI 2007 Update of the Clinical Competence Statement on Cardiac Interventional Procedures. Journal of the American College of Cardiology 50:1, 82-108
CrossRef937
Subbu Venkatraman, Freddy Boey. (2007) Release profiles in drug-eluting stents: Issues and uncertainties. Journal of Controlled Release 120:3, 149-160
CrossRef938
Ron Waksman. (2007) Late stent thrombosis—The “vulnerable” stent. Catheterization and Cardiovascular Interventions 70:1, 54-56
CrossRef939
Paul Vermeersch, Pierfrancesco Agostoni, Stefan Verheye, Paul Van den Heuvel, Carl Convens, Frank Van den Branden, Glenn Van Langenhove. (2007) Increased Late Mortality After Sirolimus-Eluting Stents Versus Bare-Metal Stents in Diseased Saphenous Vein Grafts. Journal of the American College of Cardiology 50:3, 261-267
CrossRef940
E. VAN BELLE, S. SUSEN, B. JUDE, M. E. BERTRAND. (2007) Drug-eluting stents: trading restenosis for thrombosis?. Journal of Thrombosis and Haemostasis 5, 238-245
CrossRef941
Giuseppe Gioia, William Matthai, Karen Gillin, James Dralle, Alberto Benassi, Maria Francesca Gioia, Jacqueline White. (2007) Revascularization in severe left ventricular dysfunction: Outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting. Catheterization and Cardiovascular Interventions 70:1, 26-33
CrossRef942
Giuseppe De Luca, Harry Suryapranata, Jan Paul Ottervanger, Arnoud W.J. van't Hof, Jan C.A. Hoorntje, Jan-Henk Dambrink, A.T. Marcel Gosselink, Menko-Jan de Boer. (2007) Comparison between stenting and balloon in elderly patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. International Journal of Cardiology 119:3, 306-309
CrossRef943
Leslie Levin, Ron Goeree, Nancy Sikich, Birthe Jorgensen, Melissa C. Brouwers, Tony Easty, Catherine Zahn. (2007) Establishing a comprehensive continuum from an evidentiary base to policy development for health technologies: The Ontario experience. International Journal of Technology Assessment in Health Care 23:03,
CrossRef944
Marco Valgimigli, Gianluca Campo, Chiara Arcozzi, Patrizia Malagutti, Roberto Carletti, Fabrizio Ferrari, Dario Barbieri, Giovanni Parrinello, Gianfranco Percoco, Roberto Ferrari. (2007) Two-Year Clinical Follow-Up After Sirolimus-Eluting Versus Bare-Metal Stent Implantation Assisted by Systematic Glycoprotein IIb/IIIa Inhibitor Infusion in Patients With Myocardial Infarction. Journal of the American College of Cardiology 50:2, 138-145
CrossRef945
José R. López-Mínguez, Juan M. Nogales, Reyes González, Carlos Palanco, Javier Doncel, Alejandra Vaello, Fernando Giménez, Angel Morales, Rafael Alonso, Antonio Merchán. (2007) Abciximab offers greater benefits to insulin-dependent diabetic patients undergoing coronary stent implantation. Cardiovascular Revascularization Medicine 8:3, 175-182
CrossRef946
E GRUBE, L BUELLESFELD, F NEUMANN, S VERHEYE, A ABIZAID, D MCCLEAN, R MUELLER, A LANSKY, R MEHRAN, R COSTA. (2007) Six-Month Clinical and Angiographic Results of a Dedicated Drug-Eluting Stent for the Treatment of Coronary Bifurcation Narrowings. The American Journal of Cardiology 99:12, 1691-1697
CrossRef947
Marko Remmel, Franz Hartmann, Lars C. Harland, Heribert Schunkert, Peter W. Radke. (2007) Rational Use of Drug-Eluting Stents. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 6:2, 85-89
CrossRef948
Olaf Schouten, Jeroen J Bax, Don Poldermans. (2007) Management of patients with cardiac stents undergoing noncardiac surgery. Current Opinion in Anaesthesiology 20:3, 274-278
CrossRef949
J. Dawn Abbott, David O. Williams. (2007) Lessons Learned in the Drug-Eluting Stent Era. The American Heart Hospital Journal 5:3, 169-172
CrossRef950
Anderson Mehrle, Thomas Skelton, Alexandra Almonacid. (2007) Stent fracture: An unusual cause of late restenosis after sirolimus-eluting stent placement. Catheterization and Cardiovascular Interventions 69:7, 988-991
CrossRef951
FLAVIO RIBICHINI, VALERIA FERRERO, MAURO FEOLA, ANDREA ROGNONI, SANDRA BRUNELLESCHI, GIOVANNI VACCA, CORRADO VASSANELLI. (2007) Neutropenia in Patients Treated With Thienopyridines and High-Dose Oral Prednisone after Percutaneous Coronary Interventions. Journal of Interventional Cardiology 20:3, 209-213
CrossRef952
Raimund Erbel, Carlo Di Mario, Jozef Bartunek, Johann Bonnier, Bernard de Bruyne, Franz R Eberli, Paul Erne, Michael Haude, Bernd Heublein, Mark Horrigan, Charles Ilsley, Dirk Böse, Jacques Koolen, Thomas F Lüscher, Neil Weissman, Ron Waksman. (2007) Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. The Lancet 369:9576, 1869-1875
CrossRef953
Mark G. Rabbat, Anthony A. Bavry, Deepak L. Bhatt. (2007) Drug-Eluting Stents: Can We Move Beyond Stent Thrombosis?. The American Heart Hospital Journal 5:3, 155-158
CrossRef954
Akihito Muto, Tamara N. Fitzgerald, Jose M. Pimiento, Stephen P. Maloney, Desarom Teso, Jacek J. Paszkowiak, Tormod S. Westvik, Fabio A. Kudo, Toshiya Nishibe, Alan Dardik. (2007) Smooth muscle cell signal transduction: Implications of vascular biology for vascular surgeons. Journal of Vascular Surgery 45:6, A15-A24
CrossRef955
Shanta Chakrabarti, Ralph Mittal, James P Gnanapragasam, Robin P. Martin. (2007) Acquired stenosis of normally connected pulmonary veins. Cardiology in the Young 17:03, 322
CrossRef956
William J. Mauermann, Kent H. Rehfeldt, Malcolm R. Bell, Stuart M. Lowson. (2007) Percutaneous Coronary Interventions and Antiplatelet Therapy in the Perioperative Period. Journal of Cardiothoracic and Vascular Anesthesia 21:3, 436-442
CrossRef957
Aloke V. Finn, Gaku Nakazawa, Frank D. Kolodgie, Renu Virmani. (2007) Controversies Surrounding the Use of Drug-Eluting Stents. The American Heart Hospital Journal 5:3, 141-145
CrossRef958
John Cosgrave, Gloria Melzi, Simon Corbett, Giuseppe G.L. Biondi-Zoccai, Pierfrancesco Agostoni, Rade Babic, Flavio Airoldi, Alaide Chieffo, Giuseppe M. Sangiorgi, Matteo Montorfano, Iassen Michev, Mauro Carlino, Antonio Colombo. (2007) Comparable Clinical Outcomes With Paclitaxel- and Sirolimus-Eluting Stents in Unrestricted Contemporary Practice. Journal of the American College of Cardiology 49:24, 2320-2328
CrossRef959
F. Cademartiri, A. Palumbo, E. Maffei, L. Grutta, G. Runza, F. Pugliese, M. Midiri, N. R. A. Mollet, W. B. Meijboom, A. Menozzi, L. Vignali, C. Reverberi, D. Ardissino, G. P. Krestin. (2007) Diagnostic accuracy of 64-slice CT in the assessment of coronary stents. La radiologia medica 112:4, 526-537
CrossRef960
Grayson G. Geary. (2007) The Vascular Therapist. Heart, Lung and Circulation 16:3, 193-199
CrossRef961
Daniel H. Steinberg, Ron Waksman. (2007) Drug-Eluting Stent Thrombosis vs Bare Metal Stent Restenosis: Finding the Lesser of Two Evils. The American Heart Hospital Journal 5:3, 151-154
CrossRef962
A KONIG, M LEIBIG, J RIEBER, T SCHIELE, K THEISEN, U SIEBERT, R GOTHE, V KLAUSS. (2007) Randomized comparison of dexamethasone-eluting stents with bare metal stent implantation in patients with acute coronary syndrome: Serial angiographic and sonographic analysis. American Heart Journal 153:6, 979.e1-979.e8
CrossRef963
Filippo Cademartiri, Joanne D. Schuijf, Francesca Pugliese, Nico R. Mollet, J. Wouter Jukema, Erica Maffei, Lucia J. Kroft, Alessandro Palumbo, Diego Ardissino, Patrick W. Serruys, Gabriel P. Krestin, Ernst E. Van der Wall, Pim J. de Feyter, Jeroen J. Bax. (2007) Usefulness of 64-Slice Multislice Computed Tomography Coronary Angiography to Assess In-Stent Restenosis. Journal of the American College of Cardiology 49:22, 2204-2210
CrossRef964
Alexandre Abizaid, Alexandra J. Lansky, Peter J. Fitzgerald, Luis Fernando Tanajura, Fausto Feres, Rodolfo Staico, Luiz Mattos, Andrea Abizaid, Aurea Chaves, Marinella Centemero. (2007) Percutaneous Coronary Revascularization Using a Trilayer Metal Phosphorylcholine-Coated Zotarolimus-Eluting Stent. The American Journal of Cardiology 99:10, 1403-1408
CrossRef965
Gautam Kedia, Michael S. Lee. (2007) Stent thrombosis with drug-eluting stents: A re-examination of the evidence. Catheterization and Cardiovascular Interventions 69:6, 782-789
CrossRef966
Cheol Whan Lee, Jon Suh, Se-Whan Lee, Duk-Woo Park, Seung-Hwan Lee, Young-Hak Kim, Myeong-Ki Hong, Jae-Joong Kim, Seong-Wook Park, Seung-Jung Park,. (2007) Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries. Catheterization and Cardiovascular Interventions 69:6, 821-825
CrossRef967
Nico H.J. Pijls, Pepijn van Schaardenburgh, Ganesh Manoharan, Eric Boersma, Jan-Willem Bech, Marcel van’t Veer, Frits Bär, Jan Hoorntje, Jacques Koolen, William Wijns, Bernard de Bruyne. (2007) Percutaneous Coronary Intervention of Functionally Nonsignificant Stenosis. Journal of the American College of Cardiology 49:21, 2105-2111
CrossRef968
Vincenzo Pasceri, Giuseppe Patti, Giulio Speciale, Christian Pristipino, Giuseppe Richichi, Germano Di Sciascio. (2007) Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. American Heart Journal 153:5, 749-754
CrossRef969
Paolo Ortolani, Antonio Marzocchi, Cinzia Marrozzini, Tullio Palmerini, Francesco Saia, Nevio Taglieri, Matteo Aquilina, Federica Baldazzi, Simona Silenzi, Robin M.T. Cooke, Maria-Letizia Bacchi Reggiani, Angelo Branzi. (2007) Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization. Catheterization and Cardiovascular Interventions 69:6, 790-798
CrossRef970
Chi-Hang Lee, Adrian Low, Jimmy Lim, Hwee-Bee Wong, Yean-Teng Lim, Huay-Cheem Tan. (2007) CYPHER versus TAXUS stent for bifurcation lesions beyond 30 days—long-term follow-up results. International Journal of Cardiology 117:3, 422-424
CrossRef971
Hajir Dilmanian, Wilbert S Aronow, Mubasir Mundia, Anthony L Pucillo, Melvin B Weiss, Kumar Kalapatapu, Craig E Monsen. (2007) The Average Stent Length is Longer and the Average Stent Diameter is Shorter in Patients With Drug-Eluting Stents Versus Bare-Metal Stents During Percutaneous Coronary Intervention. American Journal of Therapeutics 14:3, 277-279
CrossRef972
Maurizio Menichelli, Antonio Parma, Edoardo Pucci, Rosario Fiorilli, Francesco De Felice, Marco Nazzaro, Alessia Giulivi, Domenico Alborino, Arianna Azzellino, Roberto Violini. (2007) Randomized Trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI). Journal of the American College of Cardiology 49:19, 1924-1930
CrossRef973
Ichizo Tsujino, Junya Ako, Yasuhiro Honda, Peter J Fitzgerald. (2007) Drug delivery via nano-, micro and macroporous coronary stent surfaces. Expert Opinion on Drug Delivery 4:3, 287-295
CrossRef974
Ge Zhang, Laura J. Suggs. (2007) Matrices and scaffolds for drug delivery in vascular tissue engineering. Advanced Drug Delivery Reviews 59:4-5, 360-373
CrossRef975
Duncan G. de Souza, Victor C. Baum, Natalie M. Ballert. (2007) Late Thrombosis of a Drug-eluting Stent Presenting in the Perioperative Period. Anesthesiology 106:5, 1057-1059
CrossRef976
Jeptha P. Curtis, David J. Cohen, Philip G. Jones, Richard G. Bach, John A. Spertus, Harlan M. Krumholz. (2007) Impact of the Food and Drug Administration’s Public Health Notification on the Adoption of Drug-Eluting Stents. The American Journal of Cardiology 99:9, 1227-1229
CrossRef977
Gaku Nakazawa, Kengo Tanabe, Jiro Aoki, Hirosada Yamamoto, Yasutomi Higashikuni, Yoshinobu Onuma, Sen Yachi, Hiroyoshi Nakajima, Kazuhiro Hara,. (2007) Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents. Catheterization and Cardiovascular Interventions 69:6, 808-814
CrossRef978
Tracy Y. Wang, Vic Hasselblad, John L. Peterson, William Wijns, Azin Parhizgar, Dean J. Kereiakes, Mitchell W. Krucoff. (2007) The Cobalt chromium STent with Antiproliferative for Restenosis II (COSTAR II) Trial study design: Advancing the active-control evaluation of second-generation drug-eluting stents. American Heart Journal 153:5, 743-748
CrossRef979
Juan Rondan, Inigo Lozano, Pablo Avanzas, Ramon Lopez-Palop, Jose M. Vegas, Cesar Moris. (2007) Drug eluting stents may not be the answer for myocardial bridges. International Journal of Cardiology 117:2, e76-e78
CrossRef980
G WEISZ, J MOSES, P TEIRSTEIN, D HOLMESJR, A RAIZNER, L SATLER, G MISHKEL, R WILENSKY, P WANG, R KUNTZ. (2007) Safety of Sirolimus-Eluting Stenting and Its Effect on Restenosis in Patients With Unstable Angina Pectoris (a SIRIUS Substudy). The American Journal of Cardiology 99:8, 1044-1050
CrossRef981
R ARTANG, R DIETER. (2007) Analysis of 36 Reported Cases of Late Thrombosis in Drug-Eluting Stents Placed in Coronary Arteries. The American Journal of Cardiology 99:8, 1039-1043
CrossRef982
Lin Mei, Hongfan Sun, Xu Jin, Dunwan Zhu, Rui Sun, Minfang Zhang, Cunxian Song. (2007) Modified Paclitaxel-loaded Nanoparticles for Inhibition of Hyperplasia in a Rabbit Arterial Balloon Injury Model. Pharmaceutical Research 24:5, 955-962
CrossRef983
Jung-Won Suh, Jin-Shik Park, Hyun-Jai Cho, Min-Seok Kim, Hyun-Jae Kang, Young-Seok Cho, Bon-Kwon Koo, Woo-Young Chung, Tae-Jin Youn, In-Ho Chae, Dong-Ju Choi, Hyo-Soo Kim, Dae-Won Sohn, Byung-Hee Oh, Young-Bae Park. (2007) Sirolimus-eluting stent showed better one-year outcomes than paclitaxel-eluting stent in a real life setting of coronary intervention in Koreans. International Journal of Cardiology 117:1, 31-36
CrossRef984
Yung-Wu Chen, Morey L Smith, Michael Sheets, Steve Ballaron, James M Trevillyan, Sandra E Burke, Teresa Rosenberg, Cindy Henry, Rolf Wagner, Joy Bauch, Kennan Marsh, Thomas A Fey, Gin Hsieh, Donna Gauvin, Karl W Mollison, George W Carter, Stevan W Djuric. (2007) Zotarolimus, a Novel Sirolimus Analogue With Potent Anti-proliferative Activity on Coronary Smooth Muscle Cells and Reduced Potential for Systemic Immunosuppression. Journal of Cardiovascular Pharmacology 49:4, 228-235
CrossRef985
Francisco J. Morales, Pedro Martínez-Romero, Javier Lozano, Jesús Oneto, Marisol López-Sinoga, Manuel Martínez-García, Eduardo Martínez-Morentín, Pablo González-Pérez. (2007) El comportamiento reestenótico previo como predictor pronóstico ante nueva implantación de stent convencional en distinta localización. Revista Española de Cardiología 60:4, 384-391
CrossRef986
Mark A. Turco, John A. Ormiston, Jeffrey J. Popma, Lazar Mandinov, Charles D. O’Shaughnessy, Tift Mann, Thomas F. McGarry, Chiung-Jen Wu, Charles Chan, Mark W.I. Webster, Jack J. Hall, Gregory J. Mishkel, Louis A. Cannon, Donald S. Baim, Joerg Koglin. (2007) Polymer-Based, Paclitaxel-Eluting TAXUS Liberté Stent in De Novo Lesions. Journal of the American College of Cardiology 49:16, 1676-1683
CrossRef987
Ajay J. Kirtane, Jeffrey W. Moses. (2007) Revascularization in Heart Failure: The Role of Percutaneous Coronary Intervention. Heart Failure Clinics 3:2, 229-235
CrossRef988
FLAVIO RIBICHINI, VALERIA FERRERO, ANDREA ROGNONI, PAOLO MARINO, SANDRA BRUNELLESCHI, CORRADO VASSANELLI. (2007) Percutaneous Treatment of Coronary Bifurcations: Lesion Preparation Before Provisional Bare Metal Stenting and Subsequent Immunosuppression with Oral Prednisone. The IMPRESS-Y Study. Journal of Interventional Cardiology 20:2, 114-121
CrossRef989
Alexandre Abizaid. (2007) Sirolimus-eluting coronary stents: a review. Vascular Health and Risk Management 3:2, 191-201
CrossRef990
AHMED A. KHATTAB, ANDREAS OTTO, MATTHIAS HOCHADEL, RALPH TOELG, VOLKER GEIST, GERT RICHARDT. (2007) Drug-Eluting Stents Versus Bare Metal Stents Following Rotational Atherectomy for Heavily Calcified Coronary Lesions: Late Angiographic and Clinical Follow-Up Results. Journal of Interventional Cardiology 20:2, 100-106
CrossRef991
Giuseppe De Luca, Giannignazio Carbone, AntonGiulio Maione, Giovanni Gregorio. (2007) In-stent thrombosis after discontinuation of antiplatelet therapy 2 years after DES implantation: A case report. International Journal of Cardiology 116:3, 399-400
CrossRef992
Peter Barlis, Mark Horrigan, Safari Elis, Robert Chan, Michael Wong, Omar Farouque, George Proimos, Andrew E. Ajani, David J. Clark. (2007) Treatment of unprotected left main disease with drug-eluting stents in patients at high risk for coronary artery bypass grafting. Cardiovascular Revascularization Medicine 8:2, 84-89
CrossRef993
Takayuki Ohno, Shinichi Takamoto, Jiro Ando, Toshihiro Morita, Hideo Fujita, Yasunobu Hirata, Takashi Shigeeda, Akira Hirose, Ryozo Nagai. (2007) Diabetic Retinopathy and Coronary Implantation of Sirolimus-Eluting Stents. Journal of Interventional Cardiology 20:2, 122-131
CrossRef994
Matteo Cassin, Marzia De Biasio, Franco Macor, Claudio Burelli, Fauzia Vendrametto, Mauro Driussi, Gian Luigi Nicolosi. (2007) Late coronary thrombosis in paclitaxel-eluting stents. Case reports. Journal of Cardiovascular Medicine 8:4, 284-288
CrossRef995
(2007) Curcumin-Loaded PLGA Nanoparticles Coating onto Metal Stent by Electrophoretic Deposition Techniques. Bulletin of the Korean Chemical Society 28:3, 397-402
CrossRef996
Kastrati, Adnan, Mehilli, Julinda, Pache, Jürgen, Kaiser, Christoph, Valgimigli, Marco, Kelbæk, Henning, Menichelli, Maurizio, Sabaté, Manel, Suttorp, Maarten J., Baumgart, Dietrich, Seyfarth, Melchior, Pfisterer, Matthias E., Schömig, Albert, . (2007) Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents. New England Journal of Medicine 356:10, 1030-1039
Full Text997
Stone, Gregg W., Moses, Jeffrey W., Ellis, Stephen G., Schofer, Joachim, Dawkins, Keith D., Morice, Marie-Claude, Colombo, Antonio, Schampaert, Erick, Grube, Eberhard, Kirtane, Ajay J., Cutlip, Donald E., Fahy, Martin, Pocock, Stuart J., Mehran, Roxana, Leon, Martin B., . (2007) Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents. New England Journal of Medicine 356:10, 998-1008
Full Text998
Mauri, Laura, Hsieh, Wen-hua, Massaro, Joseph M., Ho, Kalon K.L., D'Agostino, Ralph, Cutlip, Donald E., . (2007) Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents. New England Journal of Medicine 356:10, 1020-1029
Full Text999
Spaulding, Christian, Daemen, Joost, Boersma, Eric, Cutlip, Donald E., Serruys, Patrick W., . (2007) A Pooled Analysis of Data Comparing Sirolimus-Eluting Stents with Bare-Metal Stents. New England Journal of Medicine 356:10, 989-997
Full Text1000
Lagerqvist, Bo, James, Stefan K., Stenestrand, Ulf, Lindbäck, Johan, Nilsson, Tage, Wallentin, Lars, . (2007) Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden. New England Journal of Medicine 356:10, 1009-1019
Full Text1001
Daniel H. Steinberg, Sundeep Mishra, Aamir Javaid, Tina L. Pinto Slottow, Ashesh N. Buch, Probal Roy, Teruo Okabe, Kimberly A. Smith, Rebecca Torguson, Zhenyi Xue, Augusto D. Pichard, Lowell F. Satler, Kenneth M. Kent, William O. Suddath, Ron Waksman. (2007) Comparison of Effectiveness of Bare Metal Stents Versus Drug-Eluting Stents in Large (≥3.5 mm) Coronary Arteries. The American Journal of Cardiology 99:5, 599-602
CrossRef1002
Min-zhou Zhang. (2007) The prevention and treatment of restenosis in the era of drug-eluting stent. Chinese Journal of Integrative Medicine 13:1, 6-7
CrossRef1003
Mimi Q. Le, Craig R. Narins. (2007) Mycotic pseudoaneurysm of the left circumflex coronary artery: A fatal complication following drug-eluting stent implantation. Catheterization and Cardiovascular Interventions 69:4, 508-512
CrossRef1004
Victor Legrand. (2007) Therapy Insight: diabetes and drug-eluting stents. Nature Clinical Practice Cardiovascular Medicine 4:3, 143-150
CrossRef1005
Giora Weisz, Jeffrey W Moses. (2007) New percutaneous approaches for chronic total occlusion of coronary arteries. Expert Review of Cardiovascular Therapy 5:2, 231-241
CrossRef1006
Adriano M. Caixeta, Fábio S. Brito, Marco A. Costa, Carlos V. Serrano, João L. Petriz, Protásio L. Da Luz. (2007) Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis. Catheterization and Cardiovascular Interventions 69:4, 500-507
CrossRef1007
J. Dawn Abbott, Helen A. Vlachos, Faith Selzer, Barry L. Sharaf, Elizabeth Holper, Ruchira Glaser, Alice K. Jacobs, David O. Williams. (2007) Gender-Based Outcomes in Percutaneous Coronary Intervention With Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic Registry). The American Journal of Cardiology 99:5, 626-631
CrossRef1008
Pierfrancesco Agostoni, John Cosgrave, Giuseppe G.L. Biondi-Zoccai, Giuseppe M. Sangiorgi, Lei Ge, Gloria Melzi, Simon Corbett, Flavio Airoldi, Matteo Montorfano, Alaide Chieffo, Iassen Michev, Mauro Carlino, Antonio Colombo. (2007) Angiographic Analysis of Pattern of Late Luminal Loss in Sirolimus- and Paclitaxel-Eluting Stents. The American Journal of Cardiology 99:5, 593-598
CrossRef1009
Tom Adriaenssens, Julinda Mehilli, Rainer Wessely, Gjin Ndrepepa, Melchior Seyfarth, Anna Wieczorek, Birgit Blaich, Raisuke Iijima, Jürgen Pache, Adnan Kastrati, Albert Schömig. (2007) Does Addition of Estradiol Improve the Efficacy of a Rapamycin-Eluting Stent?. Journal of the American College of Cardiology 49:12, 1265-1271
CrossRef1010
Mátyás Keltai. (2007) A gyógyszerkibocsátó coronariastentek alkalmazásának hatásai. Orvosi Hetilap 148:10, 443-450
CrossRef1011
Tim A. Fischell, David R. Holmes. (2007) Late DES thrombosis: A lot of smoke, very little fire?. Catheterization and Cardiovascular Interventions 69:4, 609-615
CrossRef1012
Mariko Ehara, Masato Kawai, Jean-François Surmely, Tetsuo Matsubara, Mitsuyasu Terashima, Etsuo Tsuchikane, Yoshihisa Kinoshita, Tatsuya Ito, Yoshihiro Takeda, Kenya Nasu, Nobuyoshi Tanaka, Akira Murata, Hiroshi Fujita, Koyo Sato, Atsuko Kodama, Osamu Katoh, Takahiko Suzuki. (2007) Diagnostic Accuracy of Coronary In-Stent Restenosis Using 64-Slice Computed Tomography. Journal of the American College of Cardiology 49:9, 951-959
CrossRef1013
Waqar Habib Ahmed. (2007) Review of the TAXUS® Liberté™ SR paclitaxel-eluting coronary stent. Expert Review of Medical Devices 4:2, 117-120
CrossRef1014
John Cosgrave, Gloria Melzi, Simon Corbett, Giuseppe G.L. Biondi-Zoccai, Rade Babic, Flavio Airoldi, Alaide Chieffo, Giuseppe M. Sangiorgi, Matteo Montorfano, Iassen Michev, Mauro Carlino, Antonio Colombo. (2007) Repeated drug-eluting stent implantation for drug-eluting stent restenosis: The same or a different stent. American Heart Journal 153:3, 354-359
CrossRef1015
Jiro Aoki, Gaku Nakazawa, Kengo Tanabe, Angela Hoye, Hirosada Yamamoto, Tomohiro Nakayama, Yoshinobu Onuma, Yasutomi Higashikuni, Syuji Otsuki, Atsuhiko Yagishita, Sen Yachi, Hiroyoshi Nakajima, Kazuhiro Hara. (2007) Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation. Catheterization and Cardiovascular Interventions 69:3, 380-386
CrossRef1016
Michael S. Lee, Daniel Jurewitz, Joseph Aragon, James Forrester, Raj R. Makkar, Saibal Kar. (2007) Stent fracture associated with drug-eluting stents: Clinical characteristics and implications. Catheterization and Cardiovascular Interventions 69:3, 387-394
CrossRef1017
Jose de Ribamar Costa, Gary S. Mintz, Stéphane G. Carlier, Kenichi Fujii, Koichi Sano, Masashi Kimura, Kaoru Tanaka, Ricardo A. Costa, Joanna Lui, Yingbo Na, Celia Castellanos, Sinan Biro, Issam Moussa, Gregg W. Stone, Jeffrey W. Moses, Martin B. Leon. (2007) Intravascular ultrasound assessment of drug-eluting stent expansion. American Heart Journal 153:2, 297-303
CrossRef1018
K.H. Chan, J. Armstrong, S. Withers, N. Malik, D.C. Cumberland, J. Gunn, C.M. Holt. (2007) Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents. Biomaterials 28:6, 1218-1224
CrossRef1019
Eugenia Nikolsky, Gregg W. Stone. (2007) Utility of drug-eluting stents in complex lesions and high-risk patients. Current Treatment Options in Cardiovascular Medicine 9:1, 11-28
CrossRef1020
Philip Urban, Edoardo De Benedetti. (2007) Thrombosis: the last frontier of coronary stenting?. The Lancet 369:9562, 619-621
CrossRef1021
Joost Daemen, Peter Wenaweser, Keiichi Tsuchida, Linda Abrecht, Sophia Vaina, Cyrill Morger, Neville Kukreja, Peter Jüni, Georgios Sianos, Gerrit Hellige, Ron T van Domburg, Otto M Hess, Eric Boersma, Bernhard Meier, Stephan Windecker, Patrick W Serruys. (2007) Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. The Lancet 369:9562, 667-678
CrossRef1022
Marco A. Costa, Manel Sabate, Rodolfo Staico, Fernando Alfonso, Ana C. Seixas, Mariano Albertal, Arthur Crossman, Dominick J. Angiolillo, Martin Zenni, J. Eduardo Sousa, Carlos Macaya, Theodore A. Bass. (2007) Anatomical and physiologic assessments in patients with small coronary artery disease: Final results of the Physiologic and Anatomical Evaluation Prior to and After Stent Implantation in Small Coronary Vessels (PHANTOM) trial. American Heart Journal 153:2, 296.e1-296.e7
CrossRef1023
PETER W. GROENEVELD, JANICE J. SUH, MARY ANNE MATTA. (2007) The Costs and Quality-of-Life Outcomes of Drug-Eluting Coronary Stents: A Systematic Review. Journal of Interventional Cardiology 20:1, 1-9
CrossRef1024
Cecile Tissot, Eduardo da Cruz, Yacine Aggoun. (2007) Rescue left main coronary artery stenting for acute myocardial ischemia after coronary angiography in a 7-year-old girl with homozygous familial hypercholesterolemia. Catheterization and Cardiovascular Interventions 69:2, 243-247
CrossRef1025
Anna Sonia Petronio, Marco De Carlo, Giulia Branchitta, Barbara Papini, Nicola Ciabatti, Roberto Gistri, Bernardo Cortese, Gherardo Gherarducci, Antonio Barsotti. (2007) Randomized Comparison of Sirolimus and Paclitaxel Drug-Eluting Stents for Long Lesions in the Left Anterior Descending Artery. Journal of the American College of Cardiology 49:5, 539-546
CrossRef1026
Juan Sánchez-Rubio Lezcano, José Gabriel Galache Osuna, Isabel Calvo Cebollero, Antonela Lukic, José Antonio Diarte de Miguel, Luis Javier Placer Peralta. (2007) Resultados a largo plazo del empleo de stents recubiertos de fármacos en la práctica clínica habitual. Comparación entre los stents liberadores de rapamicina y los stents liberadores de paclitaxol. Medicina Clínica 128:6, 211-213
CrossRef1027
James S. W. Kong, Suzanne S. Teuber, M. Eric Gershwin. (2007) Aspririn and nonsteroidal anti-inflammatory drug hypersensitivity. Clinical Reviews in Allergy & Immunology 32:1, 97-109
CrossRef1028
Junbo Ge, Juying Qian, Xiangfei Wang, Qibing Wang, Wei Yan, Yan Yan, Bing Fan, Lei Ge, Xuebo Liu. (2007) Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries. Catheterization and Cardiovascular Interventions 69:2, 198-202
CrossRef1029
Joseph Dubin, Donald E Cutlip. (2007) Current issues in coronary artery stenting in the elderly. Aging Health 3:1, 105-114
CrossRef1030
R APPLEGATE, M SACRINTY, M KUTCHER, T BAKI, S GANDHI, R SANTOS, W LITTLE. (2007) Comparison of Drug-Eluting Versus Bare Metal Stents on Later Frequency of Acute Myocardial Infarction and Death. The American Journal of Cardiology 99:3, 333-338
CrossRef1031
Joost Daemen, Patrick W Serruys. (2007) Optimal revascularization strategies for multivessel coronary artery disease. Current Opinion in Internal Medicine 6:1, 19-25
CrossRef1032
F. Unger, U. Westedt, P. Hanefeld, R. Wombacher, S. Zimmermann, A. Greiner, M. Ausborn, T. Kissel. (2007) Poly(ethylene carbonate): A thermoelastic and biodegradable biomaterial for drug eluting stent coatings?. Journal of Controlled Release 117:3, 312-321
CrossRef1033
Ashesh N. Buch, Ron Waksman. (2007) Cypher Versus Taxus: All Smoke and No Fire: Lessons for Future Comparative Drug-Eluting Stent Trials in Interventional Cardiology. The American Journal of Cardiology 99:3, 424-427
CrossRef1034
Colin Berry, Jean-Claude Tardif, Martial G. Bourassa. (2007) Coronary Heart Disease in Patients With Diabetes. Journal of the American College of Cardiology 49:6, 643-656
CrossRef1035
ZHEN KUN YANG, WEI FENG SHEN, RUI YAN ZHANG, YE KONG, JIAN SHENG ZHANG, JIAN HU, QI ZHANG, FENG HUA DING. (2007) Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention with Drug-Eluting Stent Implantation in Patients with Multivessel Coronary Disease. Journal of Interventional Cardiology 20:1, 10-16
CrossRef1036
F. Migliavacca, F. Gervaso, M. Prosi, P. Zunino, S. Minisini, L. Formaggia, G. Dubini. (2007) Expansion and drug elution model of a coronary stent. Computer Methods in Biomechanics and Biomedical Engineering 10:1, 63-73
CrossRef1037
Massimo Fineschi, Tommaso Gori, Carlo Pierli, Stefano Casini, Giuseppe Sinicropi, Alberto Buti, Alessandro Iadanza, Achille Bravi. (2007) Symptomatic failure after sirolimus-eluting stent implantation: A rare but challenging condition. Canadian Journal of Cardiology 23:2, 139-142
CrossRef1038
Chung-Han Lee, Ken Inoki, Kun-Liang Guan. (2007) mTOR Pathway as a Target in Tissue Hypertrophy. Annual Review of Pharmacology and Toxicology 47:1, 443-467
CrossRef1039
Jonathan Tobis, Babak Azarbal, Leo Slavin. (2007) Assessment of Intermediate Severity Coronary Lesions in the Catheterization Laboratory. Journal of the American College of Cardiology 49:8, 839-848
CrossRef1040
Alban Dibra, Adnan Kastrati, Fernando Alfonso, Melchior Seyfarth, Maria-José Pérez-Vizcayno, Julinda Mehilli, Albert Schömig. (2007) Effectiveness of Drug-Eluting Stents in Patients With Bare-Metal In-Stent Restenosis. Journal of the American College of Cardiology 49:5, 616-623
CrossRef1041
Valentin Fuster, Javier Sanz. (2007) Gene therapy and stem cell therapy for cardiovascular diseases today: a model for translational research. Nature Clinical Practice Cardiovascular Medicine 4, S1-S8
CrossRef1042
Chi-Hang Lee, Mark Y. Chan. (2007) Dilemma of drug-eluting stent implantation in a patient with systemic lupus erythematosus. International Journal of Cardiology 114:3, E107-E108
CrossRef1043
Susanne S. Pedersen, Johan Denollet, Andrew T.L. Ong, Patrick W. Serruys, Ruud A.M. Erdman, Ron T. van Domburg. (2007) Impaired health status in Type D patients following PCI in the drug-eluting stent era. International Journal of Cardiology 114:3, 358-365
CrossRef1044
Sou-Tung Chiu-Tsao, Dennis R. Schaart, Christopher G. Soares, Ravinder Nath. (2007) Dose calculation formalisms and consensus dosimetry parameters for intravascular brachytherapy dosimetry: Recommendations of the AAPM Therapy Physics Committee Task Group No. 149. Medical Physics 34:11, 4126
CrossRef1045
Soichiro Fuke, Kiyoaki Maekawa, Kenji Kawamoto, Hironori Saito, Tetsuya Sato, Toru Hioka, Tohru Ohe. (2007) Impaired Endothelial Vasomotor Function After Sirolimus-Eluting Stent Implantation. Circulation Journal 71:2, 220-225
CrossRef1046
Pascal Meier, Rainer Zbinden, Mario Togni, Peter Wenaweser, Stephan Windecker, Bernhard Meier, Christian Seiler. (2007) Coronary Collateral Function Long After Drug-Eluting Stent Implantation. Journal of the American College of Cardiology 49:1, 15-20
CrossRef1047
Leo Slavin, Ankush Chhabra, Jonathan M. Tobis. (2007) Drug-Eluting Stents. Cardiology in Review 15:1, 1-12
CrossRef1048
Simon J. Corbett, John Cosgrave, Antonio Colombo. (2007) Concurrent implantation of sirolimus- and paclitaxel-eluting stents in the same vessel. Catheterization and Cardiovascular Interventions 69:1, 109-114
CrossRef1049
Naoki Ishio, Yoshio Kobayashi, Hideo Takebayashi, Yoshihiro Iijima, Junji Kanda, Takashi Nakayama, Nakabumi Kuroda, Joseph De Gregorio, Yukinori Kouno, Masaru Suzuki, Seiichi Haruta, Issei Komuro. (2007) Impact of Drug-Eluting Stents on Clinical and Angiographic Outcomes in Dialysis Patients. Circulation Journal 71:10, 1525-1529
CrossRef1050
Karel K.J. Kuiper, Mohamed Salem, Svein Rotevatn, Joseph Mills, Jan Erik Nordrehaug. (2007) Implementing a best-treatment strategy with intracoronary brachytherapy for in-stent restenosis in patients at high risk for recurrence. Cardiovascular Revascularization Medicine 8:1, 9-14
CrossRef1051
Byoung-Keuk Kim, Seung Jin Oh, Dong Woon Jeon, Kyung Heui Kim, Joo Young Yang. (2007) Is Stent Underexpansion the Main Cause of In-Stent Restenosis after Sirolimus-Eluting Stent Implantation?: An Intravascular Ultrasound Study. Korean Circulation Journal 37:2, 58
CrossRef1052
Christoph Schukro, Bonni Syeda, Christian Kirisits, Rainer Schmid, Philipp Pichler, Boris Pokrajac, Irene Lang, Richard Pötter, Dietmar Glogar. (2007) Randomized comparison between intracoronary β-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis. Radiotherapy and Oncology 82:1, 18-23
CrossRef1053
Soon Jun Hong, Moo Hyun Kim, Tae Hoon Ahn, Wan Joo Shim, Seong Mi Park, Jong Il Choi, Hyung Joon Joo, Seung Yong Shin, Sang Yup Lim, Do-Sun Lim. (2007) Comparison of the Predictors of Coronary Restenosis after Drug-Eluting Stent Implantation in Diabetic and Nondiabetic Patients. Korean Circulation Journal 37:11, 530
CrossRef1054
Chang-Wook Nam, Kwon-Bae Kim, Seung-Ho Hur, Yun-Kyeong Cho, Hyung Seop Kim, Seong-Wook Han, Yoon-Nyun Kim, In-Sung Chung, Young-Soo Lee, Kee-Sik Kim. (2007) Impact of Optimal Stent Expansion on Late Outcomes after Sirolimus-Eluting Stent Implantation: An Intravascular Ultrasound Study. Korean Circulation Journal 37:6, 244
CrossRef1055
Cheol Whan Lee, Seung-Jung Park. (2007) Predictive Factors for Restenosis after Drug-Eluting Stent Implantation. Korean Circulation Journal 37:3, 97
CrossRef1056
Kyung Sun Park, Sung Tae Cha, Jung Hoon Sung, In Jae Kim, Sang Wook Lim, Dong Hoon Cha. (2007) A Case of Coronary Artery Aneurysm after Sirolimus-Eluting Stent Implantation. Korean Circulation Journal 37:3, 127
CrossRef1057
2007. A. , 3-25.
CrossRef1058
Dong Won Lee, Jae Kyung Ha, Sung Gyu An, Jae-Hoon Choi, Tae Kun Lee, Han Cheol Lee, Jun Kim, June Hong Kim, Kook-Jin Chun, Taek Jong Hong, Yung Woo Shin. (2007) Comparison of the Clinical and Angiographic Outcomes of Compromised Side Branches (Stent Jail) after Percutaneous Coronary Intervention between Sirolimus-Eluting Stents and Paclitaxel-Eluting Stents. Korean Circulation Journal 37:12, 630
CrossRef1059
Yukio Ozaki, Tetsu Yamaguchi, Takahiko Suzuki, Masato Nakamura, Michihiko Kitayama, Hideo Nishikawa, Teruo Inoue, Kazuhiro Hara, Fumihiko Usuba, Masami Sakurada, Kojiro Awano, Hitoshi Matsuo, Sugao Ishiwata, Tatsuya Yasukawa, Tevfik F. Ismail, Hitoshi Hishida, Osamu Kato. (2007) Impact of Cutting Balloon Angioplasty (CBA) Prior to Bare Metal Stenting on Restenosis. Circulation Journal 71:1, 1-8
CrossRef1060
Shuzou Tanimoto, Joost Daemen, Keiichi Tsuchida, Héctor M. García-García, Peter de Jaegere, Ron T. van Domburg, Patrick W. Serruys. (2007) Two-year clinical outcome after coronary stenting of small vessels using 2.25-mm sirolimus- and paclitaxel-eluting stents: Insight into the RESEARCH and T-SEARCH registries. Catheterization and Cardiovascular Interventions 69:1, 94-103
CrossRef1061
Jung Im Jung. (2007) Multidector CT Imaging of Coronary Artery Stents: Is This Method Ready for Use?. Korean Circulation Journal 37:11, 521
CrossRef1062
Sachiko ASAMASU-SATO, Mitsuo MITA, Ryuichi OGAWA, Mahito ISAKA, Masaki SAITO. (2007) Analysis of Clinical Factors that Influence Re-stenosis after Percutaneous Coronary Stenting. YAKUGAKU ZASSHI 127:8, 1309-1315
CrossRef1063
Gian M. Novaro, Aparna Cherla, Kenneth R. Fromkin, Howard S. Bush. (2007) Drug-eluting stent implantation in ST-elevation acute myocardial infarction: ‘real world’ 30-day and mid-term results. Cardiovascular Revascularization Medicine 8:1, 5-8
CrossRef1064
Atsushi Seo, Takuro Fujii, Terumasa Inoue, Satoru Onoda, Atsushi Koga, Yasuyuki Tanaka, Keiichi Chin, Takashi Kurusu, Kazutoshi Takikawa, Takahiro Shibata, Masayuki Taniguchi, Seibu Mochizuki. (2007) Initial and Long-Term Outcomes of Sirolimus-Eluting Stents for Calcified Lesions Compared With Bare-Metal Stents. International Heart Journal 48:2, 137-147
CrossRef1065
Feng Zhang, Junbo Ge, Juying Qian, Bing Fan, Qibing Wang, Lei Ge, Xuebo Liu. (2007) Sirolimus-Eluting Stents in Real-World Patients With ST-Segment Elevation Acute Myocardial Infarction. International Heart Journal 48:3, 303-311
CrossRef1066
Hisataka Sasao, Daisuke Hotta, Takuto Maeda, Norie Saito, Satoru Takagi, Kazuaki Shimamoto. (2007) Comparison of Long-Term Clinical Outcome After Sirolimus-Eluting Stent Implantation in Patients With and Without Hemodialysis. International Heart Journal 48:6, 689-700
CrossRef1067
Cheol Whan Lee, Chang-Bum Park, Young-Hak Kim, Myeong-Ki Hong, Jae-Joong Kim, Seong-Wook Park, Seung-Jung Park. (2007) Incidence and predictors of recurrent restenosis following implantation of drug-eluting stents for in-stent restenosis. Catheterization and Cardiovascular Interventions 69:1, 104-108
CrossRef1068
Saravanan Balamuthusamy, Rohit Arora. (2007) Hematologic Adverse Effects of Clopidogrel. American Journal of Therapeutics 14:1, 106-112
CrossRef1069
Seong-Man Kim, Doo-Il Kim, Hwan-Jin Cho, Sang-Hoon Seol, Dae-Kyeong Kim, Tae-Hyun Yang, Dong-Soo Kim. (2007) Effects of Cilostazol on the Drug-Eluting Stent in Native Coronary Arteries. Korean Circulation Journal 37:7, 304
CrossRef1070
Katsuhisa Waseda, Junya Ako, Hideaki Kaneda, Akiyoshi Miyazawa, Yoshihisa Shimada, Yoshihiro Morino, Yasuhiro Honda, Peter J. Fitzgerald. (2007) Effect of Lumen Narrowing Within Sirolimus-Eluting Stents on Proximal and Distal Vessel Segments. Circulation Journal 72:4, 534-537
CrossRef1071
Turkay Ozcan, V. Gokhan Cin, Mustafa Yurtdas, Burak Akcay, Sabri Seyis, Armagan Acele, Dilek Cicek, Ahmet Camsari, Necdet Akkus, Oben Doven. (2007) Angiographic and Clinical Outcome Following Sirolimus-Eluting Stent (Cypher) Implantation. International Heart Journal 48:1, 11-23
CrossRef1072
Jae-Youn Moon, Myung Ho Jeong, In Soo Kim, Chung Hwan Jun, Jung Sun Cho, Jong Won Chung, Doosun Sim, Young Joon Hong, Ju Han Kim, Youngkeun Ahn, Jeong Gwan Cho, Jong Chun Park, Jung Chaee Kang. (2007) The Frequency, Treatment and Clinical Outcomes of Stent Thrombosis after Use of TAXUS??Stent. Korean Circulation Journal 37:12, 641
CrossRef1073
Saeko Takahashi, Hideaki Kaneda, Shinji Tanaka, Yusuke Miyashita, Takaaki Shiono, Yoshio Taketani, Hiroshi Domae, Junya Matsumi, Shingo Mizuno, Yoshiyasu Minami, Kazuya Sugitatsu, Shigeru Saito. (2007) Late Angiographic Stent Thrombosis After Sirolimus-Eluting Stent Implantation. Circulation Journal 71:2, 226-228
CrossRef1074
Nandini Duraiswamy, Richard T. Schoephoerster, Michael R. Moreno, James E. Moore. (2007) Stented Artery Flow Patterns and Their Effects on the Artery Wall. Annual Review of Fluid Mechanics 39:1, 357-382
CrossRef1075
Asako Aoki, Jun Tanabe, Toru Inami, Michio Ogano, Nobuaki Kobayashi, Yusuke Hosokawa, Hiroyuki Yokoyama, Hitoshi Takano, Kyoichi Mizuno. (2007) Late Multiple Stent Fractures Following Deployment of Sirolimus-Eluting Stents for Diffuse Right Coronary Artery Stenosis. International Heart Journal 48:6, 767-772
CrossRef1076
Marcel AM Beijk, Jan J Piek. (2007) XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent. Expert Review of Medical Devices 4:1, 11-21
CrossRef1077
Pil-Ki Min, Jae-Hun Jung, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Won-Heum Shim. (2007) Effect of Cilostazol on In-Stent Neointimal Hyperplasia After Coronary Artery Stenting. Circulation Journal 71:11, 1685-1690
CrossRef1078
Gerrit J. de Borst, Rob G.A. Ackerstaff, Jean-Paul P.M. de Vries, Erik D vd Pavoordt, Jan Albert Vos, Tim T. Overtoom, Frans L. Moll. (2007) Carotid angioplasty and stenting for postendarterectomy stenosis: Long-term follow-up. Journal of Vascular Surgery 45:1, 118-123
CrossRef1079
Kenichi Fukushima, Yoshio Kobayashi, Tomonobu Okuno, Yoshitake Nakamura, Masayoshi Sakakibara, Takashi Nakayama, Nakabumi Kuroda, Akira Miyazaki, Youichi Shimizu, Issei Komuro. (2007) Incidence of Side-Effects of Ticlopidine After Sirolimus-Eluting Stent Implantation. Circulation Journal 71:4, 617-619
CrossRef1080
Masanori Okumura, Yukio Ozaki, Junichi Ishii, Shino Kan, Hiroyuki Naruse, Shigeru Matsui, Makoto Ishikawa, Kousuke Hattori, Tomoko Gochi, Tadashi Nakano, Akira Yamada, Shigeru Kato, Sadako Motoyama, Masayoshi Sarai, Yasushi Takagi, Tevfik F. Ismail, Masanori Nomura, Hitoshi Hishida. (2007) Restenosis and Stent Fracture Following Sirolimus-Eluting Stent (SES) Implantation. Circulation Journal 71:11, 1669-1677
CrossRef1081
Corrado Tamburino, Gian Paolo Ussia, Marco Zimarino, Alfredo R. Galassi, Raffaele De Caterina. (2007) Early restenosis after drug-eluting stent implantation: A putative role for platelet activation. Canadian Journal of Cardiology 23:1, 57-59
CrossRef1082
Woong Kim, Jong-Seon Park, Sang-Hee Lee, Geu-Ru Hong, Dong-Gu Shin, Young-Jo Kim, Bong-Sup Shim, Yoon-Kyung Cho, Hyung-Seop Kim, Chang-Wook Nam, Seung-Ho Hur, Yoon-Nyun Kim, Kwon-Bae Kim, Sang-Hoon Seol, Tae-Hyun Yang, Dae-Kyung Kim, Sung-Man Kim, Doo-Il Kim, Dong-Soo Kim. (2007) Risk Factors Associated with Hemodynamic Instability during Stent Implantation in Unprotected Left Main Lesions without Routine IABP: Identification of the High Risk Patients. Korean Circulation Journal 37:3, 108
CrossRef1083
David Tanous, Jan Hinrich Bräsen, Katherine Choy, Ben J. Wu, Krishna Kathir, Antony Lau, David S. Celermajer, Roland Stocker. (2006) Probucol inhibits in-stent thrombosis and neointimal hyperplasia by promoting re-endothelialization. Atherosclerosis 189:2, 342-349
CrossRef1084
Henry W. Huang, Bruce N. Brent, Richard E. Shaw. (2006) Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era—a report from the American College of Cardiology-National Cardiovascular data registry (ACC-NCDR). Catheterization and Cardiovascular Interventions 68:6, 867-872
CrossRef1085
Harold L. Dauerman. (2006) Drug Eluting Stents. Coronary Artery Disease 17:8, 657-659
CrossRef1086
SIGMUND SILBER. (2006) A New and Rapid Scoring System to Assess the Scientific Evidence from Clinical Trials. Journal of Interventional Cardiology 19:6, 485-492
CrossRef1087
Mark H. Wernick, Allen Jeremias, Joseph P. Carrozza. (2006) Drug-eluting stents and stent thrombosis: a cause for concern?. Coronary Artery Disease 17:8, 661-665
CrossRef1088
Paul Vermeersch, Pierfrancesco Agostoni, Stefan Verheye, Paul Van den Heuvel, Carl Convens, Nico Bruining, Frank Van den Branden, Glenn Van Langenhove. (2006) Randomized Double-Blind Comparison of Sirolimus-Eluting Stent Versus Bare-Metal Stent Implantation in Diseased Saphenous Vein Grafts. Journal of the American College of Cardiology 48:12, 2423-2431
CrossRef1089
Jeffrey M. Caves, Elliot L. Chaikof. (2006) The evolving impact of microfabrication and nanotechnology on stent design. Journal of Vascular Surgery 44:6, 1363-1368
CrossRef1090
Matthias Pfisterer, Hans Peter Brunner-La Rocca, Peter T. Buser, Peter Rickenbacher, Patrick Hunziker, Christian Mueller, Raban Jeger, Franziska Bader, Stefan Osswald, Christoph Kaiser. (2006) Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents. Journal of the American College of Cardiology 48:12, 2584-2591
CrossRef1091
David E. Kandzari, Martin B. Leon, Jeffrey J. Popma, Peter J. Fitzgerald, Charles O’Shaughnessy, Michael W. Ball, Mark Turco, Robert J. Applegate, Paul A. Gurbel, Mark G. Midei, Sejal S. Badre, Laura Mauri, Kweli P. Thompson, LeRoy A. LeNarz, Richard E. Kuntz. (2006) Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients With Native Coronary Artery Disease. Journal of the American College of Cardiology 48:12, 2440-2447
CrossRef1092
Gordon E. Pate, May Lee, Karin Humphries, Eric Cohen, Robert Lowe, Rebecca S. Fox, Robert Teskey, Christopher E. Buller. (2006) Characterizing the spectrum of in-stent restenosis: Implications for contemporary treatment. Canadian Journal of Cardiology 22:14, 1223-1229
CrossRef1093
Duk-Woo Park, Myeong-Ki Hong, Gary S. Mintz, Cheol Whan Lee, Jong-Min Song, Ki-Hoon Han, Duk-Hyun Kang, Sang-Sig Cheong, Jae-Kwan Song, Jae-Joong Kim, Neil J. Weissman, Seong-Wook Park, Seung-Jung Park. (2006) Two-Year Follow-Up of the Quantitative Angiographic and Volumetric Intravascular Ultrasound Analysis After Nonpolymeric Paclitaxel-Eluting Stent Implantation. Journal of the American College of Cardiology 48:12, 2432-2439
CrossRef1094
Huyen Tran, Shamir R Mehta, John W Eikelboom. (2006) Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI). Vascular Health and Risk Management 2:4, 379-387
CrossRef1095
Christian M Matter, Izabela Rozenberg, Andrea Jaschko, Helen Greutert, David J Kurz, Stephan Wnendt, Bernd Kuttler, Hana Joch, J??rg Gr??nenfelder, Gregor Z??nd, Felix C Tanner, Thomas F L??scher. (2006) Effects of Tacrolimus or Sirolimus on Proliferation of Vascular Smooth Muscle and Endothelial Cells. Journal of Cardiovascular Pharmacology 48:6, 286-292
CrossRef1096
ELLIOT J. SMITH, AJAY K. JAIN, MARTIN T. ROTHMAN. (2006) New Developments in Coronary Stent Technology. Journal of Interventional Cardiology 19:6, 493-499
CrossRef1097
Donald E. Cutlip. (2006) Drug-eluting stent era: will we improve 5-year outcomes?. Coronary Artery Disease 17:8, 681-684
CrossRef1098
Leonardo C. Clavijo, Daniel H. Steinberg, Rebecca Torguson, Pramod K. Kuchulakanti, William W. Chu, Jana Fournadjiev, Lowell F. Satler, Kenneth M. Kent, William O. Suddath, Ron Waksman, Augusto D. Pichard. (2006) Sirolimus-eluting stents and calcified coronary lesions: Clinical outcomes of patients treated with and without rotational atherectomy. Catheterization and Cardiovascular Interventions 68:6, 873-878
CrossRef1099
Arturo A Ayon, Michael Cantu, Kalpana Chava, C Mauli Agrawal, Marc D Feldman, Dave Johnson, Devang Patel, Denes Marton, Emily Shi. (2006) Drug loading of nanoporous TiO 2 films. Biomedical Materials 1:4, L11-L15
CrossRef1100
Srihari Thanigaraj, Jason R. Wollmuth, Alan Zajarias, Jacob Chemmalakuzhy, John M. Lasala. (2006) From randomized trials to routine clinical practice: an evidence-based approach for the use of drug-eluting stents. Coronary Artery Disease 17:8, 673-679
CrossRef1101
Duane S. Pinto, Jason Ryan, David J. Cohen. (2006) Drug-eluting stents for stent thrombosis elevation acute myocardial infarction: do we need randomized trials?. Coronary Artery Disease 17:8, 667-671
CrossRef1102
Robert A. Harrington, Robert M. Califf. (2006) Late Ischemic Events After Clopidogrel Cessation Following Drug-Eluting Stenting. Journal of the American College of Cardiology 48:12, 2592-2595
CrossRef1103
Camenzind, Edoardo, . (2006) Treatment of In-Stent Restenosis — Back to the Future?. New England Journal of Medicine 355:20, 2149-2151
Full Text1104
A BUCHWALD, C KUNZE, J WALTENBERGER, C UNTERBERGBUCHWALD. (2006) Transfection of the DNA for the Receptor KDR/flk-1 Attenuates Neointimal Proliferation and Luminal Narrowing in a Coronary Stent Angioplasty Model. Journal of Surgical Research 136:1, 120-124
CrossRef1105
Antonio Maria Calafiore. (2006) Efficacy and Safety of Drug-Eluting Stents: Current Best Available Evidence. Journal of Cardiac Surgery 21:6, 613-614
CrossRef1106
Glenn N Levine, Peter B Berger, David J Cohen, Andrew O Maree, Kenneth Rosenfield, Barbara S Wiggins, Sarah A Spinler. (2006) Newer Pharmacotherapy in Patients Undergoing Percutaneous Coronary Interventions: A Guide for Pharmacists and Other Health Care Professionals. Pharmacotherapy 26:11, 1537-1556
CrossRef1107
Glen E Cooke, Pascal J Goldschmidt-Clermont. (2006) The safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart disease. Expert Opinion on Drug Safety 5:6, 815-826
CrossRef1108
Shahzad G. Raja, Gilles D. Dreyfus. (2006) Efficacy and Safety of Drug-Eluting Stents: Current Best Available Evidence. Journal of Cardiac Surgery 21:6, 605-612
CrossRef1109
S. Kumar, V. Suresh, B.D. Prendergast, N.H. Brooks, P. Wicks, R.D. Levy, S.G. Ray, D.H. Bennett, H.S. Lee. (2006) Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID)—A single-center study comparing Cypher™ sirolimus-eluting with Taxus™ paclitaxel-eluting stents. Catheterization and Cardiovascular Interventions 68:5, 663-668
CrossRef1110
D Charytan, R E Kuntz. (2006) The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney International
CrossRef1111
2006. Parkinson's Disease. .
CrossRef1112
Shpend Elezi, Alban Dibra, Julinda Mehilli, Jürgen Pache, Rainer Wessely, Albert Schömig, Adnan Kastrati. (2006) Vessel Size and Outcome After Coronary Drug-Eluting Stent Placement. Journal of the American College of Cardiology 48:7, 1304-1309
CrossRef1113
Richard J. Parkinson, Christopher P. Demers, Joseph G. Adel, Elad I. Levy, Eric Sauvageau, Ricardo A. Hanel, Ali Shaibani, Lee R. Guterman, L Nelson Hopkins, H Hunt Batjer, Bernard R. Bendok. (2006) Use of Heparin-coated Stents in Neurovascular Interventional Procedures: Preliminary Experience with 10 Patients. Neurosurgery 59:4, 812-821
CrossRef1114
Pilar Jiménez-Quevedo, Manel Sabaté, Dominick J. Angiolillo, Fernando Alfonso, Rosana Hernández-Antolín, José A. Gómez-Hospital, Marcelo Sanmartín, Camino Bañuelos, Raúl Moreno, Javier Escaned, Cristina Fernández, Marco A. Costa, Francisco Fernández-Avilés, Carlos Macaya. (2006) Eficacia de la implantación del stent recubierto de rapamicina en pacientes diabéticos con vasos muy pequeños (≤ 2,25 mm). Subanálisis del estudio DIABETES. Revista Española de Cardiología 59:10, 1000-1007
CrossRef1115
MICHAEL J. COWLEY. (2006) Drug-Eluting Stent Restenosis: Incidence, Predictors, Mechanisms, and Treatment. Journal of Interventional Cardiology 19:s5, S47-S53
CrossRef1116
Jae-Hun Jung, Pil-Ki Min, Jong-Youn Kim, Sungha Park, Eui-Young Choi, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Won-Heum Shim, Seung-Yun Cho. (2006) Systemic immunosuppressive therapy inhibits in-stent restenosis in patients with renal allograft. Catheterization and Cardiovascular Interventions 68:4, 567-573
CrossRef1117
MATTHEW J. PRICE. (2006) Unprotected Left Main Coronary Intervention with Drug-Eluting Stents. Journal of Interventional Cardiology 19:s5, S21-S26
CrossRef1118
DAVID E. KANDZARI, MARTIN B. LEON. (2006) Overview of Pharmacology and Clinical Trials Program with the Zotarolimus-Eluting Endeavor Stent. Journal of Interventional Cardiology 19:5, 405-413
CrossRef1119
JOHN M. LASALA, GREGG W. STONE, KEITH D. DAWKINS, PATRICK W. SERRUYS, ANTONIO COLOMBO, EBERHARD GRUBE, JOERG KOGLIN, STEPHEN ELLIS. (2006) An Overview of the TAXUS
CrossRef1120
Y.H. Lin, Y.C. Liu, W.Y.I. Tseng, J.M. Juang, C.S. Hung, J.W. Lin, J.S. Jeng, P.K. Yip, H.L. Kao. (2006) The Impact of Lesion Length on Angiographic Restenosis after Vertebral Artery Origin Stenting. European Journal of Vascular and Endovascular Surgery 32:4, 379-385
CrossRef1121
Francesco Saia, Giancarlo Piovaccari, Antonio Manari, Andrea Santarelli, Alberto Benassi, Enrico Aurier, Pietro Sangiorgio, Fabio Tarantino, Giuseppe Geraci, Giuseppe Vecchi, Paolo Guastaroba, Roberto Grilli, Antonio Marzocchi. (2006) Clinical Outcomes for Sirolimus-Eluting Stents and Polymer-Coated Paclitaxel-Eluting Stents in Daily Practice. Journal of the American College of Cardiology 48:7, 1312-1318
CrossRef1122
KEVIN C. FLOYD, JOHN E. JAYNE, AARON V. KAPLAN, BRUCE J. FRIEDMAN, NATHANIEL W. NILES, BRUCE D. HETTLEMAN, JOHN F. ROBB, CRAIG A. THOMPSON. (2006) Age-Based Differences of Percutaneous Coronary Intervention in the Drug-Eluting Stent Era. Journal of Interventional Cardiology 19:5, 381-387
CrossRef1123
JOSEPH P. CARROZZA. (2006) Duration of Clopidogrel Therapy with Drug-Eluting Stents. Journal of Interventional Cardiology 19:s5, S40-S46
CrossRef1124
Spaulding, Christian, Henry, Patrick, Teiger, Emmanuel, Beatt, Kevin, Bramucci, Ezio, Carrié, Didier, Slama, Michel S., Merkely, Bela, Erglis, Andrejs, Margheri, Massimo, Varenne, Olivier, Cebrian, Ana, Stoll, Hans-Peter, Snead, David B., Bode, Christoph, . (2006) Sirolimus-Eluting versus Uncoated Stents in Acute Myocardial Infarction. New England Journal of Medicine 355:11, 1093-1104
Full Text1125
O'Neill, William W., . (2006) Risk of Bleeding after Elective Percutaneous Coronary Intervention. New England Journal of Medicine 355:10, 1058-1060
Full Text1126
Victor Y. Lim, Lutz Buellesfeld, Ulrich Gerckens, Ralf Mueller, Thomas Schmidt, Eberhard Grube. (2006) Use of Taxus polymer-coated paclitaxel-eluting stents for treatment of in-stent restenosis in real world patients: Results of clinical and angiographic follow-up at six months in a single-center registry. Catheterization and Cardiovascular Interventions 68:3, 343-348
CrossRef1127
Kyung W Park. (2006) Intracoronary Brachytherapy and Drug-Eluting Coronary Stents. International Anesthesiology Clinics 43:2, 91-100
CrossRef1128
Jörg Hausleiter, Adnan Kastrati. (2006) Is there a role for oral rapamycin in restenosis prevention after bare-metal stent implantation?. Nature Clinical Practice Cardiovascular Medicine 3:9, 476-477
CrossRef1129
Hideki Futamatsu, Manel Sabaté, Dominick J. Angiolillo, Pilar Jimenez-Quevedo, Cecilia Corros, Kino Morikawa-Futamatsu, Fernando Alfonso, Julie Jiang, Pavel Cervinka, Rosana Hernandez-Antolin, Carlos Macaya, Theodore A. Bass, Marco A. Costa. (2006) Characterization of Plaque Prolapse After Drug-Eluting Stent Implantation in Diabetic Patients. Journal of the American College of Cardiology 48:6, 1139-1145
CrossRef1130
Giuseppe Gioia, William Matthai, Alberto Benassi, Hamza Rana, Howard A. Levite, Lannae G. Ewing. (2006) Improved survival with drug-eluting stent implantation in comparison with bare metal stent in patients with severe left ventricular dysfunction. Catheterization and Cardiovascular Interventions 68:3, 392-398
CrossRef1131
Jürg Schwitter. (2006) Future strategies in the management of coronary artery disease. Future Cardiology 2:5, 555-566
CrossRef1132
CHAIM LOTAN, YARON ALMAGOR, KAREL KUIPER, MAARTEN J. SUTTORP, WILLIAM WIJNS. (2006) Sirolimus-Eluting Stent in Chronic Total Occlusion: The SICTO Study. Journal of Interventional Cardiology 19:4, 307-312
CrossRef1133
José R. Balaguer-Malfagón, Francisco Pomar-Domingo, Juan V. Vilar-Herrero, Ana M. Planas-del Viejo, Emilio Pérez-Fernández. (2006) Trombosis del stent en la era moderna: incidencia, consecuencias y factores predictores. Revista Española de Cardiología 59:8, 842-845
CrossRef1134
Michael Jonas, James C. Fang, John C. Wang, Satyendra Giri, Dan Elian, Yedael Har-Zahav, Hung Ly, Philip A. Seifert, Jeffrey J. Popma, Campbell Rogers. (2006) In-Stent Restenosis and Remote Coronary Lesion Progression Are Coupled in Cardiac Transplant Vasculopathy But Not in Native Coronary Artery Disease. Journal of the American College of Cardiology 48:3, 453-461
CrossRef1135
Xiao-Ming Gao, Geoffrey Wong, Binghui Wang, Helen Kiriazis, Xiao-Lei Moore, Yi-Dan Su, Anthony Dart, Xiao-Jun Du. (2006) Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis. Journal of Hypertension 24:8, 1663-1670
CrossRef1136
Gary S. Mintz, Neil J. Weissman. (2006) Intravascular Ultrasound in the Drug-Eluting Stent Era. Journal of the American College of Cardiology 48:3, 421-429
CrossRef1137
Nicolas Benard, Robert Perrault, Damien Coisne. (2006) Computational Approach to Estimating the Effects of Blood Properties on Changes in Intra-stent Flow. Annals of Biomedical Engineering 34:8, 1259-1271
CrossRef1138
J. JENSEN, B. LAGERQVIST, M. AASA, T. SAREV, T. NILSSON, P. TORNVALL. (2006) Clinical and angiographic follow-up after coronary drug-eluting and bare metal stent implantation. Do drug-eluting stents hold the promise?. Journal of Internal Medicine 260:2, 118-124
CrossRef1139
MARCO L. ROSSI, GUIDO BELLI, DENNIS ZAVALLONI PARENTI, MELANIA SCATTURIN, PAOLO PAGNOTTA, GABRIELE GASPARINI, PATRIZIA PRESBITERO. (2006) "Do Least Harm" Philosophy May Suffice for Percutaneous Coronary Intervention in Octogenarians. Journal of Interventional Cardiology 19:4, 313-318
CrossRef1140
Alfredo Rodriguez, Carlos Fernández-Pereira, Máximo Rodriguez-Alemparte. (2006) Oral Sirolimus after bare metal stent implantation. Catheterization and Cardiovascular Interventions 68:2, 334-335
CrossRef1141
Meital Zilberman, Robert C. Eberhart. (2006) DRUG-ELUTING BIORESORBABLE STENTS FOR VARIOUS APPLICATIONS. Annual Review of Biomedical Engineering 8:1, 153-180
CrossRef1142
Andrew J. Carter, Anastasia Brodeur, Robin Collingwood, Sarah Ross, Lori Gibson, Chi-An Wang, Scott Haller, Leslie Coleman, Renu Virmani. (2006) Experimental efficacy of an everolimus eluting cobalt chromium stent. Catheterization and Cardiovascular Interventions 68:1, 97-103
CrossRef1143
Shpend Elezi, Alban Dibra, Ulrike Folkerts, Julinda Mehilli, Sylvia Heigl, Albert Schömig, Adnan Kastrati. (2006) Cost Analysis From Two Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in High-Risk Patients With Coronary Artery Disease. Journal of the American College of Cardiology 48:2, 262-267
CrossRef1144
Fausto Feres, J. Ribamar Costa, Alexandre Abizaid. (2006) Very late thrombosis after drug-eluting stents. Catheterization and Cardiovascular Interventions 68:1, 83-88
CrossRef1145
Alanna Coolong, Laura Mauri. (2006) Clopidogrel treatment surrounding percutaneous coronary intervention: When should it be started and stopped?. Current Cardiology Reports 8:4, 267-271
CrossRef1146
Lei Zhao, Tilo Grosser, Susanne Fries, Leena Kadakia, He Wang, Jonathan Zhao, Robert Falotico. (2006) Lipoxygenase and prostaglandin G/H synthase cascades in cardiovascular disease. Expert Review of Clinical Immunology 2:4, 649-658
CrossRef1147
Jaroslav Pelisek, Alexandra T. Fuchs, Andreas Kuehnl, Wen Tian, Michael T. Kuhlmann, Pierre H. Rolland, Choukri Mekkaoui, Lars Gaedtke, Sigrid Nikol. (2006) C-type natriuretic peptide for reduction of restenosis: gene transfer is superior over single peptide administration. The Journal of Gene Medicine 8:7, 835-844
CrossRef1148
Francesco Liistro, Massimo Fineschi, Paolo Angioli, Giuseppe Sinicropi, Giovanni Falsini, Tommaso Gori, Kenneth Ducci, Achille Bravi, Leonardo Bolognese. (2006) Effectiveness and Safety of Sirolimus Stent Implantation for Coronary In-Stent Restenosis. Journal of the American College of Cardiology 48:2, 270-275
CrossRef1149
Bryan P. Yan, Ronen Gurvitch, Andrew E. Ajani. (2006) Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation. Cardiovascular Revascularization Medicine 7:3, 155-158
CrossRef1150
Ameet Bakhai, Gregg W. Stone, Elizabeth Mahoney, Tara A. Lavelle, Chunxue Shi, Ronna H. Berezin, Betsy J. Lahue, Mary Ann Clark, Michael J. Lacey, Mary E. Russell, Stephen G. Ellis, James B. Hermiller, David A. Cox, David J. Cohen. (2006) Cost Effectiveness of Paclitaxel-Eluting Stents for Patients Undergoing Percutaneous Coronary Revascularization. Journal of the American College of Cardiology 48:2, 253-261
CrossRef1151
William W. Chu, Pramod K. Kuchulakanti, Rebecca Torguson, Betty Wang, Leonardo C. Clavijo, William O. Suddath, Augusto D. Pichard, Lowell F. Satler, Kenneth M. Kent, Ron Waksman. (2006) Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention. Catheterization and Cardiovascular Interventions 68:1, 62-66
CrossRef1152
Kunal Sarkar, Samin K Sharma, Rajesh Sachdeva, Francesco Romeo, Luis Garza, Jawahar L Mehta. (2006) Coronary artery restenosis: vascular biology and emerging therapeutic strategies. Expert Review of Cardiovascular Therapy 4:4, 543-556
CrossRef1153
Simon J. Corbett, Rade Babic, John Cosgrave, Giuseppe M. Sangiorgi, Antonio Colombo. (2006) Is sirolimus better than paclitaxel? A review of the comparative data on drug-eluting stents. Cardiovascular Revascularization Medicine 7:3, 159-164
CrossRef1154
Salah-Eddine Hassani, Roswitha M. Wolfram, Pramod K. Kuchulakanti, Zhenyi Xue, Natalie Gevorkian, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Neil J. Weissman, Ron Waksman,. (2006) Percutaneous coronary intervention with drug-eluting stents in octogenarians: Characteristics, clinical presentation, and outcomes. Catheterization and Cardiovascular Interventions 68:1, 36-43
CrossRef1155
Sandra E. Burke, Richard E. Kuntz, Lewis B. Schwartz. (2006) Zotarolimus (ABT-578) eluting stents. Advanced Drug Delivery Reviews 58:3, 437-446
CrossRef1156
Jeffrey W. Moses, Gregg W. Stone, Eugenia Nikolsky, Gary S. Mintz, George Dangas, Eberhard Grube, Stephen G. Ellis, Alexandra J. Lansky, Giora Weisz, Martin Fahy, Yingbo Na, Mary E. Russell, Dennis Donohoe, Martin B. Leon, Roxana Mehran. (2006) Drug-Eluting Stents in the Treatment of Intermediate Lesions. Journal of the American College of Cardiology 47:11, 2164-2171
CrossRef1157
John Cosgrave, Gloria Melzi, Giuseppe G.L. Biondi-Zoccai, Flavio Airoldi, Alaide Chieffo, Giuseppe M. Sangiorgi, Matteo Montorfano, Iassen Michev, Mauro Carlino, Erminio Bonizzoni, Antonio Colombo. (2006) Drug-Eluting Stent Restenosis. Journal of the American College of Cardiology 47:12, 2399-2404
CrossRef1158
JENNIFER WHITE. (2006) Proceedings of the TCT: Questions Surround Antithrombotic Therapy in Coronary DES Implantation. Journal of Interventional Cardiology 19:3, 232-235
CrossRef1159
Pavel Červinka, Marco A. Costa, Dominick J. Angiolillo, Radim Špaček, Marian Bystroň, Martin Kvašňák, Josef Veselka, Hitesh Nanda, Hideki Futamatsu, Kino Futamatsu. (2006) “Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: An intravascular ultrasound study”. Catheterization and Cardiovascular Interventions 67:6, 846-851
CrossRef1160
Pilar Jiménez-Quevedo, Manel Sabaté, Dominick J. Angiolillo, Marco A. Costa, Fernando Alfonso, Joan Antoni Gómez-Hospital, Rosana Hernández-Antolín, Camino Bañuelos, Javier Goicolea, Francisco Fernández-Avilés, Theodore Bass, Javier Escaned, Raul Moreno, Cristina Fernández, Carlos Macaya. (2006) Vascular Effects of Sirolimus-Eluting Versus Bare-Metal Stents in Diabetic Patients. Journal of the American College of Cardiology 47:11, 2172-2179
CrossRef1161
Eli I. Lev, Nawar Tayyan, Albert E. Raizner, Stuart L. Solomon, Donna Simmons, Neal S. Kleiman. (2006) Initial impact of drug-eluting stent use on the spectrum of patients undergoing percutaneous coronary intervention. Coronary Artery Disease 17:4, 379-384
CrossRef1162
Georgios Sianos, Sofia Vaina, Angela Hoye, Patrick W. Serruys. (2006) Bifurcation stenting with drug eluting stents: Illustration of the crush technique. Catheterization and Cardiovascular Interventions 67:6, 839-845
CrossRef1163
David J. Clark, Sara Lessio, Margaret O’Donoghue, Con Tsalamandris, Robert Schainfeld, Kenneth Rosenfield. (2006) Mechanisms and Predictors of Carotid Artery Stent Restenosis. Journal of the American College of Cardiology 47:12, 2390-2396
CrossRef1164
Einat Cohen-Sela, Ohad Rosenzweig, Jianchuan Gao, Hila Epstein, Irith Gati, Reuven Reich, Haim D. Danenberg, Gershon Golomb. (2006) Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosis. Journal of Controlled Release 113:1, 23-30
CrossRef1165
David R. Holmes, Charanjit Rihal. (2006) The 5-Year Projection on the Future of Interventional Cardiology. The American Heart Hospital Journal 4:3, 195-201
CrossRef1166
Kalpana R. Kamath, James J. Barry, Kathleen M. Miller. (2006) The Taxus™ drug-eluting stent: A new paradigm in controlled drug delivery. Advanced Drug Delivery Reviews 58:3, 412-436
CrossRef1167
A. Mercalli, V. Sordi, M. Ponzoni, P. Maffi, F. De Taddeo, G. Gatti, P. Servida, M. Bernardi, L. Bellio, F. Bertuzzi, A. Secchi, E. Bonifacio, L. Piemonti. (2006) Rapamycin Induces a Caspase-Independent Cell Death in Human Monocytes. American Journal of Transplantation 6:6, 1331-1341
CrossRef1168
Harold L. Dauerman. (2006) Treatment of Stent Restenosis. Journal of the American College of Cardiology 47:11, 2161-2163
CrossRef1169
Hidehiko Hara, Masato Nakamura, Julio C. Palmaz, Robert S. Schwartz. (2006) Role of stent design and coatings on restenosis and thrombosis. Advanced Drug Delivery Reviews 58:3, 377-386
CrossRef1170
Thomas A. Vassiliades, John S. Douglas, Douglas C. Morris, Peter C. Block, Ziyad Ghazzal, S. Tanveer Rab, Christopher U. Cates. (2006) Integrated coronary revascularization with drug-eluting stents: Immediate and seven-month outcome. The Journal of Thoracic and Cardiovascular Surgery 131:5, 956-962
CrossRef1171
Patrick W. Serruys. (2006) Fourth Annual American College of Cardiology International Lecture. Journal of the American College of Cardiology 47:9, 1754-1768
CrossRef1172
Donald E. Cutlip. (2006) Drug-eluting stent era: will we improve 5-year outcomes?. Coronary Artery Disease 17:3, 289-292
CrossRef1173
Jun-ichi Kotani, Masaki Awata, Shinsuke Nanto, Masaaki Uematsu, Fusako Oshima, Hitoshi Minamiguchi, Gary S. Mintz, Seiki Nagata. (2006) Incomplete Neointimal Coverage of Sirolimus-Eluting Stents. Journal of the American College of Cardiology 47:10, 2108-2111
CrossRef1174
Nuno M.M. Pires, J. Wouter Jukema, Mat J.A.P. Daemen, Paul H.A. Quax. (2006) Drug-eluting stents studies in mice: Do we need atherosclerosis to study restenosis?. Vascular Pharmacology 44:5, 257-264
CrossRef1175
Chang-Bum Park, Cheol Whan Lee, Bong-Ki Lee, Young-Hak Kim, Myeong-Ki Hong, Jae-Joong Kim, Seong-Wook Park, Seung-Jung Park. (2006) Safety and efficacy with drug-eluting stent in st-segment elevation and non-ST-segment elevation myocardial infarction. Clinical Cardiology 29:5, 199-203
CrossRef1176
Luis S. Díaz de la Llera, Sara M. Ballesteros, Agustín Guisado, Almudena Aguilera, Ana Campos, Ángel Sánchez, Manuel Villa, Gabriel Retegui. (2006) Tratamiento de las lesiones bifurcadas mediante técnica de crush T stenting: resultados inmediatos y a medio plazo. Revista Española de Cardiología 59:5, 458-464
CrossRef1177
Gretchen M. Ray, James J. Nawarskas, William H. Frishman. (2006) The Paclitaxel-Eluting Stent in Percutaneous Coronary Intervention: Part II. Cardiology in Review 14:3, 143-150
CrossRef1178
Angela Hoye, Ioannis Iakovou, Lei Ge, Carlos A.G. van Mieghem, Andrew T.L. Ong, John Cosgrave, Giuseppe M. Sangiorgi, Flavio Airoldi, Matteo Montorfano, Iassen Michev, Alaide Chieffo, Mauro Carlino, Nicola Corvaja, Jiro Aoki, Gaston A. Rodriguez Granillo, Marco Valgimigli, Georgios Sianos, Willem J. van der Giessen, Pim J. de Feyter, Ron T. van Domburg, Patrick W. Serruys, Antonio Colombo. (2006) Long-Term Outcomes After Stenting of Bifurcation Lesions With the “Crush” Technique. Journal of the American College of Cardiology 47:10, 1949-1958
CrossRef1179
Rüdiger Blindt, Felix Vogt, Irina Astafieva, Christian Fach, Mihail Hristov, Nicole Krott, Berthold Seitz, Aphrodite Kapurniotu, Connie Kwok, Manfred Dewor, Anja-Katrin Bosserhoff, Jürgen Bernhagen, Peter Hanrath, Rainer Hoffmann, Christian Weber. (2006) A Novel Drug-Eluting Stent Coated With an Integrin-Binding Cyclic Arg-Gly-Asp Peptide Inhibits Neointimal Hyperplasia by Recruiting Endothelial Progenitor Cells. Journal of the American College of Cardiology 47:9, 1786-1795
CrossRef1180
G. W. Stone, H. D. Aronow. (2006) Long-term Care After Percutaneous Coronary Intervention: Focus on the Role of Antiplatelet Therapy. Mayo Clinic Proceedings 81:5, 641-652
CrossRef1181
John R. Liddicoat, Ralph De La Torre, Kalon K.L. Ho, Senthil Nathan, Sidney Levitsky, Judy Krempin, Frank Sellke. (2006) Initial Impact of Drug-Eluting Stents on Coronary Artery Bypass Graft Surgery. The Annals of Thoracic Surgery 81:4, 1239-1242
CrossRef1182
William W. Chu, Pramod K. Kuchulakanti, Rebecca Torguson, Betty Wang, Leonardo C. Clavijo, William O. Suddath, Augusto D. Pichard, Lowell F. Satler, Kenneth M. Kent, Ron Waksman. (2006) Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention. Catheterization and Cardiovascular Interventions 67:4, 595-599
CrossRef1183
Giora Weisz, Martin B. Leon, David R. Holmes, Dean J. Kereiakes, Mel R. Clark, Barry M. Cohen, Stephen G. Ellis, Patrick Coleman, Carolyn Hill, Chunxue Shi, Donald E. Cutlip, Richard E. Kuntz, Jeffrey W. Moses. (2006) Two-Year Outcomes After Sirolimus-Eluting Stent Implantation. Journal of the American College of Cardiology 47:7, 1350-1355
CrossRef1184
Tony Y. Eng, M.K. Boersma, C.D. Fuller, J.Y. Luh, A. Siddiqi, S. Wang, C.R. Thomas. (2006) The Role of Radiation Therapy in Benign Diseases. Hematology/Oncology Clinics of North America 20:2, 523-557
CrossRef1185
Peng Wu, David W. Grainger. (2006) Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials 27:11, 2450-2467
CrossRef1186
Ekaterina Iofina, Peter Radke, Daniela Schubert, Roswitha Langenberg, Rüdiger Blindt, Peter Hanrath, Rainer Hoffmann. (2006) Three-year follow-up after intracoronary beta-radiation therapy for in-stent restenosis. Catheterization and Cardiovascular Interventions 67:4, 600-606
CrossRef1187
Kyoung-Ha Park, Seong-Wook Park, Myeong-Ki Hong, Young-Hak Kim, Bong-Ki Lee, Duk-Woo Park, Bong-Ryong Choi, Mi-Jeong Kim, Kyoung-Min Park, Cheol Whan Lee, Sang-Sig Cheong, Jae-Joong Kim, Seung-Jung Park. (2006) Comparison of the effectiveness of sirolimus- and paclitaxel-eluting stents for small coronary artery lesions. Catheterization and Cardiovascular Interventions 67:4, 589-594
CrossRef1188
Ken Inoki, Kun-Liang Guan. (2006) Complexity of the TOR signaling network. Trends in Cell Biology 16:4, 206-212
CrossRef1189
Alfredo E. Rodriguez, Juan F. Granada, Máximo Rodriguez-Alemparte, Cesar F. Vigo, Juan Delgado, Carlos Fernandez-Pereira, Antonio Pocovi, Alfredo M. Rodriguez-Granillo, Daryl Schulz, Albert E. Raizner, Igor Palacios, William O’Neill, Grzegorz L. Kaluza, Gregg Stone. (2006) Oral Rapamycin After Coronary Bare-Metal Stent Implantation to Prevent Restenosis. Journal of the American College of Cardiology 47:8, 1522-1529
CrossRef1190
JOSE VALENCIA, ALBERTO BERENGUER, VICENTE MAINAR, PASCUAL BORDES, SILVIA GOMEZ, ANTONIO TELLO, MIGUEL ANGEL LOPEZ-ARANDA, JUAN CATURLA. (2006) Two-Year Follow-up of Sirolimus-Eluting Stents for the Treatment of Proximal Left Anterior Descending Coronary Artery Stenosis. Journal of Interventional Cardiology 19:2, 126-134
CrossRef1191
Issam Moussa. (2006) Are drug-eluting stents cost-effective when compared with bare-metal stents in a real-world setting?. Nature Clinical Practice Cardiovascular Medicine 3:4, 192-193
CrossRef1192
C. Bauer, O. Lidove, C. Lamotte, T. Petit, D. Lieberherr, M.P. Chauveheid, C. Legendre, B. Crestani, M.C. Dombret, J.P. Laissy, C. Antoine, B. Pegaz-Fiornet, T. Papo. (2006) Pneumopathie organisée au sirolimus : un diagnostic à évoquer chez le patient transplanté d'organe. La Revue de Médecine Interne 27:3, 248-252
CrossRef1193
José M. de la Torre-Hernández, Fermín Sainz-Laso, Miguel Llano-Cardenal, Marta Ruiz-Lera, Leticia Rodríguez-Friera, Virginia Burgos, Javier Zueco, Álvaro Figueroa, Thierry Colman. (2006) Seguimiento clínico a 2 años de 200 pacientes tratados con stent liberador de rapamicina en lesiones de alto riesgo de reestenosis. Revista Española de Cardiología 59:3, 225-231
CrossRef1194
Angela Migliorini, Guia Moschi, Ruben Vergara, Guido Parodi, Nazario Carrabba, David Antoniucci. (2006) Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion. Catheterization and Cardiovascular Interventions 67:3, 344-348
CrossRef1195
Feras M. Bader, Abdallah G. Kfoury, Edward M. Gilbert, William H. Barry, Naeem Humayun, Mary E. Hagan, Heidi Thomas, Dale Renlund. (2006) Percutaneous Coronary Interventions With Stents in Cardiac Transplant Recipients. The Journal of Heart and Lung Transplantation 25:3, 298-301
CrossRef1196
Peter McCullough. (2006) Outcomes of contrast-induced nephropathy: Experience in patients undergoing cardiovascular intervention. Catheterization and Cardiovascular Interventions 67:3, 335-343
CrossRef1197
Shahzad G. Raja. (2006) Drug-Eluting Stents and the Future of Coronary Artery Bypass Surgery: Facts and Fiction. The Annals of Thoracic Surgery 81:3, 1162-1171
CrossRef1198
Serruys, Patrick W., Kutryk, Michael J.B., Ong, Andrew T.L., . (2006) Coronary-Artery Stents. New England Journal of Medicine 354:5, 483-495
Full Text1199
BRUCE R. BRODIE. (2006) Adjunctive Balloon Postdilatation after Stent Deployment: Is It Still Necessary with Drug-Eluting Stents?. Journal of Interventional Cardiology 19:1, 43-50
CrossRef1200
Gianfranco Percoco, Antonio Manari, Paolo Guastaroba, Gianluca Campo, Vincenzo Guiducci, Enrico Aurier, Pietro Sangiorgio, Francesco Passerini, Giuseppe Geraci, Giancarlo Piovaccari, Monica Naldi, Francesco Saia, Antonio Marzocchi, . (2006) Safety and Long-Term Efficacy of Sirolimus Eluting Stent in ST-elevation Acute Myocardial Infarction: The REAL (Registro REgionale AngiopLastiche Emilia-Romagna) Registry. Cardiovascular Drugs and Therapy 20:1, 63-68
CrossRef1201
Manel Sabaté. (2006) Insulinodependencia, ¿rapamicina-resistencia?. Revista Española de Cardiología 59:2, 91-93
CrossRef1202
Rainer Wessely, Albert Schömig, Adnan Kastrati. (2006) Sirolimus and Paclitaxel on Polymer-Based Drug-Eluting Stents. Journal of the American College of Cardiology 47:4, 708-714
CrossRef1203
DEMOSTHENES G. KATRITSIS, SOCRATES KOROVESIS, ILIAS KARABINOS, ELEFTHERIOS GIAZITZOGLOU, SPYRIDOULA THEODOROU, EVANGELIA KARVOUNI, EUTYCHIOS VORIDIS. (2006) Sirolimus- versus Paclitaxel-Eluting Stents: A Comparison of Two Consecutive Series in Routine Clinical Practice. Journal of Interventional Cardiology 19:1, 31-37
CrossRef1204
Young-Hak Kim, Seong-Wook Park, Cheol Whan Lee, Myeong-Ki Hong, Hyeon-Cheol Gwon, Yangsoo Jang, Myoung Mook Lee, Bon Kwon Koo, Dong Joo Oh, Ki Bae Seung, Seung-Jae Tahk, Junghan Yoon, Seung-Jung Park. (2006) Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions. Catheterization and Cardiovascular Interventions 67:2, 181-187
CrossRef1205
Sheila A Doggrell. (2006) Sirolimus- or paclitaxel-eluting stents for coronary artery revascularisation. Expert Opinion on Pharmacotherapy 7:2, 225-228
CrossRef1206
Satya Reddy Atmakuri, Eli I. Lev, Carlos Alviar, Edward Ibarra, Albert E. Raizner, Stuart L. Solomon, Neal S. Kleiman. (2006) Initial Experience With a Magnetic Navigation System for Percutaneous Coronary Intervention in Complex Coronary Artery Lesions. Journal of the American College of Cardiology 47:3, 515-521
CrossRef1207
Thierry Charron, Nafiseh Nili, Bradley H. Strauss. (2006) The cell cycle: A critical therapeutic target to prevent vascular proliferative disease. Canadian Journal of Cardiology 22, 41B-55B
CrossRef1208
Donald S. Baim, Laura Mauri, Donald C. Cutlip. (2006) Drug-Eluting Stenting for Unprotected Left Main Coronary Artery Disease. Journal of the American College of Cardiology 47:4, 878-881
CrossRef1209
Jianmin Yang, Ningfu Wang, Xingwei Zhang, Jian Xu, Feng Ling, Liang Zhou, Xianhua Ye. (2006) Late Angiographic Stent Thrombosis in a Drug-Eluting Stent That Occurred 20 Months After Premature Discontinuation of Clopidogrel Administration. International Heart Journal 47:5, 707-713
CrossRef1210
Craig A. Thompson, Aaron V. Kaplan, Bruce J. Friedman, John E. Jayne, Barbara R. Gerling, Nathaniel W. Niles, Bruce D. Hettleman, John F. Robb. (2006) Gender-based differences of percutaneous coronary intervention in the drug-eluting stent era. Catheterization and Cardiovascular Interventions 67:1, 25-31
CrossRef1211
Henning Kelbæk, Leif Thuesen, Steffen Helqvist, Lene Kløvgaard, Erik Jørgensen, Samir Aljabbari, Kari Saunamäki, Lars R. Krusell, Gunnar V.H. Jensen, Hans E. Bøtker, Jens F. Lassen, Henning R. Andersen, Per Thayssen, Anders Galløe, Anton van Weert. (2006) The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) Trial. Journal of the American College of Cardiology 47:2, 449-455
CrossRef1212
Joannis E. Vamvakopoulos, Lyubomir Petrov, Silja Aavik, Satu Lehti, Einari Aavik, Pekka Häyry. (2006) Synergistic Suppression of Rat Neointimal Hyperplasia by Rapamycin and Imatinib Mesylate: Implications for the Prevention of Accelerated Arteriosclerosis. Journal of Vascular Research 43:2, 184-192
CrossRef1213
Jonathan R. Nebeker, Renu Virmani, Charles L. Bennett, Jennifer M. Hoffman, Matthew H. Samore, Jorge Alvarez, Charles J. Davidson, June M. McKoy, Dennis W. Raisch, Brian K. Whisenant, Paul R. Yarnold, Steven M. Belknap, Dennis P. West, Jonathan E. Gage, Richard E. Morse, Gordana Gligoric, Laura Davidson, Marc D. Feldman. (2006) Hypersensitivity Cases Associated With Drug-Eluting Coronary Stents. Journal of the American College of Cardiology 47:1, 175-181
CrossRef1214
Alfredo E. Rodriguez, Juan Mieres, Carlos Fernandez-Pereira, Cesar F. Vigo, Maximo Rodriguez-Alemparte, Daniel Berrocal, Liliana Grinfeld, Igor Palacios. (2006) Coronary Stent Thrombosis in the Current Drug-Eluting Stent Era: Insights From the ERACI III Trial. Journal of the American College of Cardiology 47:1, 205-207
CrossRef1215
Babak Azarbal, Jesse W. Currier. (2006) Allergic Reactions After the Implantation of Drug-Eluting Stents. Journal of the American College of Cardiology 47:1, 182-183
CrossRef1216
Edo Kaluski, Alberto Hendler, Nir Uriel, Olga Milo‐Cotter, Zvi Vered, Ricardo Krakover, Gad Cotter. (2006) Adjunctive pharmacotherapy for coronary interventions—time to read the writing on the wall. Acute Cardiac Care 8:4, 186-195
CrossRef1217
Lloyd W. Klein. (2006) Are Drug-Eluting Stents the Preferred Treatment for Multivessel Coronary Artery Disease?. Journal of the American College of Cardiology 47:1, 22-26
CrossRef1218
Hidetsugu Sakai, Naotsugu Oyama, Noriaki Kishimoto, Masashige Takahashi, Kazushi Urasawa, Hiroyuki Tsutsui. (2006) Revascularization of Malignant Coronary Instent Restenosis Resulting From Takayasu's Arteritis Using Sirolimus-Eluting Stents. International Heart Journal 47:5, 795-801
CrossRef1219
Nakazawa Gaku, Tanabe Kengo, Jiro Aoki, Yoshinobu Onuma, Hirosada Yamamoto, Yasutomi Higashikuni, Hiroyoshi Nakajima, Kazuhiro Hara. (2006) Clinical and Angiographic Outcomes of Sirolimus-Eluting Stents Implantation in Japanese Patients in Daily Practice. Circulation Journal 70:11, 1367-1371
CrossRef1220
G SARDELLA, P MARIANI, M DALESSANDRO, L DELUCA, M PIERRO, M MANCONE, A PORRETTA, D ACCAPEZZATO, F FEDELE, M PAROLI. (2006) Early elevation of interleukin-1β and interleukin-6 levels after bare or drug-eluting stent implantation in patients with stable angina. Thrombosis Research 117:6, 659-664
CrossRef1221
Ariel Roguin, Ehud Grenadier. (2006) Stent‐based percutaneous coronary interventions in small coronary arteries. Acute Cardiac Care 8:2, 70-74
CrossRef1222
F. Vochelet, C. Tron, H. Eltchaninoff, L. Sebagh, A. Tavildari, A. Cribier. (2006) Résultats immédiats et suivi clinique des patients traités par implantation de stents actifs en pratique courante. Annales de Cardiologie et d Angéiologie 55:4, 199
CrossRef1223
St??phane Rinfret, David J Cohen, Amir A Tahami Monfared, Jacques LeLorier, Jean Mireault, Erick Schampaert. (2006) Cost Effectiveness of the Sirolimus-Eluting Stent in High-Risk Patients in Canada. American Journal of Cardiovascular Drugs 6:3, 159-168
CrossRef1224
Robert F. Bonvini, Taoufik Hendiri, Giovanni Leo, Nicolas Aeby, Jacques Noble, Ulrich Sigwart, Vitali Verin. (2006) Feasibility and safety of intra‐coronary Beta irradiation with 144 Ce/Pr for prevention of restenosis after percutaneous transluminal coronary angioplasty of in‐stent restenotic lesions. Acute Cardiac Care 8:4, 217-223
CrossRef1225
M. T. R. Grapow, R. Wattenwyl, H.-R. Zerkowski. (2006) Aktuelle evidenzbasierte Situation in der Koronarrevaskularisation—. Clinical Research in Cardiology 95:S1, i31-i34
CrossRef1226
Lan Ni, Hiroki Teragawa, Kentaro Ueda, Hiroaki Takemoto, Takayuki Hidaka, Kenji Nishioka, Junko Soga, Noboru Oda, Yukiko Nakano, Tetsuji Shingu, Kazuaki Chayama. (2006) Successive, Rapid Recurrences of In-stent Restenoses in a Woman with Angina Pectoris. Internal Medicine 45:19, 1093-1096
CrossRef1227
Sidney C. Smith, Ted E. Feldman, John W. Hirshfeld, Alice K. Jacobs, Morton J. Kern, Spencer B. King, Douglass A. Morrison, William W. O’Neill, Hartzell V. Schaff, Patrick L. Whitlow, David O. Williams, Elliott M. Antman, Sidney C. Smith, Cynthia D. Adams, Jeffrey L. Anderson, David P. Faxon, Valentin Fuster, Jonathan L. Halperin, Loren F. Hiratzka, Sharon Ann Hunt, Alice K. Jacobs, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel. (2006) ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention. Journal of the American College of Cardiology 47:1, e1-e121
CrossRef1228
Robert S Dieter, Mohammed Ahmed, Sohail Ikram, John P Pacanowski Jr, Aravinda Nanjundappa. (2006) Clinical efficacy of drug-eluting stents in patients with diabetes. Therapy 3:1, 1-3
CrossRef1229
Atasu K Nayak, Akio Kawamura, Richard W Nesto, Gershan Davis, Jennifer Jarbeau, Christopher T Pyne, David E Gossman, Thomas C Piemonte, Nabila Riskalla, Manish S Chauhan. (2006) Myocardial Infarction as a Presentation of Clinical In-Stent Restenosis. Circulation Journal 70:8, 1026-1029
CrossRef1230
AB Mehta, Sameer Shah. (2006) Unstable or high risk plaque: How do we approach it?. Medical Journal Armed Forces India 62:1, 2-7
CrossRef1231
Harald Seifarth, Murat ??zg??n, Rainer Raupach, Thomas Flohr, Walter Heindel, Roman Fischbach, David Maintz. (2006) 64- Versus 16-Slice CT Angiography for Coronary Artery Stent Assessment. Investigative Radiology 41:1, 22-27
CrossRef1232
Shunya Ikeda, Mia Kobayashi. (2006) Economic evaluation of drug-eluting stents in Japan. The Keio Journal of Medicine 55:1, 15-22
CrossRef1233
(2005) Drug-Eluting Coronary Stents. New England Journal of Medicine 353:22, 2404-2408
Full Text1234
Gaëlle Pellé, Ychen Xu, Noujoud Khoury, Béatrice Mougenot, Eric Rondeau. (2005) Thrombotic Microangiopathy in Marginal Kidneys After Sirolimus Use. American Journal of Kidney Diseases 46:6, 1124-1128
CrossRef1235
Michael S. Lee, Atman P. Shah, Joseph Aragon, Aamer Jamali, Suhail Dohad, Saibal Kar, Raj R. Makkar. (2005) Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts. Catheterization and Cardiovascular Interventions 66:4, 507-511
CrossRef1236
Manuel Galiñanes. (2005) Nuevas expectativas en la revascularización miocárdica quirúrgica. Revista Española de Cardiología 58:12, 1459-1468
CrossRef1237
Andrew TL Ong, Patrick W Serruys. (2005) Technology Insight: an overview of research in drug-eluting stents. Nature Clinical Practice Cardiovascular Medicine 2:12, 647-658
CrossRef1238
JUN TANIGAWA, NILESH SUTARIA, OMER GOKTEKIN, CARLO DI MARIO. (2005) Treatment of Unprotected Left Main Coronary Artery Stenosis in the Drug-Eluting Stent Era. Journal of Interventional Cardiology 18:6, 455-465
CrossRef1239
SIGMUND SILBER. (2005) Cypher Versus Taxus: Are There Differences?. Journal of Interventional Cardiology 18:6, 441-446
CrossRef1240
Arkadiusz Derkacz, Marcin Protasiewicz, Nicholas Kipshidze, Dariusz Biały, Rafał Poręba, Elżbieta Bereś-Pawlik, Krzysztof Abramski, Andwalentyna Mazurek. (2005) Endoluminal Phototherapy for Prevention of Restenosis: Preliminary Results at 6-Month Follow-Up. Photomedicine and Laser Surgery 23:6, 536-542
CrossRef1241
Itzhak Herz, Yaron Moshkovitz, Dan Loberman, Gideon Uretzky, Rony Braunstein, Alberto Hendler, Einat Zivi, Yanai Ben-Gal, Rephael Mohr. (2005) Drug-Eluting Stents Versus Bilateral Internal Thoracic Grafting for Multivessel Coronary Disease. The Annals of Thoracic Surgery 80:6, 2086-2090
CrossRef1242
On-Hing Kwok, Wing-Hing Chow, Tin-Chu Law, Alex Chiu, William Ng, Wai-Fat Lam, Mun K. Hong, Jeffrey J. Popma. (2005) First human experience with angiopeptin-eluting stent: A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Catheterization and Cardiovascular Interventions 66:4, 541-546
CrossRef1243
Rainer Hoffmann, Giulio Guagliumi, Giuseppe Musumeci, Bernhard Reimers, Anna S Petronio, Clemens Disco, Giovanni Amoroso, Jeffrey W. Moses, Peter J. Fitzgerald, Joachim Schofer, Martin B. Leon, Günther Breithardt. (2005) Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: Comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials. Catheterization and Cardiovascular Interventions 66:4, 499-506
CrossRef1244
Roger J. Laham. (2005) Drug eluting stents for everyone and everything?. Catheterization and Cardiovascular Interventions 66:4, 512-513
CrossRef1245
PAUL VERMEERSCH, PIERFRANCESCO AGOSTONI. (2005) Should Degenerated Saphenous Vein Grafts Routinely Be Sealed with Drug-Eluting Stents?. Journal of Interventional Cardiology 18:6, 467-473
CrossRef1246
Chun-Ming Shih, Chun-Che Shih, Yea-Yang Su, Nen-Chung Chang, Shing-Jong Lin. (2005) In vitro study of drug loading on polymer-free oxide films of metallic implants. Journal of Biomedical Materials Research Part A 75A:3, 519-529
CrossRef1247
Áurea J. Chaves, Amanda G.M.R. Sousa, Luiz A. Mattos, Alexandre Abizaid, Fausto Feres, Rodolfo Staico, Marinella Centemero, Luiz F. Tanajura, Andrea C. Abizaid, Arilson Rodrigues, Ângela Paes, Gary S. Mintz, J. Eduardo Sousa. (2005) Pilot study with an intensified oral sirolimus regimen for the prevention of in-stent restenosis in de novo lesions: A serial intravascular ultrasound study. Catheterization and Cardiovascular Interventions 66:4, 535-540
CrossRef1248
Gjin Ndrepepa, Siegmund Braun, Alban Dibra, Julinda Mehilli, Wolfgang Vogt, Albert Schömig, Adnan Kastrati. (2005) Iron status and clinical outcome in patients with coronary artery disease after coronary stenting. Nutrition, Metabolism and Cardiovascular Diseases 15:6, 418-425
CrossRef1249
Tae-Hyun Yang, Seong-Wook Park, Myeong-Ki Hong, Duk-Woo Park, Kyoung-Min Park, Young-Hak Kim, Ki-Hoon Han, Cheol Whan Lee, Sang-Sig Cheong, Jae-Joong Kim, Seung-Jung Park. (2005) Impact of Diabetes Mellitus on Angiographic and Clinical Outcomes in the Drug-Eluting Stents Era. The American Journal of Cardiology 96:10, 1389-1392
CrossRef1250
Jiro Aoki, Alexandre C. Abizaid, Patrick W. Serruys, Andrew T.L. Ong, Eric Boersma, J. Eduardo Sousa, Nico Bruining. (2005) Evaluation of Four-Year Coronary Artery Response After Sirolimus-Eluting Stent Implantation Using Serial Quantitative Intravascular Ultrasound and Computer-Assisted Grayscale Value Analysis for Plaque Composition in Event-Free Patients. Journal of the American College of Cardiology 46:9, 1670-1676
CrossRef1251
M. Rau, C. Maikowski, M. Weber, E. Keil, A. Elsässer, H. Möllmann, C. Hamm. (2005) Treatment of in-stent restenosis with sirolimus-eluting-stents—. Zeitschrift für Kardiologie 94:11, 742-747
CrossRef1252
T. M. Schiele. (2005) Current understanding of coronary in-stent restenosis. Zeitschrift für Kardiologie 94:11, 772-790
CrossRef1253
THOMAS NEUMANN, JOHANNES SPERZEL, THORSTEN DILL, ALEXANDER KLUGE, ALI ERDOGAN, HARALD GREIS, JOCHEN HANSEL, ALEXANDER BERKOWITSCH, KLAUS KURZIDIM, MALTE KUNISS, CHRISTIAN W. HAMM, HEINZ-F. PITSCHNER. (2005) Percutaneous Pulmonary Vein Stenting for the Treatment of Severe Stenosis After Pulmonary Vein Isolation. Journal of Cardiovascular Electrophysiology 16:11, 1180-1188
CrossRef1254
Hideaki Kaneda, Junya Ako, Yasuhiro Honda, Mitsuyasu Terashima, Yoshihiro Morino, Paul G. Yock, Jeffrey J. Popma, Martin B. Leon, Jeffrey W. Moses, Peter J. Fitzgerald. (2005) Impact of Asymmetric Stent Expansion on Neointimal Hyperplasia Following Sirolimus-Eluting Stent Implantation. The American Journal of Cardiology 96:10, 1404-1407
CrossRef1255
Catherine Cagiannos, Omran R. Abul-Khoudoud, Waldemar DeRijk, Daniel H. Shell, Lisa K. Jennings, Elizabeth A. Tolley, Charles R. Handorf, Timothy C. Fabian. (2005) Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model. Journal of Vascular Surgery 42:5, 980-988
CrossRef1256
Manuel Pan, José Suárez De Lezo, Alfonso Medina, Miguel Romero, Antonio Delgado, José Segura, Soledad Ojeda, Djordje Pavlovic, Javier Ariza, Jaime Fernández-Dueñas, Juan Herrador, Isabel Ureña. (2005) Ecografía intracoronaria durante el seguimiento en la valoración de stents liberadores de rapamicina para el tratamiento de las lesiones en bifurcación: implicaciones técnicas. Revista Española de Cardiología 58:11, 1278-1286
CrossRef1257
Paolo Ortolani, Diego Ardissino, Claudio Cavallini, Ezio Bramucci, Ciro Indolfi, Matteo Aquilina, Antonio Marzocchi. (2005) Effect of Sirolimus-Eluting Stent in Diabetic Patients With Small Coronary Arteries (A SES-SMART Substudy). The American Journal of Cardiology 96:10, 1393-1398
CrossRef1258
Rajbabu Pakala, Eugenio Stabile, Gil Jin Jang, Leonardo Clavijo, Ron Waksman. (2005) Rapamycin Attenuates Atherosclerotic Plaque Progression in Apolipoprotein E Knockout Mice. Journal of Cardiovascular Pharmacology 46:4, 481-486
CrossRef1259
Yoshinobu Murasato, Hiroshi Suzuka, Fumihiko Kamezaki. (2005) Vascular endoscopic and macroscopic observations after crush stenting of coronary artery bifurcations in pigs. Catheterization and Cardiovascular Interventions 66:2, 237-243
CrossRef1260
Gregg W. Stone, Antonio Colombo, Paul S. Teirstein, Jeffrey W. Moses, Martin B. Leon, Nicolaus J. Reifart, Gary S. Mintz, Angela Hoye, David A. Cox, Donald S. Baim, Bradley H. Strauss, Matthew Selmon, Issam Moussa, Takahiko Suzuki, Hideo Tamai, Osamu Katoh, Kazuaki Mitsudo, Eberhard Grube, Louis A. Cannon, David E. Kandzari, Mark Reisman, Robert S. Schwartz, Steven Bailey, George Dangas, Roxana Mehran, Alexander Abizaid, Patrick W. Serruys. (2005) Percutaneous recanalization of chronically occluded coronary arteries: Procedural techniques, devices, and results. Catheterization and Cardiovascular Interventions 66:2, 217-236
CrossRef1261
Raúl Moreno. (2005) How cost-effective are sirolimus-eluting stents when compared with bare-metal stents?. Nature Clinical Practice Cardiovascular Medicine 2:10, 512-513
CrossRef1262
L. Buellesfeld, V. Lim, U. Gerckens, R. Mueller, E. Grube. (2005) Comparative endoluminal visualization of TAXUS crush-stenting at 9 months follow-up by intravascular ultrasound and optical coherence tomography. Zeitschrift für Kardiologie 94:10, 690-694
CrossRef1263
Yoritaka Otsuka, Masato Nakamura, Satoshi Yasuda, Ken Kozuma, Hisao Hara, Isao Morii, Atsushi Kawamura, Kazuhiro Sase, Shunichi Miyazaki. (2005) Comparison of Pharmacokinetics of the Sirolimus-Eluting Stent in Japanese Patients with Those in American Patients. Journal of Cardiovascular Pharmacology 46:4, 468-473
CrossRef1264
Raed Aqel, Ritesh Gupta, Jose A. Tallaj, Gilbert J. Zoghbi. (2005) Re-Stenosis of a Sirolimus-Coated Stent in a Heart Transplant Recipient With Allograft Vasculopathy. The Journal of Heart and Lung Transplantation 24:9, 1444.e9-1444.e11
CrossRef1265
José M Morales, Beatriz Dominguez-Gil. (2005) Cardiovascular risk profile with the new immunosuppressive combinations after renal transplantation. Journal of Hypertension 23:9, 1609-1616
CrossRef1266
Junya Ako, Yoshihiro Morino, Yasuhiro Honda, Ali Hassan, Shinjo Sonoda, Paul G. Yock, Martin B. Leon, Jeffrey W. Moses, Heidi N. Bonneau, Peter J. Fitzgerald. (2005) Late Incomplete Stent Apposition After Sirolimus-Eluting Stent Implantation. Journal of the American College of Cardiology 46:6, 1002-1005
CrossRef1267
Nicholas N Kipshidze, Mykola V Tsapenko, Martin B Leon, Gregg W Stone, Jeffrey W Moses. (2005) Update on drug-eluting coronary stents. Expert Review of Cardiovascular Therapy 3:5, 953-968
CrossRef1268
Rainer Wessely, Jurgen Pache, Albert Schomig. (2005) Recurrence of in-stent restenosis in cardiac allograft vasculopathy following implantation of a sirolimus-eluting stent. Transplant International 18:9, 1113-1115
CrossRef1269
Ki-Bae Seung, Young-Hak Kim, Duk-Woo Park, Bong-Ki Lee, Cheol Whan Lee, Myeong-Ki Hong, Pum-Joon Kim, Wook-Sung Chung, Seung-Jea Tahk, Seong-Wook Park, Seung-Jung Park. (2005) Effectiveness of Sirolimus-Eluting Stent Implantation for the Treatment of Ostial Left Anterior Descending Artery Stenosis With Intravascular Ultrasound Guidance. Journal of the American College of Cardiology 46:5, 787-792
CrossRef1270
Daniel C Bezerra, Julien Bogousslavky. (2005) Clopidogrel: cardiologists’ panacea or neurologists’ headache?. Future Cardiology 1:5, 579-590
CrossRef1271
Christoph Kaiser, Hans Peter Brunner-La Rocca, Peter T Buser, Piero O Bonetti, Stefan Osswald, André Linka, Alain Bernheim, Andreas Zutter, Michael Zellweger, Leticia Grize, Matthias E Pfisterer. (2005) Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET). The Lancet 366:9489, 921-929
CrossRef1272
Dibra, Alban, Kastrati, Adnan, Mehilli, Julinda, Pache, Jürgen, Schühlen, Helmut, von Beckerath, Nicolas, Ulm, Kurt, Wessely, Rainer, Dirschinger, Josef, Schömig, Albert, . (2005) Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic Patients. New England Journal of Medicine 353:7, 663-670
Full Text1273
Windecker, Stephan, Remondino, Andrea, Eberli, Franz R., Jüni, Peter, Räber, Lorenz, Wenaweser, Peter, Togni, Mario, Billinger, Michael, Tüller, David, Seiler, Christian, Roffi, Marco, Corti, Roberto, Sütsch, Gabor, Maier, Willibald, Lüscher, Thomas, Hess, Otto M., Egger, Matthias, Meier, Bernhard, . (2005) Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary Revascularization. New England Journal of Medicine 353:7, 653-662
Full Text1274
Moliterno, David J., . (2005) Healing Achilles — Sirolimus versus Paclitaxel. New England Journal of Medicine 353:7, 724-727
Full Text1275
Mithal Nasser, Michael Kapeliovich, Walter Markiewicz. (2005) Late thrombosis of sirolimus-eluting stents following noncardiac surgery. Catheterization and Cardiovascular Interventions 65:4, 516-519
CrossRef1276
Jorge A. Belardi, Fernando Cura, Mariano Albertal, Lucio Padilla, German Solioz, Pablo Perez Balino, Julio A. Pascua, Carlos Fava, Daniel Berrocal, Oscar Mendiz, Liliana Grinfeld. (2005) Use of drug-eluting stents for the treatment of in-stent restenosis in routine clinical practice. Coronary Artery Disease 16:5, 327-330
CrossRef1277
Bon-Kwon Koo, Hyun-Jai Kang, Tae-Jin Youn, In-Ho Chae, Dong-Joo Choi, Hyo-Soo Kim, Dae-Won Sohn, Byung-Hee Oh, Myoung-Mook Lee, Young-Bae Park, Yun-Shik Choi, Seung-Jae Tahk. (2005) Physiologic Assessment of Jailed Side Branch Lesions Using Fractional Flow Reserve. Journal of the American College of Cardiology 46:4, 633-637
CrossRef1278
William W. Chu, Seung-Woon Rha, Pramod K. Kuchulakanti, Edouard Cheneau, Rebecca Torguson, Rajbabu Pakala, Ellen E. Pinnow, Augusto D. Pichard, Lowell F. Satler, Kenneth M. Kent, Joseph Lindsay, Ron Waksman. (2005) Selective versus exclusive use of sirolimus-eluting stent implantation in multivessel coronary artery disease. Catheterization and Cardiovascular Interventions 65:4, 473-477
CrossRef1279
Edouard Cheneau, Seung-Woon Rha, Pramod K. Kuchulakanti, Eugenio Stabile, Timothy Kinnaird, Rebecca Torguson, Augusto D. Pichard, Lowell F. Satler, Kenneth M. Kent, Ron Waksman. (2005) Impact of sirolimus-eluting stents on outcomes of patients treated for acute myocardial infarction by primary angioplasty. Catheterization and Cardiovascular Interventions 65:4, 469-472
CrossRef1280
Patrick W. Serruys, Andrew T.L. Ong, Lex A. van Herwerden, J. Eduardo Sousa, Adib Jatene, Johannes J.R.M. Bonnier, Jacques P.M.A. Schönberger, Nigel Buller, Robert Bonser, Clemens Disco, Bianca Backx, Paul G. Hugenholtz, Brian G. Firth, Felix Unger. (2005) Five-Year Outcomes After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease. Journal of the American College of Cardiology 46:4, 575-581
CrossRef1281
Jiro Aoki, Gastón A. Rodríguez-Granillo, Patrick W. Serruys. (2005) Estrategias emergentes en cardiología intervencionista. Revista Española de Cardiología 58:8, 962-973
CrossRef1282
Robert M. Califf. (2005) Stenting or Surgery. Journal of the American College of Cardiology 46:4, 589-591
CrossRef1283
Philippe Garot, Thierry Lefèvre, Michael Savage, Yves Louvard, William R. Bamlet, James T. Willerson, Marie-Claude Morice, David R. Holmes. (2005) Nine-Month Outcome of Patients Treated by Percutaneous Coronary Interventions for Bifurcation Lesions in the Recent Era. Journal of the American College of Cardiology 46:4, 606-612
CrossRef1284
F PHILIPPE, A DIBIE, F LARRAZET, T MEZIANE, T FOLLIGUET, F LABORDE. (2005) Les stents à élution de médicaments : preuves, incertitudes et pratiques. Annales de Cardiologie et d'Angéiologie 54:4, 201-211
CrossRef1285
Alaide Chieffo, Antonio Colombo. (2005) Treatment of unprotected left main coronary artery disease with drug-eluting stents: is it time for a randomized trial?. Nature Clinical Practice Cardiovascular Medicine 2:8, 396-400
CrossRef1286
Lei Ge, Flavio Airoldi, Ioannis Iakovou, John Cosgrave, Iassen Michev, Giuseppe M. Sangiorgi, Matteo Montorfano, Alaide Chieffo, Mauro Carlino, Nicola Corvaja, Antonio Colombo. (2005) Clinical and Angiographic Outcome After Implantation of Drug-Eluting Stents in Bifurcation Lesions With the Crush Stent Technique. Journal of the American College of Cardiology 46:4, 613-620
CrossRef1287
Richard E. Waters, David E. Kandzari, Harry R. Phillips, Lawrence E. Crawford, Michael H. Sketch. (2005) Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy. Catheterization and Cardiovascular Interventions 65:4, 520-524
CrossRef1288
Thomas Jahnke. (2005) Cryoplasty for the Treatment of Femoropopliteal Arterial Disease: Will Freezing Solve the Problem of Cold Feet?. Journal of Vascular and Interventional Radiology 16:8, 1051-1054
CrossRef1289
SIMONE A JOOSTEN, YVO W J SIJPKENS, CEES VAN KOOTEN, LEENDERT C PAUL. (2005) Chronic renal allograft rejection: Pathophysiologic considerations. Kidney International 68:1, 1-13
CrossRef1290
Patrick W. Serruys, Georgios Sianos, Alexandre Abizaid, Jiro Aoki, Peter den Heijer, Hans Bonnier, Pieter Smits, Dougal McClean, Stefan Verheye, Jorge Belardi, Jose Condado, Michel Pieper, Louise Gambone, Marco Bressers, Janette Symons, Eduardo Sousa, Frank Litvack. (2005) The Effect of Variable Dose and Release Kinetics on Neointimal Hyperplasia Using a Novel Paclitaxel-Eluting Stent Platform. Journal of the American College of Cardiology 46:2, 253-260
CrossRef1291
Raúl Moreno. (2005) Stents recubiertos y otros dispositivos antirreestenosis. Revista Española de Cardiología 58:7, 842-862
CrossRef1292
Masataka Sata, Daiju Fukuda, Kimie Tanaka, Yukari Kaneda, Hisako Yashiro, Ibuki Shirakawa. (2005) The role of circulating precursors in vascular repair and lesion formation. Journal of Cellular and Molecular Medicine 9:3, 557-568
CrossRef1293
B. Scheller, A. Grandt, S. Wnendt, G. Lorenz, M. Böhm, G. Nickenig. (2005) Comparative study of tacrolimus and paclitaxel stent coating in the porcine coronary model. Zeitschrift für Kardiologie 94:7, 445-452
CrossRef1294
Pilar Jiménez-Quevedo, Manel Sabaté. (2005) Percutaneous coronary revascularization in diabetics: from balloon angioplasty to drug-eluting stents. Expert Review of Cardiovascular Therapy 3:4, 635-646
CrossRef1295
Mario Togni, Stephan Windecker, Rosangela Cocchia, Peter Wenaweser, Stephane Cook, Michael Billinger, Bernhard Meier, Otto M. Hess. (2005) Sirolimus-Eluting Stents Associated With Paradoxic Coronary Vasoconstriction. Journal of the American College of Cardiology 46:2, 231-236
CrossRef1296
Ralf Zahn, Christian W. Hamm, Steffen Schneider, Uwe Zeymer, Christoph A. Nienaber, Gert Richardt, Malte Kelm, Benny Levenson, Tassilo Bonzel, Ulrich Tebbe, Georg Sabin, Jochen Senges. (2005) Incidence and Predictors of Target Vessel Revascularization and Clinical Event Rates of the Sirolimus-Eluting Coronary Stent (Results from the Prospective Multicenter German Cypher Stent Registry). The American Journal of Cardiology 95:11, 1302-1308
CrossRef1297
PAOLO ORTOLANI, ANTONIO MARZOCCHI, MATTEO AQUILINA, WILLIAM GAIBA, STEFANO NERI, CINZIA MARROZZINI, TULLIO PALMERINI, NEVIO TAGLIERI, A. BRANZI. (2005) 32P Brachytherapy in the Treatment of Complex Cypher In-Stent Restenosis. Journal of Interventional Cardiology 18:3, 205-211
CrossRef1298
Paul Schoenhagen, Richard D. White, E. Murat Tuzcu. (2005) Comprehensive imaging of coronary artery disease Impact on contemporary treatment approaches. Comprehensive Therapy 31:2, 159-165
CrossRef1299
Robin Collingwood, Lori Gibson, Souad Sedlik, Renu Virmani, Andrew J. Carter. (2005) Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model. Catheterization and Cardiovascular Interventions 65:2, 227-232
CrossRef1300
Edouard Cheneau, Lowell F. Satler, Esteban Escolar, William O. Suddath, Kenneth M. Kent, Neil J. Weissman, Ron Waksman, Augusto D. Pichard. (2005) Underexpansion of sirolimus-eluting stents: Incidence and relationship to delivery pressure. Catheterization and Cardiovascular Interventions 65:2, 222-226
CrossRef1301
Michael Schlüter, Joachim Schofer. (2005) Direct Stenting With Sirolimus-Eluting Stents. The American Heart Hospital Journal 3:3, 182-192
CrossRef1302
Matthew J. Price, Neil Sawhney, John A. Kao, Antonio Madrid, Richard A. Schatz, Paul S. Teirstein. (2005) Clinical outcomes after sirolimus-eluting stent implantation for de novo saphenous vein graft lesions. Catheterization and Cardiovascular Interventions 65:2, 208-211
CrossRef1303
Kiyosumi Maeda, Akira Furukawa, Michio Yamasaki, Kiyoshi Murata. (2005) Percutaneous transluminal angioplasty for Brescia-Cimino hemodialysis fistula dysfunction: technical success rate, patency rate and factors that influence the results. European Journal of Radiology 54:3, 426-430
CrossRef1304
(2005) Guías de Práctica Clínica sobre intervencionismo coronario percutáneo. Revista Española de Cardiología 58:6, 679-728
CrossRef1305
Hannan, Edward L., Racz, Michael J., Walford, Gary, Jones, Robert H., Ryan, Thomas J., Bennett, Edward, Culliford, Alfred T., Isom, O. Wayne, Gold, Jeffrey P., Rose, Eric A., . (2005) Long-Term Outcomes of Coronary-Artery Bypass Grafting versus Stent Implantation. New England Journal of Medicine 352:21, 2174-2183
Full Text1306
Eulogio García. (2005) Intervencionismo en el contexto del infarto de miocardio. Conceptos actuales. Revista Española de Cardiología 58:5, 567-584
CrossRef1307
Ron T. van Domburg, Johanna J.M. Takkenberg, Leo J. Noordzij, Francesco Saia, Lex A. van Herwerden, Patrick W.J.C. Serruys, Ad J.J.C. Bogers. (2005) Late Outcome After Stenting or Coronary Artery Bypass Surgery for the Treatment of Multivessel Disease: A Single-Center Matched-Propensity Controlled Cohort Study. The Annals of Thoracic Surgery 79:5, 1563-1569
CrossRef1308
Taewon Seo, Levanto G. Schachter, Abdul I. Barakat. (2005) Computational Study of Fluid Mechanical Disturbance Induced by Endovascular Stents. Annals of Biomedical Engineering 33:4, 444-456
CrossRef1309
Bodo E. Knudsen, Ben H. Chew, John D. Denstedt. (2005) Drug-eluting biomaterials in urology: the time is ripe. BJU International 95:6, 726-727
CrossRef1310
Prospero B. Gogo, David J. Schneider, Matthew W. Watkins, Edward F. Terrien, Burton E. Sobel, Harold L. Dauerman. (2005) Systemic Inflammation After Drug-Eluting Stent Placement. Journal of Thrombosis and Thrombolysis 19:2, 87-92
CrossRef1311
Ioannis Iakovou, Giuseppe M. Sangiorgi, Goran Stankovic, Nicola Corvaja, Giancarlo Vitrella, Massimo Ferraro, Antonio Colombo. (2005) Results and follow-up after implantation of four or more sirolimus-eluting stents in the same patient. Catheterization and Cardiovascular Interventions 64:4, 436-439
CrossRef1312
Dean J. Kereiakes, Richard E. Kuntz, Laura Mauri, Mitchell W. Krucoff. (2005) Surrogates, substudies, and real clinical end points in trials of drug-eluting stents**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.. Journal of the American College of Cardiology 45:8, 1206-1212
CrossRef1313
Tim A. Fischell, Alok Maheshwari, Rubina A. Mirza, Scott Haller, Andrew J. Carter, Jeffrey J. Popma. (2005) Impact of frame selection on quantitative coronary angiographic analysis after coronary stenting. Catheterization and Cardiovascular Interventions 64:4, 460-467
CrossRef1314
Y MIZUNO, H IWATA, H TAKAGI, S YOSHIKAWA, Y UMEDA, Y MATSUNO, Y MORI, H TAKEMURA. (2005) Sonoporation with doxorubicin enhances suppression of intimal hyperplasia in a vein graft model. Journal of Surgical Research 124:2, 312-317
CrossRef1315
Marius Hartmann, Olav Jansen. (2005) Angioplasty and stenting of intracranial stenosis. Current Opinion in Internal Medicine 4:2, 132-138
CrossRef1316
A. Zimmermann, B. P
CrossRef1317
Stephen G. Ellis, Jeffrey J. Popma, John M. Lasala, Joerg J. Koglin, David A. Cox, James Hermiller, Charles O’Shaughnessy, James Tift Mann, Mark Turco, Ronald Caputo, Patrick Bergin, Joel Greenberg, Gregg W. Stone. (2005) Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation. Journal of the American College of Cardiology 45:8, 1193-1200
CrossRef1318
Alexandra J. Lansky, Ricardo A. Costa, Michael Mooney, Mark G. Midei, Henry K. Lui, Warren Strickland, Roxana Mehran, Martin B. Leon, Mary E. Russell, Stephen G. Ellis, Gregg W. Stone. (2005) Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease. Journal of the American College of Cardiology 45:8, 1180-1185
CrossRef1319
F
CrossRef1320
Javier Zueco Gil. (2005) Importancia de los factores clínicos y anatómicos en el intervencionismo coronario. Revista Española de Cardiología 58:4, 430-441
CrossRef1321
Neil J. Weissman, Joerg Koglin, David A. Cox, James Hermiller, Charles O’Shaughnessy, James Tift Mann, Mark Turco, Ronald Caputo, Patrick Bergin, Joel Greenberg, Michael Kutcher, S. Chiu Wong, Warren Strickland, Michael Mooney, Mary E. Russell, Stephen G. Ellis, Gregg W. Stone. (2005) Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation. Journal of the American College of Cardiology 45:8, 1201-1205
CrossRef1322
George Dangas, Stephen G. Ellis, Richard Shlofmitz, Stanley Katz, David Fish, Steven Martin, Roxana Mehran, Mary E. Russell, Gregg W. Stone. (2005) Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery. Journal of the American College of Cardiology 45:8, 1186-1192
CrossRef1323
Jeffrey W. Moses, Roxana Mehran, Eugenia Nikolsky, John M. Lasala, Woodrow Corey, Glenn Albin, Cary Hirsch, Martin B. Leon, Mary E. Russell, Stephen G. Ellis, Gregg W. Stone. (2005) Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes. Journal of the American College of Cardiology 45:8, 1165-1171
CrossRef1324
E COSSON, J ATTALI, P VALENSI. (2005) Markers for silent myocardial ischemia in diabetes. Are they helpful?. Diabetes & Metabolism 31:2, 205-213
CrossRef1325
Johnathan A. Engh, Elad I. Levy, Jay U. Howington, Lee R. Guterman. (2005) Intracranial angioplasty and stenting: modern approaches to revascularization for atherosclerotic disease. Neurosurgery Clinics of North America 16:2, 297-308
CrossRef1326
Raúl Moreno, Cristina Fernández, Rosana Hernández, Fernando Alfonso, Dominick J. Angiolillo, Manel Sabaté, Javier Escaned, Camino Bañuelos, Antonio Fernández-Ortiz, Carlos Macaya. (2005) Drug-eluting stent thrombosis. Journal of the American College of Cardiology 45:6, 954-959
CrossRef1327
Anita Wokhlu, James G. (2005) Dollars and Stents: The Economics of Drug-Eluting Stents. The American Heart Hospital Journal 3:2, 94-104
CrossRef1328
Ellis W. Lader, Christopher P. Cannon. (2005) How to Join a Clinical Trial. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 4:1, 26-29
CrossRef1329
José M. de La Torre Hernández, Fermín Sainz Laso, Cristina Ruisánchez, Javier Zueco, Álvaro Figueroa, Thierry Colman. (2005) Tratamiento de lesiones con alto riesgo de reestenosis. Estudio comparativo en 300 pacientes del stent liberador de rapamicina, el stent con polímero liberador de paclitaxel y el stent convencional. Revista Española de Cardiología 58:3, 262-269
CrossRef1330
Andrew T.L. Ong, Angela Hoye, Jiro Aoki, Carlos A.G. van Mieghem, Gaston A. Rodriguez Granillo, Karel Sonnenschein, Evelyn Regar, Eugene P. McFadden, Georgios Sianos, Willem J. van der Giessen, Peter P.T. de Jaegere, Pim de Feyter, Ron T. van Domburg, Patrick W. Serruys. (2005) Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. Journal of the American College of Cardiology 45:6, 947-953
CrossRef1331
Nicholas N. Kipshidze, Thomas R. Porter, George Dangas, Hamid Yazdi, Fermin Tio, Feng Xie, David Hellinga, Roswitha Wolfram, Rufus Seabron, Ron Waksman, Alexander Abizaid, Gary Roubin, Sriram Iyer, Antonio Colombo, Martin B. Leon, Jeffrey W. Moses, Patrick Iversen. (2005) Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model. Catheterization and Cardiovascular Interventions 64:3, 389-394
CrossRef1332
Vaughn A. Starnes. (2005) Presidential address: An evolving discipline. The Journal of Thoracic and Cardiovascular Surgery 129:3, 483-487
CrossRef1333
A. A. Khattab, C. W. Hamm, J. Senges, R. Toelg, V. Geist, T. Bonzel, M. Kelm, B. Levenson, C. A. Nienaber, G. Sabin, S. Schneider, U. Tebbe, G. Richardt. (2005) Sirolimus-eluting stent treatment for isolated proximal left anterior descending artery stenoses. Zeitschrift f
CrossRef1334
Ehtisham Mahmud, Babek Pezeshki, Ali Salami, Shahin Keramati. (2005) Highlights of the 2004 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting: Clinical implications. Journal of the American College of Cardiology 45:5, 796-801
CrossRef1335
Pierre-Frédéric Keller, Reda Ibrahim, Jean-Claude Tardif. (2005) The drug-based pipeline against restenosis. Expert Opinion on Emerging Drugs 10:1, 67-86
CrossRef1336
Thomas M Schiele. (2005) Can oral sirolimus therapy prevent in-stent restenosis?. Nature Clinical Practice Cardiovascular Medicine 2:2, 76-77
CrossRef1337
Aloke V. Finn, Igor F. Palacios, Adnan Kastrati, Herman K. Gold. (2005) Drug-eluting stents for diabetes mellitus. Journal of the American College of Cardiology 45:4, 479-483
CrossRef1338
Seung-Jung Park, Young-Hak Kim, Bong-Ki Lee, Seung-Whan Lee, Cheol Whan Lee, Myeong-Ki Hong, Jae-Joong Kim, Gary S. Mintz, Seong-Wook Park. (2005) Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis. Journal of the American College of Cardiology 45:3, 351-356
CrossRef1339
Marius Hartmann, Olav Jansen. (2005) Angioplasty and stenting of intracranial stenosis. Current Opinion in Neurology 18:1, 39-45
CrossRef1340
Emmanuel Mah??, Emmanuel Morelon, Sophie Lechaton, Kim-Hanh Le Quan Sang, Rafik Mansouri, Marie-Fran??oise Ducasse, Marie-France Mamzer-Bruneel, Yves de Prost, Henri Kreis, Christine Bodemer. (2005) Cutaneous Adverse Events in Renal Transplant Recipients Receiving Sirolimus-Based Therapy1. Transplantation 79:4, 476-482
CrossRef1341
Lindsay Machan. (2005) Drug Eluting Stents: Is the SFA Just a Big Coronary Artery?. Journal of Vascular and Interventional Radiology 16:2, P73-P76
CrossRef1342
James B Hermiller. (2005) Drug-Eluting Stents in the Management of Coronary Artery Disease. Disease Management & Health Outcomes 13:1, 1-7
CrossRef1343
Richard A. Anderson, Farzin Fath‐Ordoubadi, Sheraz Younas, Anthony Bainbridge, Rosie A. Swallow, Keith D. Dawkins, Nicholas P. Curzen. (2005) Drug‐eluting stents for the treatment of in‐stent restenosis – ‘real world’ double centre experience in consecutive patients. Acute Cardiac Care 7:4, 188-192
CrossRef1344
Itzhak Herz, Yaron Moshkovitz, Alberto Hendler, Sharon Z. Adam, Gideon Uretzky, Yanai Ben-Gal, Rephael Mohr. (2005) Revascularization of Left Anterior Descending Artery With Drug-Eluting Stents: Comparison With Off-Pump Surgery. The Annals of Thoracic Surgery 79:1, 88-92
CrossRef1345
Dirk R J Kuypers. (2005) Benefit-Risk Assessment of Sirolimus in Renal Transplantation. Drug Safety 28:2, 153-181
CrossRef1346
Marco Zimarino, Giulia Renda, Raffaele De Caterina. (2005) Optimal Duration of Antiplatelet Therapy in Recipients of Coronary Drug-Eluting Stents. Drugs 65:6, 725-732
CrossRef1347
Jose M. Morales. (2005) Cardiovascular risk profile in patients treated with sirolimus after renal transplantation. Kidney International 67:s93, S69-S73
CrossRef1348
Daniel W. Isenbarger, Jon R. Resar. (2005) Drug‐eluting versus third‐generation bare metal stents: The US strategy. Acute Cardiac Care 7:4, 171-175
CrossRef1349
Michael Schlüter, Joachim Schofer, Anthony H. Gershlick, Erick Schampaert, William Wijns, Günter Breithardt. (2005) Direct stenting of native de novo coronary artery lesions with the sirolimus-eluting stent. Journal of the American College of Cardiology 45:1, 10-13
CrossRef1350
Hisataka Sasao, Hitoko Ogata, Daisuke Hotta. (2005) Clinical and Angiographic Outcomes After Multi-Link PENTA Stent Implantation in Japanese Patients With Coronary Artery Disease. International Heart Journal 46:6, 997-1006
CrossRef1351
Gennaro Sardella, Daniele Accapezzato, Angelo Di Roma, Vittorio Francavilla, Cristian Di Russo, Gino Iannucci, Maria Isabella Sirinian, Laura Giacomelli, Francesco Fedele, Marino Paroli. (2005) Altered trafficking of CD8+ memory T cells after implantation of rapamycin-eluting stents in patients with coronary artery disease. Immunology Letters 96:1, 85-91
CrossRef1352
Ran Kornowski, Hana Vaknin‐Assa, Abid Assali, Shmuel Fuchs. (2005) Acute and intermediate‐term procedural results using cypher stenting to treat multi‐vessel coronary artery disease. Acute Cardiac Care 7:3, 122-125
CrossRef1353
Flavio Ribichini, Valeria Ferrero, Andrea Rognoni, Giovanni Vacca, Corrado Vassanelli. (2005) Angiotensin Antagonism in Coronary Artery Disease. Drugs 65:8, 1073-1096
CrossRef1354
Norihiko Shinozaki, Hiroyoshi Yokoi, Masashi Iwabuchi, Hideyuki Nosaka, Kazushige Kadota, Kazuaki Mitsudo, Masakiyo Nobuyoshi. (2005) Initial and Follow-up Results of the BiodivYsio Phosphorylcholine Coated Stent for Treatment of Coronary Artery Disease. Circulation Journal 69:3, 295-300
CrossRef1355
Elad I. Levy, Ricardo A. Hanel, Tsz Lau, Christopher J. Koebbe, Naveh Levy, David J. Padalino, Kim Marie Malicki, Lee R. Guterman, L. Nelson Hopkins. (2005) Frequency and management of recurrent stenosis after carotid artery stent implantation. Journal of Neurosurgery 102:1, 29-37
CrossRef1356
William W. Chu, Ron Waksman. (2005) Contemporary use of drug-eluting stents. Current Treatment Options in Cardiovascular Medicine 7:1, 35-46
CrossRef1357
Ekaterina Iofina, Philipp K. Haager, Peter W. Radke, Roswitha Langenberg, R
CrossRef1358
Masato Nakamura, Masamichi Wada, Hisao Hara, Ken Kozuma, Yoritaka Otsuka, Shunichi Miyazaki. (2005) Angiographic and Clinical Outcomes of a Pharmacokinetic Study of Sirolimus-Eluting Stents. Circulation Journal 69:10, 1196-1201
CrossRef1359
P. Couppié, F. De Poli, C. Thalouarn, F. Fellinger, M. Hanssen, MC. Dickelé. (2005) Le stent « actif » en 2005 : remplit-il ses promesses ?. Annales de Cardiologie et d Angéiologie 54:6, 325
CrossRef1360
Masahito Kawata, Emi Kuramoto, Toshio Kataoka, Atsushi Saito, Kazumasa Adachi, Akira Matsuura, Susumu Sakamoto. (2005) Comparative Inhibitory Effects of Cilostazol and Ticlopidine on Subacute Stent Thrombosis and Platelet Function in Acute Myocardial Infarction Patients With Percutaneous Coronary Intervention. International Heart Journal 46:1, 13-22
CrossRef1361
Angela Hoye, Carlos A. G. van Mieghem, Andrew T. L. Ong, Jiro Aoki, Gaston A. Rodriguez Granillo, Marco Valgimigli, Keiichi Tsuchida, Georgios Sianos, Eugene P. Mcfadden, Willem J. van der Giessen, Pim J. de Feyter, Ron T. van Domburg, Patrick W. Serruys. (2005) Percutaneous therapy of bifurcation lesions with drug‐eluting stent implantation: the Culotte technique revisited. Acute Cardiac Care 7:1, 36-40
CrossRef1362
Wolfgang Bocksch, Suzanne Fateh-Moghadam, Eda Mueller, Sonja Huehns, Juergen Waigand, Rainer Dietz. (2005) Percutaneous Coronary Intervention in Patients with End-Stage Renal Disease. Kidney and Blood Pressure Research 28:5-6, 275-279
CrossRef1363
Christopher J. Koebbe, Kenneth Liebman, Erol Veznedaroglu, Robert Rosenwasser. (2005) Carotid artery angioplasty and stent placement for recurrent stenosis. Neurosurgical FOCUS 18:1, 1-3
CrossRef1364
Abdallah G Rebeiz, Joseph Adams, Robert A Harrington. (2005) Interventional Cardiovascular Pharmacotherapy. American Journal of Cardiovascular Drugs 5:2, 93-102
CrossRef1365
Gast
CrossRef1366
F. Weber, H. Schneider, C. Schwarz, C. Holzhausen, M. Petzsch, C. A. Nienaber. (2004) Sirolimus-eluting stents for percutaneous coronary intervention in acute myocardial infarction. Zeitschrift f
CrossRef1367
Gerald S. Werner, Andreas Krack, Gero Schwarz, Dirk Prochnau, Stefan Betge, Hans R. Figulla. (2004) Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents. Journal of the American College of Cardiology 44:12, 2301-2306
CrossRef1368
RAGHUNANDAN KAMINENI, RICHARD R. HEUSER. (2004) New Approaches to Long Lesions. Journal of Interventional Cardiology 17:6, 405-409
CrossRef1369
HANS STORGER, EBERHARD GRUBE, MANFRED HOFMANN, FRANZ SCHWARZ, JURGEN HAASE. (2004) Clinical Experiences Using Everolimus-Eluting Stents in Patients with Coronary Artery Disease. Journal of Interventional Cardiology 17:6, 387-390
CrossRef1370
SIGMUND SILBER. (2004) Which Parameter Should Be Chosen as Primary Endpoint for Randomized Drug-Eluting Stent Studies?. Journal of Interventional Cardiology 17:6, 375-385
CrossRef1371
Donald S Baim. (2004) New devices for percutaneous coronary intervention are rapidly making bypass surgery obsolete. Current Opinion in Cardiology 19:6, 593-597
CrossRef1372
Thomas M Schiele, Florian Krötz, Volker Klauss. (2004) Vascular restenosis – striving for therapy. Expert Opinion on Pharmacotherapy 5:11, 2221-2232
CrossRef1373
Sheila A Doggrell. (2004) Sirolimus- or paclitaxel-eluting stents to prevent coronary artery restenosis. Expert Opinion on Pharmacotherapy 5:11, 2209-2220
CrossRef1374
Adnan Kastrati. (2004) Drug-eluting stents for secondary prevention of restenosis. Catheterization and Cardiovascular Interventions 63:3, 265-266
CrossRef1375
Paul P. Dobesh, Zachary A. Stacy, Alexander J. Ansara, Jason M. Enders. (2004) Drug-Eluting Stents: A Mechanical and Pharmacologic Approach to Coronary Artery Disease. Pharmacotherapy 24:11, 1554-1577
CrossRef1376
Eric K Rowinsky. (2004) Targeting the molecular target of rapamycin (mTOR). Current Opinion in Oncology 16:6, 564-575
CrossRef1377
Gavin J. Murphy, Alan J. Bryan, Gianni D. Angelini. (2004) Hybrid Coronary Revascularization in the Era of Drug-Eluting Stents. The Annals of Thoracic Surgery 78:5, 1861-1867
CrossRef1378
Grzegorz L Kaluza, Albert E Raizner. (2004) Brachytherapy for restenosis after stenting for coronary artery disease: its role in the drug-eluting stent era. Current Opinion in Cardiology 19:6, 601-607
CrossRef1379
J. Hausleiter, A. Kastrati, J. Mehilli, H. Schuhlen, J. Pache, F. Dotzer, C. Glatthor, S. Siebert, J. Dirschinger, A. Schomig, . (2004) A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries. Journal of Internal Medicine 256:5, 388-397
CrossRef1380
Gerald S. Werner, Ulf Emig, Andreas Krack, Gero Schwarz, Hans R. Figulla. (2004) Sirolimus-eluting stents for the prevention of restenosis in a worst-case scenario of diffuse and recurrent in-stent restenosis. Catheterization and Cardiovascular Interventions 63:3, 259-264
CrossRef1381
Ron Waksman, Andrew E. Ajani, Augusto D. Pichard, Rebecca Torguson, Ellen Pinnow, Daniel Canos, Lowell F. Satler, Kenneth M. Kent, Pramod Kuchulakanti, Chrysoula Pappas, Louise Gambone, Neil Weissman, Maureen C. Abbott, Joseph Lindsay. (2004) Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions. Journal of the American College of Cardiology 44:7, 1386-1392
CrossRef1382
Robert S. Schwartz, Nicolas A. Chronos, Renu Virmani. (2004) Preclinical restenosis models and drug-eluting stents. Journal of the American College of Cardiology 44:7, 1373-1385
CrossRef1383
Teruo Inoue, Toshihiko Uchida, Masashi Sakuma, Yoshitaka Imoto, Yasushi Ozeki, Yukio Ozaki, Yutaka Hikichi, Koichi Node. (2004) Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation. Journal of the American College of Cardiology 44:7, 1408-1414
CrossRef1384
Eugenio Stabile, Edouard Cheneau, Timothy Kinnaird, William O. Suddath, Neil J. Weissman, Rebecca Torguson, Kenneth M. Kent, Augusto D. Pichard, Lowell F. Satler, Ron Waksman. (2004) Late thrombosis in cypher stents after the discontinuation of antiplatelet therapy. Cardiovascular Radiation Medicine 5:4, 173-176
CrossRef1385
Santhi K Ganesh, Kimberly A Skelding, Laxmi Mehta, Kathleen O’Neill, Jungnam Joo, Gang Zheng, James Goldstein, Robert Simari, Eric Billings, Nancy L Geller, David Holmes, William W O’Neill, Elizabeth G Nabel. (2004) Rationale and study design of the CardioGene Study: genomics of in-stent restenosis. Pharmacogenomics 5:7, 949-1004
CrossRef1386
Nicolas Nelken, Peter A. Schneider. (2004) Advances in stent technology and drug-eluting stents. Surgical Clinics of North America 84:5, 1203-1236
CrossRef1387
Mark J Eisenberg. (2004) Drug-eluting stents: some bare facts. The Lancet 364:9444, 1466-1467
CrossRef1388
Itzhak Herz, Rephael Mohr, Yaron Moshkovitz, Yanai Ben-Gal, Sharon Z Adam, Roni Braunstein, Gideon Uretzky. (2004) Revascularization of the Left Anterior Descending Artery with Drug-Eluting Stents: Comparison with Arterial Off-Pump Surgery. The Heart Surgery Forum 7:5, E490-E492
CrossRef1389
Susanne S. Pedersen, Pedro A. Lemos, Priya R. van Vooren, Tommy K.K. Liu, Joost Daemen, Ruud A.M. Erdman, Pieter C. Smits, Patrick W.J.C. Serruys, Ron T. van Domburg. (2004) Type D personality predicts death or myocardial infarction after bare metal stent or sirolimus-eluting stent implantation. Journal of the American College of Cardiology 44:5, 997-1001
CrossRef1390
Richard V. Aghababian. (2004) Emergency Department Evaluation and Treatment of Patients With ST-Segment Elevation Myocardial Infarction. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 3:3, 110-113
CrossRef1391
Kuang-Hueih Chen, Xiaomei Guo, Dalong Ma, Yanhong Guo, Qian Li, Dongmei Yang, Pengfei Li, Xiaoyan Qiu, Shaojun Wen, Rui-Ping Xiao, Jian Tang. (2004) Dysregulation of HSG triggers vascular proliferative disorders. Nature Cell Biology 6:9, 872-883
CrossRef1392
Daniel Talmor. (2004) Risk stratification in the changing field of cardiac surgery*. Critical Care Medicine 32:9, 1970-1971
CrossRef1393
Ganesan Karthikeyan, Balram Bhargava. (2004) Prevention of restenosis after coronary angioplasty. Current Opinion in Cardiology 19:5, 500-509
CrossRef1394
Antonio Colombo. (2004) Single-digit target vessel revascularization in multivessel coronary interventions with sirolimus-eluting stents: Goodbye to coronary bypass grafting. Catheterization and Cardiovascular Interventions 63:1, 61-62
CrossRef1395
Harold L Dauerman. (2004) Approaches to restenosis: mechanical and pharmacological strategies. Coronary Artery Disease 15:6, 303-305
CrossRef1396
Ioannis Iakovou, Lei Ge, Iassen Michev, Giuseppe M. Sangiorgi, Matteo Montorfano, Flavio Airoldi, Alaide Chieffo, Goran Stankovic, Giancarlo Vitrella, Mauro Carlino, Nicola Corvaja, Carlo Briguori, Antonio Colombo. (2004) Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions. Journal of the American College of Cardiology 44:5, 967-971
CrossRef1397
Sheila A Doggrell. (2004) Clinical trials in restenosis with 7-hexanoyltaxol and paclitaxel-eluting stents. Expert Review of Cardiovascular Therapy 2:5, 745-752
CrossRef1398
Monia Marchetti. (2004) Drug-eluting stents: from evidence to policy. Expert Review of Medical Devices 1:1, 49-63
CrossRef1399
Xiaoshun Liu, Ivan De Scheerder, Walter Desmet. (2004) Dexamethasone-eluting stent: an anti-inflammatory approach to inhibit coronary restenosis. Expert Review of Cardiovascular Therapy 2:5, 653-660
CrossRef1400
Kenichi Fujii, Motomaru Masutani, Yoshio Kobayashi, Jun Tateishi, Daizo Kawasaki, Mitsumasa Ohyanagi, Gary S. Mintz, Martin B. Leon. (2004) Contribution of early lumen loss after balloon angioplasty for in-stent restenosis to lumen loss at follow-up. Catheterization and Cardiovascular Interventions 63:1, 52-56
CrossRef1401
Mohan N Babapulle, Lawrence Joseph, Patrick Bélisle, James M Brophy, Mark J Eisenberg. (2004) A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. The Lancet 364:9434, 583-591
CrossRef1402
Ron Waksman. (2004) Vascular Brachytherapy and Coronary Stenting for De Novo Lesions. Journal of the American College of Cardiology 44:3, 538-540
CrossRef1403
Francesco Saia, Pedro A. Lemos, Angela Hoye, Georgios Sianos, Chourmouzios A. Arampatzis, Pim J. de Feyter, Willem J. van der Giessen, Pieter C. Smits, Ron T. van Domburg, Patrick W. Serruys. (2004) Clinical outcomes for sirolimus-eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis. Catheterization and Cardiovascular Interventions 62:3, 283-288
CrossRef1404
Marino Paroli, Paola Mariani, Daniele Accapezzato, Mariadomenica D'Alessandro, Cristian Di Russo, Maura Bifolco, Maria Isabella Sirinian, Francesco Fedele, Guglielmo Bruno, Gennaro Sardella. (2004) Modulation of tachykinin and cytokine release in patients with coronary disease undergoing percutaneous revascularization. Clinical Immunology 112:1, 78-84
CrossRef1405
Ron Waksman. (2004) Vascular brachytherapy vs. drug-eluting stents for the treatment of in-stent restenosis: The jury's still out. Catheterization and Cardiovascular Interventions 62:3, 290-291
CrossRef1406
S HAFIZI, V MORDI, K ANDERSSON, A CHESTER, M YACOUB. (2004) Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling. Vascular Pharmacology 41:4-5, 167-176
CrossRef1407
Shinjo Sonoda, Yoshihiro Morino, Junya Ako, Mitsuyasu Terashima, Ali H.M Hassan, Heidi N Bonneau, Martin B Leon, Jeffrey W Moses, Paul G Yock, Yasuhiro Honda, Richard E Kuntz, Peter J Fitzgerald. (2004) Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation. Journal of the American College of Cardiology 43:11, 1959-1963
CrossRef1408
Raúl Moreno, Cristina Fernández, Fernando Alfonso, Rosana Hernández, Maria J. Pérez-Vizcayno, Javier Escaned, Manel Sabaté, Camino Bañuelos, Dominick J. Angiolillo, Luis Azcona, Carlos Macaya. (2004) Coronary stenting versus balloon angioplasty in small vessels. Journal of the American College of Cardiology 43:11, 1964-1972
CrossRef1409
Richard E. Kuntz, John C. Wang, Laura Mauri, David J. Cohen. (2004) An Evidence-Based Approach to the Use of Drug-Eluting Stents in Clinical Practice. The American Heart Hospital Journal 2:3, 132-141
CrossRef1410
Sheila A Doggrell. (2004) Sirolimus- versus paclitaxel-eluting stents in patients with stenosis in a native coronary artery. Expert Opinion on Pharmacotherapy 5:6, 1431-1434
CrossRef1411
Fumikiyo Ganaha, Edward Y. Kao, Humberto Wong, Christopher J. Elkins, Jane Lee, Shoreh Modanlou, Ceron Rhee, Michael D. Kuo, Eser Yuksel, Pamela N. Cifra, Jacob M. Waugh, Michael D. Dake. (2004) Stent-based Controlled Release of Intravascular Angiostatin to Limit Plaque Progression and In-Stent Restenosis. Journal of Vascular and Interventional Radiology 15:6, 601-608
CrossRef1412
Brian D. Powell, Charanjit S. Rihal, Malcolm R. Bell, Kenton J. Zehr, David R. Holmes. (2004) Anticipated Impact of Drug-Eluting Stents on Referral Patterns for Coronary Artery Bypass Graft Surgery: A Population-Based Angiographic Analysis. Mayo Clinic Proceedings 79:6, 769-772
CrossRef1413
B. D. Powell, C. S. Rihal, M. R. Bell, K. J. Zehr, D. R. Holmes. (2004) Anticipated Impact of Drug-Eluting Stents on Referral Patterns for Coronary Artery Bypass Graft Surgery: A Population-Based Angiographic Analysis. Mayo Clinic Proceedings 79:6, 769-772
CrossRef1414
J MARCO. (2004) Les endoproth
CrossRef1415
J MACHECOURT. (2004) Le registre national EVASTENT:
CrossRef1416
Angela Cheng-Lai, William H. Frishman. (2004) Sirolimus-Eluting Coronary Stents: Novel Devices for the Management of Coronary Artery Disease. American Journal of Therapeutics 11:3, 218-228
CrossRef1417
P LEMOS. (2004) Stent coronaire
CrossRef1418
D BLANCHARD. (2004) Endoproth
CrossRef1419
J SCHOFER. (2004) Les essais cliniques E-SIRIUS et ?New? sirius. Annales de Cardiologie et d?Ang
CrossRef1420
P URBAN. (2004) Le registre e-Cypher : objectifs et organisation. Annales de Cardiologie et d?Ang
CrossRef1421
I FONTES. (2004) Du sirolimus au stent CypherS: les
CrossRef1422
John McB. Hodgson, Randy K. Bottner, Lloyd W. Klein, Howard T. Walpole, David J. Cohen, Donald E. Cutlip, Randolph B. Fenninger, Brian G. Firth, Dan Greenberg, Ilona Kalisky, Thomas Meskan, Wayne Powell, Gregg W. Stone, James P. Zito, Mary Ann Clark. (2004) Drug-eluting stent task force: Final report and recommendations of the working committees on cost-effectiveness/economics, access to care, and medicolegal issues. Catheterization and Cardiovascular Interventions 62:1, 1-17
CrossRef1423
Udho Thadani. (2004) Recurrent and refractory angina following revascularization procedures in patients with stable angina pectoris. Coronary Artery Disease 15:Supplement 1, S1-S4
CrossRef1424
Nicholas N. Kipshidze, Patrick Iversen, Han-Soo Kim, Hamid Yiazdi, George Dangas, Rufus Seaborn, Gishel New, Fermin Tio, Ron Waksman, Roxana Mehran, Mykola Tsapenko, Gregg W. Stone, Gary S. Roubin, Sriram Iyer, Martin B. Leon, Jeffrey W. Moses. (2004) Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model. Catheterization and Cardiovascular Interventions 61:4, 518-527
CrossRef1425
J. Puel, P. Valensi, G. Vanzetto, V. Lassmann-Vague, J.-L. Monin, Ph. Moulin, Ch. Ziccarelli, H. Mayaudon, M. Ovize, S. Bernard, E. Van Belle, S. Halimi. (2004) Identification of myocardial ischemia in the diabetic patient Joint ALFEDIAM and SFC recommendations. Diabetes & Metabolism 30:2, 3S3-3S18
CrossRef1426
George W Vetrovec. (2004) Don't blame the stents. Journal of the American College of Cardiology 43:8, 1355-1357
CrossRef1427
Caroline A Kavanagh, Yuri A Rochev, William M Gallagher, Kenneth A Dawson, Alan K Keenan. (2004) Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems. Pharmacology & Therapeutics 102:1, 1-15
CrossRef1428
Joseph P Carrozza. (2004) Sirolimus-eluting stents: does a great stent still need a good interventionalist?**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of the JACC or the American College of Cardiology.. Journal of the American College of Cardiology 43:6, 1116-1117
CrossRef1429
William W. O'Neill, Simon R. Dixon. (2004) The year in interventional cardiology. Journal of the American College of Cardiology 43:5, 875-890
CrossRef1430
John A. Bittl, Derek P. Chew, Eric J. Topol, David F. Kong, Robert M. Califf. (2004) Meta-Analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplasty. Journal of the American College of Cardiology 43:6, 936-942
CrossRef1431
Bruce E. Murphy. (2004) Drug-Eluting Stents: Some First-Generation Problems. The American Heart Hospital Journal 2:2, 80-84
CrossRef1432
Renu Virmani, Frank D. Kolodgie, Andrew Farb. (2004) Drug-Eluting Stents: Are They Really Safe?. The American Heart Hospital Journal 2:2, 85-88
CrossRef1433
Erick Schampaert, Eric A. Cohen, Michael Schlüter, François Reeves, Mouhieddin Traboulsi, Lawrence M. Title, Richard E. Kuntz, Jeffrey J. Popma. (2004) The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). Journal of the American College of Cardiology 43:6, 1110-1115
CrossRef1434
Ehtisham Mahmud, Shahin Keramati. (2004) highlights of the 2003 transcatheter cardiovascular therapeutics annual meeting: clinical implications. Journal of the American College of Cardiology 43:4, 684-690
CrossRef1435
Andrew J. Carter. (2004) TOR of the cell cycle: Are there important implications for diabetics in the era of the drug-eluting stent?. Catheterization and Cardiovascular Interventions 61:2, 233-236
CrossRef1436
Pedro A Lemos, Francesco Saia, Sjoerd H Hofma, Joost Daemen, Andrew T.L Ong, Chourmouzios A Arampatzis, Angela Hoye, Eugene McFadden, Georgios Sianos, Pieter C Smits, Willem J van der Giessen, Pim de Feyter, Ron T van Domburg, Patrick W Serruys. (2004) Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. Journal of the American College of Cardiology 43:4, 704-708
CrossRef1437
Dan Greenberg, Ameet Bakhai, David J Cohen. (2004) Can we afford to eliminate restenosis?. Journal of the American College of Cardiology 43:4, 513-518
CrossRef1438
Ian J. Sarembock. (2004) Stent restenosis and the use of drug-eluting stents in patients with diabetes mellitus. Current Diabetes Reports 4:1, 13-19
CrossRef1439
(2004) Sirolimus-Eluting Coronary Stents. New England Journal of Medicine 350:4, 413-414
Full Text1440
Stone, Gregg W., Ellis, Stephen G., Cox, David A., Hermiller, James, O'Shaughnessy, Charles, Mann, James Tift, Turco, Mark, Caputo, Ronald, Bergin, Patrick, Greenberg, Joel, Popma, Jeffrey J., Russell, Mary E., . (2004) A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease. New England Journal of Medicine 350:3, 221-231
Full Text1441
Harald Vik‐Mo, Rune Wiseth, Knut Hegbom. (2004) Coronary aneurysm after implantation of a paclitaxel‐eluting stent. Scandinavian Cardiovascular Journal 38:6, 349-352
CrossRef1442
Johannes M M Boots, Maarten H L Christiaans, Johannes P van Hooff. (2004) Effect of Immunosuppressive Agents on Long-Term Survival of Renal Transplant Recipients. Drugs 64:18, 2047-2073
CrossRef1443
S. Cattan, P. Michaud, O. Nallet, P. Allouch, R. Elmamoud, F. Leyer, R. Osman. (2004) Indication des stents actifs. Annales de Cardiologie et d Angéiologie 53:6, 335
CrossRef1444
Tadashi NONAKA, Tatsufumi NOMURA, Kazuhisa YOSHIFUJI. (2004) Stenting for Intracranial Atherosclerotic Stenosis with the Use of a Coronary Stent. Surgery for Cerebral Stroke 32:1, 25-31
CrossRef1445
Cynthia A. Yock, Paul G. Yock. (2004) The Drug-Eluting Stent Information Gap. The American Heart Hospital Journal 2:1, 21-25
CrossRef1446
Balram Bhargava, Ganesan Karthikeyan, Prabhakar Tripuraneni. (2004) Intravascular Brachytherapy. American Journal of Cardiovascular Drugs 4:6, 385-394
CrossRef1447
R. O. Feneck. (2003) Cardiac anaesthesia: the last 10 years. Anaesthesia 58:12, 1171-1177
CrossRef1448
Marks, Andrew R., . (2003) Sirolimus for the Prevention of In-Stent Restenosis in a Coronary Artery. New England Journal of Medicine 349:14, 1307-1309
Full Text1449
C SHIRODARIA. (2002) What's new in & Ischaemic heart disease and MI. Medicine 30:5, 1-4
CrossRef
- Letters
